export default 
[
  {
    "id": 2495,
    "bank": "clinicalMep",
    "title": "**Which of the following would you NOT be able to supply in instalments?**",
    "text": "A prescriber rings your pharmacy as they are due to start a new service for patients as part of a managed substance withdrawal clinic.\u00a0 He is keen to know what drugs he can prescribe for patients on an instalment basis as part of a withdrawal regimen.",
    "why": "Correct Answer: \r\n\r\nC. Chlordiazepoxide\r\n\r\nRationale:\r\n\r\nChlordiazepoxide is classified as a Schedule 4 Part I controlled drug (CD4(1)) under the Misuse of Drugs Regulations 2001.\r\nWhile technically, controlled drugs in Schedule 2, 3, and 4 Part I may be prescribed on an instalment basis, chlordiazepoxide is not suitable for instalment dispensing in clinical practice.\r\nChlordiazepoxide is prescribed for short-course alcohol withdrawal (typically 7\u201310 days) and does not require phased supervised dispensing like methadone or buprenorphine regimens do.\r\nInstalments are mainly used for long-term substance withdrawal programmes to promote compliance and reduce misuse, which does not apply to chlordiazepoxide's short-term use.\r\n\r\nThus, even though chlordiazepoxide is legally a controlled drug, it is not appropriate for instalment prescribing in practice.\r\n\r\nExplanation of other options:\r\n\r\nA. Buprenorphine:\r\n\r\nA Schedule 3 controlled drug widely used in opioid substitution therapy. Instalment prescribing is appropriate and commonly used to promote adherence and prevent diversion or misuse.\r\n\r\nB. Buprenorphine/naloxone combination:\r\n\r\nA Schedule 3 controlled drug used for opioid dependence treatment. Also suitable for instalment prescribing under supervised withdrawal frameworks.\r\n\r\nD. Diazepam:\r\n\r\nA Schedule 4 Part I controlled drug. Diazepam can be prescribed on an instalment basis during supervised withdrawal regimens for benzodiazepine dependence or drug detoxification.\r\n\r\nE. Methadone:\r\n\r\nA Schedule 2 controlled drug and the mainstay of opioid substitution therapy. Instalment dispensing is standard practice to maintain therapeutic levels, improve compliance, and minimise overdose risk.\r\n\r\nUnder the Misuse of Drugs Regulations 2001 and BNF guidance, instalment prescribing is allowed for controlled drugs in Schedule 2, 3, and 4 Part I, when clinically appropriate.\r\nMedicines like methadone, buprenorphine, buprenorphine/naloxone, and diazepam are commonly dispensed via instalments to support long-term withdrawal management.\r\nAlthough chlordiazepoxide is a Schedule 4 Part I controlled drug, it is not suitable for instalment prescribing because alcohol withdrawal regimens are short-term treatments that do not require phased supervised dispensing.\r\n\r\nPharmacists must ensure instalment prescriptions:\r\n\r\n- Specify the amount per instalment,\r\n\r\n- State the interval between instalments,\r\n\r\n- Use correct legally required wording (e.g., \"Dispense X amount on [specific dates]\").\r\n\r\n- Strict adherence to these requirements supports safe and effective management of withdrawal while remaining fully compliant with legal standards.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Buprenorphine",
        "answer_number": 1
      },
      {
        "text": "Buprenorphine/naloxone (combination product)",
        "answer_number": 2
      },
      {
        "text": "Chlordiazepoxide",
        "answer_number": 3
      },
      {
        "text": "Diazepam",
        "answer_number": 4
      },
      {
        "text": "Methadone",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2452,
    "bank": "clinicalTherapeutics",
    "title": "A 65-year-old woman with moderate Parkinson's disease has mild dysphagia and difficulty initiating swallowing. She was previously taking co-beneldopa (Madopar) capsules three times a day, but she finds them hard to swallow and sometimes they get stuck in her throat.",
    "text": "**Theme: Management of Parkinson's disease with swallowing difficulties or feeding tubes in situ**\r\n\r\n**For each of the following scenarios, select the best alternative medicine option from the list above. Each option may be used once, more than once or not at all.**",
    "why": "C. Co-beneldopa (Madopar) dispersible tablets\r\n\r\nRationale:\r\n\r\nFor a patient with Parkinson's disease and mild dysphagia, co-beneldopa dispersible tablets are the most appropriate option. These tablets can be dissolved in water, making them easier to swallow compared to capsules. They also provide a faster onset of action due to improved absorption.\r\n\r\nIn this scenario, the patient's difficulty initiating swallowing can be alleviated with the dispersible formulation while maintaining effective management of Parkinson's symptoms. Dose adjustments may be required as the dispersible formulation has higher bioavailability than capsules.\r\n\r\nExplanation of Other Options\r\n\r\nA. Apomorphine (APO-go) subcutaneous infusion\r\n\r\nApomorphine is typically reserved for patients with advanced Parkinson's disease experiencing severe motor fluctuations or when oral treatments fail. It is not indicated for patients with mild dysphagia and moderate Parkinson's disease as seen in this case.\r\n\r\nB. Co-beneldopa (Madopar) capsules\r\n\r\nCapsules are not suitable for patients who have difficulty swallowing, as they can cause discomfort or become lodged in the throat. This formulation does not address the patient's specific swallowing issue.\r\n\r\nD. Co-careldopa (Sinemet) controlled release tablets\r\n\r\nControlled-release tablets are harder to swallow due to their size and composition. They also have a slower onset of action, which may not align with the patient's needs for quicker symptom relief.\r\n\r\nE. Co-careldopa (Sinemet) standard release tablets\r\n\r\nAlthough effective for managing Parkinson's symptoms, standard-release tablets are not specifically designed for patients with swallowing difficulties, making them less practical in this scenario.\r\n\r\nF. Levodopa/carbidopa/entacapone (Stalevo) tablets\r\n\r\nStalevo is generally used when patients require additional symptom control beyond standard levodopa therapy. It is not suitable as an alternative to co-beneldopa for a patient with mild dysphagia due to its tablet form and added components.\r\n\r\nG. Ropinirole (Requip) tablets\r\n\r\nRopinirole is a dopamine agonist, typically prescribed in early Parkinson's disease or as an adjunct therapy. It is not an equivalent alternative to co-beneldopa for managing dysphagia.\r\n\r\nH. Rotigotine (Neupro) transdermal patch\r\n\r\nWhile rotigotine bypasses swallowing difficulties entirely, it is unnecessary in this case since the patient has a milder issue that can be resolved with a dispersible formulation. It is generally used in more severe cases or for those unable to take oral medications.\r\n\r\nPatients with Parkinson's disease and swallowing difficulties should have their medication tailored to their needs.\r\nDispersible formulations or liquid preparations are preferred for managing dysphagia.\r\nTransdermal dopamine agonists (e.g., rotigotine) may be considered for patients with severe swallowing issues or those who cannot tolerate oral medications.\r\n\r\nFor more information watch BNF lesson (Chapter 4) Central Nervous System:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Apomorphine (APO-go) subcutaneous infusion",
        "answer_number": 1
      },
      {
        "text": "Co-beneldopa (Madopar) capsules",
        "answer_number": 2
      },
      {
        "text": "Co-beneldopa (Madopar) dispersible tablets",
        "answer_number": 3
      },
      {
        "text": "Co-careldopa (Sinemet) controlled release tablets",
        "answer_number": 4
      },
      {
        "text": "Co-careldopa (Sinemet) standard release tablets",
        "answer_number": 5
      },
      {
        "text": "Levodopa/carbidopa/entacapone (Stalevo) tablets",
        "answer_number": 6
      },
      {
        "text": "Ropinirole (Requip) tablets",
        "answer_number": 7
      },
      {
        "text": "Rotigotine (Neupro) transdermal patch",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2490,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropiate disposal method for MST?**",
    "text": "The dog\u2019s owner has also brought in some of the old strength MST for suitable disposal.",
    "why": "D. Record in Patient\u2019s Controlled Drug return register and denature the medication in adequate time without a witness if necessary.\r\n\r\nRationale:\r\n\r\nAccording to the Medicines, Ethics, and Practice (MEP) guidelines, patient-returned Schedule 2 Controlled Drugs (such as MST, which contains morphine) must be denatured before disposal. These returns do not require an authorised witness (this is only mandatory for the disposal of expired stock from the pharmacy\u2019s Controlled Drug register).\r\n\r\nPatient returns should be recorded in the Patient\u2019s Controlled Drug Return register, and denaturing should be performed in a reasonable timeframe to prevent misuse. While it is ideal to have another staff member as a witness for transparency, this is not a legal requirement.\r\n\r\nWhy the Other Options Are Incorrect:\r\n\r\nA. Denature the medication straight away once you have contacted another pharmacist to witness the process.\r\nThis is incorrect. While it is good practice to have a witness when denaturing controlled drugs, it is not mandatory for patient-returned Schedule 2 CDs. Contacting another pharmacist unnecessarily delays the process.\r\n\r\nB. Dispose of it in the medicines bin immediately as patient-controlled drug returns do not require denaturing.\r\nThis is incorrect. Even though patient returns do not require an authorised witness, Schedule 2 CDs must still be denatured before disposal to prevent potential misuse.\r\n\r\nC. Record in Patient\u2019s Controlled Drug return register and contact another pharmacist to witness the denature.\r\nThis is incorrect. Although it is good practice to have another staff member as a witness, it is not a legal requirement. Requiring another pharmacist is unnecessary and may delay the disposal process.\r\n\r\nE. Record the return in the pharmacy\u2019s Controlled Drug register and denature the MST in adequate time.\r\nThis is incorrect because patient returns are recorded in the Patient\u2019s Controlled Drug Return register, not the pharmacy\u2019s Controlled Drug register. The latter is reserved for controlled drug stock held by the pharmacy.\r\n\r\nSummary:\r\n\r\nPatient returns of Schedule 2 Controlled Drugs, such as MST (morphine), must be denatured before disposal to ensure safety and prevent misuse. These returns are recorded in the Patient\u2019s Controlled Drug Return register and do not require an authorised witness for disposal. While it is good practice to have another staff member as a witness, this is not a legal requirement. Denaturing should occur in a timely manner, following proper protocols, and the denatured material should be disposed of in the appropriate pharmaceutical waste container.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Denature the medication straight away once you have contacted another pharmacist to witness the process.",
        "answer_number": 1
      },
      {
        "text": "Dispose it in the medicines bin immediately as patient controlled drug returns do not require denaturing.",
        "answer_number": 2
      },
      {
        "text": "Record in Patient\u2019s Controlled Drug return register and contact another pharmacist to witness the denature",
        "answer_number": 3
      },
      {
        "text": "Record in Patient\u2019s Controlled Drug return register and denature the medication in adequate time without a witness if necessary",
        "answer_number": 4
      },
      {
        "text": "Record the return in the pharmacy\u2019s Controlled Drug register and denature the MST in adequate time.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 987,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the correct dose for paracetamol 120mg/5mL oral suspension for the child?**",
    "text": "A mother presents to the pharmacy with her 2 year old son. Her son has chickenpox and would like to purchase paracetamol for his fever.",
    "why": "The recommended oral dose of paracetamol for children aged 2 to 3 years is 180 mg every 4 to 6 hours, with a maximum of 4 doses per day therefore 7.5mL QDS",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "2.5mL four times a day",
        "answer_number": 1
      },
      {
        "text": "5mL four times a day",
        "answer_number": 2
      },
      {
        "text": "7.5mL four times a day",
        "answer_number": 3
      },
      {
        "text": "10mL three times a day",
        "answer_number": 4
      },
      {
        "text": "10mL four times a day",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 986,
    "bank": "clinicalOtc",
    "title": "**After how long should eye drops be discarded?**",
    "text": "An 82 year old patient presents to the pharmacy and asks if she could use hypomellose eye drops she found in her cupboard for dry eyes.",
    "why": "The rationale is that hypomellose eye drops have a shelf life of 4 weeks after opening, according to the manufacturer's information leaflet\u00b2\u2074\u2075. This is to prevent the risk of microbial contamination and infection, which can be higher in older patients and those with dry eyes. Therefore, the patient should not use the eye drops she found in her cupboard if they have been opened for more than 4 weeks, or if they have passed the expiry date printed on the label",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "After the course is complete",
        "answer_number": 1
      },
      {
        "text": "1 week after opening",
        "answer_number": 2
      },
      {
        "text": "2 weeks after opening",
        "answer_number": 3
      },
      {
        "text": "4 weeks after opening",
        "answer_number": 4
      },
      {
        "text": "8 weeks after opening",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 993,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate product for her?**",
    "text": "A 50-year-old woman comes to your pharmacy with a complaint of vaginal itching and discharge. She says she has been experiencing these symptoms for the past two days and they are very uncomfortable. She has no other medical conditions or allergies. She is sexually active with one partner and uses condoms. She asks you to recommend something that can treat her condition, she prefers not to use topical preparations",
    "why": "Fluconazole is an antifungal agent that can be used to treat uncomplicated vulvovaginal candidiasis (thrush)\u00b2. It is a single-dose oral treatment that is effective and well-tolerated",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Clotrimazole 2% cream",
        "answer_number": 1
      },
      {
        "text": "Fluconazole 150 mg capsule",
        "answer_number": 2
      },
      {
        "text": "Metronidazole 400 mg tablets",
        "answer_number": 3
      },
      {
        "text": "Hydrocortisone 1% cream",
        "answer_number": 4
      },
      {
        "text": "Lactobacillus acidophilus capsules",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2503,
    "bank": "clinicalMep",
    "title": "**Which one of the following is INCORRECT regarding the sale and supply of codeine based medication?**",
    "text": "There has been tighter controls of over the counter medicines containing codeine",
    "why": "d) Pack sizes containing 48 unit doses are licensed as a pharmacy medicine.\r\n\r\nRationale\r\n\r\nThe maximum pack size for codeine-containing medicines classified as pharmacy (P) medicines is 32 unit doses. A pack containing 48 unit doses exceeds this limit and would not qualify as a pharmacy medicine. Larger pack sizes are classified as prescription-only medicines (POM) to help mitigate the risks of misuse and dependency associated with codeine.\r\n\r\nExplanation of the Other Options\r\n\r\na) Codeine-containing medications are licensed for short-term acute and moderate pain.\r\n\r\nThis is correct. Codeine-containing OTC medicines are indicated for short-term acute moderate pain when alternative pain relief, such as paracetamol or ibuprofen, alone is insufficient.\r\n\r\nb) Codeine-containing medicine is licensed for 3 days' use only.\r\n\r\nThis is correct. The use of codeine-containing medicines is limited to 3 days, and longer use increases the risk of addiction and dependence.\r\n\r\nc) Indications for cold and flu have been removed.\r\n\r\nThis is correct. Licences for OTC codeine have removed indications such as cold and flu symptoms because evidence suggests they do not provide significant relief for these conditions while posing a risk of addiction.\r\n\r\ne) The warning \"Can cause addiction\" must be prominently displayed on the packaging.\r\n\r\nThis is correct. Labelling regulations require all OTC medicines containing codeine to display a clear and prominent addiction warning to inform patients of the risks of misuse.\r\n\r\nCodeine-containing OTC medicines are tightly controlled to reduce the risks of dependency and misuse. These products are only approved for short-term acute moderate pain relief, with a usage limit of 3 days. Indications for less severe conditions like cold and flu have been removed, and the maximum pack size for pharmacy medicines is 32 unit doses. Larger pack sizes are classified as prescription-only medicines. Packaging must include warnings to inform patients about the potential for addiction. Pharmacists are responsible for providing counselling to ensure safe and appropriate use.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Codeine containing medications is licensed for short term acute and moderate pain",
        "answer_number": 1
      },
      {
        "text": "Codeine containing medicine is licensed for 3 days use only",
        "answer_number": 2
      },
      {
        "text": "Indications for cold and flu have been removed",
        "answer_number": 3
      },
      {
        "text": "Pack sizes containing 48 unit doses is licensed as a pharmacy medicine",
        "answer_number": 4
      },
      {
        "text": "The warning \"can cause addiction\" must be prominently displayed on the packaging",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2499,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT correct regarding the classification of medicines?**",
    "text": "The Human Medicines Regulations 2012 regulates the authorisation, sale and supply of medicinal products for human use.",
    "why": "d) Pharmacy medicines can only be sold by the responsible pharmacist.\r\n\r\nRationale\r\n\r\nPharmacy (P) medicines do not need to be sold exclusively by the responsible pharmacist. They can be sold by appropriately trained pharmacy staff (e.g., pharmacy assistants or dispensers with qualifications such as NVQ Level 2 or equivalent) under the supervision of the responsible pharmacist. This ensures safe and appropriate supply while allowing the pharmacist to oversee other duties within the pharmacy.\r\n\r\nExplanation of the Other Options\r\n\r\na) General sale medicines are self-selection of medicines in registered pharmacies.\r\n\r\nThis is correct. General Sale List (GSL) medicines are available for self-selection in registered pharmacies and other approved retail outlets.\r\n\r\nb) General sale medicines can be sold in retail outlets.\r\n\r\nThis is correct. GSL medicines can be sold outside of pharmacies in general retail outlets such as supermarkets, provided the packaging remains intact, and the sale complies with relevant regulations.\r\n\r\nc) General sale medicines can be sold whilst the responsible pharmacist is physically absent for a limited time period whilst remaining responsible.\r\n\r\nThis is correct. GSL medicines can be sold in a registered pharmacy even when the responsible pharmacist is temporarily absent, provided appropriate procedures are in place.\r\n\r\nd) Pharmacy medicines can only be sold by the responsible pharmacist.\r\n\r\nThis is incorrect. Pharmacy medicines can be sold by trained pharmacy staff under the supervision of the responsible pharmacist. The responsible pharmacist does not need to sell them personally.\r\n\r\ne) Pharmacy medicines must not be accessible for self-selection.\r\n\r\nThis is correct. Pharmacy (P) medicines must not be openly accessible for customers to select themselves. They must be stored in a manner that requires staff intervention to supply them.\r\n\r\nKey Points About the Classification of Medicines\r\n\r\nGeneral Sale List (GSL) Medicines:\r\n\r\nCan be sold in retail outlets, including supermarkets, and are available for self-selection.\r\nMay also be sold in pharmacies even in the temporary absence of the responsible pharmacist.\r\nPharmacy (P) Medicines:\r\n\r\nOnly available in registered pharmacies.\r\nMust be supplied under the supervision of the responsible pharmacist.\r\nCannot be self-selected by customers and must be stored behind the counter or in a restricted area.\r\nPrescription Only Medicines (POMs):\r\n\r\nRequire a valid prescription for supply.\r\nMust be dispensed by a pharmacist or under their direct supervision.\r\n\r\nThe Human Medicines Regulations 2012 define the rules for classifying and selling medicines to ensure safe and appropriate supply. General Sale List (GSL) medicines can be sold in retail outlets or pharmacies and are available for self-selection. Pharmacy (P) medicines, however, require supervision by the responsible pharmacist but can be supplied by trained staff, ensuring compliance without requiring the pharmacist to sell them personally. Clear differentiation between GSL, P, and Prescription Only Medicines (POMs) is essential for maintaining patient safety and adherence to legal requirements.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "General sale medicines are self selection of medicines in registered pharmacies",
        "answer_number": 1
      },
      {
        "text": "General sale medicines can be sold in retail outlets",
        "answer_number": 2
      },
      {
        "text": "General sale medicines can be sold whilst the responsible pharmacist is physically absent for a limited time period whilst remaining responsible",
        "answer_number": 3
      },
      {
        "text": "Pharmacy medicines can only be sold by the responsible pharmacist",
        "answer_number": 4
      },
      {
        "text": "Pharmacy medicines must not be accessible for self selection",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2262,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is the most suitable drug to recommend?**",
    "text": "A patient who presents to hospital with a three-month history of feeling chronically tired.\u00a0 He has been feeling sick for the last week and is pale in colour.\u00a0The medical team order haematinics, which come back as follows:\u00a0\r\n\r\nHaemoglobin. 110 g/L (130 \u2013 170 g/L)\r\nMCV 112 fL (80-99 fL)\r\nMCH 36 pg (27-32 pg)\r\nFerritin 50 ng/L (20-200 ng/L)\r\nFolate 4 ng/L (3-13 ng/L)\r\nB12 97 ng/L (200-800 ng/L)\r\n\r\nThe doctor looking after the patient asks for your advice as to an appropriate treatment for the condition.",
    "why": "Correct Answer:\r\n\r\nE) Hydroxocobalamin\r\n\r\nRationale:\r\n\r\nThe patient's blood test results indicate macrocytic anaemia, as seen by the elevated mean corpuscular volume (MCV) of 112 fL (reference range: 80\u201399 fL) and low haemoglobin of 110 g/L (reference range: 130\u2013170 g/L).\r\n\r\nThe likely cause is vitamin B12 deficiency, as the patient's B12 level is critically low at 97 ng/L (reference range: 200\u2013800 ng/L). The most appropriate treatment is hydroxocobalamin, the preferred first-line therapy for vitamin B12 deficiency in the UK.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Cyanocobalamin \r\n\r\nWhile cyanocobalamin is an oral form of vitamin B12, it is not recommended for patients with severe deficiency, neurological symptoms, or suspected malabsorption.\r\nNICE recommends hydroxocobalamin as the first-line treatment.\r\n\r\n(B) Epoetin alfa \r\n\r\nEpoetin alfa (erythropoiesis-stimulating agent) is used in anaemia of chronic kidney disease (CKD) or chemotherapy-induced anaemia, not in vitamin B12 deficiency.\r\n\r\n(C) Ferrous sulfate \r\n\r\nUsed for iron-deficiency anaemia, but this patient has normal ferritin levels (50 ng/L), ruling out iron deficiency.\r\n\r\n(D) Folic acid \r\n\r\nThe patient has a low folate level (4 ng/L; reference range 3\u201313 ng/L), but the B12 deficiency must be corrected first, as giving folic acid alone can worsen neurological complications in B12 deficiency.\r\nOnce B12 levels are replenished, folic acid supplementation may be considered.\r\n\r\n\r\nVitamin B12 Deficiency \r\n\r\nVitamin B12 deficiency causes macrocytic anaemia and, if untreated, can lead to neurological complications (e.g., peripheral neuropathy, cognitive impairment, and subacute combined degeneration of the spinal cord).\r\n\r\nNICE recommends the following treatment:\r\n\r\n- First-line therapy: Hydroxocobalamin IM 1 mg three times weekly for two weeks.\r\n\r\n- Maintenance therapy:\r\n\r\n- For pernicious anaemia: 1 mg IM every three months for life.\r\n\r\n- For dietary B12 deficiency (e.g., vegan diet): Oral cyanocobalamin 50\u2013150 mcg daily can be considered.\r\n\r\n- Folic acid replacement should follow after B12 correction if folate levels are also low.\r\n\r\nFor more information, please watch BNF lesson Chapter 9 (Nutrition and Blood):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Cyanocobalamin",
        "answer_number": 1
      },
      {
        "text": "Epoetin alfa",
        "answer_number": 2
      },
      {
        "text": "Ferrous sulfate",
        "answer_number": 3
      },
      {
        "text": "Folic acid",
        "answer_number": 4
      },
      {
        "text": "Hydroxocobalamin",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2290,
    "bank": "clinicalTherapeutics",
    "title": "Mrs W presents a prescription for her 3-year-old son who has just had an appointment with his family doctor. She tells you he has been complaining of earache for the past three days and that the doctor who examined him has said that he has an inflamed left ear. The prescription you receive is for Otomize\u00ae ear spray.",
    "text": "**Theme: Eye, ear, nose and oropharynx\r\n\r\n\r\n\r\n**For each of the following scenarios select the dose that best corresponds to the counselling required to be given for an initial dose of the products mentioned. Each option may be used once, more than once or not all.**",
    "why": "1 spray TDS\r\n\r\nRationale:\r\n\r\nOtomize\u00ae ear spray is a topical treatment used for acute otitis externa (outer ear infection), which presents with ear pain, inflammation, and possible discharge. It contains:\r\n\r\nDexamethasone (a corticosteroid to reduce inflammation)\r\nNeomycin (an aminoglycoside antibiotic to treat bacterial infections)\r\nAcetic acid (which creates an acidic environment to inhibit bacterial and fungal growth)\r\n\r\nThe standard dosing for Otomize ear spray is:\r\n\r\n1 spray into the affected ear TDS (three times daily).\r\nTreatment should continue for at least 7 days but no longer than 10 days.\r\nThe patient should shake the bottle before use and avoid water exposure in the affected ear during treatment.\r\nThus, the correct initial dose is 1 spray TDS.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 1 drop TDS\r\n\r\nIncorrect; Otomize is an ear spray, not ear drops.\r\n\r\nB: 1 drop QDS\r\n\r\nIncorrect; Otomize is not given four times daily; the standard regimen is TDS.\r\n\r\nC: 1 drop every 2 hours\r\n\r\nIncorrect; this frequency is too high and is not required for Otomize.\r\n\r\nD: 2 drops BD\r\n\r\nIncorrect; Otomize is sprayed, not dropped, and BD dosing is insufficient.\r\n\r\nE: 1 spray OD\r\n\r\nIncorrect; once daily application is too infrequent for effective bacterial eradication.\r\n\r\nG: 6 drops OD\r\n\r\nIncorrect; Otomize is a spray, and once-daily dosing is not appropriate.\r\n\r\nH: 7 drops BD\r\n\r\nIncorrect; drops are not the correct formulation, and BD is not the standard dosing frequency.\r\n\r\nOtitis Externa\r\n\r\nAccording to NICE guidelines (2025) and BNF recommendations, the treatment of acute otitis externa includes:\r\n\r\nFirst-line treatment:\r\n\r\nTopical antibiotic-corticosteroid ear spray (e.g., Otomize\u00ae) \u2013 1 spray TDS for 7\u201310 days.\r\nAcetic acid 2% ear drops may be used for mild cases.\r\n\r\nAdditional counselling:\r\n\r\nKeep the ear dry \u2013 avoid swimming and excessive water exposure.\r\nDo not use cotton buds, as they can worsen irritation.\r\nReferral criteria:\r\n\r\nIf symptoms persist beyond 7\u201310 days despite treatment.\r\nIf the infection is spreading beyond the ear canal.\r\nIf the patient has fever, severe pain, or facial swelling (indicating a possible deep infection or cellulitis).\r\n\r\nFor more information please watch BNF Lesson ( Chapter 12) ENT:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 6,
    "weighting": 3,
    "answers": [
      {
        "text": "1 drop TDS",
        "answer_number": 1
      },
      {
        "text": "1 drop QDS",
        "answer_number": 2
      },
      {
        "text": "1 drop every 2 hours",
        "answer_number": 3
      },
      {
        "text": "2 drops BD",
        "answer_number": 4
      },
      {
        "text": "1 spray OD",
        "answer_number": 5
      },
      {
        "text": "1 spray TDS",
        "answer_number": 6
      },
      {
        "text": "6 drops OD",
        "answer_number": 7
      },
      {
        "text": "7 drops BD",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2483,
    "bank": "clinicalMep",
    "title": "**In which of the following situations is the concept of whistleblowing most appropriate?**",
    "text": "whistleblowing concerns  help to improve NHS services for patients and the working environment for staff.",
    "why": "D. Being witness to a culture of bullying within the organisation.\r\n\r\nRationale:\r\n\r\nWhistleblowing involves raising concerns about serious wrongdoing or risks within an organisation that affect patient care, staff wellbeing, or public safety. NHS staff are encouraged to report incidents such as:\r\n\r\nUnsafe practices or care that could harm patients.\r\nA culture of bullying or harassment.\r\nFraud or financial malpractice.\r\nBreaches of confidentiality or laws.\r\nA culture of bullying can negatively impact staff morale, retention, and the quality of patient care, making it a legitimate and serious concern for whistleblowing.\r\n\r\nWhy the Other Options Are Incorrect:\r\n\r\nA. A member of staff who consistently turns up late to work.\r\nThis issue is related to individual performance and should be addressed through standard HR processes, not whistleblowing.\r\n\r\nB. An organisational restructure that has put your job at risk.\r\nConcerns about job security during a restructure should be raised through internal channels like unions or grievance processes, not whistleblowing.\r\n\r\nC. A patient who complains about receiving generic atorvastatin tablets.\r\nA patient\u2019s complaint regarding generic medication substitution is a common and individual concern. It does not meet the threshold for whistleblowing, which addresses systemic or organisational issues.\r\n\r\nE. Hearing two colleagues at work gossiping about another colleague.\r\nWorkplace gossip, while unprofessional, is not typically serious enough to warrant whistleblowing. Such issues should be resolved informally or through workplace conduct policies.\r\n\r\nWhistleblowing addresses serious organisational issues that can affect patient safety, staff wellbeing, or public confidence in NHS services. Witnessing a culture of bullying is a valid reason for whistleblowing, as it can harm employees and compromise the quality of care. NHS guidelines and policies encourage staff to report such concerns in a safe and supported manner. For other matters like lateness, job insecurity, or unprofessional behaviour, appropriate alternative routes such as HR or management intervention should be used.\r\n\r\nFor more information watch MEP lesson Chapter 5 (Appendices):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep\r\n\r\nFor more information on the topic also watch: \r\n\r\nhttps://improvement.nhs.uk/uploads/documents/whistleblowing_policy_final.pdf",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "A member of staff who consistently turns up late to work",
        "answer_number": 1
      },
      {
        "text": "An organisational restructure that has put your job at risk",
        "answer_number": 2
      },
      {
        "text": "A patient who complains about receiving generic atorvastatin tablets",
        "answer_number": 3
      },
      {
        "text": "Being witness to a culture of bullying within the organisation**",
        "answer_number": 4
      },
      {
        "text": "Hearing two colleagues at work gossiping about another colleague",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2423,
    "bank": "clinicalTherapeutics",
    "title": "A patient with cancer and chemotherapy-induced anaemia (haemoglobin 9.5 g/dL) who is receiving platinum-based chemotherapy.",
    "text": "**Theme: Most suitable dose of epoetin alpha**\r\n\r\n\r\n**Instruction: For each scenario, select the most suitable dose of epoetin alpha from the list of answer options. Each option may be used once, more than once or not at all.**\u2028\u2028The sPmC for Eprex has been provided for you.\u2028[SmPC for Eprex](https://www.medicines.org.uk/emc/product/3442/smpc#gref)",
    "why": "450 IU/kg once weekly\r\n\r\nRationale:\r\n\r\nFor a patient with cancer and chemotherapy-induced anaemia (haemoglobin 9.5 g/dL) who is receiving platinum-based chemotherapy, the SmPC for Eprex recommends the following dose:\r\n\r\nStarting dose: 450 IU/kg once weekly.\r\nIndication: This dosing regimen is aimed at managing anaemia in patients undergoing chemotherapy, with a haemoglobin level of 9.5 g/dL.\r\nEpoetin alpha, a recombinant erythropoietin, stimulates red blood cell production in patients with anaemia, particularly in those undergoing chemotherapy. Starting at a dose of 450 IU/kg weekly provides an adequate boost to erythropoiesis without overtly increasing the risk of adverse effects, such as thromboembolism, which is a concern in cancer patients.\r\n\r\nExplanation of Other Options:\r\n\r\n50 IU/kg twice weekly\r\n\r\nThis dose is lower than the recommended starting dose for chemotherapy-induced anaemia. While it could still be used in certain patients, 450 IU/kg once weekly is more appropriate for patients undergoing platinum-based chemotherapy with haemoglobin around 9.5 g/dL.\r\n\r\n50 IU/kg three times a week\r\n\r\nThis dosing is also too low for the initial treatment of chemotherapy-induced anaemia in this case. The recommended dose for this scenario is 450 IU/kg once weekly, which provides more consistent efficacy in boosting haemoglobin.\r\n\r\n75 IU/kg three times weekly\r\n\r\n75 IU/kg three times weekly could be considered for some patients, but it is still below the recommended starting dose. For platinum-based chemotherapy patients with anaemia, the more suitable dose would be 450 IU/kg once weekly to ensure proper management of anaemia.\r\n\r\n100 IU/kg once weekly\r\n\r\nThe dose of 100 IU/kg once weekly is still too low for this patient population. 450 IU/kg once weekly provides a higher initial dose, which is more effective for managing chemotherapy-induced anaemia.\r\n\r\n150 IU/kg once every two weeks\r\n\r\nThis dose is too infrequent for the management of chemotherapy-induced anaemia. Epoetin alpha should be administered at least once a week to maintain effective stimulation of erythropoiesis. The recommended dose of 450 IU/kg once weekly would be more suitable for this patient.\r\n\r\n300 IU/kg once every four weeks\r\n\r\nThis dosing frequency is too spaced out for effective management of chemotherapy-induced anaemia. The starting dose should be administered more frequently, at 450 IU/kg once weekly.\r\n\r\n600 IU/kg once weekly\r\n\r\nThis dose is higher than the recommended starting dose. While higher doses may be used in some patients with more severe anaemia or insufficient response to standard doses, it is not the preferred starting dose in most cases. 450 IU/kg once weekly is the standard starting dose.\r\n\r\nMonitoring: Patients on epoetin alpha should be monitored for blood pressure, as erythropoiesis-stimulating agents (ESAs) can increase the risk of hypertension. Additionally, haemoglobin levels should be checked regularly to avoid overcorrection, which can lead to complications such as thromboembolic events.\r\n\r\nDuration of Use: Epoetin alpha therapy is usually continued until the patient's haemoglobin reaches a stable level. If there is no improvement after several weeks of therapy, the dose may be adjusted.\r\n\r\nNICE recommends the use of epoetin alpha for the treatment of chemotherapy-induced anaemia when haemoglobin levels fall below 10 g/dL, particularly for patients receiving platinum-based chemotherapy.\r\n\r\nFor more information watch BNF lesson Chapter 9 (Blood and Nutrition):\r\n\r\nhttps://preregshortcuts.com/preview-question/2432",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "50 IU/kg twice weekly",
        "answer_number": 1
      },
      {
        "text": "50 IU/kg three times a week.",
        "answer_number": 2
      },
      {
        "text": "75 IU/kg three times weekly",
        "answer_number": 3
      },
      {
        "text": "100 IU/kg once weekly",
        "answer_number": 4
      },
      {
        "text": "150 IU/kg once every two weeks",
        "answer_number": 5
      },
      {
        "text": "300 IU/kg once every four weeks",
        "answer_number": 6
      },
      {
        "text": "450 IU/kg once weekly",
        "answer_number": 7
      },
      {
        "text": "600 IU/kg once weekly",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2484,
    "bank": "clinicalMep",
    "title": "**Which of the following courses of action is the most appropriate?**",
    "text": "Miss A, who is visiting the UK from Malta where she was given a private prescription from her family doctor. Miss A presents the prescription to your chemist on 28/04/17 and tells you that she is \u2018scared of flying\u2019 and needs to take the medication prior to her journey home.\r\n\r\nYou contact Miss A\u2019s surgery in Malta and are assured the prescription is genuine. You also confirm that she has no known allergies or any significant medical conditions.\r\n\u00a0\r\n![Screenshot-2024-01-08-at-10-23-17](https://i.ibb.co/C57NqHg/Screenshot-2024-01-08-at-10-23-17.png)",
    "why": "D. You dispense the script and make a record in the prescription register.\r\n\r\nRationale:\r\n\r\nUnder The Human Medicines Regulations 2012, prescriptions written by a doctor from an EEA (European Economic Area) country, such as Malta, are legally valid in the UK, provided they meet all legal requirements. Diazepam is a Schedule 4 Controlled Drug (CD), and while Schedule 4 CDs are subject to specific regulations, they can be prescribed by an EEA healthcare professional.\r\n\r\nFor private prescriptions, a record of the supply must be made in the private prescription register, and all standard prescription requirements must be met, including:\r\n\r\nPatient details (full name, address, and date of birth).\r\nPrescriber details (name, professional address, qualification, and signature).\r\nMedicine details (name, strength, formulation, dose, and quantity).\r\nDate of issue.\r\n\r\nWhy the Other Options Are Incorrect:\r\n\r\nA. You cannot dispense the prescription as it is missing some legal parameters.\r\nThis is incorrect as the scenario does not indicate that the prescription is incomplete. It is stated that the prescription is valid and meets all legal requirements.\r\n\r\nB. You cannot dispense the script as Malta is not in the EEA.\r\nMalta is part of the EEA, and prescriptions from EEA healthcare professionals are legally valid in the UK when requirements are met.\r\n\r\nC. You cannot dispense the script as diazepam is a controlled drug.\r\nDiazepam, a Schedule 4 CD, can be dispensed on an EEA prescription. Unlike Schedule 2 and 3 CDs, it does not require additional CD requisition or register documentation for supply in this scenario.\r\n\r\nE. You dispense the script and make a record in the controlled drugs register.\r\nWhile Schedule 4 CDs like diazepam are controlled, they do not require an entry in the controlled drugs register. A record in the private prescription register is sufficient.\r\n\r\nDiazepam is a Schedule 4 Controlled Drug that can be legally dispensed on an EEA prescription if all requirements are met. The pharmacist must record the supply in the private prescription register, ensuring all details are correctly documented. Unlike Schedule 2 or 3 CDs, there is no requirement for entry in the controlled drugs register or for additional witness procedures. Pharmacists must be diligent in verifying the authenticity of the prescription, especially when issued from another country.\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "You cannot dispense the prescription as it is missing some legal parameters",
        "answer_number": 1
      },
      {
        "text": "You cannot dispense the script as Malta is not in the EAA",
        "answer_number": 2
      },
      {
        "text": "You cannot dispense the script as diazepam is a controlled drug",
        "answer_number": 3
      },
      {
        "text": "You dispense the script and make a record in the prescription register",
        "answer_number": 4
      },
      {
        "text": "You dispense the script and make a record in the controlled drugs register",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2529,
    "bank": "clinicalMep",
    "title": "**What is the maximum number of days you can supply?**",
    "text": "A 32 year old male patient presents to your pharmacy explaining he is away from home and requires an emergency supply of co-codamol 30/500mg tablets.. After checking the Summary Care Record, you determine the request is valid.",
    "why": "B) 5 days\r\n\r\nRationale: \r\n\r\nWhen supplying a controlled drug (CD) under an emergency supply, the maximum quantity that can be provided is dependent on the schedule of the medication and the specific legal requirements set out in the Human Medicines Regulations 2012, as amended. For Schedule 5 controlled drugs, such as co-codamol 30/500mg (which contains codeine phosphate), you can only provide a maximum of 5 days' worth of treatment under an emergency supply.\r\n\r\nEmergency supply regulations (Regulation 225) dictate that, for Schedule 5 CDs, the quantity supplied should be no more than a 5-day supply. If a patient requires more than 5 days' worth, they must have a prescription issued from a registered prescriber.\r\nOther Options:\r\n\r\nA) 3 days: This is not correct as the maximum supply for a Schedule 5 controlled drug is 5 days, not 3 days. A 3-day supply could apply to other medications or different emergency supply situations, but not for Schedule 5 controlled drugs.\r\n\r\nC) 7 days: This is incorrect. A 7-day supply could be applicable for some medications, such as non-controlled drugs under emergency supply regulations, but for Schedule 5 controlled drugs, the limit is 5 days.\r\n\r\nD) 28 days: This is not appropriate for controlled drugs. A 28-day supply is typically seen for other prescriptions like regular, non-controlled medications or repeat prescriptions, but controlled drugs like co-codamol 30/500mg are strictly regulated.\r\n\r\nE) 30 days: Similarly, a 30-day supply is far beyond the legal limit for controlled drugs under emergency supply provisions, especially for Schedule 5 drugs. This would be more appropriate for chronic conditions but not for controlled drugs like co-codamol.\r\n\r\nUnder Regulation 225 of the Human Medicines Regulations 2012, the maximum supply for a Schedule 5 controlled drug, such as co-codamol 30/500mg, can only be up to 5 days in an emergency situation. This regulation ensures that while emergency supplies can be made to prevent harm to the patient, there is a limit on how much controlled substance can be dispensed without a prescription. Beyond 5 days, a prescription is required to comply with legal standards and patient safety.\r\n\r\nThis guideline is essential for pharmacy practice to ensure that controlled drugs are handled appropriately and within the constraints of the law, safeguarding both the patient and the pharmacy.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "3",
        "answer_number": 1
      },
      {
        "text": "5",
        "answer_number": 2
      },
      {
        "text": "7",
        "answer_number": 3
      },
      {
        "text": "28",
        "answer_number": 4
      },
      {
        "text": "30",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2579,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the patient's symptoms?**",
    "text": "A 57 year old female patient presents to the pharmacy with a rash on her face.\r\nA picture of the patient\u2019s rash is presented below:\u00a0![rosacea](https://i.ibb.co/pdWh4sT/rosacea.jpg \"500x500\")",
    "why": "e) Rosacea\r\n\r\nRationale:\r\n\r\nRosacea is the most likely diagnosis based on the patient\u2019s symptoms and the location of the rash. Rosacea typically presents on the face, often affecting the cheeks, nose, chin, and forehead, with persistent redness, visible blood vessels (telangiectasia), and sometimes pustules or bumps. This condition is more common in adults over the age of 30 and is particularly seen in fair-skinned individuals. Triggers such as sun exposure, stress, alcohol, and spicy foods often worsen symptoms.\r\n\r\nExplanation of Options\r\n\r\na) Atopic eczema\r\n\r\nAlthough atopic eczema can affect the face, it commonly presents with intense itching, redness, and dry patches, usually in children and often associated with a history of allergies or asthma. Eczema is also more prevalent in flexural areas, such as the inner elbows and knees, making it less likely in this case.\r\n\r\nb) Acne vulgaris\r\n\r\nAcne vulgaris primarily occurs in adolescents and young adults, presenting with comedones (blackheads and whiteheads), pustules, and occasionally cysts on the face, back, and chest. The absence of comedones and the patient's age make acne vulgaris an unlikely diagnosis here.\r\n\r\nc) Pityriasis versicolour\r\n\r\nPityriasis versicolour is a fungal infection that presents as small, flaky, discoloured patches, usually on the trunk, shoulders, and back. It is uncommon on the face and typically does not present as persistent redness with visible blood vessels, as seen in rosacea.\r\n\r\nd) Psoriasis\r\n\r\nPsoriasis is a chronic skin condition that commonly affects extensor surfaces like the elbows, knees, and scalp, presenting with well-defined, scaly plaques. While it can affect the face, facial psoriasis is rare, and it typically presents differently from rosacea.\r\n\r\n\r\nRosacea is a chronic inflammatory skin condition primarily affecting the face. According to NICE guidelines, initial management focuses on identifying and avoiding known triggers, such as sun exposure, hot beverages, spicy foods, and alcohol, which can exacerbate symptoms. Topical treatments, including metronidazole and azelaic acid, are often recommended for mild to moderate cases to reduce inflammation and redness.\r\n\r\nFor more severe cases, NICE advises oral treatments, such as doxycycline, especially if pustules or papules are present. Skincare recommendations include gentle cleansers and moisturisers to protect the skin barrier, as well as daily use of a high-SPF sunscreen to minimise UV-triggered flares. Laser therapy may be considered in cases with persistent visible blood vessels. Education on the chronic nature of rosacea, proper skincare, and adherence to treatment plans is important to help manage symptoms and improve quality of life.\r\n\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Atopic eczema",
        "answer_number": 1
      },
      {
        "text": "Acne vulgaris",
        "answer_number": 2
      },
      {
        "text": "Pityriasis versicolor",
        "answer_number": 3
      },
      {
        "text": "Psoriasis",
        "answer_number": 4
      },
      {
        "text": "Rosacea",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2574,
    "bank": "clinicalOtc",
    "title": "**How many grams of permethrin cream would you need to supply?**",
    "text": "A parent comes in to your pharmacy and tells you that some of her family has contracted scabies. She wishes to buy some permethrin 5%w/v cream which was recommended to her. You question her further and find she is looking for treatment of a 2 year old, a 4 year old, one 9 year old and an adult who is a normal size.\u00a0\r\nThe SmPC for permethrin has been provided for this question. \r\n[SmPC for Permethrin](https://www.medicines.org.uk/emc/product/6540/smpc#gref)",
    "why": "b) 60 grams\r\n\r\nRationale:\r\n\r\nThe Summary of Product Characteristics (SmPC) for permethrin 5% w/v cream provides specific guidance on the amount required by age group for treating scabies:\r\n\r\n2-year-old: 7.5 grams\r\n4-year-old: 7.5 grams\r\n9-year-old: 15 grams\r\nAdult: 30 grams\r\nAdding these quantities results in a total requirement of 60 grams. Therefore, 60 grams of permethrin cream should be supplied for the treatment of this family.\r\n\r\nExplanation of Other Options:\r\n\r\na) 30 grams: This amount would be insufficient for the entire family, covering only the adult treatment.\r\nc) 75 grams: While slightly over the requirement, this is more than needed according to the SmPC.\r\nd) 120 grams: This exceeds the calculated amount by double, making it unnecessary and wasteful.\r\ne) 150 grams: This is even more excessive, given the specific amounts needed for effective treatment.\r\n\r\n\r\nScabies is a contagious skin condition caused by the Sarcoptes scabiei mite, resulting in intense itching and a pimple-like rash. Permethrin 5% w/v cream is the first-line treatment recommended by NICE for scabies due to its high efficacy and safety profile.\r\n\r\nApplication: Apply the cream to the entire body, including under the nails, avoiding the face and eyes. Leave it on for 8\u201312 hours (usually overnight).\r\nDosage by Age: NICE guidelines and the SmPC specify age-adjusted quantities, as seen in the posology table provided in the SmPC. These quantities help ensure complete coverage and effectiveness.\r\n\r\nRepeat Treatment: Treatment should be repeated after 7 days to eliminate any newly hatched mites.\r\nClose Contacts: All close contacts should be treated simultaneously to prevent re-infestation, even if they show no symptoms.\r\nRegular monitoring for symptom improvement and educating patients on the importance of applying the cream thoroughly is essential to achieving effective treatment outcomes.\r\n\r\nFor more information please watch OTC lesson chapter 5 (Infestations):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "30 grams",
        "answer_number": 1
      },
      {
        "text": "60 grams",
        "answer_number": 2
      },
      {
        "text": "75 grams",
        "answer_number": 3
      },
      {
        "text": "120 grams",
        "answer_number": 4
      },
      {
        "text": "150 grams",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2605,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the LEAST appropriate advice?**",
    "text": "A 33 year old female patient presents to the pharmacy with irritable bowel syndrome. She would like some dietary and lifestyle advice.",
    "why": "The least appropriate advice for the patient is:\r\n\r\nEat 5 portions of fruit per day, each portion should be 80g.\r\n\r\nRationale:\r\n\r\nWhile a balanced diet is important for overall health, individuals with irritable bowel syndrome (IBS) should be cautious with their fruit intake. Eating too much fruit, especially certain types, can exacerbate IBS symptoms like bloating, gas, and diarrhoea due to the fructose content. NICE guidelines recommend that patients with IBS limit their fruit intake to no more than 3 portions per day, as excess fruit consumption may worsen symptoms.\r\n\r\nAvoid missing meals or leaving long gaps between meals is appropriate advice, as regular meals can help regulate bowel function and reduce IBS flare-ups.\r\nEnsure adequate hydration by drinking at least 8 cups of fluid per day is essential for maintaining digestive health and preventing constipation, a common symptom in IBS.\r\nIf suffering from diarrhoea, avoid sorbitol due to its laxative properties is also appropriate advice, as sorbitol, a sugar alcohol found in some fruits and sugar-free products, can aggravate diarrhoea in IBS patients.\r\nReduce intake of alcohol and fizzy drinks is recommended because both can trigger or worsen IBS symptoms.\r\n\r\nNICE Guidance on Dietary and Lifestyle Management for IBS\r\n\r\nNICE guidelines suggest the following strategies for managing IBS through diet and lifestyle:\r\n\r\nRegular Eating Patterns: Patients should be advised to eat meals at regular intervals and avoid skipping meals, as consistent eating patterns can help regulate bowel habits.\r\n\r\nHydration: Drinking plenty of water, at least 8 cups a day, is important, especially for those experiencing constipation. However, caffeine intake should be limited to avoid exacerbating symptoms.\r\n\r\nFruit and Fibre Intake: Patients should limit fruit consumption to no more than 3 portions per day and may need to experiment with soluble fibre (e.g., oats, linseeds) while reducing insoluble fibre (e.g., bran) to identify what works best for their symptoms.\r\n\r\nAvoiding Common Triggers: Alcohol, fizzy drinks, and foods containing sorbitol or other artificial sweeteners should be limited or avoided, especially in patients who experience diarrhoea as part of their symptoms.\r\n\r\nAdditional Insights\r\n\r\nIBS is a chronic and often unpredictable condition that can be managed effectively with dietary and lifestyle modifications. Each individual may have different triggers, so it is important to offer personalised advice and encourage patients to keep a food and symptom diary. This can help identify specific foods that worsen symptoms and enable tailored dietary adjustments.\r\n\r\nPatients should also be educated about the low FODMAP diet, which involves reducing fermentable carbohydrates to alleviate symptoms like bloating and abdominal pain. However, such dietary changes should ideally be implemented under the guidance of a healthcare professional. If symptoms persist or worsen despite these changes, a referral to a GP or dietitian for further evaluation and personalised advice may be necessary.\r\n\r\nFor more information watch OTC lesson chapter 7 Gastroenterology:\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Avoid missing meals or leaving long gaps between meals.",
        "answer_number": 1
      },
      {
        "text": "Ensure adequate hydration by drinking at least 8 cups of fluid per day",
        "answer_number": 2
      },
      {
        "text": "Eat 5 portions of fruit per day, each portion should be 80g",
        "answer_number": 3
      },
      {
        "text": "If suffering from diarrhoea, avoid the sorbitol due to its laxative properties",
        "answer_number": 4
      },
      {
        "text": "Reduce intake of alcohol and fizzy drinks",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2301,
    "bank": "clinicalTherapeutics",
    "title": "**How much of the stock solution (in ml) should the Pharmacist use?**",
    "text": "A Pharmacist needs to prepare 100ml of a 0.5% w/v solution of sodium chloride from a 10% w/v stock solution.",
    "why": "5 ml\r\n\r\nRationale:\r\n\r\nThe pharmacist needs to prepare 100 ml of a 0.5% w/v sodium chloride solution from a 10% w/v stock solution. This requires a dilution calculation, which can be solved using the dilution formula:\r\n\r\nC1 \u00d7 V1 = C2 \u00d7 V2\r\n\r\nWhere:\r\n\r\nC1 = 10% (stock solution concentration)\r\nV1 = ? (volume of stock solution required)\r\nC2 = 0.5% (final concentration needed)\r\nV2 = 100 ml (final total volume)\r\n\r\nRearrange the formula to solve for V1:\r\n\r\nV1 = (C2 \u00d7 V2) / C1\r\n\r\nV1 = (0.5 \u00d7 100) / 10\r\n\r\nV1 = 5 ml\r\n\r\nThus, the pharmacist should take 5 ml of the 10% stock solution and dilute it to a total volume of 100 ml with water.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 0.5 ml\r\n\r\nThis would result in a much lower final concentration (0.05% w/v) instead of the required 0.5% w/v, making it ineffective for the intended use.\r\n\r\nC: 10 ml\r\n\r\nThis would give a final concentration of 1% w/v, which is double the required concentration, leading to a hypertonic solution that may cause cellular dehydration if administered incorrectly.\r\n\r\nD: 50 ml\r\n\r\nThis would result in a final concentration of 5% w/v, which is ten times the required concentration, increasing the risk of hypernatremia and other osmotic imbalances.\r\n\r\nE: 100 ml\r\n\r\nThis would mean using 100 ml of the 10% stock solution without dilution, resulting in a 10% w/v solution instead of the required 0.5% w/v, making it far too concentrated for safe use.\r\n\r\nSodium Chloride Dilution \r\n\r\nAccording to NICE guidelines (2025), sodium chloride solutions are used for fluid resuscitation, wound irrigation, nebulisation, and dilution of medications. The concentration of sodium chloride must be carefully controlled to prevent electrolyte imbalances and osmotic disturbances.\r\n\r\nA 0.5% w/v sodium chloride solution is commonly used in ophthalmic preparations, wound care, and respiratory therapy. Incorrect dilution can lead to hypertonic or hypotonic effects, potentially causing cellular dehydration or oedema. Healthcare professionals must ensure accurate preparation and verify concentrations before administration to prevent adverse patient outcomes.\r\n\r\nFor further details, refer to BNF Lesson 9: Nutrition & Fluids (IV Therapy & Electrolyte Balance) at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "0.5 ml",
        "answer_number": 1
      },
      {
        "text": "5 ml",
        "answer_number": 2
      },
      {
        "text": "10 ml",
        "answer_number": 3
      },
      {
        "text": "50 ml",
        "answer_number": 4
      },
      {
        "text": "100 ml",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2620,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 52 year old female patient presents to the pharmacy requesting advice for her husband with a headache. She informs his headaches are severe intense pain at the back of the head. He also explains he has been vomiting with the pain.",
    "why": "This is an emergency situation and this could be a subarachnoid haemorrhage, although very rare you will come across this in clinical practice as many patients are either unconscious or conscious without any awareness. Additionally anyone over the age of 50 with a new onset of severe headache is a red flag referral.\r\n\r\n- **Main Symptoms of Subarachnoid Haemorrhage**:\r\n  - Sudden severe headache (\"thunderclap\" headache)\r\n  - Stiff neck\r\n  - Nausea and vomiting\r\n  - Sensitivity to light (photophobia)\r\n  - Blurred or double vision\r\n  - Stroke-like symptoms (slurred speech, weakness on one side)\r\n  - Loss of consciousness or convulsions (seizures)\r\n  \r\n- **Immediate Action**: A subarachnoid haemorrhage is a medical emergency. Call 999 for an ambulance if these symptoms occur.\r\n\r\n- **Diagnosis & Treatment**:\r\n  - CT scan to confirm bleeding.\r\n  - Transfer to a specialist neuroscience unit.\r\n  - Medications to prevent complications.\r\n  - Procedure to repair the bleeding source.\r\n\r\n- **Causes**:\r\n  - Often caused by a ruptured brain aneurysm.\r\n  - Risk factors: smoking, high blood pressure, excessive alcohol.\r\n  - Traumatic subarachnoid haemorrhage can occur due to severe head injuries.\r\n\r\n- **Affected Individuals**:\r\n  - Common in ages 45-70.\r\n  - More common in women and black individuals, partly due to high blood pressure prevalence.\r\n\r\n- **Risk Reduction**:\r\n  - Quit smoking.\r\n  - Limit alcohol consumption.\r\n  - Manage blood pressure (exercise, healthy diet, weight control).\r\n\r\n- **Complications**:\r\n  - Short-term: further bleeding, brain damage.\r\n  - Long-term: epilepsy, memory issues, mood changes (e.g., depression).\r\n\r\n- **Outlook**:\r\n  - Recovery can be slow, with possible long-term issues like fatigue, headaches, and sleep problems.\r\n\r\nFor more information watch the OTC lesson on Chapter 4 Neurology (Headaches and migraines):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the symptoms are self limiting",
        "answer_number": 1
      },
      {
        "text": "Advise to purchase 8mg/500mg co-codamol for headache",
        "answer_number": 2
      },
      {
        "text": "Advise to purchase sumatriptan 50mg tablet for headache",
        "answer_number": 3
      },
      {
        "text": "Advise to see her GP to investigate cause of headache",
        "answer_number": 4
      },
      {
        "text": "Advise to go to accident and emergency",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2300,
    "bank": "clinicalTherapeutics",
    "title": "**If the infusion is to be administered over 6 hours, what volume of the drug solution (in ml) should be administered per hour?**",
    "text": "A patient is prescribed an intravenous infusion of a drug. The drug is supplied in vials containing 250mg of the drug in 120ml of solution. The recommended dose is 5mg/kg and the patient weighs 50kg.",
    "why": "20 ml/hr\r\n\r\nRationale:\r\n\r\nThe patient is prescribed an intravenous infusion of a drug. The drug is supplied in vials containing 250 mg in 120 ml of solution. The recommended dose is 5 mg/kg, and the patient weighs 50 kg.\r\n\r\nStep-by-step calculation:\r\n\r\nDose = 5 mg/kg \u00d7 50 kg  \r\nDose = 250 mg\r\n\r\nSince 250 mg is provided in 120 ml, the entire 120 ml needs to be infused.\r\n\r\nInfusion rate = Total volume / Infusion time  \r\nInfusion rate = 120 ml / 6 hours  \r\nInfusion rate = 20 ml/hr\r\n\r\nThus, the correct infusion rate is 20 ml/hr.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 5 ml/hr\r\n\r\nThis would result in a total infusion volume of 30 ml over 6 hours, delivering only 62.5 mg of the drug\u2014far below the required 250 mg dose.\r\n\r\nB: 10 ml/hr\r\n\r\nThis would result in a total infusion volume of 60 ml, which would deliver only 125 mg of the drug\u2014half the required dose.\r\n\r\nC: 15 ml/hr\r\n\r\nThis would result in a total infusion volume of 90 ml, delivering 187.5 mg of the drug, which is less than the required 250 mg dose.\r\n\r\nE: 25 ml/hr\r\n\r\nThis would result in a total infusion volume of 150 ml, which would exceed the required 120 ml, leading to an overdose.\r\n\r\nIntravenous Infusions\r\n\r\nAccording to NICE guidelines, intravenous drug administration requires careful dose calculation, dilution accuracy, and infusion rate monitoring to prevent under-dosing or overdosing. For weight-based dosing, dose accuracy is critical, particularly in drugs with a narrow therapeutic index.\r\n\r\nErrors in infusion rates can lead to sub-therapeutic effects or toxicity, especially in critically ill patients. Healthcare professionals must double-check infusion rates, verify dose calculations, and monitor patient response throughout the infusion. Electronic infusion pumps should be used whenever possible to ensure accurate administration rates.\r\n\r\nFor further details, refer to BNF Lesson 5: Infections & IV Therapy Administration at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "5 ml/hr",
        "answer_number": 1
      },
      {
        "text": "10 ml/hr",
        "answer_number": 2
      },
      {
        "text": "15 ml/hr",
        "answer_number": 3
      },
      {
        "text": "20 ml/hr",
        "answer_number": 4
      },
      {
        "text": "25 ml/hr",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2617,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "A mother presents to the pharmacy with her 3 year old son requesting to purchase something for her son's headache. She explains to you her son has had flu symptoms and a headache. Upon further examination you notice the child has a stiff neck and a non blanching rash.\u00a0 She informs you her son regularly takes levetiracetam 100mg/5mL oral suspension.",
    "why": "Call for an ambulance immediately.\r\n\r\nRationale:\r\n\r\nSymptoms Indicating Serious Condition: The child presents with flu-like symptoms, a headache, a stiff neck, and a non-blanching rash. These symptoms are concerning and may indicate meningitis, which is a medical emergency.\r\n\r\nNon-Blanching Rash: The presence of a non-blanching rash in conjunction with a stiff neck and headache is particularly alarming, as it could indicate meningococcal meningitis or sepsis, both of which require urgent medical attention.\r\n\r\nImmediate Action Required: In such situations, it is critical to act quickly. Calling for an ambulance ensures that the child receives immediate medical evaluation and treatment, which is crucial for conditions like meningitis.\r\n\r\nInformation on Meningitis:\r\nAccording to NICE guidelines, meningitis is an infection of the protective membranes covering the brain and spinal cord. It can be caused by bacteria or viruses, with bacterial meningitis being more severe and requiring urgent medical intervention. Common symptoms in children include:\r\n\r\nFever: Often high and persistent\r\nHeadache: Severe and often described as different from other headaches\r\nStiff Neck: Difficulty in flexing the neck and resistance to movement\r\nRash: A non-blanching rash, particularly with meningococcal meningitis, which can appear as petechiae or purpura\r\nAltered Mental Status: Lethargy or irritability, changes in responsiveness, and seizures can occur in severe cases\r\nNICE emphasizes the importance of early identification and management of meningitis to prevent complications. If meningitis is suspected, immediate referral to emergency services is necessary for further evaluation, lumbar puncture, and possible initiation of antibiotic therapy.\r\n\r\nInformation on Sepsis in Children:\r\nNICE guidelines also highlight sepsis as a life-threatening condition that arises when the body's response to infection causes tissue and organ injury. In children, early recognition is vital, as symptoms can progress rapidly. Key signs of sepsis include:\r\n\r\nAltered Consciousness or lethargy\r\nPersistent Vomiting\r\nSevere Abdominal Pain\r\nRash that does not blanch (especially petechiae or purpura)\r\nCold Extremities, or mottled or discolored skin\r\nNICE underscores that any child presenting with these symptoms, especially when accompanied by signs of infection, should be assessed urgently.\r\n\r\n\r\nFor more information watch the BNF lesson on Chapter 5 Infections (Sepsis):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Call for an ambulance immediately",
        "answer_number": 1
      },
      {
        "text": "Her son is experiencing a side effect of levetiracetam and whilst safe to continue taking it, she may wish to see her GP for an alternative",
        "answer_number": 2
      },
      {
        "text": "Sell paracetamol 120mg/5mL oral suspension",
        "answer_number": 3
      },
      {
        "text": "She should see his GP as soon as possible",
        "answer_number": 4
      },
      {
        "text": "Stop taking levetiracetam straight away and see her GP as soon as possible",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2599,
    "bank": "clinicalOtc",
    "title": "**Which of the following medicines is the most likely cause of constipation?**",
    "text": "A 72 year old patient presents to the pharmacy with constipation. Upon questioning, you suspect medicine induced constipation.",
    "why": "Carbamazepine\r\n\r\nRationale:\r\n\r\nCarbamazepine is an anticonvulsant and mood-stabilizing medication that has anticholinergic effects, which can lead to constipation. While lercanidipine, a calcium channel blocker, can also contribute to constipation, carbamazepine is more commonly recognized in this context due to its side effect profile.\r\n\r\nExplanation of Other Options:\r\n\r\nLisinopril: This medication, an ACE inhibitor, is generally not associated with constipation.\r\n\r\nLercanidipine: While it may cause constipation, it is less frequently reported compared to carbamazepine in clinical settings.\r\n\r\nMetformin: This drug is primarily associated with gastrointestinal side effects like diarrhea rather than constipation.\r\n\r\nRivastigmine: Although it may cause gastrointestinal upset, constipation is not a typical side effect.\r\n\r\n\r\nConstipation is a common condition in older adults, particularly when medication regimens include drugs that impact bowel motility. NICE guidelines suggest that healthcare providers should carefully assess medications known to cause constipation, particularly in vulnerable populations. Anticholinergic medications, opioids, and certain antiepileptics, like carbamazepine, are notable for their potential to induce constipation. Appropriate management includes reviewing medications, advising on dietary changes, and ensuring adequate fluid intake to alleviate symptoms effectively.\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Carbamazepine",
        "answer_number": 1
      },
      {
        "text": "Lisinopril",
        "answer_number": 2
      },
      {
        "text": "Lercandipine",
        "answer_number": 3
      },
      {
        "text": "Metformin",
        "answer_number": 4
      },
      {
        "text": "Rivastigmine",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2592,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the LEAST appropriate reason for referral?**",
    "text": "A 52 year old patient presents to the pharmacy requesting to purchase Daktarin (miconazole) oral gel.",
    "why": "Side effect from antibiotics\r\n\r\nRationale:\r\n\r\nThe least appropriate reason for referral in this scenario is \"Side effect from antibiotics.\" Antibiotic use, particularly broad-spectrum antibiotics, can lead to oral thrush due to the disruption of the normal microbial flora. In many cases, this can be managed effectively with over-the-counter treatments such as Daktarin (miconazole) oral gel, and does not usually require immediate referral unless the infection persists or is severe.\r\n\r\nExplanation of Other Options:\r\n\r\nDiabetic patient: Diabetics are at a higher risk of recurrent or severe fungal infections due to immune dysfunction and elevated blood glucose levels, which can promote fungal growth. Recurrent fungal infections in diabetics could indicate hyperglycaemia, and therefore, referral is important to ensure appropriate monitoring and management.\r\n\r\nDuration longer than 3 weeks: If an oral fungal infection lasts for more than 3 weeks, it could suggest treatment failure or an underlying condition (such as immunosuppression). In these cases, referral is necessary to investigate further. This could indicate that the treatment is not effective or the condition might not be fungal in origin.\r\n\r\nImmunocompromised patients: Patients with weakened immune systems may require different or additional treatment, as they are at increased risk of severe and recurrent fungal infections. Referral ensures that more comprehensive management, including systemic treatment, is provided.\r\n\r\nPainless lesions: Painless lesions could be leukoplakia, a premalignant condition, and therefore patients must be referred for diagnosis. Persistent or unusual lesions that do not resolve with standard treatment warrant further investigation.\r\n\r\nAccording to NICE guidelines, oral thrush is often a consequence of disruption of normal flora, particularly following antibiotic use, especially with broad-spectrum antibiotics. First-line treatment includes topical antifungal agents such as miconazole or nystatin. Most cases resolve with treatment, but referral is required if the patient has predisposing factors like diabetes, immunosuppression, or persistent symptoms lasting more than 3 weeks. Managing the underlying cause, such as reviewing antibiotic therapy, is essential to preventing recurrence.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Diabetic patient",
        "answer_number": 1
      },
      {
        "text": "Duration longer than 3 weeks",
        "answer_number": 2
      },
      {
        "text": "Immunocompromised patients",
        "answer_number": 3
      },
      {
        "text": "Painless lesions",
        "answer_number": 4
      },
      {
        "text": "Side effect from antibiotics",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2591,
    "bank": "clinicalOtc",
    "title": "**What is the most likely cause of his toenail problem?**",
    "text": "A 45-year-old man comes to the pharmacy with a complaint of thickened and discoloured toenails. He says he has been wearing tight shoes for work and often has sweaty feet. He has no other medical conditions or allergies. He shows you a picture of his toenails on his phone.\r\n\r\n![fungalnail](https://i.ibb.co/Sf14R2S/fungalnail.jpg \"650x500\")",
    "why": "Fungal nail infection\r\n\r\nRationale:\r\n\r\nThe most likely cause of this patient's toenail problem is fungal nail infection (onychomycosis). Thickened, discoloured nails are typical signs of a fungal infection, especially in individuals who wear tight shoes and have sweaty feet. These conditions create a moist environment conducive to fungal growth. Fungal infections commonly affect toenails and can lead to a yellow, white, or brown discolouration, thickening, and crumbling of the nail.\r\n\r\nExplanation of Other Options:\r\n\r\nLichen planus: This is a chronic inflammatory condition that can affect the skin, hair, nails, and mucous membranes. In nail involvement, it may cause nail thinning, splitting, or ridging rather than the thickening and discolouration seen with fungal infections. It is less likely in this case given the patient's description and history.\r\n\r\nMelanoma: Subungual melanoma may cause dark streaks or pigmentation changes under the nail, but it does not typically lead to thickening and is less common compared to fungal infections. Melanoma should be considered if there is a new dark patch or streak under the nail, but this does not seem to match the patient\u2019s description.\r\n\r\nPsoriasis: Psoriatic nail disease can cause pitting, thickening, or separation of the nail from the nail bed. However, psoriasis tends to affect the skin as well, and without a history of psoriatic skin lesions, it is less likely to be the cause in this scenario.\r\n\r\nTrauma: Repeated trauma from tight shoes can cause nail thickening or discolouration, but the patient\u2019s complaint of thickened, discoloured nails, coupled with a history of wearing tight shoes and sweating, is more indicative of a fungal infection.\r\n\r\n\r\nAccording to NICE guidelines, fungal nail infections (onychomycosis) are common, particularly in people with risk factors like wearing tight shoes, having sweaty feet, or experiencing trauma to the nail. Diagnosis is usually clinical, based on nail appearance, but confirmation through nail clippings or scrapings for mycology may be required. First-line treatment includes topical antifungals (e.g., amorolfine) for mild infections, or oral antifungals like terbinafine for more severe or extensive infections. Proper foot hygiene, keeping nails dry, and wearing well-fitting shoes are recommended preventive measures.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Fungal nail infection",
        "answer_number": 1
      },
      {
        "text": "Lichen planus",
        "answer_number": 2
      },
      {
        "text": "Melanoma",
        "answer_number": 3
      },
      {
        "text": "Psoriasis",
        "answer_number": 4
      },
      {
        "text": "Trauma",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2573,
    "bank": "clinicalOtc",
    "title": "**What is the most likely cause of her symptoms?**",
    "text": "A 22-year-old woman visits the pharmacy with a rash on her face and body. She says she has been feeling unwell for the last few days with a headache, sore throat, and swollen glands. She has no other medical conditions or allergies. She shows you a picture of her rash on her phone.\r\n\r\n![rubella](https://i.ibb.co/Tbywc9M/rubella.jpg \"500x500\")",
    "why": "d) Rubella\r\n\r\nRationale:\r\n\r\nRubella, also known as German measles, typically presents with a rash that begins on the face and spreads to the body. Common accompanying symptoms include mild fever, headache, sore throat, and swollen glands, particularly behind the ears (posterior auricular lymphadenopathy). The symptoms described by the patient and the rash\u2019s appearance and progression align closely with rubella.\r\n\r\nExplanation of Other Options:\r\n\r\na) Allergic reaction: While allergic reactions can cause rashes, they are usually not accompanied by systemic symptoms like swollen glands or fever.\r\nb) Chickenpox: The chickenpox rash typically consists of itchy, fluid-filled blisters that crust over, usually starting on the torso before spreading. This does not match the description of the rash or symptoms in this case.\r\nc) Measles: Measles can cause a similar rash, but it usually includes additional symptoms like Koplik spots in the mouth, severe cough, and conjunctivitis, which are not reported by the patient.\r\ne) Scarlet fever: The rash of scarlet fever typically feels rough (like sandpaper) and is often accompanied by a red, \"strawberry\" tongue and a history of sore throat caused by Streptococcus infection, which does not align with this patient\u2019s presentation.\r\n\r\nRubella is a mild, contagious viral infection caused by the rubella virus, presenting with a distinctive red or pink rash, low-grade fever, headache, and swollen lymph nodes. The rash typically starts on the face and spreads to the trunk and limbs. Symptoms are usually mild, but rubella can be particularly dangerous during pregnancy as it may cause congenital rubella syndrome, resulting in severe birth defects.\r\n\r\n\r\nTransmission: Rubella spreads through respiratory droplets, so isolation during the infectious period (usually 7 days before and after rash onset) is advised to prevent transmission.\r\nVaccination: The MMR (measles, mumps, rubella) vaccine is effective in preventing rubella and is part of the routine immunisation schedule.\r\nManagement: Generally, rubella is self-limiting, and treatment focuses on relieving symptoms, such as using antipyretics for fever.\r\nPublic Health: Notification of suspected cases to public health authorities is necessary to control outbreaks and prevent complications in vulnerable populations, especially pregnant women.\r\n\r\nFor more information please watch OTC lesson chapter 1 (paediatrics):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Allergic reaction",
        "answer_number": 1
      },
      {
        "text": "Chickenpox",
        "answer_number": 2
      },
      {
        "text": "Measles",
        "answer_number": 3
      },
      {
        "text": "Rubella",
        "answer_number": 4
      },
      {
        "text": "Scarlet fever",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2603,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 22 year old male patient presents to the pharmacy with irritable bowel syndrome (IBS) . He was diagnosed with IBS six months ago and has been adhering to the dietary advice his GP gave him.\u00a0\r\nHe informs you despite adhering to dietary advice, he is still suffering with constipation.",
    "why": "Suggest a bulk-forming laxative to produce regular, soft, well-formed stool.\r\n\r\nRationale:\r\n\r\nFor patients with irritable bowel syndrome (IBS) who suffer from constipation, NICE recommends dietary and lifestyle interventions as first-line treatment, such as increasing fibre intake (with soluble fibre preferred over insoluble fibre) and ensuring adequate fluid intake. However, when these measures are insufficient, the next step is to consider pharmacological treatment.\r\n\r\nBulk-forming laxatives are the first-line pharmacological treatment for constipation in IBS. They help form regular, soft, well-formed stools and are generally well-tolerated, making them an effective and appropriate option for managing constipation in IBS. NICE advises avoiding stimulant or osmotic laxatives, such as lactulose, as they may cause bloating and discomfort in IBS patients.\r\n\r\nExplanation of Other Options:\r\n\r\nLinaclotide is reserved for patients with severe IBS with constipation who have not responded to laxatives or other treatments. Referral to a gastroenterologist is also not needed at this stage.\r\nReinforcing dietary advice is important but insufficient as the patient is already following such advice without improvement.\r\nLactulose is not recommended due to its potential to worsen bloating and abdominal discomfort in IBS patients.\r\nIrritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterised by symptoms such as abdominal pain, bloating, and altered bowel habits, including constipation and/or diarrhoea. \r\n\r\nThe management of IBS begins with dietary and lifestyle modifications, emphasising the importance of a balanced diet and adequate fluid intake. Patients are often advised to increase their intake of soluble fibre while avoiding high-fat and high-sugar foods, which can exacerbate symptoms. If dietary changes alone do not alleviate symptoms, NICE recommends the use of bulk-forming laxatives as a first-line treatment for constipation-predominant IBS, helping to produce regular and well-formed stools. For those with more severe symptoms or those who do not respond to initial treatments, further options may include prescription medications or referrals for additional support.            \r\nRegular follow-up is important to tailor management strategies and address any new or worsening symptoms.\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise to see his GP for a prescription for linaclotide",
        "answer_number": 1
      },
      {
        "text": "Advise he needs to be referred to a gastroenterologist",
        "answer_number": 2
      },
      {
        "text": "Reinforce general dietary advice",
        "answer_number": 3
      },
      {
        "text": "Suggest a bulk forming laxative to produce\u00a0 regular, soft well-formed stool.",
        "answer_number": 4
      },
      {
        "text": "Suggest regular use of a lactulose for constipation treatment",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2596,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of her diarrhoea?**",
    "text": "A 42 year old female presents to the pharmacy with diarrhoea and bloating for the past 3 weeks. She informs you her stools are frothy and often float on the toilet. She also informs you she has been feeling very tired.",
    "why": "Malabsorption syndrome\r\n\r\nRationale:\r\n\r\nThe symptoms of frothy, floating stools, bloating, diarrhoea for 3 weeks, and feeling very tired suggest malabsorption syndrome. Frothy stools that float indicate the presence of fat, a sign of fat malabsorption, which is characteristic of conditions like coeliac disease or chronic pancreatitis. Tiredness can be due to nutrient deficiencies caused by poor absorption of vitamins and minerals.\r\n\r\nExplanation of Other Options:\r\n\r\nCrohn's disease: While Crohn's disease can cause diarrhoea and fatigue, the hallmark symptoms typically include abdominal pain and sometimes bloody stools. Crohn\u2019s can affect any part of the gastrointestinal tract, but fat malabsorption and frothy stools are more specific to malabsorption syndromes.\r\n\r\nColorectal cancer: Colorectal cancer can present with changes in bowel habits, blood in the stool, and weight loss, but frothy, floating stools are not typical. Fatigue may occur due to anaemia or other systemic effects, but the presentation here points more to malabsorption.\r\n\r\nGastro-enteritis: This would generally present with acute diarrhoea, vomiting, and possibly fever, but it is usually short-lived and resolves within a week or two. The chronic nature of the symptoms here suggests a longer-term condition like malabsorption syndrome.\r\n\r\nUlcerative colitis: Ulcerative colitis causes bloody diarrhoea and urgency but not typically frothy or fatty stools. The lack of abdominal pain and the nature of the stools make this less likely.\r\n\r\nMalabsorption syndromes involve the improper absorption of nutrients in the gastrointestinal tract. Common causes include coeliac disease, chronic pancreatitis, and small bowel bacterial overgrowth. Symptoms include diarrhoea, bloating, fatigue, and steatorrhoea (fatty stools). NICE guidelines recommend evaluating patients with chronic diarrhoea, unexplained weight loss, and signs of malnutrition for potential malabsorption. Diagnosis is often made via blood tests for nutritional deficiencies, stool tests for fat content, and possibly endoscopy or biopsy for underlying conditions like coeliac disease. Treatment focuses on managing the underlying cause and supplementing deficient nutrients.\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Crohn's disease",
        "answer_number": 1
      },
      {
        "text": "Colorectal cancer",
        "answer_number": 2
      },
      {
        "text": "Gastro-enteritis",
        "answer_number": 3
      },
      {
        "text": "Malabsorption syndrome",
        "answer_number": 4
      },
      {
        "text": "Ulcerative colitis",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2293,
    "bank": "clinicalTherapeutics",
    "title": "A family come in and ask to be vaccinated so they are safe to go on the annual Muslim pilgrimage to Mecca",
    "text": "**Theme: Vaccines and immunisations**\r\n** For each of the following scenarios choose the vaccination which needs to be administered and/or which best applies**",
    "why": "E: Meningococcal quadrivalent ACWY\r\n\r\nRationale:\r\n\r\nThe Meningococcal quadrivalent ACWY vaccine (MenACWY) is required for all travellers to Mecca (Hajj or Umrah pilgrims). The Saudi Arabian government mandates this vaccination to prevent the spread of meningococcal disease, as large gatherings increase the risk of outbreaks.\r\n\r\nThe MenACWY vaccine protects against Neisseria meningitidis serogroups A, C, W, and Y, which are responsible for severe meningitis and septicaemia.\r\nA certificate of vaccination is required for visa approval, and the vaccine must be administered at least 10 days before travel.\r\nThus, the MenACWY vaccine is the appropriate choice for this family before travelling for Hajj or Umrah.\r\n\r\nExplanation of Other Options:\r\n\r\nA: BCG vaccine\r\n\r\nThe BCG vaccine is used to prevent tuberculosis (TB) and is not a travel requirement for Hajj or Umrah.\r\n\r\nB: Hepatitis B vaccine\r\n\r\nThe hepatitis B vaccine is recommended for long-term travel to regions where hepatitis B is endemic, particularly for healthcare workers and those at risk of bloodborne transmission, but is not a requirement for Hajj/Umrah.\r\n\r\nC: Influenza vaccine\r\n\r\nSeasonal influenza vaccination is recommended for pilgrims due to the risk of respiratory infections in crowded conditions but is not a visa requirement.\r\n\r\nD: Meningococcal B vaccine\r\n\r\nMenB vaccine protects against meningococcal serogroup B, which is not covered by MenACWY but is not a Hajj/Umrah requirement.\r\n\r\nF: Pneumococcal conjugate vaccine\r\n\r\nPneumococcal vaccines are important for elderly and high-risk individuals, but they are not required for Hajj/Umrah travel.\r\n\r\nG: Rotavirus vaccine\r\n\r\nThe rotavirus vaccine is an oral vaccine given to infants to prevent severe diarrhoea, unrelated to Hajj/Umrah travel.\r\n\r\nH: Tetanus immunoglobulin\r\n\r\nTetanus immunoglobulin (TIG) is only given for tetanus-prone wounds and is not required for travel vaccinations.\r\n\r\nHajj and Umrah Vaccination Requirements \r\n\r\nAccording to NICE guidelines (2025) and UK Travel Health Advice, the following vaccinations are required or recommended for Hajj and Umrah pilgrims:\r\n\r\nMandatory:\r\n\r\nMeningococcal ACWY vaccine (required for visa approval, must be given at least 10 days before travel).\r\n\r\nRecommended:\r\n\r\nInfluenza vaccine (to reduce respiratory infection risk).\r\nHepatitis A & B vaccines (if not previously vaccinated).\r\nPolio booster (if travelling from a country where polio is endemic or recent outbreaks have occurred).\r\nTravellers should also be advised on personal hygiene, food safety, and infection prevention during their pilgrimage.\r\n\r\nFor more Information please watch BNF Lesson (Chapter 14) Vaccines:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "BCG vaccine",
        "answer_number": 1
      },
      {
        "text": "Hepatitis B vaccine",
        "answer_number": 2
      },
      {
        "text": "Influenza vaccine",
        "answer_number": 3
      },
      {
        "text": "Meningococcal B vaccine",
        "answer_number": 4
      },
      {
        "text": "Meningococcal quadrivalent ACWY",
        "answer_number": 5
      },
      {
        "text": "Pneumococcal conjugate vaccine",
        "answer_number": 6
      },
      {
        "text": "Rotavirus vaccine",
        "answer_number": 7
      },
      {
        "text": "Tetanus immunoglobulin",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2497,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a legal requirement to be included on the signed order?**",
    "text": "Schools can obtain supplies of adrenaline auto injectors (AAI) from a pharmacy on a signed order. Adrenaline auto injectors can be administered by trained persons in an emergency to pupils previously prescribed such medicine where parental consent has been received.",
    "why": "a) Appropriate headed paper\r\n\r\nRationale\r\n\r\nHeaded paper is not a legal requirement for a signed order to obtain adrenaline auto-injectors (AAI) for schools. However, it is considered a professional requirement, as it helps verify the authenticity of the request.\r\n\r\nThe legal requirements for a signed order include:\r\n\r\nName of the school: To identify the institution requesting the medication.\r\nDetails of the medicinal product: To specify the required medicine (e.g., adrenaline auto-injector).\r\nTotal quantity required: To clarify the number of devices requested.\r\nSignature of the head teacher or principal: To provide authorisation for the request.\r\nIncluding the above ensures that the pharmacy can lawfully supply the AAI under the relevant exemption in the Human Medicines Regulations 2012.\r\n\r\nExplanation of the Other Options\r\n\r\nb) Medicinal product details\r\n\r\nThis is a legal requirement to ensure the correct medicine is supplied.\r\n\r\nc) Name of the school\r\n\r\nThe signed order must include the school\u2019s name to verify the institution making the request.\r\n\r\nd) Signature of the head teacher or principal of the school\r\n\r\nThe signature is mandatory as it acts as official authorisation for the request.\r\n\r\ne) Total quantity required\r\n\r\nSpecifying the quantity ensures clarity and prevents ambiguity in supply.\r\n\r\nKey Points About Adrenaline Auto-Injector Supply to Schools\r\n\r\nLegal Exemption: Schools are permitted to obtain AAIs under an exemption in the Human Medicines Regulations 2012, provided a valid signed order is presented.\r\n\r\nPurpose of Supply: The AAIs are for emergency use on pupils who have been prescribed such medication and where parental consent is in place.\r\n\r\nProfessional Considerations: While headed paper is not legally required, pharmacies are encouraged to request it to ensure the signed order is genuine and to maintain professional standards.\r\n\r\nStorage and Training: Schools must ensure AAIs are stored safely and that staff administering them are adequately trained.\r\n\r\n\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Appropriate headed paper",
        "answer_number": 1
      },
      {
        "text": "Medicinal product details",
        "answer_number": 2
      },
      {
        "text": "Name of the school",
        "answer_number": 3
      },
      {
        "text": "Signature of the head teacher or principle of the school",
        "answer_number": 4
      },
      {
        "text": "Total quantity required",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2519,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "It is a Saturday morning, a 60 year old patient presents to the pharmacy requesting an emergency supply of Clobazam 10mg tablets. He informs he is away from home and he needs medication to prevent nocturnal seizures.",
    "why": "D) Supply 5 days worth of treatment as an emergency supply\r\n\r\nRationale:\r\n\r\nThe most appropriate action is to supply 5 days' worth of Clobazam 10mg tablets as an emergency supply. Clobazam, a Schedule 4 Part I controlled drug, is legally allowed to be supplied in an emergency, but only for a maximum of 5 days. This emergency supply ensures the patient can manage his nocturnal seizures temporarily until he can obtain a full prescription.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Advise him it is illegal for you to give controlled medicines as an emergency supply \u2013 This option is incorrect. Although some controlled drugs are restricted in emergency supply situations, Schedule 4 Part I drugs, including Clobazam, can be supplied legally for up to 5 days in an emergency. Advising the patient otherwise would deprive him of needed medication and could increase the risk of seizures.\r\n\r\nB) Refer him to accident and emergency \u2013 This option may not be appropriate in this context. While A&E could provide emergency care, the patient requires ongoing seizure management, which a short-term emergency supply of Clobazam can address without needing to escalate to A&E. Providing the emergency supply within legal limits is more suitable and supports the patient\u2019s need promptly.\r\n\r\nC) Refer him to his general practitioner \u2013 Referring him to his GP may not be feasible on a Saturday, as most GP practices are closed on weekends. Given that an emergency supply of Clobazam is legally allowed, this option is unnecessary and may delay the patient from receiving essential medication.\r\n\r\nE) Supply 28 days worth of treatment \u2013 This option is not appropriate, as it exceeds the legal limit for supplying Schedule 4 Part I drugs as an emergency supply. The law permits a maximum of 5 days' supply, making this option non-compliant and potentially unsafe.\r\n\r\n\r\nThe Medicines, Ethics and Practice (MEP) guidelines provide clear instructions on emergency supplies of controlled drugs. Pharmacists may supply certain controlled medicines, such as Schedule 4 Part I drugs like Clobazam, for a maximum of 5 days in an emergency, provided there is an immediate need, such as preventing seizures. This regulation supports continuity of care while upholding legal restrictions to prevent misuse. Referring patients to A&E or GP services should be reserved for situations where an emergency supply is not legally permissible or if the patient\u2019s condition is unstable and requires immediate medical intervention.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise him it is illegal for you to give controlled medicines as an emergency supply",
        "answer_number": 1
      },
      {
        "text": "Refer him to accident and emergency",
        "answer_number": 2
      },
      {
        "text": "Refer him to his general practitioner",
        "answer_number": 3
      },
      {
        "text": "Supply 5 days worth of treatment as an emergency supply",
        "answer_number": 4
      },
      {
        "text": "Supply 28 days worth of treatment",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2515,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a relevant prescriber to authorise emergency supplies?**",
    "text": "Regulation 224 of the human medicines regulations 2012 enables emergencies supplies on the request of a prescriber",
    "why": "B) Doctor from Pakistan\r\n\r\nRationale:\r\n\r\nThis answer is incorrect because a doctor from Pakistan is not an appropriate prescriber to authorise emergency supplies under Regulation 224 of the Human Medicines Regulations 2012. The regulation allows emergency supplies to be authorised by prescribers from the UK and EU only. A doctor from outside the EU, such as one from Pakistan, does not meet the criteria for prescribing in the context of emergency supply requests under UK law.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Doctor from France \u2013 A doctor from France is an appropriate prescriber. France is part of the European Union, and under the Human Medicines Regulations 2012, prescribers from EU countries are recognised as authorised to make emergency supply requests in the UK.\r\n\r\nC) UK Nurse Independent Prescriber \u2013 A UK Nurse Independent Prescriber is authorised to make emergency supply requests. Nurse independent prescribers in the UK are able to prescribe certain medications, including in emergency situations, as long as they follow the regulatory requirements.\r\n\r\nD) UK Optometrist Prescriber \u2013 A UK Optometrist Prescriber is also authorised to make emergency supply requests within their scope of practice. Optometrists in the UK, under specific conditions, can prescribe medications and request emergency supplies for patients in need of treatment.\r\n\r\nE) UK Podiatrist Independent Prescriber \u2013 A UK Podiatrist Independent Prescriber is eligible to authorise emergency supplies. As with other independent prescribers in the UK, podiatrists can prescribe and request emergency supplies of medicines within their professional remit.\r\n\r\n\r\nRegulation 224 of the Human Medicines Regulations 2012 permits emergency supplies to be made at the request of a prescriber, but only those from recognised professional bodies within the UK and the EU are eligible. This ensures that prescribers have the necessary qualifications and are subject to appropriate regulatory oversight to ensure patient safety.\r\n\r\nDoctors, nurse independent prescribers, optometrists, and podiatrists from the UK are authorised to make emergency supply requests for prescription-only medicines (POMs), provided they meet the necessary criteria. However, prescribers from outside the EU, such as those from Pakistan, do not have the authority to request emergency supplies under UK law. This regulatory framework helps maintain patient safety while allowing appropriate access to medications in urgent circumstances.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Doctor from France",
        "answer_number": 1
      },
      {
        "text": "Doctor from Pakistan",
        "answer_number": 2
      },
      {
        "text": "UK nurse independent prescriber",
        "answer_number": 3
      },
      {
        "text": "UK Optometrist prescriber",
        "answer_number": 4
      },
      {
        "text": "UK Podiatrist independent prescriber",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2493,
    "bank": "clinicalMep",
    "title": "**The patient asks why the prescription is only for a 30-day supply. What is the most appropriate response?**",
    "text": "A female patient who wears contact lenses and has been initiated on isotretinoin. Their blood test results are shown below:\r\n\r\nLDL 1.9 mmol/L (<3mmol/L)\r\nALT 42 units/L (7 \u2013 56 units/L)\r\nTotal bilirubin 0.7 mg/dL (0.3 - 1.9 mg/dL)",
    "why": "E. To ensure the patient is not pregnant whilst taking the drug.\r\n\r\nRationale\r\n\r\nIsotretinoin is a highly teratogenic drug, meaning it poses a significant risk of severe birth defects if taken during pregnancy. For this reason, strict measures are in place to ensure that women of childbearing potential do not conceive while taking isotretinoin. The Pregnancy Prevention Programme (PPP) mandates that:\r\n\r\nWomen of childbearing potential must have monthly negative pregnancy tests before receiving a new supply.\r\n\r\nPrescriptions for isotretinoin must be limited to a maximum of 30 days to align with these tests and prevent overuse or misuse.\r\n\r\nA. It is routine to supply prescriptions for one month to reduce wastage (Incorrect):\r\n\r\nWhile reducing wastage is a valid pharmacy practice, it is not the primary reason for restricting isotretinoin supplies to a 30-day limit.\r\n\r\nB. To allow for closer monitoring of interacting medicines (Incorrect):\r\n\r\nAlthough isotretinoin has potential drug interactions (e.g., with tetracyclines or vitamin A), the 30-day restriction is specifically linked to the PPP, not to monitoring of drug interactions.\r\n\r\nC. To allow for monthly blood tests and adjust the dose if needed (Incorrect):\r\n\r\nMonitoring blood tests (e.g., lipid profile and liver function tests) is essential during isotretinoin therapy, but the frequency of testing varies by clinical need and is not necessarily tied to the monthly prescription limit.\r\n\r\nD. To ensure good overall adherence with the therapy (Incorrect):\r\n\r\nAlthough adherence is a general goal in any treatment, it is not the rationale for limiting isotretinoin prescriptions to a 30-day supply.\r\n\r\nE. To ensure the patient is not pregnant whilst taking the drug (Correct):\r\n\r\nThe monthly supply restriction ensures that pregnancy tests can be performed regularly and that the patient has ongoing access to contraception, both essential components of the PPP.\r\n\r\nIsotretinoin prescriptions are limited to a 30-day supply for women of childbearing potential due to the Pregnancy Prevention Programme (PPP). This programme aims to minimise the risk of pregnancy during isotretinoin therapy through monthly negative pregnancy tests and strict adherence to contraception.\r\n\r\nAdditional monitoring, such as liver function tests and lipid profiles, is conducted during therapy but does not directly determine the prescription duration. By enforcing these measures, healthcare providers help mitigate the significant risks of isotretinoin-associated teratogenicity.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "It is routine to supply prescriptions for one month to reduce wastage",
        "answer_number": 1
      },
      {
        "text": "To allow for closer monitoring of interacting medicines",
        "answer_number": 2
      },
      {
        "text": "To allow for monthly blood tests and adjust the dose if needed",
        "answer_number": 3
      },
      {
        "text": "To ensure good overall adherence with the therapy",
        "answer_number": 4
      },
      {
        "text": "To ensure the patient is not pregnant whilst taking the drug",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2524,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A male patient presents to the pharmacy requesting to purchase chloramphenicol 0.5% eye drops for his pet dog",
    "why": "A. Refuse the sale and advise him he must have a prescription by the veterinary surgeon.\r\n\r\nRationale\r\n\r\nThe correct answer is A. Refuse the sale and advise him he must have a prescription by the veterinary surgeon. Under the Veterinary Medicines Regulations 2013, it is illegal to sell human medicines for use in animals unless the product is prescribed by a veterinary surgeon under the veterinary cascade. This regulation ensures that veterinary medicines are used safely and appropriately, as they are specifically formulated for animal use and may differ in strength, formulation, or dosage compared to human medicines.\r\n\r\nExplanation of Other Options\r\n\r\nB. Refuse the sale but advise he can purchase in another pharmacy. \u2013 Incorrect. It is not lawful to advise the customer to purchase the medicine elsewhere. The regulation applies to all pharmacies, not just the one in question.\r\nC. Refuse the sale and request he gets a prescription for his GP. \u2013 Incorrect. A GP prescription would not be appropriate for an animal. Only a veterinary surgeon can prescribe medicines for animals.\r\nD. Say you have not got any in stock. \u2013 Incorrect. This option misrepresents the issue. The problem is not about stock availability but the legal requirement for a veterinary prescription for animal use.\r\nE. Sell chloramphenicol eye drops. \u2013 Incorrect. As mentioned, human medicines cannot be sold for use in animals without a prescription from a veterinary surgeon under the veterinary cascade.\r\n\r\n\r\nUnder the Veterinary Medicines Regulations 2013, it is illegal to sell human medicines, such as chloramphenicol eye drops, for use in animals without a veterinary prescription. These regulations ensure animal welfare and safety, as medications need to be specifically prescribed by a veterinary surgeon, considering the different needs of animals versus humans. Therefore, the correct course of action is to refuse the sale and advise the customer to obtain a prescription from a veterinary surgeon.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Refuse the sale and advise him he must have a prescription by the veterinary surgeon.",
        "answer_number": 1
      },
      {
        "text": "Refuse the sale but advice he can purchase in another pharmacy",
        "answer_number": 2
      },
      {
        "text": "Refuse the sale and request he gets a prescription for his GP",
        "answer_number": 3
      },
      {
        "text": "Say you have not got any in stock",
        "answer_number": 4
      },
      {
        "text": "Sell chloramphenicol eye drops",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 989,
    "bank": "clinicalOtc",
    "title": "A 46- year old man with a burning pain behind his breastbone which occurs after eating. He also experiences an acidic taste at the back of his throat",
    "text": "**Theme: Gastroenterology conditions**\u2028\u2028\r\n\r\n**Instruction: select the most appropriate gastroenterology condition correlating with the symptoms associated with each patient. Each option may be used once, more than once or not at all**",
    "why": "The most suitable condition for the patient described is heartburn. Heartburn is a burning pain in the chest, just behind the breastbone. The pain is often worse after eating, in the evening, or when lying down or bending over. Heartburn occurs when stomach acid backs up into the tube that carries food from your mouth to your stomach (esophagus). This can cause a burning sensation in your chest or throat and an acidic or bitter taste in your mouth.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 6,
    "weighting": 3,
    "answers": [
      {
        "text": "Bowel Obstruction",
        "answer_number": 1
      },
      {
        "text": "Constipation",
        "answer_number": 2
      },
      {
        "text": "Carcinoma",
        "answer_number": 3
      },
      {
        "text": "Diarrhoea",
        "answer_number": 4
      },
      {
        "text": "Haemorrhoids",
        "answer_number": 5
      },
      {
        "text": "Heartburn",
        "answer_number": 6
      },
      {
        "text": "Irritable bowel syndrome",
        "answer_number": 7
      },
      {
        "text": "Stomach Ulcer",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2612,
    "bank": "clinicalOtc",
    "title": "Which of the following is the most appropriate action for you?",
    "text": "A 35-year-old man comes to your pharmacy with a complaint of persistent cough. He says he has been coughing for more than three weeks and sometimes produces yellowish sputum. He has no fever, chest pain, shortness of breath or other symptoms. He is a non-smoker and has no other medical conditions or allergies. He has tried several over-the-counter cough remedies, but none of them have worked. He asks you to recommend something that can stop his cough.",
    "why": "Advise him to see his GP as soon as possible.\r\n\r\nRationale:\r\nPersistent Cough: The patient has been experiencing a cough for more than three weeks, which warrants further investigation, especially since it has not responded to over-the-counter remedies. NICE guidelines recommend that a cough lasting more than three weeks should be assessed by a healthcare professional to rule out any underlying causes such as infection, asthma, or other respiratory conditions.\r\n\r\nYellowish Sputum: The production of yellowish sputum may indicate an underlying infection, such as bronchitis. While the absence of fever, chest pain, or shortness of breath suggests it might not be severe, it still needs to be evaluated to determine the appropriate course of treatment, which may include antibiotics if a bacterial infection is suspected.\r\n\r\nNon-Smoker and No Other Medical Conditions: Although the patient is a non-smoker and does not have other medical conditions, the persistence of the cough along with sputum production should not be dismissed. Persistent coughs can sometimes be linked to conditions such as chronic bronchitis, asthma, or even gastroesophageal reflux disease (GERD). Referral to the GP is essential to diagnose the cause accurately.\r\n\r\nOther Options:\r\n\r\nMucolytic Agent (Carbocisteine): This may help with mucus clearance, but it is not appropriate without a confirmed diagnosis.\r\nAntitussive Agent (Codeine): Codeine is not recommended as a first-line treatment for persistent cough, especially when the underlying cause is unknown, as it may mask symptoms.\r\nExpectorant (Guaifenesin): Although expectorants can help with mucus clearance, they are not appropriate without further evaluation in a persistent cough lasting more than three weeks.\r\nDrink Fluids and Rest: While staying hydrated and resting is beneficial, these general measures alone are insufficient in cases where the cough has persisted for an extended period.\r\n\r\nAccording to NICE guidelines, an acute cough that persists beyond three weeks is classified as a chronic cough and requires medical evaluation. NICE highlights that healthcare professionals should assess for:\r\n\r\nUnderlying infections (e.g., pneumonia or bronchitis)\r\nAsthma, especially if the patient has a history of wheezing or shortness of breath\r\nGastroesophageal reflux disease (GERD) as a possible cause of chronic cough\r\nPostnasal drip or rhinitis as potential contributors\r\nNICE also recommends that a persistent cough with sputum, particularly if it is coloured (e.g., yellow or green), should be investigated further to rule out bacterial infections or other conditions like chronic obstructive pulmonary disease (COPD) or lung cancer (in smokers).\r\n\r\nPatients with coughs that do not resolve with simple measures or over-the-counter treatments, or those showing additional symptoms like sputum production, should be referred to their GP for assessment and appropriate management.\r\n\r\nConclusion:\r\nThe most appropriate action is to advise the patient to see his GP as soon as possible to identify the underlying cause of the cough and receive appropriate treatment.\r\n\r\nFor more information watch the OTC lesson on chapter 2 Respiratory (cough):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise him to take a mucolytic agent such as carbocisteine",
        "answer_number": 1
      },
      {
        "text": "Advise him to take an antitussive agent such as codeine",
        "answer_number": 2
      },
      {
        "text": "Advise him to take an expectorant agent such as guaifenesin",
        "answer_number": 3
      },
      {
        "text": "Advise him to see his GP as soon as possible",
        "answer_number": 4
      },
      {
        "text": "Advise him to drink plenty of fluids and rest",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2547,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate action?\u00a0**",
    "text": "You receive a prescription for a 49-year-old female. She is currently in your community pharmacy and you notice that she is getting more aggressive and inpatient whilst she waits in the pharmacy.\u00a0\r\n\r\nAn extract of the prescription has been provided for you.\r\n\r\n![4](https://i.ibb.co/KKDthhV/4.png)",
    "why": "(a) Call the police immediately\r\n\r\nRationale:\r\n\r\nThe correct response is to call the police immediately. The NHS England guidelines advise pharmacists not to dispense potentially suspicious prescriptions under these circumstances, especially if a patient becomes aggressive. Pharmacists are advised to stall for time and verify the prescription with the prescriber using a verified, published contact number\u2014not the number listed on the prescription itself, which could be falsified.\r\n\r\nIf the patient remains in the pharmacy and becomes aggressive or poses a potential threat, calling 999 is essential to ensure the safety of staff and other customers. Additionally, pharmacists should notify NHS England and the NHS Counter Fraud Authority to report the incident, allowing further investigation and monitoring of potentially fraudulent or unsafe prescriptions.\r\n\r\nExplanation of Other Options:\r\n\r\n(b) Call the prescriber using the number on the prescription \u2013 Using the number on the prescription is discouraged as it may not be legitimate. NHS England recommends using a verified, public number.\r\n\r\n(c) Dispense both amoxicillin and diazepam \u2013 Dispensing the medication without verification may be unsafe, especially given the aggressive behavior and potential risk of misuse with diazepam, a controlled drug.\r\n\r\n(d) Dispense amoxicillin only \u2013 Partial dispensing without verification is also inappropriate in a suspicious scenario.\r\n\r\n(e) Tell her the medicine is not in stock and give the prescription back \u2013 This may not resolve the situation and could increase the potential for conflict without addressing safety concerns.\r\n\r\n\r\nWhen faced with a potentially aggressive patient presenting a prescription that includes controlled substances like diazepam, pharmacists are advised to prioritise safety and adhere to NHS England guidance. This includes refraining from dispensing the medication, verifying the prescriber's details using an official contact, and notifying the police if necessary. Reporting incidents to NHS England and NHS Counter Fraud Authority is crucial for broader monitoring and preventing prescription fraud or misuse.\r\n\r\n\r\nFor more information:\u00a0\r\n\r\nWatch MEP lesson on Chapter 1 ( Core concepts and skills)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep\r\n\r\nhttps://www.england.nhs.uk/south/wp-content/uploads/sites/6/2021/08/2021-22-forged-prescriptions-guidance.pdf",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Call the police immediately",
        "answer_number": 1
      },
      {
        "text": "Call the prescriber using the number on the prescription",
        "answer_number": 2
      },
      {
        "text": "Dispense both amoxicillin and diazepam",
        "answer_number": 3
      },
      {
        "text": "Dispense amoxicillin only",
        "answer_number": 4
      },
      {
        "text": "Tell her the medicine is not in stock and give the prescription back",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2396,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is the most appropriate advice?\u00a0**",
    "text": "A 45-year-old woman with multiple sclerosis (MS) has been prescribed Sativex oromucosal spray to reduce her muscle stiffness (spasticity). She asks you how to use the spray.\u00a0\r\n\r\nThe SmPC of Sativex has been provided for you\r\n\r\n[SmPC for Sativex](https://www.medicines.org.uk/emc/product/602/smpc#gref)",
    "why": "A) Start with one spray under the tongue in the evening and increase the dose gradually up to a maximum of 12 sprays per day, until they achieve optimum symptom relief.\r\n\r\nRationale:\r\n\r\nSativex is a cannabis-based medicine containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). It is licensed in the UK for the treatment of moderate to severe MS-related spasticity when other treatments have failed or caused intolerable side effects.\r\n\r\nThe starting dose for Sativex is one spray under the tongue or into the cheek in the evening. The dose is then gradually increased, typically by adding one spray per day, to a maximum of 12 sprays per day. The optimal dose varies for each patient and depends on achieving the best balance between symptom relief and tolerability.\r\n\r\nExplanation of Other Options:\r\n\r\nB) Start with two sprays in each cheek twice a day: This would exceed the recommended starting dose of Sativex, increasing the risk of side effects such as dizziness and fatigue.\r\n\r\nC) Start with one spray in each cheek three times a day: Maintaining a constant dose for four weeks without titration is not aligned with the guidance, as doses should be gradually adjusted based on the patient\u2019s response.\r\n\r\nD) Start with two sprays under the tongue once a day: Increasing the dose by two sprays weekly is too slow for achieving effective symptom management within a reasonable timeframe.\r\n\r\nE) Start with one spray under the tongue or in the cheek as needed: Sativex is not intended for \"as needed\" use, as consistent dosing is crucial for controlling MS-related spasticity effectively.\r\n\r\nSativex is a specialised medication approved for MS-related spasticity that has not responded adequately to conventional treatments. NICE guidelines recommend a trial period of Sativex to assess its effectiveness. Treatment should only continue if there is a clinically significant improvement in spasticity-related symptoms, such as reduced stiffness and improved mobility.\r\n\r\nPatients should be monitored closely for adverse effects, which may include dizziness, fatigue, dry mouth, or psychiatric effects (e.g., mood changes).\r\nDose adjustments should be individualised, as response and tolerance can vary significantly between patients.\r\n\r\nFor more information watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Start with one spray under the tongue in the evening and increase the dose gradually up to a maximum of 12 sprays per day, until they achieve optimum symptom relief.",
        "answer_number": 1
      },
      {
        "text": "Start with two sprays in each cheek twice a day and increase the dose by one spray every three days until she reaches a maximum of 12 sprays per day.",
        "answer_number": 2
      },
      {
        "text": "Start with one spray in each cheek three times a day and keep the dose constant for four weeks before reassessing the need for further adjustment.",
        "answer_number": 3
      },
      {
        "text": "Start with two sprays under the tongue once a day and increase the dose by two sprays every week until she experiences significant improvement in her spasticity symptoms.",
        "answer_number": 4
      },
      {
        "text": "Start with one spray under the tongue or in the cheek as needed and use no more than 10 sprays per day.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2252,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Analgesics**\r\n\r\n**Instruction: For the following scenarios select the most suitable analgesic in each of the following scenarios. Each option may be used once, more than once, or not at all**",
    "text": "A 9-year-old girl presents with her mum to your chemist after having fallen over and grazed her knee earlier that day. She is experiencing mild pain and mum tells you that she has a history of mild asthma and an allergy to penicillin.",
    "why": "Correct Answer:\r\n\r\nG) Paracetamol suspension\r\n\r\nRationale \r\n\r\nThe child has mild pain from a grazed knee, and the most suitable first-line analgesic in children is paracetamol.\r\n\r\n- Paracetamol is safe, well-tolerated, and effective for mild to moderate pain.\r\n\r\n- Paracetamol suspension is the preferred formulation for a 9-year-old child.\r\n\r\n- NSAIDs (e.g., ibuprofen, naproxen, diclofenac) should be avoided in children with asthma unless they have previously tolerated them.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Aspirin tablets \r\n\r\nAspirin is contraindicated in children under 16 years due to the risk of Reye\u2019s syndrome, a rare but serious condition affecting the liver and brain.\r\n\r\nB) Codeine liquid \r\n\r\nCodeine is not recommended in children under 12 years due to the risk of respiratory depression and variable metabolism.\r\n\r\nC) Diazepam tablets \r\n\r\nDiazepam is not an analgesic and is inappropriate for pain management.\r\n\r\nD) Diclofenac tablets \r\n\r\nNSAIDs like diclofenac should be avoided in children with asthma, as they can trigger bronchospasm.\r\n\r\n(E) Ibuprofen tablets \r\n\r\nAlthough ibuprofen is commonly used for pain relief, it should be avoided in children with asthma unless previous tolerance is confirmed.\r\n\r\nF) Naproxen tablets \r\n\r\nNaproxen is an NSAID, which may worsen asthma symptoms.\r\nIt is also not typically used for mild pain in children.\r\n\r\n\r\nH) Tramadol capsules \r\n\r\nTramadol is an opioid and is not recommended for mild pain in children.\r\n\r\nPain Management in Children with Asthma \r\n\r\n- Paracetamol is the first-line analgesic for children due to its safety and effectiveness.\r\n\r\n- NSAIDs (ibuprofen, naproxen, diclofenac) should be avoided in children with asthma, as they can trigger bronchospasm unless the child has previously tolerated them.\r\n\r\n- Aspirin is contraindicated in children under 16 years due to the risk of Reye\u2019s syndrome.\r\n\r\n- Opioids like codeine and tramadol are not recommended for mild pain in children due to the risk of respiratory depression.\r\n\r\nFor minor injuries like grazes or cuts, pain management should be combined with wound cleaning, antiseptic application, and reassurance. In most cases, paracetamol suspension provides effective relief without risk of asthma exacerbation.\r\n\r\nFor more information, please watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "Aspirin tablets",
        "answer_number": 1
      },
      {
        "text": "Codeine liquid",
        "answer_number": 2
      },
      {
        "text": "Diazepam tablets",
        "answer_number": 3
      },
      {
        "text": "Diclofenac tablets",
        "answer_number": 4
      },
      {
        "text": "Ibuprofen tablets",
        "answer_number": 5
      },
      {
        "text": "Naproxen tablets",
        "answer_number": 6
      },
      {
        "text": "Paracetamol suspension",
        "answer_number": 7
      },
      {
        "text": "Tramadol capsules",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2239,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Medical emergencies**\r\n\r\n**Instruction: For the following scenarios select the correct dose and product that should be utilised in each of the following medical emergencies. Each option may be used once, more than once, or not at all**",
    "text": "A 57-year-old woman who is suffering from severe chest pains and shortness of breath and is unable to speak properly.",
    "why": "Correct Answer:\r\n\r\nG) 300 mg aspirin dispersible tablet\r\n\r\nRationale:\r\n\r\nThis patient is showing signs of a suspected myocardial infarction (MI) \u2014 severe chest pain, breathlessness, and difficulty speaking are red flag symptoms.\r\n\r\nAccording to NICE guidelines, NHS emergency protocols, and Resuscitation Council UK, a patient with suspected MI who is conscious should be given:\r\n\r\n- 300 mg of aspirin to chew or swallow (dispersible or soluble form), unless contraindicated (e.g. true aspirin allergy or active GI bleeding)\r\n\r\n- Aspirin works by inhibiting platelet aggregation, reducing clot formation, and improving outcomes in acute coronary syndromes. It is a first-line emergency intervention before paramedics arrive or definitive care is started.\r\n\r\nExplanation of Other Options:\r\n\r\nA) 150 micrograms adrenaline (1 mg/mL) \r\n\r\nThis is the paediatric dose for anaphylaxis, not MI.\r\n\r\nB) 500 micrograms adrenaline (1 mg/mL) \r\n\r\nAdult dose for anaphylaxis, not used in myocardial infarction unless cardiac arrest is involved with no output (in which case adrenaline is used during CPR).\r\n\r\nC) 1 mg glucagon injection \r\n\r\nUsed in severe hypoglycaemia when the patient is unconscious or unable to take oral glucose. Not indicated in MI.\r\n\r\nD) 2 mg chlorphenamine syrup \r\n\r\nAn antihistamine for mild allergic reactions. No role in cardiac chest pain.\r\n\r\nE) 5 mg diazepam rectal tube \r\n\r\nUsed for seizures, particularly status epilepticus, not MI.\r\n\r\nF) 20 mg isosorbide mononitrate \r\n\r\nUsed in angina prophylaxis, but not part of first-line emergency management for acute MI.\r\n\r\nH) 55 \u2013 110 mL Lucozade\u00ae \r\n\r\nTreats hypoglycaemia, not indicated for chest pain.\r\n\r\n- According to NICE guidelines (NG185 \u2013 Acute Coronary Syndromes) and NHS emergency care protocols, early administration of 300 mg of aspirin plays a vital role in reducing mortality from suspected myocardial infarction. \r\n\r\n- It works by inhibiting thromboxane A2, thereby reducing platelet aggregation and limiting further clot formation.       \r\n\r\n- In community or pre-hospital settings, if a patient presents with severe chest pain, is breathless, and still conscious, they should be offered 300 mg aspirin to chew, unless contraindicated. This can be given as a dispersible or soluble tablet and is safe even before a final diagnosis is confirmed. \r\n\r\n- The early use of aspirin in MI has been shown to significantly improve survival rates when combined with rapid emergency medical response.\r\n\r\nFor more information please watch BNF lesson Chapter 2 (Cardiovascular System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "150 micrograms (0.15 mL) of adrenaline (1 mg/mL)",
        "answer_number": 1
      },
      {
        "text": "500 micrograms (0.5 mL) of adrenaline (1 mg/mL)",
        "answer_number": 2
      },
      {
        "text": "1 mg glucagon injection",
        "answer_number": 3
      },
      {
        "text": "2 mg chlorphenamine syrup (4mg/5mL)",
        "answer_number": 4
      },
      {
        "text": "5 mg diazepam rectal tube",
        "answer_number": 5
      },
      {
        "text": "20 mg of isosorbide mononitrate",
        "answer_number": 6
      },
      {
        "text": "300mg aspirin dispersible tablet",
        "answer_number": 7
      },
      {
        "text": "55 \u2013 110 mL of Lucozade\u00ae energy drink",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2270,
    "bank": "clinicalTherapeutics",
    "title": "**What is the required fluid volume to keep the child hydrated prior to and after therapy?**",
    "text": "This question relates to the use of pamidronate and calcium supplementation in the treatment of osteogenesis imperfecta in paediatric patients. The child is 10 kg.\r\n\r\nA resource has been provided for this question\r\n\r\n[![2270-clinical-question-bank-min.png](https://i.postimg.cc/1zzCSQ9v/2270-clinical-question-bank-min.png)](https://postimg.cc/5XZq5DQz)",
    "why": "Correct Answer: \r\n\r\n1250 mL\r\n\r\nRationale:\r\n\r\nAccording to the provided table in the resource, fluid maintenance therapy is weight-dependent. For a child weighing 10\u201315 kg, the recommended daily fluid intake is 1.25 L/day (1250 mL). This ensures adequate hydration before and after pamidronate infusion, reducing the risk of nephrotoxicity and other complications associated with bisphosphonate therapy.\r\n\r\nPamidronate is a bisphosphonate used in paediatric patients with osteogenesis imperfecta (OI) to reduce bone fragility and improve bone density. It is administered via IV infusion and requires careful monitoring due to potential renal complications. Adequate hydration before and after infusion is crucial to prevent nephrotoxicity, a known adverse effect of bisphosphonates. NICE guidelines recommend optimising fluid balance and electrolyte status to minimise the risk of renal impairment. Additionally, calcium supplementation is required to prevent hypocalcaemia following bisphosphonate therapy. Monitoring of renal function, serum calcium, and vitamin D levels is advised throughout treatment.\r\n\r\nFor more information watch BNF lesson Chapter 6 (Endocrine System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "1250 mL",
        "answer_number": 1
      },
      {
        "text": "1500 mL",
        "answer_number": 2
      },
      {
        "text": "1800 mL",
        "answer_number": 3
      },
      {
        "text": "2000 mL",
        "answer_number": 4
      },
      {
        "text": "2500 mL",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2213,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Drugs used in musculoskeletal and joint diseases**\u2028\r\n\r\n**Instruction: For each of the scenarios below, select the single most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 65-year-old woman with polymyalgia rheumatica who has severe muscle pain and stiffness in her shoulders and hips.",
    "why": "Prednisolone is a corticosteroid drug that can be used for the treatment of severe muscle pain and stiffness in polymyalgia rheumatica. It has potent anti-inflammatory and immunosuppressive effects and can rapidly improve the symptoms and markers of inflammation. However, it can cause various adverse effects, such as osteoporosis, diabetes, hypertension, and infections, and should be tapered gradually to the lowest effective dose\u2075, p. 10-8)",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 8,
    "weighting": 3,
    "answers": [
      {
        "text": "Allopurinol",
        "answer_number": 1
      },
      {
        "text": "Colchicine",
        "answer_number": 2
      },
      {
        "text": "Febuxostat",
        "answer_number": 3
      },
      {
        "text": "Hydroxychloroquine",
        "answer_number": 4
      },
      {
        "text": "Methotrexate",
        "answer_number": 5
      },
      {
        "text": "Naproxen",
        "answer_number": 6
      },
      {
        "text": "Paracetamol",
        "answer_number": 7
      },
      {
        "text": "Prednisolone",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2356,
    "bank": "clinicalTherapeutics",
    "title": "**According to the NICE guidelines and BNF, what should be the maximum duration of treatment with this topical Vitamin D preparation?**",
    "text": "A 35-year-old patient with psoriasis has been prescribed a topical Vitamin D preparation.",
    "why": "D. 56 days\r\n\r\nRationale:\r\n\r\nAccording to NICE guidelines and the BNF, topical Vitamin D preparations should be applied once or twice a day for up to 8 weeks (56 days). This duration allows adequate time for the treatment to show therapeutic effects.\r\n\r\nIf the psoriasis does not improve after 4 weeks of concurrent treatment with a potent corticosteroid and the Vitamin D preparation, the corticosteroid should be stopped. The Vitamin D preparation can then be applied twice daily for the remaining weeks to complete the 8-week treatment course.\r\n\r\nFor patients unable to use topical corticosteroids, the Vitamin D preparation alone is an option. If there is no satisfactory response after 8 weeks, alternative treatments such as coal tar preparations should be considered, or the patient should be referred to a specialist.\r\n\r\nTopical Vitamin D preparations are a cornerstone for mild-to-moderate psoriasis management and must be used within the specified duration to ensure safety and efficacy without unnecessary prolonged exposure.\r\n\r\nFor more information watch BNF lesson Chapter 13 (Skin):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "14",
        "answer_number": 1
      },
      {
        "text": "28",
        "answer_number": 2
      },
      {
        "text": "42",
        "answer_number": 3
      },
      {
        "text": "56",
        "answer_number": 4
      },
      {
        "text": "84",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2542,
    "bank": "clinicalMep",
    "title": "**How long should the pharmacy record be retained in the pharmacy?**",
    "text": "The pharmacy record is an important document under the Responsible Pharmacist regulations 2008 (as amended)",
    "why": "(c) 5 years\r\n\r\nRationale:\r\n\r\nUnder the Responsible Pharmacist Regulations 2008 (as amended), the pharmacy record must be retained for 5 years. This record documents the pharmacist responsible for overseeing the safe and effective operation of the pharmacy each day, as well as any significant operational changes or procedures implemented during their shift. Keeping these records for five years ensures regulatory compliance and provides an auditable trail for potential investigations or inspections.\r\n\r\nOther Options Explained:\r\n\r\n(a) 2 years: Incorrect. Although certain documents like some NHS prescriptions need to be retained for two years, this retention period does not apply to the pharmacy record.\r\n\r\n(b) 3 years: Incorrect. There is no requirement under the Responsible Pharmacist Regulations to retain pharmacy records for three years.\r\n\r\n(d) 7 years: Incorrect. Seven years is not specified as the retention period for pharmacy records, though it may apply to other medical records in some contexts.\r\n\r\n(e) 10 years: Incorrect. The pharmacy record does not need to be retained for ten years, though this duration may apply to other clinical records in certain cases.\r\n\r\nAccording to the Medicines, Ethics, and Practice (MEP) guide, the Responsible Pharmacist (RP) must ensure an accurate and complete pharmacy record, documenting their time in charge of the pharmacy each day. This record includes key details such as the RP\u2019s name, registration number, the dates and times they assumed and relinquished responsibility, and any temporary absences. Additionally, any significant operational adjustments that ensure the safe and effective operation of the pharmacy, such as changes in staffing or procedures, must also be documented. The five-year retention ensures an audit trail that can support regulatory investigations or inspections if any operational concerns or legal queries arise within this period.\r\n\r\nFor more information watch MEP lesson chapter 4 (The Responsible Pharmacist)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "2 years",
        "answer_number": 1
      },
      {
        "text": "3 years",
        "answer_number": 2
      },
      {
        "text": "5 years",
        "answer_number": 3
      },
      {
        "text": "7 years",
        "answer_number": 4
      },
      {
        "text": "10 years",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 867,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following statements is correct regarding the carbon footprint of inhaler use?**",
    "text": "A 30-year-old woman with asthma visits her GP for a routine check-up. She is currently using a metered dose inhaler (MDI) containing salbutamol as a reliever and a MDI containing fluticasone and salmeterol as a preventer. She has good asthma control and no adverse effects from her inhalers. She expresses concern about the environmental impact of her inhalers\r\n\r\nAn extract from the NHS website has been provided for you.",
    "why": "Information from resource: Inhaler emissions account for approximately 3% of the NHS carbon footprint. The propellant used in metered dose inhalers is responsible for most of these emissions. Alternative options with a significantly lower carbon footprint exist, such as *dry powder inhalers*",
    "resource_image": "https://bucketeer-e785e884-c4af-45ab-9a36-63a60ccc6444.s3.amazonaws.com/bucketeer-e785e884-c4af-45ab-9a36-63a60ccc6444/media/public/bd3ee90f-ee0d-4808-bf04-5284b0f0a00a.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIARVGPJVYVHK6QIBWU%2F20250729%2Feu-west-1%2Fs3%2Faws4_request&X-Amz-Date=20250729T222430Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=f4e24d108990965321dcd95cc27beafd29240666a295a1a14d8b7320a33ac10f",
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Changing inhaler devices does not provide safe and effective care",
        "answer_number": 1
      },
      {
        "text": "Dry powder inhalers have a significantly lower carbon footprint compared to metered dose inhalers",
        "answer_number": 2
      },
      {
        "text": "Inhaler emissions account for approximately 4% of the NHS carbon footprint",
        "answer_number": 3
      },
      {
        "text": "The UK has the lowest metered dose inhalers prescribing rate compared with other European countries",
        "answer_number": 4
      },
      {
        "text": "The propellant used in metered dose inhalers is not responsible for most emissions",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 982,
    "bank": "clinicalOtc",
    "title": "**What is the most likely cause of her skin lesion?**",
    "text": "A 60-year-old woman comes to the pharmacy with a skin lesion on her nose. She says it has been there for a few months and sometimes bleeds. She has fair skin and a history of sunburns. She shows you a picture of the lesion on her phone. ![basal-cell-carcinoma](https://i.ibb.co/pdfbRn2/basal-cell-carcinoma.jpg)",
    "why": "Basal cell carcinoma (BCC) is the most common type of skin cancer, caused by damage to the DNA of the basal cells in the epidermis\u00b9. BCCs often appear as shiny, pearly or translucent bumps or patches with small blood vessels, rolled borders or a central ulcer\u00b2. BCCs are usually associated with chronic exposure to ultraviolet (UV) radiation from sunlight or tanning beds, especially in people with fair skin",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Allergic reaction",
        "answer_number": 1
      },
      {
        "text": "Basal cell carcinoma",
        "answer_number": 2
      },
      {
        "text": "Melanoma",
        "answer_number": 3
      },
      {
        "text": "Psoriasis",
        "answer_number": 4
      },
      {
        "text": "Squamous cell carcinoma",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 980,
    "bank": "clinicalMep",
    "title": "A 55 year old patient presenting the pharmacy with an owing slip for zopiclone 3.75mg tablets",
    "text": "**Theme: Timeframes**\r\n\r\n**For the following descriptions, please select the most suitable validity of prescriptions from or after the appropriate date, from the list. Each option may be used once, more than once or not at all.**",
    "why": "Owing slips for schedule 2 - 4 CDs are valid for 28 days after the appropriate date on the prescription.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "7 days",
        "answer_number": 1
      },
      {
        "text": "28 days",
        "answer_number": 2
      },
      {
        "text": "30 days",
        "answer_number": 3
      },
      {
        "text": "6 months",
        "answer_number": 4
      },
      {
        "text": "2 years",
        "answer_number": 5
      },
      {
        "text": "5 years",
        "answer_number": 6
      },
      {
        "text": "7 years",
        "answer_number": 7
      },
      {
        "text": "10 years",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 990,
    "bank": "clinicalOtc",
    "title": "A 25-year old woman under a lot of stress due to her job; she is suffering from abdominal pain with alternating constipation and diarrhoea",
    "text": "**Theme: Gastroenterology conditions**\r\n\r\n\u2028\u2028**Instruction: select the most appropriate gastroenterology condition correlating with the symptoms associated with each patient. Each option may be used once, more than once or not at all**",
    "why": "The most suitable condition for the patient described is irritable bowel syndrome (IBS). IBS is a common disorder that affects the large intestine and can cause symptoms such as abdominal pain, bloating, constipation, and diarrhoea. Stress is a common trigger for IBS symptoms, and many people with IBS report that their symptoms worsen during periods of high stress.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "Bowel Obstruction",
        "answer_number": 1
      },
      {
        "text": "Constipation",
        "answer_number": 2
      },
      {
        "text": "Carcinoma",
        "answer_number": 3
      },
      {
        "text": "Diarrhoea",
        "answer_number": 4
      },
      {
        "text": "Haemorrhoids",
        "answer_number": 5
      },
      {
        "text": "Heartburn",
        "answer_number": 6
      },
      {
        "text": "Irritable bowel syndrome",
        "answer_number": 7
      },
      {
        "text": "Stomach Ulcer",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 886,
    "bank": "clinicalOtc",
    "title": "A 18-year old girl with small fluid filled blisters on the edge of the lip which is slightly painful",
    "text": "**Theme: Dermatology Conditions**\u2028\u2028\r\n\r\n**For the patient described, please select the most suitable condition. Each option may be used once, more than once or not at all**",
    "why": "Cold sores are caused by herpes simplex virus 1 and begin as small fluid-filled blisters that develop on the lips or around the mouth and can be slightly painful which then crusts over. Usually cold sores clear up on their own within 10 days however antiviral creams such as aciclovir (Zovirax) stops further viral replication therefore is a suitable OTC treatment.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Acne Vulgaris",
        "answer_number": 1
      },
      {
        "text": "Contact Dermatitis",
        "answer_number": 2
      },
      {
        "text": "Cold Sore",
        "answer_number": 3
      },
      {
        "text": "Eczema",
        "answer_number": 4
      },
      {
        "text": "Impetigo",
        "answer_number": 5
      },
      {
        "text": "Mouth ulcers",
        "answer_number": 6
      },
      {
        "text": "Oral Thrush",
        "answer_number": 7
      },
      {
        "text": "Psoriasis",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2230,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate initial dose of subcutaneous diamorphine for this patient?**",
    "text": "A 55-year-old woman with advanced breast cancer has been taking morphine modified-release tablets 100 mg twice daily and morphine 10 mg/5mL oral solution, 5mL QDS for breakthrough pain. She has been experiencing difficulty swallowing and vomiting as side effects of morphine. Her palliative care team decides to switch her to subcutaneous diamorphine via a continuous syringe driver.\u00a0\r\n\r\n![morphinetable](https://i.ibb.co/WGZRmV0/morphinetable.png \"900x800\")",
    "why": "Correct Answer: \r\n\r\nB) 80 mg/24 hours\r\n\r\nRationale:\r\n\r\n- The patient was on 240 mg total oral morphine per 24 hours.\r\n\r\n- NICE and palliative care guidelines recommend converting oral morphine to subcutaneous diamorphine using the 3:1 ratio.\r\n\r\n- So: 240 mg oral morphine \u00f7 3 = 80 mg diamorphine s/c\r\n\r\n- This is confirmed by the table shown in the image.\r\n\r\nFor more information, please watch BNF lesson chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "50mg/24 hours",
        "answer_number": 1
      },
      {
        "text": "80mg/24 hours",
        "answer_number": 2
      },
      {
        "text": "100mg/24 hours",
        "answer_number": 3
      },
      {
        "text": "150mg/24 hours",
        "answer_number": 4
      },
      {
        "text": "200mg/24 hours",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2303,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate dose of citalopram oral drops for the patient?**",
    "text": "You are a pharmacist working in the stroke ward. One of your patients has been prescribed citalopram 40mg tablets. After a SaLT assessment, the patient\u2019s swallowing has been compromised therefore requires citalopram liquid.\r\nThe dose equivalence is provided below:\r\n4 oral drops of citalopram (8 mg) is equivalent in therapeutic effect to 10 mg tablets.",
    "why": "16 drops once daily\r\n\r\nRationale:\r\n\r\nThe patient has been prescribed citalopram 40 mg tablets but requires an alternative formulation due to swallowing difficulties. The dose equivalence provided states:\r\n\r\n4 drops = 8 mg\r\n\r\n10 mg tablets = 4 drops\r\n\r\nTo calculate the equivalent dose for 40 mg:\r\n\r\n10 mg tablets = 4 drops\r\n40 mg tablets = (40 mg \u00f7 10 mg) \u00d7 4 drops\r\n40 mg tablets = 16 drops\r\nThus, the correct dose of citalopram oral drops is 16 drops once daily, maintaining the therapeutic equivalence of 40 mg tablets.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 8 drops once daily\r\n\r\nThis corresponds to 20 mg tablets (half the required dose), leading to subtherapeutic effects and inadequate treatment of depression.\r\n\r\nB: 12 drops once daily\r\n\r\nThis is equivalent to 30 mg tablets, which is still lower than the required 40 mg dose and may lead to ineffective treatment.\r\n\r\nD: 20 drops once daily\r\n\r\nThis equates to 50 mg tablets, exceeding the prescribed dose and increasing the risk of adverse effects such as QT prolongation and hyponatraemia, especially in elderly patients or those with underlying cardiovascular risks.\r\n\r\nE: 24 drops once daily\r\n\r\nThis equates to 60 mg tablets, which exceeds the maximum recommended dose of citalopram, significantly increasing the risk of dose-dependent QT prolongation, serotonin syndrome, and other side effects.\r\n\r\nAccording to NICE guidelines (2025), citalopram is a commonly used SSRI for post-stroke depression. Patients who have suffered a stroke are at increased risk of developing depression, which can negatively impact recovery and rehabilitation.\r\n\r\nFor patients with swallowing difficulties post-stroke, liquid formulations should be considered, ensuring correct dose equivalence to prevent subtherapeutic dosing or overdosing. Special caution is advised in stroke patients due to the increased risk of hyponatraemia, especially in those with additional risk factors such as older age or concurrent diuretic use. Additionally, citalopram has been associated with QT prolongation, and doses above 40 mg daily should generally be avoided.\r\n\r\nHealthcare professionals should regularly monitor electrolytes (especially sodium) and conduct ECG monitoring in patients at risk of cardiac complications. \r\nNon-pharmacological interventions, including cognitive behavioural therapy (CBT), should also be considered alongside pharmacotherapy for optimal patient outcomes.\r\n\r\nFor more Information please watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "8 drops once daily",
        "answer_number": 1
      },
      {
        "text": "12 drops once daily",
        "answer_number": 2
      },
      {
        "text": "16 drops once daily",
        "answer_number": 3
      },
      {
        "text": "20 drops once daily",
        "answer_number": 4
      },
      {
        "text": "24 drops once daily",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2320,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following electrolyte imbalances is the patient most likely to experience as a side effect of this medication?**",
    "text": "A 50-year-old male patient has been diagnosed with hypertension. He has been prescribed a thiazide diuretic.",
    "why": "Hypokalemia\r\n\r\nRationale:\r\n\r\nThiazide diuretics, such as bendroflumethiazide and indapamide, are commonly used to treat hypertension. These medications work by inhibiting the sodium-chloride symporter in the distal convoluted tubule of the nephron, leading to increased sodium and water excretion. However, this process also promotes the excretion of potassium, resulting in hypokalemia, a common side effect characterised by low potassium levels in the blood.\r\n\r\nSymptoms of hypokalemia can include muscle weakness, fatigue, palpitations, and, in severe cases, arrhythmias. Patients taking thiazide diuretics should have their serum potassium levels monitored regularly, particularly if they are on medications that may exacerbate hypokalemia (e.g., beta-agonists or corticosteroids).\r\n\r\nExplanation of Other Options:\r\n\r\nA: Hypercalcemia\r\n\r\nThiazide diuretics reduce calcium excretion in the urine and may lead to mild hypercalcemia. However, hypercalcemia is less common compared to hypokalemia and is typically seen in predisposed individuals.\r\n\r\nB: Hyperkalemia\r\n\r\nThiazide diuretics promote potassium loss, making hyperkalemia highly unlikely. Potassium-sparing diuretics, such as spironolactone or amiloride, are associated with hyperkalemia.\r\n\r\nC: Hypermagnesemia\r\n\r\nThiazides increase urinary magnesium excretion, making hypomagnesemia more likely than hypermagnesemia.\r\n\r\nD: Hypocalcemia\r\n\r\nThiazides reduce calcium excretion, which increases serum calcium levels, reducing the risk of hypocalcemia.\r\n\r\nThiazide diuretics are first-line options for managing hypertension in adults over 55 years or in those of Black African or Caribbean descent, as recommended by NICE NG136. These diuretics effectively lower blood pressure by reducing sodium and water retention. However, common side effects include hypokalemia, hyponatremia, and hypomagnesemia, necessitating periodic electrolyte monitoring. Hypercalcemia may occur due to reduced calcium excretion but is less clinically significant compared to hypokalemia.\r\n\r\nPatients should be advised to recognise symptoms of electrolyte disturbances (e.g., muscle weakness or palpitations) and to maintain a balanced diet rich in potassium-containing foods like bananas and oranges. If hypokalemia becomes severe or symptomatic, potassium supplements or a combination therapy with potassium-sparing diuretics may be considered.\r\n\r\nFor more information please watch BNF lesson Chapter 2 (Cardiovascular System)\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Hypercalcemia",
        "answer_number": 1
      },
      {
        "text": "Hyperkalemia",
        "answer_number": 2
      },
      {
        "text": "Hypermagnesemia",
        "answer_number": 3
      },
      {
        "text": "Hypocalcemia",
        "answer_number": 4
      },
      {
        "text": "Hypokalemia",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2247,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following would be the most appropriate recommendation?**",
    "text": "A 38-year-old man presents with hay fever; his main symptoms are a runny nose and he would like a nasal spray to treat this. He has no known drug allergies and tells you that he is currently taking darunavir 800 mg, ritonavir 100 mg and Truvada\u00ae (emtricitabine and tenofovir) all at a dose of 1 tablet once daily.",
    "why": "A) Beclometasone nasal spray\r\n\r\nRationale:\r\n\r\nThis patient is taking darunavir, ritonavir, and Truvada\u00ae (emtricitabine/tenofovir) for HIV treatment. Ritonavir is a potent CYP3A4 inhibitor, which can increase the systemic absorption of corticosteroids that undergo significant hepatic metabolism. This can lead to iatrogenic Cushing\u2019s syndrome and adrenal suppression when combined with corticosteroids that have higher systemic bioavailability.\r\n\r\nAmong nasal corticosteroids, beclometasone is the safest option, as it has lower systemic bioavailability and is less affected by CYP3A4 inhibition.\r\n\r\nFluticasone and triamcinolone (Nasacort\u00ae) should be avoided, as they have higher systemic absorption, increasing the risk of serious corticosteroid side effects.\r\n\r\nOtrivine\u00ae (xylometazoline) is a decongestant that does not treat allergic rhinitis long-term and can cause rebound congestion (rhinitis medicamentosa).\r\n\r\nSterimar\u00ae (saline nasal spray) only helps nasal irrigation and does not reduce inflammation, making it less effective for hay fever.\r\n\r\nExplanation of Other Options:\r\n\r\nB) Fluticasone nasal spray\r\n\r\nNot appropriate because it is highly metabolised by CYP3A4, and co-administration with ritonavir has been associated with iatrogenic Cushing\u2019s syndrome and adrenal suppression.\r\nNICE advises avoiding fluticasone in patients taking protease inhibitors (PIs) such as darunavir/ritonavir.\r\n\r\nC) Nasacort\u00ae (Triamcinolone nasal spray)\r\n\r\nNot recommended because it is also metabolised by CYP3A4 and has a higher systemic absorption than beclometasone, increasing the risk of adrenal suppression when taken with ritonavir.\r\n\r\nD) Otrivine\u00ae (Xylometazoline nasal drops)\r\n\r\nNot suitable for allergic rhinitis because it is a nasal decongestant, not a treatment for allergic rhinitis.\r\nProlonged use beyond seven days can lead to rebound congestion (rhinitis medicamentosa).\r\n\r\nE) Sterimar\u00ae (Saline nasal spray)\r\n\r\nNot an effective choice because saline nasal sprays can help clear allergens and mucus but do not reduce inflammation, making them a supportive but insufficient treatment for hay fever.\r\n\r\n\r\n\r\n\r\n\r\n\r\nCorticosteroid Nasal Sprays and CYP3A4 Inhibition:\r\n\r\nCorticosteroid nasal sprays are commonly used for allergic rhinitis. However, CYP3A4 inhibitors (e.g., ritonavir, cobicistat) can increase the systemic effects of some corticosteroids, leading to Cushing\u2019s syndrome and adrenal suppression.\r\n\r\nKey considerations when prescribing nasal corticosteroids in patients on CYP3A4 inhibitors include avoiding fluticasone and triamcinolone due to their higher systemic bioavailability and risk of Cushing\u2019s syndrome/adrenal suppression. Beclometasone is preferred due to its lower systemic absorption and minimal interaction with CYP3A4 inhibitors.\r\n\r\nPatients should be monitored for systemic corticosteroid side effects, such as weight gain, moon face, skin thinning, and fatigue, especially if using corticosteroids long term. If systemic corticosteroid effects occur, the intranasal steroid should be reviewed and switched if needed.\r\n\r\nSince beclometasone has the lowest systemic absorption and minimal risk of interaction with ritonavir, the correct answer is:\r\n\r\nA) Beclometasone nasal spray\r\n\r\nFor more information please watch BNF lesson Chapter 12 (Ear Nose and Throat):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Beclometasone nasal spray",
        "answer_number": 1
      },
      {
        "text": "Fluticasone nasal spray",
        "answer_number": 2
      },
      {
        "text": "Nasacort\u00ae nasal spray",
        "answer_number": 3
      },
      {
        "text": "Otrivine\u00ae nasal drops",
        "answer_number": 4
      },
      {
        "text": "Sterimar\u00ae nasal spay",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2468,
    "bank": "clinicalTherapeutics",
    "title": "**What is the maximum infusion rate of Nutriflex peri solution for infusion?**",
    "text": "A 60-year-old male patient with malnutrition is admitted to the hospital. He has been initiated on Nutriflex peri solution. The patient's weight is 65 kg.\r\n\r\n\r\nThe SmPC for Nutriflex Peri Solution has been provided for this question. [SmPC for Nutriflex](https://www.medicines.org.uk/emc/product/15206/smpc#gref)",
    "why": "C. 130 ml/hour\r\n\r\nExplanation\r\n\r\nThe SmPC (Summary of Product Characteristics) for Nutriflex Peri solution states:\r\n\r\nMaximum infusion rate: 2 ml per kg body weight per hour.\r\n\r\nFor a patient weighing 65 kg:\r\n\r\n2ml/kg/hour\u00d765kg=130ml/hour.\r\n\r\nThis infusion rate corresponds to:\r\n\r\nAmino acids: up to 0.08 g/kg/hour.\r\nGlucose: up to 0.16 g/kg/hour.\r\nThe calculated rate ensures that the patient's nutritional and metabolic needs are met without overloading the system.\r\n\r\nNutriflex peri solution is typically administered continuously to reduce the risk of complications such as hyperglycaemia, electrolyte imbalances, or fluid overload.\r\nMonitoring of serum glucose, electrolytes, and hydration status is essential during administration.\r\n\r\nFor more information please watch BNF lesson Chapter 9 (Blood and Nutrition)\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "50 ml/hour",
        "answer_number": 1
      },
      {
        "text": "100 ml/hour",
        "answer_number": 2
      },
      {
        "text": "130 ml/hour",
        "answer_number": 3
      },
      {
        "text": "200 ml/hour",
        "answer_number": 4
      },
      {
        "text": "250 ml/hour",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2569,
    "bank": "clinicalOtc",
    "title": "**What is the most suitable dose of paracetamol for this child?**",
    "text": "You have been asked by the paediatric registrar as to a suitable licensed dose of paracetamol oral suspension for a child who requires it following a small procedure. The child is 7-year-old and weighs 22 kg.",
    "why": "b) 250 mg every 4-6 hours, max 4 doses per day\r\n\r\nRationale:\r\n\r\nFor a 7-year-old child weighing 22 kg, the most appropriate licensed dose of paracetamol oral suspension is 250 mg every 4-6 hours, with a maximum of 4 doses in 24 hours. According to the BNF for Children, the typical paracetamol dose for children aged 6-8 years is 250 mg, which aligns with their weight and age group. This dose ensures effective pain relief while adhering to safety guidelines and avoiding the risk of overdose.\r\n\r\nExplanation of Other Options:\r\n\r\na) 180 mg every 4-6 hours, max 4 doses per day: This dose is below the recommended amount for a 7-year-old child and may not provide sufficient pain relief after a procedure.\r\nc) 330 mg every 4-6 hours, max 4 doses per day: This dose exceeds the standard recommended dose for this age and weight category, increasing the risk of side effects or overdose.\r\nd) 440 mg every 4-6 hours, max 4 doses per day: This dose is also too high for a 7-year-old and may be unsafe, as it surpasses the recommended limits for both age and weight.\r\ne) 500 mg every 4-6 hours, max 4 doses per day: 500 mg is the typical dose for older children and adults, making it unsuitable and potentially harmful for a 7-year-old weighing 22 kg.\r\n\r\nAccording to NICE guidelines and the BNF for Children, paracetamol dosing in pediatric patients should be based on both age and weight to ensure efficacy and safety. The dosing range generally allows for every 4-6 hours administration, with a maximum of four doses within 24 hours. Proper dosing is crucial to avoid potential toxicity, particularly in younger children. For acute pain relief following procedures, ensuring adequate but safe dosing of analgesics like paracetamol is key to effective symptom management without overexposure to medication.\r\n\r\n\r\n\r\nFor more information please watch BNF lesson chapter 4 (central nervous system):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "180 mg every 4-6 hours, max 4 doses per day",
        "answer_number": 1
      },
      {
        "text": "250 mg every 4-6 hours, max 4 doses per day",
        "answer_number": 2
      },
      {
        "text": "330 mg every 4 -6 hours, max 4 doses per day",
        "answer_number": 3
      },
      {
        "text": "440 mg every 4-6 hours, max 4 doses per day",
        "answer_number": 4
      },
      {
        "text": "500mg every 4-6 hours, max 4 doses per day",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2564,
    "bank": "clinicalOtc",
    "title": "**What is the most suitable product to recommend in this scenario?**",
    "text": "A 28-year-old female who is 12 weeks pregnant comes to your community pharmacy with a complaint of nasal congestion and sneezing for the past four days. She says she has no fever, chest pain, or weight loss. She has no other medical conditions or allergies. She does not smoke and works as a librarian. She asks you for a product to relieve her nasal congestion.",
    "why": "E) A product containing saline nasal spray or drops.\r\n\r\nRationale: \r\n\r\nIn this scenario, recommending a saline nasal spray or drops is the safest and most suitable option for a pregnant woman experiencing nasal congestion. Saline solutions help to moisten the nasal passages and effectively relieve congestion without the risks associated with medicated nasal decongestants, which may not be advised during pregnancy.\r\n\r\nExplanation of Other Options:\r\n\r\nA) A product containing paracetamol and phenylephrine is not recommended due to potential risks associated with phenylephrine during pregnancy. While paracetamol is safe, combining it with a decongestant could pose unnecessary risks.\r\nB) A product containing ibuprofen and pseudoephedrine is contraindicated during pregnancy, especially in the third trimester, due to potential adverse effects on the fetus.\r\nC) A product containing acetylcysteine and guaifenesin is typically used for mucolytic and expectorant purposes but does not address nasal congestion directly and is not recommended in pregnancy without medical advice.\r\nD) A product containing xylometazoline is a topical decongestant that should be used with caution during pregnancy due to potential systemic absorption and associated risks.\r\n\r\n\r\nAccording to NICE guidelines, managing nasal congestion in pregnant women should prioritise non-pharmacological treatments whenever possible. Saline nasal sprays or drops are safe and effective products for relieving nasal congestion in pregnant women. They work by moistening the nasal passages and thinning the mucus, making it easier to clear. Saline solutions have no adverse effects and can be used as often as needed. The other products are not suitable because paracetamol and phenylephrine are oral sympathomimetics that can relieve pain and nasal congestion, but they may cause adverse effects such as hypertension, hyperglycaemia, and fetal growth restriction. Ibuprofen and pseudoephedrine can have similar effects as paracetamol and phenylephrine, but they may also cause adverse effects such as gastric irritation, hypertension, hyperglycaemia, and fetal malformations. Acetylcysteine and guaifenesin are expectorants that may loosen mucus and ease cough, but they have limited evidence of efficacy and may cause nausea, vomiting, and rash. Xylometazoline is a nasal sympathomimetic that can reduce nasal congestion by narrowing the blood vessels in the nose, but it may cause adverse effects such as rebound congestion, hypertension, and tachycardia. It is essential for healthcare providers to remain cautious in recommending treatments and to support patients in making informed decisions about their health during pregnancy.\r\n\r\nFor more information please watch BNF lesson chapter 2 (Respiratory):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "A product containing paracetamol and phenylephrine",
        "answer_number": 1
      },
      {
        "text": "A product containing ibuprofen and pseudoephedrine",
        "answer_number": 2
      },
      {
        "text": "A product containing acetylcysteine and guaifenesin",
        "answer_number": 3
      },
      {
        "text": "A product containing xylometazoline",
        "answer_number": 4
      },
      {
        "text": "A product containing saline nasal spray or drops",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2576,
    "bank": "clinicalOtc",
    "title": "**What is the age restriction of the steroid cream Clobetasone 0.05% over the counter?**",
    "text": "Steroid creams can be purchased over the counter for skin conditions.",
    "why": "c) 12 years and over\r\n\r\nRationale:\r\n\r\nClobetasone 0.05% cream is a mild-to-moderate potency steroid and is one of the few corticosteroids that can be sold over the counter (OTC) for treating skin conditions such as eczema and dermatitis. According to OTC regulations, clobetasone 0.05% should only be used in individuals aged 12 years and over for safe and effective management of mild to moderate inflammatory skin conditions. For younger children, steroid creams should be prescribed by a healthcare provider to ensure appropriate use and monitoring due to the potential for skin thinning and other side effects with improper use.\r\n\r\nExplanation of Options\r\n\r\na) 8 years and over\r\n\r\nIncorrect. Clobetasone 0.05% is not approved for OTC use in children under 12 due to safety considerations, such as a higher risk of skin atrophy in younger skin.\r\n\r\nb) 10 years and over\r\n\r\nIncorrect. Although the lower age threshold for some medications may be set at 10 years, clobetasone is restricted to individuals aged 12 and over for OTC sales.\r\n\r\nc) 12 years and over\r\n\r\nCorrect. Clobetasone 0.05% can be sold OTC for patients aged 12 years and above, making this the correct answer.\r\n\r\nd) 15 years and over\r\n\r\nIncorrect. While certain medications might restrict use to 15 years and above, clobetasone is safe to use in patients 12 years and older when used correctly.\r\n\r\ne) 18 years and over\r\n\r\nIncorrect. Clobetasone 0.05% does not have an age restriction of 18 for OTC sales; the correct age limit for OTC use is 12 years and over.\r\nSummary of Steroid Cream Usage According to NICE Guidelines\r\nSteroid creams are commonly used for managing inflammatory skin conditions such as eczema and dermatitis. According to NICE guidelines, low-to-moderate potency corticosteroids like clobetasone can be recommended for short-term use to reduce inflammation and symptoms. For OTC use, clobetasone 0.05% is limited to individuals aged 12 years and over. It is important to advise patients to follow application guidelines to avoid potential side effects, including skin thinning and irritation, particularly when used on delicate areas or for extended periods.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "8 years and over",
        "answer_number": 1
      },
      {
        "text": "10 years and over",
        "answer_number": 2
      },
      {
        "text": "12 years and over",
        "answer_number": 3
      },
      {
        "text": "15 years and over",
        "answer_number": 4
      },
      {
        "text": "18 years and over",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2589,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the patient's symptoms?**",
    "text": "A 25-year-old man presents to the pharmacy with a circular rash on his left arm. He says it is itchy and scaly, and he noticed it a week ago after playing with his friend's dog. He has no other symptoms or medical conditions. He shows you a picture of the rash on his phone.\r\n\r\n![ringworm](https://i.ibb.co/SVYSt4B/ringworm.jpg \"650x500\")",
    "why": "### Correct Answer: **Ringworm**\r\n\r\n### Rationale:\r\n\r\nThe most likely cause of this patient's symptoms is **ringworm** (tinea corporis), a fungal infection characterized by an **itchy, scaly, circular rash**. The rash typically has a **raised, red border with a clear center**, which is a hallmark of this type of infection. The fact that the rash appeared after playing with a dog is significant, as **ringworm can be transmitted from animals to humans**. Ringworm is commonly caused by dermatophytes, fungi that thrive on the keratin found in skin, hair, and nails.\r\n\r\n### Explanation of Other Options:\r\n\r\n- **Contact dermatitis**: Usually causes red, itchy, inflamed skin after direct contact with an allergen or irritant. The rash tends to appear in the area that came into contact with the substance, but it is not typically circular or scaly.\r\n- **Eczema**: A chronic skin condition that causes patches of red, inflamed, and itchy skin, but it usually does not form a well-defined circular rash like ringworm. It also tends to appear in areas prone to dryness.\r\n- **Impetigo**: A bacterial infection characterized by red sores or blisters that ooze and form a golden crust. It is not typically circular, scaly, or associated with animals.\r\n- **Psoriasis**: Causes thick, scaly patches of skin, often on the elbows, knees, or scalp. The rash is not circular and tends to have white or silver scales, not ring-shaped lesions.\r\n\r\nAccording to NICE guidelines, **ringworm** is a common fungal infection that causes a **ring-shaped rash** on the skin. It can be passed on through **contact with infected animals, people, or objects**. The rash may look **red or darker than the surrounding skin**, depending on the skin tone, and may be **scaly, dry, swollen, or itchy**. The other options are less likely because they have different features or triggers. \r\n\r\nFor instance:\r\n\r\n- **Psoriasis** causes thick, silvery scales on red patches of skin.\r\n- **Eczema** causes dry, cracked, and inflamed skin that may ooze fluid.\r\n- **Impetigo** causes blisters or sores that crust over and are usually yellowish.\r\n- **Contact dermatitis** triggers an allergic reaction to something that touches the skin, such as soap, detergent, or cosmetics.\r\n\r\nRingworm is commonly treated with **topical antifungal agents** like **terbinafine** or **clotrimazole**, typically applied for 1\u20134 weeks. For more severe or resistant cases, **oral antifungal medications** may be required. Maintaining proper hygiene and avoiding direct contact with infected animals or humans can help prevent its spread.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Contact dermatitis",
        "answer_number": 1
      },
      {
        "text": "Eczema",
        "answer_number": 2
      },
      {
        "text": "Impetigo",
        "answer_number": 3
      },
      {
        "text": "Psoriasis",
        "answer_number": 4
      },
      {
        "text": "Ringworm",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2585,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of her symptoms?**",
    "text": "A 24 year old female patient presents to the pharmacy, she explains the corners of her mouth air sore and red and cracked.\u00a0\r\n![\"angular-cheilitis-0006-Watermarked-Wy-JXYXRlcm1hcmtl-ZCJd](https://i.ibb.co/TkP0vnh/angular-cheilitis-0006-Watermarked-Wy-JXYXRlcm1hcmtl-ZCJd.jpg \"650x500\")",
    "why": "Angular cheilitis\r\n\r\nRationale: \r\n\r\nThe most likely diagnosis is angular cheilitis, which causes red, sore fissures at the corners (angles) of the mouth. It can result from a fungal or bacterial infection, nutritional deficiencies (such as vitamin B12 or iron deficiency), or mechanical irritation, such as licking the lips or wearing poorly fitted dentures. It is commonly associated with Candida or Staphylococcus aureus infections, and treatment may involve anti-fungal or antibacterial medication, as well as improving oral hygiene.\r\n\r\nThe other options are less likely because:\r\n\r\nAphthous ulcers (mouth ulcers) occur inside the mouth, not at the corners. Minor aphthous ulcers are less than 1 cm in size and can appear singly or in clusters of up to 5. Major aphthous ulcers are larger than 1 cm and can appear in numbers up to 10 at a time.\r\nDermatitis around the mouth (perioral dermatitis) usually appears as acne-like red bumps on the lower half of the face, rather than isolated soreness at the corners of the mouth.\r\nHerpes simplex (cold sores - HSV 1) typically begins as a tingling sensation on the lip, progressing to a fluid-filled blister that later crusts over. It usually does not cause fissures at the corners of the mouth.\r\nImpetigo is common in children but can affect adults as well. It is caused by Staphylococcus aureus or Streptococcus pyogenes. Impetigo starts as a red rash with vesicles around the nose and mouth, which ooze and form a distinctive \"golden crust.\" It does not typically present as soreness limited to the corners of the mouth.\r\n\r\n\r\nAccording to NICE guidelines, angular cheilitis is often linked to Candida or Staphylococcus aureus infection, with contributing factors such as drooling, lip licking, or wearing dentures. Treatment should target the underlying cause, whether it is an infection, a nutritional deficiency, or mechanical irritation. Using barrier creams or emollients can protect the area from further irritation. Referral is advised for recurrent or severe cases, which may require more comprehensive investigation and treatment.**Image reference: DermNetnz.org**\r\n\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Angular chelitis",
        "answer_number": 1
      },
      {
        "text": "Amphous ulcers",
        "answer_number": 2
      },
      {
        "text": "Dermatitis",
        "answer_number": 3
      },
      {
        "text": "Herpes simplex",
        "answer_number": 4
      },
      {
        "text": "Impetigo",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2595,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 29 year old male patient presents to the pharmacy with an acute onset of watery diarrhoea. He has had these symptoms for the past 4 days, and recently travelled back from indonesia. He has no allergies. His regular medication is below:\u00a0\r\n\r\nLevetiracetam 500mg tablets\r\nClobazam 10mg tablets",
    "why": "He should see his GP as soon as possible for antibiotic treatment\r\n\r\nRationale:\r\n\r\nThe patient presents with acute watery diarrhoea after recent travel to Indonesia, which raises concern for traveller's diarrhoea, likely caused by bacterial or parasitic infection (such as E. coli, Salmonella, or Giardia). Traveller\u2019s diarrhoea is typically treated with antibiotics, particularly if the symptoms last more than a couple of days or involve severe dehydration. Given the prolonged symptoms and the travel history, a GP visit is important for appropriate testing and management, which may include antibiotics depending on the cause.\r\n\r\nExplanation of Other Options:\r\n\r\nHe is experiencing a side effect of levetiracetam: While levetiracetam can cause gastrointestinal side effects, diarrhoea is uncommon, and acute onset following travel makes infection a more likely cause.\r\n\r\nHis symptoms are viral in origin and therefore self-limiting: Although viral causes of diarrhoea are possible, the recent travel history increases the likelihood of bacterial or parasitic infection, which might require specific treatment like antibiotics.\r\n\r\nStop taking levetiracetam straight away and see his GP: There is no indication that the diarrhoea is related to levetiracetam, and stopping it suddenly could risk worsening seizure control. Therefore, stopping the medication without consulting a GP would not be appropriate.\r\n\r\nSell loperamide 2mg capsules for symptomatic treatment: Loperamide can be useful for symptom relief in uncomplicated diarrhoea, but it is not recommended for traveller\u2019s diarrhoea caused by bacterial infections, as it can prolong the illness by trapping the bacteria in the intestines. Proper evaluation and antibiotic treatment are more appropriate in this case.\r\n\r\nTraveller\u2019s diarrhoea is a common condition for people returning from areas with lower sanitation standards. It is often caused by bacterial infections (most commonly E. coli) but can also be viral or parasitic. NICE recommends that patients with diarrhoea lasting more than 3 days, or those with severe symptoms (e.g., fever, blood in stool, dehydration), should seek medical attention for possible antibiotic treatment. For less severe cases, hydration and self-care measures may be sufficient. Anti-motility agents like loperamide should be used with caution and only in uncomplicated cases, as they may worsen bacterial infections.\r\n\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "He is experiencing a side effect of levetiracetam, and whilst safe to continue taking it, he may wish to see her GP for an alternative",
        "answer_number": 1
      },
      {
        "text": "His symptoms are viral in origin and therefore self limiting.",
        "answer_number": 2
      },
      {
        "text": "He should see his GP as soon as possible for antibiotic treatment",
        "answer_number": 3
      },
      {
        "text": "Stop taking levetiracetam straight away and see his GP as soon as possible",
        "answer_number": 4
      },
      {
        "text": "Sell loperamide 2mg capsules for symptomatic treatment.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2606,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the patient's symptoms?**",
    "text": "A 42 year old female patient presents to the pharmacy regarding a problem with her mouth.\u00a0\r\nA picture of the patient\u2019s mouth is presented below:\r\n![mouth-ulcer](https://i.ibb.co/YTrk83d/mouth-ulcer.jpg \"650x500\")",
    "why": "The most likely cause of the patient\u2019s symptoms is:\r\n\r\nMinor aphthous ulcer.\r\n\r\nRationale: \r\n\r\nMinor aphthous ulcers are the most common type of mouth ulcer. They usually appear as small, round or oval sores with a white or yellow centre and a red border. These ulcers are generally less than 1 cm in diameter, occur on the non-keratinised mucosa (such as the inside of the lips, cheeks, or under the tongue), and heal within 1\u20132 weeks without scarring. The description and the typical location of the ulcer in the patient\u2019s mouth match these characteristics.\r\n\r\nMajor aphthous ulcers are larger (greater than 1 cm), deeper, and can take several weeks to heal, often leaving scars.\r\nMedicine-induced ulcers are typically associated with medications such as NSAIDs or chemotherapeutic agents. If the patient had a relevant medication history, this would be considered.\r\n\r\nHerpetiform ulcers are multiple tiny ulcers that may fuse together, unlike the single ulcer observed.\r\nOral carcinoma often presents as a persistent, non-healing sore or ulcer with indurated (hard) edges, which does not match the appearance of a minor aphthous ulcer.\r\n\r\nNICE Guidance on Management of Minor Aphthous Ulcers\r\n\r\nAccording to NICE guidelines, the management of minor aphthous ulcers includes:\r\n\r\nTopical Analgesics: Application of topical anaesthetics like lidocaine gel can provide temporary pain relief.\r\n\r\nAntiseptic Mouthwashes: Using chlorhexidine mouthwash may reduce bacterial growth and promote healing, although it may not alleviate pain.\r\n\r\nTopical Steroids: Hydrocortisone buccal tablets or other mild corticosteroids can be used to reduce inflammation and promote healing if symptoms are severe.\r\n\r\nDiet and Irritant Avoidance: Advising the patient to avoid spicy, acidic, or rough-textured foods that may aggravate the ulcer can help minimise discomfort.\r\n\r\nAdditional Insights\r\n\r\nMinor aphthous ulcers are usually self-limiting and often do not require specific medical treatment beyond symptom management. Stress, hormonal changes, or minor trauma (e.g., biting the inside of the cheek) are common triggers for these ulcers. While they are generally harmless, recurrent episodes may warrant further investigation to rule out underlying systemic conditions like nutrient deficiencies (e.g., iron, vitamin B12) or gastrointestinal disorders (e.g., coeliac disease).\r\n\r\nEducating patients on good oral hygiene and the importance of a balanced diet can also help in preventing recurrence. If the ulcer persists beyond two weeks or if the patient experiences recurrent episodes with severe symptoms, referral to a GP or dentist for further evaluation may be necessary to rule out other causes.\r\n\r\nFor more information watch OTC lesson on Chapter 8 Dermatology:\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Major aphthous ulcer",
        "answer_number": 1
      },
      {
        "text": "Minor aphthous ulcer",
        "answer_number": 2
      },
      {
        "text": "Medicine induced ulcer",
        "answer_number": 3
      },
      {
        "text": "Herpetiform ulcers",
        "answer_number": 4
      },
      {
        "text": "Oral carcinoma",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2622,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A mother presents to the pharmacy requesting her advice for her 15 year old daughter. She informs you her daughter is suffering from insomnia. She has been suffering with insomnia over the past 5 days due to exam stress.",
    "why": "OTC products for insomnia cannot be sold to those under the age of 16.\r\n\r\n\r\n- **Definition**: Insomnia involves difficulty falling or staying asleep, or poor sleep quality, despite adequate opportunity, causing daytime impairment.\r\n\r\n- **Daytime Symptoms**: Fatigue, mood disturbances, irritability, cognitive issues.\r\n\r\n- **Types**:\r\n  - **Short-term**: Lasts <3 months, often due to stress or changes.\r\n  - **Chronic**: Lasts \u22653 months, often linked to medical or psychiatric conditions.\r\n\r\n- **Assessment**: Includes history, evaluation, and a sleep diary.\r\n\r\n- **Treatment**:\r\n  - **Sleep hygiene** and **CBTi** are first-line.\r\n  - Hypnotics (e.g., z-drugs) for short-term, severe insomnia, with caution in older adults.\r\n  - Avoid long-term medication use.\r\n\r\n- **Referral**: Consider for suspected other sleep disorders or persistent insomnia.\r\n\r\n\r\n\r\n\r\nFor more information watch the OTC lesson on  Chapter 4 Neurology (Insomnia):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise to purchase diphenhydramine 25mg tablets",
        "answer_number": 1
      },
      {
        "text": "Advise to purchase diphenhydramine 50mg tablets",
        "answer_number": 2
      },
      {
        "text": "Advise to purchase promethazine 10mg tablets",
        "answer_number": 3
      },
      {
        "text": "Advise to purchase promethazine 20mg tablets",
        "answer_number": 4
      },
      {
        "text": "Provide sleep hygiene and advise to see her GP",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2555,
    "bank": "clinicalMep",
    "title": "A pharmacist independent prescriber is considering prescribing a controlled drug for a patient with chronic pain.",
    "text": "**Theme: Controlled drug prescribing**\r\n**Instruction: For each of the scenarios below, select the most appropriate answer option from the list above. Each option may be used once, more than once, or not at all.**",
    "why": "F. Schedules 2-5 for any medical condition within their competence, except diamorphine, cocaine, and dipipanone for the treatment of addiction\r\n\r\nRationale:\r\n\r\nPharmacist independent prescribers are permitted to prescribe controlled drugs in Schedules 2-5 for any medical condition within their competence, except for diamorphine, cocaine, and dipipanone if the purpose is treating addiction. However, these drugs can be prescribed for other conditions, such as chronic pain management or palliative care, provided that the prescriber is competent to manage the patient\u2019s condition and the treatment falls within their scope of practice.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Cannot prescribe controlled drugs in Schedules 2-5\r\nIncorrect. Pharmacist independent prescribers have broader prescribing rights and can prescribe controlled drugs from Schedules 2-5, with certain restrictions.\r\n\r\nB. Can only prescribe oral diazepam, lorazepam, temazepam, and dihydrocodeine\r\nIncorrect. This restriction applies to podiatrist independent prescribers. Pharmacists have a broader range of controlled drugs they can prescribe.\r\n\r\nC. Can only prescribe oral diazepam, lorazepam, temazepam, dihydrocodeine, oxycodone, IV and oral morphine, and fentanyl patches\r\nIncorrect. Pharmacist prescribers are not limited to these specific drugs and can prescribe across Schedules 2-5 for appropriate conditions within their competence.\r\n\r\nD. Can prescribe Schedules 2-5 controlled drugs and does not need a standardised form for private prescriptions for Schedules 2 and 3\r\nIncorrect. A standardised form is required for private prescriptions for Schedule 2 and 3 controlled drugs.\r\n\r\nE. Can prescribe any controlled drug listed in Schedules 2-5 for the treatment of addiction\r\nIncorrect. Pharmacists are restricted from prescribing diamorphine, cocaine, and dipipanone for addiction treatment, though these may be prescribed for other medical indications.\r\n\r\nG. Schedule 2 and 3 controlled drugs only\r\nIncorrect. Pharmacist independent prescribers can prescribe Schedules 2-5 within their professional scope and competence.\r\n\r\nH. Schedule 4 and 5 controlled medicines only\r\nIncorrect. This limitation does not apply to pharmacist independent prescribers, who may prescribe Schedules 2-5 with specified restrictions.\r\n\r\nUnder MEP guidelines, pharmacist independent prescribers have prescribing authority for controlled drugs in Schedules 2-5, excluding diamorphine, cocaine, and dipipanone when used for treating addiction. This authority is intended to provide appropriate access to controlled medications for the management of medical conditions such as chronic pain, while safeguarding against inappropriate prescribing for addiction. Pharmacists are expected to prescribe within their competence, ensuring patient safety and adherence to regulatory standards.\r\n\r\nFor more information watch OTC lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 6,
    "weighting": 3,
    "answers": [
      {
        "text": "Cannot prescribe controlled drugs \u00a0Schedule 2-5 controlled drugs",
        "answer_number": 1
      },
      {
        "text": "Can only prescribe oral diazepam, lorazepam, temazepam and dihydrocodeine.",
        "answer_number": 2
      },
      {
        "text": "Can only prescribe oral diazepam, lorazepam, temazepam and dihydrocodeine and oxycodone. As well as IV and oral morphine and fentanyl patches. .",
        "answer_number": 3
      },
      {
        "text": "Can prescribe schedule 2 - 5 controlled drugs and does not need a standardised form for private prescriptions for schedule 2 and 3",
        "answer_number": 4
      },
      {
        "text": "Can prescribe any controlled drug listed in schedules 2-5 for the treatment of addiction",
        "answer_number": 5
      },
      {
        "text": "Schedules 2-5 for any medical condition within their competence, except diamorphine, cocaine and dipipanone for the treatment of addiction1.",
        "answer_number": 6
      },
      {
        "text": "Schedule 2 and 3 controlled drugs only.",
        "answer_number": 7
      },
      {
        "text": "Schedule 4 and 5 controlled medicines only",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2250,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate course of action?**",
    "text": "A 45-year-old lady presents to the pharmacy with calf pain in her left leg which is tender. She has been recovering from a bout of severe flu which had left her bed bound for a couple of weeks and she has just started to be up and about. She has no known allergies and currently is taking tamoxifen 20mg OD.",
    "why": "Correct Answer:\r\n\r\nE) Refer the lady urgently to hospital\r\n\r\nRationale:\r\n\r\nThis patient has multiple risk factors for deep vein thrombosis (DVT):\r\n\r\n- Calf pain and tenderness \u2013 Common symptoms of DVT.\r\n\r\n- Recent prolonged immobility (bedbound due to severe flu) \u2013 One of the strongest risk factors for venous thromboembolism (VTE).\r\n\r\n- Tamoxifen use \u2013 Tamoxifen is known to increase the risk of blood clots.\r\n\r\n- No signs of trauma or injury to the leg \u2013 Making DVT more likely than a musculoskeletal cause.\r\n\r\n- Since DVT is a medical emergency, urgent referral to the hospital is necessary to confirm the diagnosis and start anticoagulation treatment if needed.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Advise simple analgesia with paracetamol plus ibuprofen and to rest the leg \r\n\r\nTreating the pain without addressing the underlying cause (DVT) could delay diagnosis and increase the risk of a pulmonary embolism (PE).\r\n\r\nB) Call an ambulance \r\n\r\nNot immediately necessary unless there are signs of pulmonary embolism (e.g., sudden breathlessness, chest pain, haemoptysis).\r\nUrgent hospital referral is the correct action, but an ambulance is not required unless PE is suspected.\r\n\r\nC) Refer the lady to her GP if symptoms worsen but to use rest, ice, compression & elevation (RICE) in the meantime \r\n\r\nRICE is used for musculoskeletal injuries, not suspected DVT.\r\nDVT requires urgent hospital referral for assessment (D-dimer, ultrasound, and possible anticoagulation).\r\n\r\nD) Refer the lady to book to see her GP and do not offer OTC medication \r\n\r\nA routine GP appointment is not appropriate as DVT is a potentially life-threatening condition that requires urgent assessment in the hospital.\r\n\r\n\r\nDeep Vein Thrombosis (DVT) \r\n\r\nDVT occurs when a blood clot forms in a deep vein, usually in the legs. It can become life-threatening if the clot dislodges and travels to the lungs, causing a pulmonary embolism (PE).\r\n\r\nCommon Risk Factors for DVT:\r\n\r\n- Recent immobility (e.g., prolonged bed rest, long-haul travel)\r\n- Use of hormonal therapy (e.g., tamoxifen, HRT, oral contraceptive pills)\r\n- History of cancer, smoking, or thrombophilia\r\n- Recent surgery or trauma\r\n\r\nSymptoms of DVT:\r\n\r\n- Unilateral leg pain and swelling\r\n- Tenderness along the deep veins\r\n- Skin warmth and redness over the affected area\r\n\r\nManagement:\r\n\r\n- Urgent hospital referral for assessment (D-dimer test, leg ultrasound).\r\n\r\n- Anticoagulation therapy (e.g., DOACs like apixaban or rivaroxaban) is the standard treatment if DVT is confirmed.\r\n\r\n- Patients should be educated on symptoms of pulmonary embolism (sudden breathlessness, chest pain, coughing blood) and instructed to seek emergency care if these occur.\r\n\r\nEarly recognition and hospital referral prevent complications and reduce mortality. This is why immediate action is required in this case.\r\n\r\nFor more information, please watch BNF lesson Chapter 2 (Cardiovascular System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise simple analgesia with paracetamol plus ibuprofen and to rest the leg",
        "answer_number": 1
      },
      {
        "text": "Call an ambulance",
        "answer_number": 2
      },
      {
        "text": "Refer the lady to her GP if symptoms worsen but to use rest, ice, compression & elevation (RICE) in the meantime",
        "answer_number": 3
      },
      {
        "text": "Refer the lady to book to see her GP and do not offer OTC medication",
        "answer_number": 4
      },
      {
        "text": "Refer the lady urgently to hospital",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2539,
    "bank": "clinicalMep",
    "title": "**Which of the following medicines would have a validity of 6 months after the appropriate date on a prescription?**",
    "text": "Some Controlled medicines have shorter validity on prescriptions",
    "why": "(c) Oramorph 10mg/5mL oral suspension\r\n\r\nRationale:\r\n\r\nOramorph 10mg/5mL oral suspension is classified as a Schedule 5 Controlled Drug. Prescriptions for Schedule 5 drugs have a validity of 6 months from the appropriate date on the prescription. This longer validity period is due to the lower potential for abuse and dependence associated with Schedule 5 drugs, compared to those in Schedules 2, 3, and 4, which have a stricter 28-day validity.\r\n\r\nOther Options Explained:\r\n\r\n(a) Clenbutarol: Not a controlled drug, but it would generally follow standard prescription validity rules, typically 6 months unless otherwise specified.\r\n\r\n(b) Methadone: Methadone is a Schedule 2 Controlled Drug, which requires prescriptions to be dispensed within 28 days of the appropriate date.\r\n\r\n(d) Oxycodone: Oxycodone is also a Schedule 2 Controlled Drug, requiring dispensing within 28 days.\r\n\r\n(e) Pregabalin: Pregabalin is a Schedule 3 Controlled Drug with a prescription validity of 28 days.\r\n\r\nIn the UK, the Medicines, Ethics, and Practice (MEP) guide and NICE guidelines outline specific validity periods for different schedules of controlled drugs. Schedule 5 drugs, such as low-strength morphine preparations (e.g., Oramorph 10mg/5mL oral suspension), have reduced regulatory controls due to their lower abuse potential, allowing prescriptions to be valid for 6 months. Higher schedules (Schedules 2, 3, and certain Schedule 4 drugs) are subject to tighter controls, including the shorter 28-day prescription validity.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Clenbutarol",
        "answer_number": 1
      },
      {
        "text": "Methadone",
        "answer_number": 2
      },
      {
        "text": "Oramorph 10mg/5mL oral suspension",
        "answer_number": 3
      },
      {
        "text": "Oxycodone",
        "answer_number": 4
      },
      {
        "text": "Pregablin",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2590,
    "bank": "clinicalOtc",
    "title": "**Which of the following antihistamines would be the most suitable?**",
    "text": "A mother presents to the pharmacy with her 18 month old daughter. Her daughter suffers from eczema and she is wondering if there is anything that can help with the itchiness.",
    "why": "Chlorphenamine\r\n\r\nRationale:\r\n\r\nThe most suitable antihistamine for an 18-month-old child with eczema-related itchiness is chlorphenamine. It is one of the few antihistamines licensed for use in children under 2 years old. Chlorphenamine is a sedating antihistamine and is often used to help relieve itching and discomfort in children with skin conditions like eczema. The sedative effect can also be helpful for nighttime itching, allowing the child to sleep better.\r\n\r\nExplanation of Other Options:\r\n\r\nAcrivastine: This is a non-sedating antihistamine but is not licensed for use in children under 12 years old. It is not appropriate for an 18-month-old child.\r\n\r\nCetirizine: Although cetirizine is a non-sedating antihistamine that can be used for allergic reactions, it is typically licensed for children aged 2 years and older, making it unsuitable for this child.\r\n\r\nFexofenadine: Another non-sedating antihistamine, fexofenadine is only licensed for children 6 years and older, so it is not suitable for an 18-month-old.\r\n\r\nLoratadine: Loratadine is a non-sedating antihistamine used for allergic reactions, but it is usually recommended for children aged 2 years and older. Therefore, it is not the most appropriate choice for this child.\r\n\r\n\r\nAccording to NICE guidelines, sedating antihistamines, such as chlorphenamine, may be used in children to relieve symptoms of pruritus (itching) related to conditions like eczema. These are particularly useful for managing night-time symptoms that disrupt sleep. Non-sedating antihistamines (such as cetirizine and loratadine) are generally preferred for long-term use due to their minimal side effects, but they are not always licensed for children under 2 years old. Parents should be advised to use antihistamines under the guidance of healthcare professionals, and treatment should be accompanied by regular use of emollients to manage eczema effectively.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Acrivastine",
        "answer_number": 1
      },
      {
        "text": "Cetirizine",
        "answer_number": 2
      },
      {
        "text": "Chlorphenamine",
        "answer_number": 3
      },
      {
        "text": "Fexofenadine",
        "answer_number": 4
      },
      {
        "text": "Loratadine",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2583,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the LEAST appropriate advice?**",
    "text": "A mother presents to the pharmacy with her 7 year old son. Her son suffers from atopic eczema and she has asked you if there is anything you could advise to help manage the condition.",
    "why": "Avoid applying emollients on moist skin (e.g. after a shower)\r\n\r\nRationale:\r\n\r\nIt is incorrect to advise avoiding the application of emollients on moist skin. In fact, it is most effective to apply emollients immediately after bathing, while the skin is still damp. This practice helps to trap moisture and enhances the emollient's effectiveness at keeping the skin hydrated and preventing dryness. Applying emollients on dry skin is also beneficial, but applying them when the skin is slightly moist increases absorption and helps in managing the symptoms of atopic eczema.\r\n\r\nThe other options are appropriate because:\r\n\r\nAvoiding scratching with nails and using knuckles helps to reduce the risk of skin damage and infection.\r\nEmollients with a higher oil content, such as ointments, are more effective than creams in maintaining moisture and reducing water loss from the skin.\r\nAvoiding hot baths and showers is essential since hot water can exacerbate skin dryness by stripping the skin of its natural oils.\r\nFrequent application of emollients throughout the day is necessary to keep the skin moisturised, reduce irritation, and prevent flare-ups.\r\n\r\n\r\nAccording to the NICE guidelines, atopic eczema is a chronic inflammatory skin condition characterised by dryness, itching, and inflammation. The mainstay of treatment involves regular and liberal use of emollients to maintain skin hydration and improve the skin barrier function. Emollients should be applied immediately after bathing and as frequently as needed to keep the skin moisturised. During flare-ups, topical corticosteroids may be required to reduce inflammation. Patients are advised to avoid trigger factors such as hot water, harsh soaps, and excessive scratching. Maintaining a daily skin care routine with appropriate emollient use can significantly reduce the frequency and severity of eczema flare-ups.\r\n\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Avoid scratching with nails where possible, rub with knuckles instead",
        "answer_number": 1
      },
      {
        "text": "Emollients with a higher oil content are much more effective",
        "answer_number": 2
      },
      {
        "text": "Avoid hot baths and showers where possible",
        "answer_number": 3
      },
      {
        "text": "Avoid applying emollients on moist skin (e.g. after a shower)",
        "answer_number": 4
      },
      {
        "text": "Apply emollients as frequently as possible",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2498,
    "bank": "clinicalMep",
    "title": "**Which one of the following activities CANNOT take place without a responsible pharmacist in charge of the pharmacy?**",
    "text": "You are the Responsible Pharmacist in your community pharmacy and you need to do a home visit for your care home patients. You expect to be absent for up to a maximum of two hours during the pharmacy business hours.",
    "why": "b) Emergency supply of a medicine(s) at the request of the patient\r\n\r\nRationale\r\n\r\nAn emergency supply of medicines at the request of a patient can only be authorised by the Responsible Pharmacist (RP). This is outlined under Regulation 225 of the Human Medicines Regulations 2012. The RP must assess the immediate need for the prescription-only medicine, confirm impracticality of obtaining a prescription without undue delay, verify a prior prescription by a relevant prescriber, and determine the appropriate dose. This responsibility cannot be delegated or carried out in the absence of the RP as per the Responsible Pharmacist Regulations 2008.\r\n\r\nExplanation of the Other Options\r\n\r\na) Date checking\r\n\r\nThis is permissible in the absence of the Responsible Pharmacist as it does not involve patient-facing activities or decisions about the supply of medicines.\r\n\r\nc) Ordering stock from pharmaceutical wholesalers\r\n\r\nThis is an administrative activity that can take place during the absence of the Responsible Pharmacist. However, dispensing or supply-related tasks require the presence of the RP.\r\n\r\nd) Sale of general sale medicines\r\n\r\nGeneral Sale List (GSL) medicines can be sold in the absence of the Responsible Pharmacist provided the absence is within the two-hour limit and proper procedures are in place.\r\n\r\ne) Taking medicine off the dispensary shelves to assemble a prescription\r\n\r\nMedicines can be prepared for assembly in the absence of the Responsible Pharmacist. However, the final accuracy check and dispensing to the patient must only occur when the RP is present.\r\n\r\nKey Points About the Role of the Responsible Pharmacist\r\n\r\nEssential Tasks That Require the RP:\r\n\r\nAuthorisation of an emergency supply of medicines (patient or prescriber request).\r\nFinal accuracy check and supply of dispensed medicines.\r\nSupervising the sale or supply of Pharmacy (P) medicines.\r\n\r\nPermissible Activities During RP Absence:\r\n\r\nAdministrative tasks such as ordering stock or managing records.\r\nSale of General Sale List (GSL) medicines.\r\nNon-patient-facing activities like cleaning, maintenance, or date checking.\r\n\r\nAbsence Regulations:\r\n\r\nThe Responsible Pharmacist may be absent for up to two hours during operational hours but must remain contactable and ensure the pharmacy is appropriately staffed to manage safe operations.\r\n\r\nThe Responsible Pharmacist plays a crucial role in overseeing patient safety and medicine supply. While certain non-critical activities (e.g., stock ordering, GSL sales) can proceed during their absence, essential tasks like authorising emergency supplies of medicines require their direct involvement. Adherence to the Responsible Pharmacist Regulations ensures legal compliance and the continuity of safe pharmacy practice.\r\n\r\n\r\nFor more information watch MEP lesson chapter 4 (The Responsible Pharmacist)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Date checking",
        "answer_number": 1
      },
      {
        "text": "Emergency supply of a medicine(s) at a request of the patient",
        "answer_number": 2
      },
      {
        "text": "Ordering stock from pharmaceutical wholesalers",
        "answer_number": 3
      },
      {
        "text": "Sale of general sale medicines",
        "answer_number": 4
      },
      {
        "text": "Taking medicine off the dispensary shelves to assemble a prescription",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2548,
    "bank": "clinicalMep",
    "title": "**Which of the following is the reason the prescription is legally invalid?**",
    "text": "You receive a veterinary prescription for a dashound called Rolls. However you realise you cannot dispense the prescription.\u00a0\r\n\r\nAn extract has been provided for this question\u00a0\r\n![3](https://i.ibb.co/nMrVLr4/3.png \"600x400\")",
    "why": "(D) The statement of \u201cto be prescribed under the cascade is missing\u201d\r\n\r\nRationale:\r\n\r\nFor a veterinary prescription to be legally valid when prescribing a medication not specifically licensed for the animal\u2019s species or condition, it must include the statement \u201cto be prescribed under the cascade.\u201d The cascade system allows veterinarians to prescribe medicines not licensed for certain animal use in specific circumstances, ensuring the treatment aligns with legal requirements for off-license use. The absence of this phrase renders the prescription legally invalid.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) No withdrawal period is stated:\r\nIncorrect. The withdrawal period is only mandatory for food-producing animals, like livestock, to ensure drug residues clear before consumption. Since Rolls is a dashound (non-food-producing animal), this information is not required.\r\n\r\n(B) Owner's date of birth is missing:\r\nIncorrect. Although the owner's name and address are necessary on a veterinary prescription, the date of birth is not a legal requirement.\r\n\r\n(C) The statement \u201cAnimal treatment only\u201d is missing:\r\nIncorrect. While \u201cAnimal treatment only\u201d is essential on the label of the dispensed medication, it is not required directly on the prescription for legal validity.\r\n\r\n(E) Veterinary prescriptions cannot be repeatable:\r\nIncorrect. Veterinary prescriptions can indeed be repeatable if the prescriber specifies repeats. For example, if noted as \u201crepeat 5 times,\u201d this means the prescription allows a total of six dispensations.\r\n\r\nThe veterinary \"cascade\" system is a regulatory framework that allows veterinarians to prescribe medications not specifically licensed for an animal's species or condition when no suitable licensed alternative is available. For any prescription issued under the cascade, it must legally include the statement \u201cto be prescribed under the cascade\u201d to ensure compliance. This phrase is essential when recommending an off-license or alternative treatment, providing clarity on the prescription's validity.\r\n\r\nThe cascade requires a hierarchy of choices: veterinarians should first use licensed medications for the specific species and condition, then consider medications licensed for other species or conditions, and only as a last resort, human medications. All veterinary prescriptions must also include the owner's name and address, the phrase \u201canimal treatment only,\u201d and full details of the medication. Withdrawal periods are only required for food-producing animals, and while the owner's name and address are necessary, their date of birth is not.\r\n\r\nPlease for more information watch the MEP lesson on Chapter 2 (Professional and Legal Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "No withdrawal period is stated",
        "answer_number": 1
      },
      {
        "text": "Owners date of birth is missing",
        "answer_number": 2
      },
      {
        "text": "The statement \u201cAnimal treatment only\u201d is missing",
        "answer_number": 3
      },
      {
        "text": "The statement of \u201cto be prescribed under the cascade is missing\u201d",
        "answer_number": 4
      },
      {
        "text": "Veterinary prescriptions cannot be repeatable",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 963,
    "bank": "clinicalMep",
    "title": "**Which of the following actions is NOT appropriate for the pharmacist to take in order to investigate the validity of the prescription?**",
    "text": "You receive a prescription and suspect that it may be a forgery.",
    "why": "Correct Answer:\r\n\r\nD) Use the title \u2018Dr\u2019 before the signature to verify the authenticity of the prescription\r\n\r\nRationale:\r\n\r\nUsing a title such as \u201cDr\u201d before a signature is not a reliable or appropriate method of verifying a prescription. Titles can be easily written by anyone and are not unique identifiers of a prescriber. Verifying authenticity requires checking with the prescriber directly using independent contact details and reviewing the content and format of the prescription thoroughly.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Confirm details with the prescriber using contact details obtained from a source other than the suspicious prescription\r\n\r\nAppropriate \u2013 This is best practice. Always use an independent and trusted source (e.g. NHS website, practice contact details on record) to contact the prescriber when in doubt.\r\n\r\nB) Confirm whether or not a prescription has been issued, the original intention of the prescriber, and whether or not there has been an alteration\r\n\r\nAppropriate \u2013 It is important to confirm the validity and intent of the prescriber if forgery is suspected.\r\n\r\nC) Scrutinise the signature carefully, possibly checking against a known genuine prescription from the same prescriber\r\n\r\nAppropriate \u2013 Comparing the signature with a known example can help spot inconsistencies or signs of forgery.\r\n\r\nE) Use contact details for the prescriber that are obtained from a source other than the suspicious prescription\r\n\r\nAppropriate \u2013 Reinforces the need to avoid using the potentially forged document itself as a source of contact details.\r\n\r\nInvestigating Forged Prescriptions (MEP Guidance):\r\n\r\nAccording to the Medicines, Ethics and Practice (MEP) guide:\r\n\r\n- Pharmacists must be vigilant and take reasonable steps to verify the authenticity of prescriptions when there is any suspicion.\r\n\r\n- Use independent contact details to speak directly with the prescriber.\r\n\r\n- Do not rely solely on the title, signature, or contact details printed on the prescription if forgery is suspected.\r\n\r\n- It is acceptable to refuse to dispense if there is reasonable doubt about authenticity and to report suspicious activity to appropriate authorities (e.g. NHS counter fraud or local controlled drug liaison officer, if relevant).\r\n\r\n- Controlled drugs carry additional forgery risks and should be scrutinised even more closely.\r\n\r\nFor more information, please watch MEP lesson Chapter 2 (Professional And Legal Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Confirm details with the prescriber using contact details obtained from a source other than the suspicious prescription.",
        "answer_number": 1
      },
      {
        "text": "Confirm whether or not a prescription has been issued, the original intention of the prescriber, and whether or not there has been an alteration.",
        "answer_number": 2
      },
      {
        "text": "Scrutinize the signature carefully, possibly checking against a known genuine prescription from the same prescriber.",
        "answer_number": 3
      },
      {
        "text": "Use the title \u2018Dr\u2019 before the signature to verify the authenticity of the prescription.",
        "answer_number": 4
      },
      {
        "text": "Use contact details for the prescriber that are obtained from a source other than the suspicious prescription.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2391,
    "bank": "clinicalTherapeutics",
    "title": "**What is the best course of action for her?**",
    "text": "A 30-year-old woman has been using chlorhexidine mouthwash twice daily for the last two weeks to treat her gingivitis. She comes to the pharmacy complaining of a dry mouth and a metallic taste in her mouth. She also notices that her teeth and tongue have become brownish in colour. She asks for your advice on how to manage these side effects.",
    "why": "B) Continue using the mouthwash but rinse her mouth with water after each use\r\n\r\nRationale\r\n\r\nChlorhexidine mouthwash can cause common side effects such as dry mouth, altered taste, and staining of the teeth, tongue, and dental appliances. The most appropriate advice is to continue using the mouthwash but rinse the mouth with water after each use. This helps to reduce staining and alter taste, and also minimises the risk of dry mouth. This strategy addresses the side effects while ensuring the ongoing effectiveness of the treatment for gingivitis.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Continue using the mouthwash but reduce the frequency to once a day\r\n\r\nReducing the frequency of chlorhexidine mouthwash could reduce its effectiveness in treating gingivitis, which is counterproductive to managing the condition.\r\n\r\nC) Continue using the mouthwash but brush her teeth with a whitening toothpaste\r\n\r\nWhile whitening toothpaste might help reduce the appearance of stains, it is unlikely to address the cause of the staining effectively. Moreover, brushing with whitening toothpaste could cause abrasion, which may worsen the side effects.\r\n\r\nD) Continue using the mouthwash but switch to a different brand\r\n\r\nThe side effects are related to the active ingredient, chlorhexidine, and switching brands may not prevent these issues, as other formulations may also contain this active ingredient.\r\n\r\nE) Stop using the mouthwash immediately and see a dentist\r\n\r\nStopping the mouthwash abruptly may worsen the gingivitis, and seeing a dentist is important if symptoms persist, but it is not the immediate step to manage the side effects of chlorhexidine use.\r\n\r\nChlorhexidine mouthwash is often used for the treatment of gingivitis. However, its use is associated with common side effects, including taste changes, dry mouth, and staining of the teeth and tongue. According to the NICE guidelines and BNF, the side effects of chlorhexidine mouthwash can be mitigated by rinsing the mouth with water after each use to reduce staining and dry mouth. It is important to continue using the mouthwash unless the side effects are unmanageable, in which case an alternative treatment may be considered. The use of mouthwash should be part of a comprehensive oral hygiene regimen, and long-term use should be monitored to avoid potential complications.\r\n\r\nFor more information watch BNF lesson Chapter 5 (Infections):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Continue using the mouthwash but reduce the frequency to once a day",
        "answer_number": 1
      },
      {
        "text": "Continue using the mouthwash but rinse her mouth with water after each use",
        "answer_number": 2
      },
      {
        "text": "Continue using the mouthwash but brush her teeth with a whitening toothpaste",
        "answer_number": 3
      },
      {
        "text": "Continue using the mouthwash but switch to a different brand",
        "answer_number": 4
      },
      {
        "text": "Stop using the mouthwash immediately and see a dentist",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2269,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is the correct dosing regimen for a 6-year-old child weighing 18 kg who is to be started on the standard treatment protocol?**",
    "text": "This question relates to the use of pamidronate and calcium supplementation in the treatment of osteogenesis imperfecta in paediatric patients.\r\n\r\nA resource has been provided for this question\r\n\r\n![Screenshot-2024-01-04-at-11-04-30](https://i.ibb.co/WDY4Zfv/Screenshot-2024-01-04-at-11-04-30.png)",
    "why": "Correct Answer:\r\n\r\nC) Pamidronate 18 mg, 100 mL diluent volume, 25 mL/hour infusion rate, 10.8 mmol daily calcium dose.\r\n\r\nRationale:\r\n\r\nFor a 6-year-old child weighing 18 kg, the correct standard treatment protocol is as follows:\r\n\r\n1. Pamidronate Dose Calculation:\r\n\r\n- Standard dose: 1 mg/kg/day for 3 consecutive days (as per protocol for children >10 kg).\r\n- Child's weight: 18 kg\r\n- Pamidronate dose = 1 mg/kg \u00d7 18 kg = 18 mg/day\r\n- Correct dose: 18 mg/day for 3 days\r\n\r\n2. Diluent Volume & Infusion Rate:\r\n\r\n    According to the administration table:\r\n\r\n- Dose <20 mg \u2192 Requires 100 mL of 0.9% sodium chloride.\r\n- Standard infusion duration: 4 hours.\r\n- Infusion rate = 100 mL \u00f7 4 hours = 25 mL/hour.\r\n- Correct diluent volume: 100 mL\r\n- Correct infusion rate: 25 mL/hour\r\n\r\n3. Calcium Supplementation:\r\n\r\n- The protocol requires 50 mg/kg/day in divided doses.\r\n- 50 mg/kg \u00d7 18 kg = 900 mg/day.\r\n- 900 mg calcium is equivalent to approximately 10.8 mmol/day (as 1 mmol calcium \u2248 83.3 mg).\r\n- Correct daily calcium dose: 10.8 mmol/day.\r\n\r\n\r\nPamidronate in the Treatment of Osteogenesis Imperfecta\r\n\r\nPamidronate is a bisphosphonate used to improve bone density and reduce fractures in paediatric patients with osteogenesis imperfecta (OI). It works by inhibiting osteoclast activity, slowing down bone resorption, and increasing bone mineralisation.\r\n\r\nStandard dosing for children >10 kg: 1 mg/kg/day for 3 consecutive days per cycle, repeated at set intervals (e.g., every 2\u20133 months).\r\nFluid hydration is essential before and after administration to reduce the risk of nephrotoxicity.\r\nCalcium supplementation is required to prevent hypocalcaemia, which can occur due to increased bone mineralisation.\r\n\r\nFor more information watch BNF lesson Chapter 6 (Endocrine System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Pamidronate 9mg, 50mL diluent volume, 12.5mL/hour infusion rate, 1g daily calcium dose.",
        "answer_number": 1
      },
      {
        "text": "Pamidronate 9mg, 100mL diluent volume, 25mL/hour infusion rate, 900mg daily calcium dose.",
        "answer_number": 2
      },
      {
        "text": "Pamidronate 18mg, 100mL diluent volume, 25mL/hour infusion rate, 10.8mmol daily calcium dose.",
        "answer_number": 3
      },
      {
        "text": "Pamidronate 9mg, 100mL diluent volume, 9mg/hour infusion rate, 12.4 daily calcium dose.",
        "answer_number": 4
      },
      {
        "text": "Pamidronate 18mg, 100mL diluent volume, 12.5mL/hour infusion rate, 900mg daily calcium dose.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2231,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following gives the correct weights of active ingredients required to make 300 g of the ointment?**",
    "text": "Betnovate ointment contains the following active ingredients:\u00a0\r\nbetamethasone valerate 0.1%\r\nliquid paraffin 12.5%\u00a0\u00a0\r\nwhite soft paraffin 15%",
    "why": "Correct Answer: \r\n\r\nC) 0.3 g betamethasone valerate; 37.5 g liquid paraffin; 45 g white soft paraffin\r\n\r\nRationale:\r\n\r\nThis is a percentage strength calculation where:\r\n\r\nA strength of X% means X grams per 100 grams of preparation.\r\n\r\nTo calculate the amount for 300 g of ointment:\r\n\r\nBetamethasone valerate 0.1%\r\n\r\n= 0.1 g / 100 g \u2192\r\n= (0.1 \u00f7 100) \u00d7 300 = 0.3 g\r\n\r\nLiquid paraffin 12.5%\r\n\r\n= 12.5 g / 100 g \u2192\r\n= (12.5 \u00f7 100) \u00d7 300 = 37.5 g\r\n\r\nWhite soft paraffin 15%\r\n\r\n= 15 g / 100 g \u2192\r\n= (15 \u00f7 100) \u00d7 300 = 45 g\r\n\r\nBetnovate (betamethasone valerate 0.1%) is a potent topical corticosteroid, used in the management of inflammatory skin conditions such as eczema and psoriasis, where milder corticosteroids are not sufficient. \r\nAccording to NICE guidelines on eczema and psoriasis, the lowest potency and shortest duration necessary to control symptoms should be used to reduce the risk of adverse effects like skin thinning. \r\nThe base components , liquid paraffin and white soft paraffin, provide an occlusive effect, enhancing skin hydration and increasing corticosteroid penetration. \r\nUnderstanding how to calculate formulation strengths is essential in both compounding and checking prescriptions.\r\n\r\nFor more information, please watch BNF lesson Chapter 13 (Skin):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "0.3 g betamethasone valerate; 37.5 g liquid paraffin; 4.5 g white soft paraffin",
        "answer_number": 1
      },
      {
        "text": "3 g betamethasone valerate; 3.75 g liquid paraffin; 4.5 g white soft paraffin",
        "answer_number": 2
      },
      {
        "text": "0.3 g betamethasone valerate; 37.5 g liquid paraffin; 45 g white soft paraffin",
        "answer_number": 3
      },
      {
        "text": "30 g betamethasone valerate; 3.75 g liquid paraffin; 4.5 g white soft paraffin",
        "answer_number": 4
      },
      {
        "text": "30 g betamethasone valerate; 37.5 g liquid paraffin; 45 g white soft paraffin",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 1106,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate action for this patient?**",
    "text": "A 42-year-old woman with ocular hypertension and mild asthma is prescribed timolol 0.25% eye drops by her ophthalmologist. She has no other medical conditions or allergies. She uses a salbutamol inhaler as needed for asthma symptom relief. After using the eye drops for two weeks, she reports that her breathing has become more difficult and wheezy. She also feels dizzy and tired.",
    "why": "Correct Answer: D) Stop using the eye drops immediately and seek urgent medical attention\r\n\r\nRationale:\r\n\r\nTimolol is a non-selective beta-blocker used in the treatment of ocular hypertension and glaucoma. It can be systemically absorbed even when administered as eye drops and may cause bronchospasm by blocking beta-2 receptors in the lungs. This poses a significant risk in patients with current or past history of asthma, and the BNF explicitly states that timolol eye drops are contraindicated in asthma.\r\n\r\nThe patient\u2019s symptoms \u2014 worsening breathlessness, wheezing, dizziness, and fatigue \u2014 strongly suggest systemic beta-blocker side effects. The correct and safest course of action is to immediately stop the timolol and seek urgent medical attention to manage her respiratory symptoms and review her treatment for ocular hypertension.\r\n\r\nExplanation of incorrect options: \r\n\r\nA) Add a nasal decongestant spray to relieve her nasal congestion \u2013 Incorrect. There is no mention of nasal congestion, and this would not address the cause of her respiratory symptoms.\r\n\r\nB) Continue using the eye drops as prescribed and use the salbutamol inhaler more frequently \u2013 Incorrect. Increasing salbutamol use would not counteract systemic beta-blockade and could worsen asthma control. This is unsafe.\r\n\r\nC) Reduce the dose of the eye drops to once a day and monitor her symptoms \u2013 Incorrect. Even low doses of timolol can cause bronchospasm in asthma patients. Contraindication remains regardless of dose.\r\n\r\nE) Switch to a different brand of eye drops with a lower concentration of timolol \u2013 Incorrect. The issue is the active ingredient, not the brand or concentration. All timolol-containing eye drops are contraindicated in asthma.\r\n\r\nFor more information, please refer to BNF lessons in Chapter 3 (Respiratory system):\u2028https://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Add a nasal decongestant spray to relieve her nasal congestion",
        "answer_number": 1
      },
      {
        "text": "Continue using the eye drops as prescribed and use the salbutamol inhaler more frequently",
        "answer_number": 2
      },
      {
        "text": "Reduce the dose of the eye drops to once a day and monitor her symptoms",
        "answer_number": 3
      },
      {
        "text": "Stop using the eye drops immediately and seek urgent medical attention",
        "answer_number": 4
      },
      {
        "text": "Switch to a different brand of eye drops with a lower concentration of timolol",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2298,
    "bank": "clinicalTherapeutics",
    "title": "**If the initial plasma concentration was 15mg/L, what is the plasma concentration after 120 hours?**",
    "text": "A 50 year old female patient is prescribed warfarin 5mg tablets, she has been diagnosed with atrial fibrillation. Warfarin has a half-life of 40 hours.",
    "why": "1.875 mg/L.\r\n\r\nRationale:\r\n\r\nWarfarin follows first-order elimination kinetics, meaning its plasma concentration reduces by half with each half-life.\r\n\r\nThe half-life of warfarin is 40 hours\r\nThe initial plasma concentration is 15 mg/L\r\nThe time elapsed is 120 hours\r\nTo determine the concentration after 120 hours, we calculate how many half-lives have passed:\r\n\r\nNumber of half-lives = Total time / Half-life  \r\nNumber of half-lives = 120 hours / 40 hours  \r\nNumber of half-lives = 3\r\n\r\nNow, we halve the concentration for each half-life:\r\n\r\n1st half-life (40 hours):  15 mg/L \u2192 7.5 mg/L  \r\n2nd half-life (80 hours):  7.5 mg/L \u2192 3.75 mg/L  \r\n3rd half-life (120 hours): 3.75 mg/L \u2192 1.875 mg/L\r\n\r\nThus, after 120 hours, the plasma concentration is 1.875 mg/L.\r\n\r\n\r\nExplanation of Other Options:\r\n\r\nA: 7.5 mg/L\r\nThis would be the plasma concentration after 40 hours, not 120 hours.\r\n\r\nC: 1.875 mg/L\r\nThis would be the plasma concentration after 160 hours, one half-life further than required.\r\n\r\nD: 0.9375 mg/L\r\nThis would be the plasma concentration after 200 hours (5 half-lives), which exceeds the given time frame.\r\n\r\nE: 0.46875 mg/L\r\nThis would be the plasma concentration after 240 hours (6 half-lives), far beyond the required 120 hours.\r\n\r\nWarfarin Monitoring \r\n\r\nAccording to NICE guidelines (2025), warfarin is a vitamin K antagonist used for the prevention of stroke in atrial fibrillation (AF), venous thromboembolism (VTE), and prosthetic heart valves. Due to its long half-life (~40 hours) and narrow therapeutic index, careful monitoring is essential.\r\n\r\nKey considerations for warfarin therapy:\r\n\r\nInternational Normalised Ratio (INR) monitoring is required, typically aiming for an INR 2.0\u20133.0 in AF.\r\nDrug interactions: Warfarin interacts with many medications, including NSAIDs, antibiotics, and amiodarone, requiring dose adjustments.\r\nDietary considerations: Patients should maintain a consistent intake of vitamin K-rich foods to prevent fluctuations in INR.\r\nBridging therapy: In cases of urgent surgery or high thrombotic risk, low molecular weight heparin (LMWH) may be used when warfarin is temporarily stopped.\r\n\r\nFor further details, refer to BNF Lesson Chapter 2 (Cardiovascular System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "7.5mg/L",
        "answer_number": 1
      },
      {
        "text": "3.75mg/L",
        "answer_number": 2
      },
      {
        "text": "1.875mg/L",
        "answer_number": 3
      },
      {
        "text": "0.9375mg/L",
        "answer_number": 4
      },
      {
        "text": "0.46875mg/L",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2511,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a legal requirement?**",
    "text": "There are legal requirements for labelling medicinal products",
    "why": "b) Keep out of reach and sight of children\r\n\r\nRationale\r\n\r\nWhile the phrase \"Keep out of reach and sight of children\" is recommended as good practice by the Royal Pharmaceutical Society (RPS) and widely included on dispensed medicines, it is not a legal requirement under the Human Medicines Regulations 2012. Legal labelling requirements for medicinal products are strictly outlined in law and focus on patient safety and traceability.\r\n\r\nExplanation of the Other Options\r\n\r\na) Date of dispensing\r\n\r\nThis is a legal requirement to ensure traceability and patient safety. The date of dispensing indicates when the medicine was prepared and supplied, helping with accountability and monitoring medication use.\r\n\r\nc) Name of medicine\r\n\r\nLegally required to identify the product being dispensed. It ensures patients and healthcare providers can accurately determine the specific medication and formulation.\r\n\r\nd) Patient name\r\n\r\nIncluding the patient\u2019s name on the label is a legal requirement to personalise the medicine and prevent confusion or misuse.\r\n\r\ne) Precautions relating to the medical product\r\n\r\nPrecautionary information such as storage conditions or usage warnings (e.g., \"Store below 25\u00b0C\" or \"Take with food\") is legally required to ensure safe and effective use of the medication.\r\n\r\nLabelling of medicinal products is governed by the Human Medicines Regulations 2012 to promote safe and effective use of medicines while ensuring traceability and reducing the risk of misuse. Essential elements that must appear on the label include:\r\n\r\nThe patient\u2019s name for personalisation and accountability.\r\nThe name of the medicine and its strength for clarity.\r\nThe date of dispensing to monitor the timeline of use.\r\nDirections for use to ensure proper administration.\r\nPrecautionary information such as storage conditions or warnings.\r\nWhile \"Keep out of reach and sight of children\" is not a legal requirement, it is a highly recommended practice to further safeguard patients, especially in homes with young children. Pharmacists must ensure compliance with these legal requirements while incorporating best practices to enhance patient safety and adherence.\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Date of dispensing",
        "answer_number": 1
      },
      {
        "text": "Keep out of reach and sight of children",
        "answer_number": 2
      },
      {
        "text": "Name of medicine",
        "answer_number": 3
      },
      {
        "text": "Patient name",
        "answer_number": 4
      },
      {
        "text": "Precautions relating to medical product",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2537,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a category of veterinary medicines?**",
    "text": "There are different categories of veterinary medicines",
    "why": "(b) AVM - P\r\n\r\nRationale:\r\n\r\nThe category AVM - P is not a recognized category of veterinary medicines. Veterinary medicines in the UK are classified into four main categories to regulate their supply, ensuring proper administration and animal safety.\r\n\r\nOther Options Explained:\r\n\r\n(a) AVM - GSL (Authorised Veterinary Medicine - General Sales List): These medicines are available for sale without a prescription and can be purchased by the public without veterinary involvement.\r\n\r\n(c) NFA - VPS (Non-Food Animal - Veterinarian, Pharmacist, Suitably Qualified Person): These medicines are for non-food-producing animals and can be supplied by a veterinarian, pharmacist, or suitably qualified person.\r\n\r\n(d) POM - V (Prescription Only Medicine - Veterinarian): These medicines require a prescription from a veterinarian and are dispensed by a veterinarian or pharmacist.\r\n\r\n(e) POM - VPS (Prescription Only Medicine - Veterinarian, Pharmacist, Suitably Qualified Person): These are prescription medicines for food-producing animals and require a prescription by one of these three qualified professionals.\r\n\r\nThe Veterinary Medicines Regulations (VMR) define these categories to ensure responsible use based on animal type, professional supervision, and public health. Each category has its specific criteria, ranging from medicines available to the general public (AVM - GSL) to those restricted to veterinary prescription (POM - V). The categories support safe supply chains, promote animal welfare, and reduce the risk of misuse in food-producing and companion animals.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "AVM - GSL",
        "answer_number": 1
      },
      {
        "text": "AVM - P",
        "answer_number": 2
      },
      {
        "text": "NFA- VPS",
        "answer_number": 3
      },
      {
        "text": "POM- V",
        "answer_number": 4
      },
      {
        "text": "POM - VPS",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 879,
    "bank": "clinicalMep",
    "title": "**Which of the following dates is the last day you can dispense the medication?**",
    "text": "You receive a prescription for Elvanse (lisdexamfetamine) 20mg tablets dated on 1st June 2023.",
    "why": "Elvanse (lisdexamfetamine) 20mg tablets is a Schedule 2 controlled drug. Schedule 2 and 3 controlled drugs are valid for 28 days AFTER the date written on the prescription",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "28th June",
        "answer_number": 1
      },
      {
        "text": "29th June",
        "answer_number": 2
      },
      {
        "text": "30th June",
        "answer_number": 3
      },
      {
        "text": "1st December",
        "answer_number": 4
      },
      {
        "text": "2nd December",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 961,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "You receive a prescription for a codeine 15mg tablet from a German patient. The prescription is written by a German doctor The prescription has the following particulars: the doctor's name, address, and signature, the date of issue, the patient's name and address, and the name, strength, and quantity of the medicine. You notice that the prescription does not contain the doctor's professional qualification or direct contact details.",
    "why": "This is based on regulation 218 (5) (c) (iii) and (iv) of the Human Medicines Regulations 2012\u00b9, which state that a prescription must contain an indication of the prescribing EEA health professional's professional qualification and direct contact details including email address and telephone or fax number with the appropriate international prefix.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Contact the doctor to obtain their professional qualification and direct contact details before dispensing the medicine.",
        "answer_number": 1
      },
      {
        "text": "Contact the General Pharmaceutical Council (GPhC) to report the doctor for breaching the regulations.",
        "answer_number": 2
      },
      {
        "text": "Dispense the medicine as prescribed and make a record of the missing particulars.",
        "answer_number": 3
      },
      {
        "text": "Dispense the medicine as prescribed and inform the patient of the risks of using a prescription without all the required particulars.",
        "answer_number": 4
      },
      {
        "text": "Refuse to dispense the medicine and advise the patient to obtain a new prescription from the doctor.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 983,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the LEAST appropriate reason for referral for oral thrush?**",
    "text": "A 52 year old patient presents to the pharmacy requesting to purchase Daktarin (miconazole) oral gel.",
    "why": "Oral thrush from antibiotics can occur because antibiotics can kill the good bacteria that normally keep Candida in check. This can lead to an overgrowth of Candida and oral thrush",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Diabetic patient",
        "answer_number": 1
      },
      {
        "text": "Duration longer than 3 weeks",
        "answer_number": 2
      },
      {
        "text": "Immunocompromised patients",
        "answer_number": 3
      },
      {
        "text": "Painless lesions or growth",
        "answer_number": 4
      },
      {
        "text": "Side effect from antibiotics",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2507,
    "bank": "clinicalMep",
    "title": "**Which of the following is INCORRECT regarding repeatable prescriptions?**",
    "text": "You are teaching pharmacy students about repeatable prescriptions",
    "why": "c) Schedule 3 and 4 Controlled drugs are repeatable on private prescriptions\r\n\r\nRationale\r\n\r\nSchedule 3 Controlled Drugs are not repeatable on private prescriptions, as per the Misuse of Drugs Regulations 2001. However, Schedule 4 (Part I and II) and Schedule 5 Controlled Drugs are repeatable. The distinction between repeatable and non-repeatable Controlled Drugs is vital for pharmacists to ensure compliance with legal requirements.\r\n\r\nExplanation of the Other Options\r\n\r\na) If the number of repeats is not stated on a repeatable private prescription then you can dispense it twice\r\n\r\nThis is correct. If a repeatable prescription does not specify the number of repeats, it can be dispensed once initially and once more (total of two dispensings).\r\n\r\nb) Private prescriptions are repeatable\r\n\r\nThis is correct. Private prescriptions can be repeatable unless restricted by the type of medication (e.g., Schedule 2 and 3 Controlled Drugs).\r\n\r\nd) The first dispensing of prescription-only medication and Schedule 5 Controlled drugs must be within 6 months of the appropriate date\r\n\r\nThis is correct. The \"appropriate date\" is either the date the prescription was signed or a later date stated by the prescriber. For most medicines, including Schedule 5 Controlled Drugs, the first dispensing must occur within 6 months.\r\n\r\ne) The first dispensing of Schedule 4 Controlled drugs must be within 28 days of the appropriate date\r\n\r\nThis is correct. Schedule 4 Controlled Drugs (e.g., benzodiazepines) must be dispensed for the first time within 28 days of the appropriate date.\r\n\r\nRepeatable prescriptions allow certain medicines to be dispensed more than once without issuing a new prescription. \r\n\r\nKey points include:\r\n\r\nPrivate prescriptions: These may be repeatable unless they involve Schedule 2 or 3 Controlled Drugs, which are not legally repeatable.\r\nNumber of repeats: If unspecified, prescriptions can be dispensed twice (initial plus one repeat).\r\nControlled Drugs:\r\nSchedule 2 and 3: Not repeatable.\r\nSchedule 4 and 5: Repeatable.\r\nDispensing timelines:\r\nSchedule 4 Controlled Drugs: First dispensing must occur within 28 days.\r\nPrescription-only medicines and Schedule 5: First dispensing must occur within 6 months.\r\nPharmacists must carefully assess prescription details to ensure compliance with legal and ethical standards.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "If the number of repeats is not stated on a repeatable private prescription then you can dispense it twice",
        "answer_number": 1
      },
      {
        "text": "Private prescriptions are repeatable",
        "answer_number": 2
      },
      {
        "text": "Schedule 3 and 4 Controlled drugs are repeatable on private prescriptions",
        "answer_number": 3
      },
      {
        "text": "The first dispensing of prescription only medication and Schedule 5 Controlled drugs must be within 6 month of the appropriate date",
        "answer_number": 4
      },
      {
        "text": "The first dispensing of Schedule 4 Controlled drugs must be within 28 days of the appropriate date",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 999,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the patient symptoms?**",
    "text": "An 18 year old male patient presents to the pharmacy with a rash on his face. He informs you he has had it for the past few days.\u00a0\r\n\r\nA photograph of the rash has been provided below:\u00a0(https://i.ibb.co/Z87QRdm/acne.jpg)",
    "why": "Acne has the following signs and symptoms: Greasy skin (seborrhoea), blackheads/whiteheads, papules, pustles, redness/inflammation, scarring. Acne can affect the face, chest and back",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Acne vulgaris",
        "answer_number": 1
      },
      {
        "text": "Atopic eczema",
        "answer_number": 2
      },
      {
        "text": "Cellulitis",
        "answer_number": 3
      },
      {
        "text": "Psoriasis",
        "answer_number": 4
      },
      {
        "text": "Rosacea",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 884,
    "bank": "clinicalOtc",
    "title": "**What is the most likely causative organism of the patient's condition?**",
    "text": "A 20-year-old patient comes to the pharmacy with a low-grade fever, sore throat, and swollen lymph nodes. They say that they have not been vaccinated against rubella and that they are pregnant. They also show you a pink, maculopapular rash that started on their face and spread to their trunk and limbs.",
    "why": "The patient has classic symptoms of rubella, which is a viral infection caused by the rubella virus\u00b9. Rubella is characterized by a mild fever, lymphadenopathy, and a pink maculopapular rash that typically starts on the face and spreads to the rest of the body\u00b9. Rubella can be prevented by vaccination with the MMR (measles, mumps, and rubella) vaccine\u00b9. Rubella is especially dangerous for pregnant women, as it can cause congenital rubella syndrome, which can result in fetal death or severe birth defects",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Measles virus",
        "answer_number": 1
      },
      {
        "text": "Parvovirus B19",
        "answer_number": 2
      },
      {
        "text": "Rubella virus",
        "answer_number": 3
      },
      {
        "text": "Streptococcus pyogenes",
        "answer_number": 4
      },
      {
        "text": "Varicella zoster virus",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 888,
    "bank": "clinicalOtc",
    "title": "A 61 \u2013 year old man with red inflamed plaques on the skin accompanied by silvery scales",
    "text": "**Theme: Dermatology Conditions**\r\n\r\n\u2028\u2028**For the patient described, please select the most suitable condition. Each option may be used once, more than once or not at all**",
    "why": "The most suitable condition for the patient described is psoriasis. Psoriasis is a chronic skin condition that causes cells to build up rapidly on the surface of the skin, forming thick, silvery scales and itchy, dry, red patches that are sometimes painful . It is a common skin condition that speeds up the life cycle of skin cells",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 8,
    "weighting": 3,
    "answers": [
      {
        "text": "Acne Vulgaris",
        "answer_number": 1
      },
      {
        "text": "Contact Dermatitis",
        "answer_number": 2
      },
      {
        "text": "Cold Sore",
        "answer_number": 3
      },
      {
        "text": "Eczema",
        "answer_number": 4
      },
      {
        "text": "Impetigo",
        "answer_number": 5
      },
      {
        "text": "Mouth ulcers",
        "answer_number": 6
      },
      {
        "text": "Oral Thrush",
        "answer_number": 7
      },
      {
        "text": "Psoriasis",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2277,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following could be an appropriate diuretic for this patient?**",
    "text": "A patient is suffering from oedema and has been prescribed furosemide. Due to the extent of the fluid overload the prescriber wishes to prescribe another diuretic.\u00a0\r\nThe patient\u2019s blood tests are as follows:\r\n\r\nSodium 137 mmol/L (135 \u2013 145 mmol/L)\r\nPotassium 2.9 mmol/L (3.5 \u2013 5.1 mmol/L)\r\neGFR. 57 mL/min",
    "why": "Correct Answer:\r\n\r\nA) Amiloride\r\n\r\nRationale:\r\n\r\nThe patient has hypokalaemia (K\u207a = 2.9 mmol/L), which must be addressed before prescribing another diuretic that could further lower potassium levels.\r\nAmiloride is a potassium-sparing diuretic, meaning it helps retain potassium while promoting diuresis. \r\nIt is often used in combination with loop or thiazide diuretics to counteract potassium loss.\r\n\r\nExplanation of Other Options:\r\n\r\nB) Bendroflumethiazide \r\n\r\nThiazide diuretics (like bendroflumethiazide) can worsen hypokalaemia and are generally avoided in patients with K\u207a <3.5 mmol/L.\r\nAdditionally, thiazides are less effective when eGFR < 30 mL/min, though this patient\u2019s eGFR is still above that threshold.\r\n\r\nC) Bumetanide \r\n\r\nBumetanide is a loop diuretic, similar to furosemide, and can further exacerbate potassium loss.\r\nIt would not correct the hypokalaemia, making it unsuitable in this case.\r\n\r\nD) Indapamide \r\n\r\nIndapamide is a thiazide-like diuretic, which can further lower potassium levels.\r\nLike bendroflumethiazide, it should be avoided in patients with significant hypokalaemia.\r\n\r\nE) Mannitol \r\n\r\nMannitol is an osmotic diuretic, primarily used for conditions such as raised intracranial pressure or acute renal failure with oliguria.\r\nIt is not used for general fluid overload in oedema and does not address potassium balance.\r\n\r\n\r\nDiuretics are commonly used for fluid overload in conditions such as heart failure, liver cirrhosis, and chronic kidney disease. \r\nThey work by increasing urine output, thereby reducing oedema and improving symptoms. \r\nHowever, different classes of diuretics have distinct mechanisms of action and electrolyte effects. \r\nLoop diuretics (e.g. furosemide, bumetanide) are the most potent and are often used for significant fluid overload but can cause hypokalaemia. \r\nThiazide and thiazide-like diuretics (e.g. bendroflumethiazide, indapamide) are weaker but effective in hypertension and mild oedema. \r\nPotassium-sparing diuretics (e.g. amiloride, spironolactone) help retain potassium and are useful when hypokalaemia is a concern, such as in this case. \r\nOsmotic diuretics (e.g. mannitol) are reserved for specific indications like raised intracranial pressure. \r\nWhen prescribing diuretics, it is crucial to monitor renal function and electrolytes regularly to prevent complications such as hypokalaemia, hyperkalaemia, or worsening renal function.\r\n\r\nFor more information, please watch BNF lesson Chapter 2 (Cardiovascular System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Amiloride",
        "answer_number": 1
      },
      {
        "text": "Bendroflumethazide",
        "answer_number": 2
      },
      {
        "text": "Bumetanide",
        "answer_number": 3
      },
      {
        "text": "Indapamide",
        "answer_number": 4
      },
      {
        "text": "Mannitol",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2309,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate response?**",
    "text": "A 50-year-old woman with a history of chronic pain syndrome is prescribed nefopam for her condition. After a few days of starting the medication, she notices her urine has turned pink and becomes concerned, she is worried there may be blood in her urine. She asks you for advice.",
    "why": "This is a common side effect of nefopam and is harmless\r\n\r\nRationale:\r\n\r\nNefopam is a non-opioid analgesic used for moderate to severe pain. A well-documented but harmless side effect of nefopam is urine discolouration, which may appear pink, orange, or red. This occurs due to excretion of drug metabolites in the urine and does not indicate bleeding, kidney dysfunction, or an allergic reaction.\r\n\r\nPatients should be reassured that this is a benign and non-harmful effect and does not require discontinuation of the medication.\r\n\r\nExplanation of Other Options:\r\n\r\nA: Increase fluid intake to clear the discolouration\r\n\r\nWhile staying hydrated is always beneficial, increased fluid intake will not prevent or clear the urine discolouration, as it results from nefopam metabolism, not dehydration.\r\n\r\nB: Stop the medication immediately and seek medical attention\r\n\r\nThis is not necessary, as urine discolouration due to nefopam is harmless and does not indicate a medical emergency.\r\n\r\nD: This is an allergic reaction to the medication\r\n\r\nAllergic reactions to nefopam typically present with rash, swelling, or breathing difficulties, not urine discolouration.\r\n\r\nE: This indicates a serious kidney problem\r\n\r\nKidney disease can cause haematuria (blood in urine), but nefopam-induced urine discolouration is unrelated to kidney damage.\r\n\r\nNefopam is an analgesic that works by inhibiting the reuptake of serotonin, noradrenaline, and dopamine, providing pain relief without opioid-related side effects. According to the NICE guidelines, a harmless but common side effect of nefopam is urine discolouration (pink, red, or orange) due to renal excretion of drug metabolites. This does not require treatment or discontinuation. Patients should be reassured that this is a known and harmless side effect and does not indicate bleeding, infection, or kidney dysfunction.\r\n\r\n\r\nFor more information, please watch BNF Lesson Chapter 4 (Central Nervous System) at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Increase fluid intake to clear the discoloration",
        "answer_number": 1
      },
      {
        "text": "Stop the medication immediately and seek medical attention",
        "answer_number": 2
      },
      {
        "text": "This is a common side effect of nefopam and is harmless",
        "answer_number": 3
      },
      {
        "text": "This is an allergic reaction to the medication",
        "answer_number": 4
      },
      {
        "text": "This indicates a serious kidney problem",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2421,
    "bank": "clinicalTherapeutics",
    "title": "A patient with chronic renal failure and symptomatic anaemia (haemoglobin 9.0 g/dL) who is on haemodialysis and requires a starting dose for correction phase treatment.",
    "text": "**Theme: Most suitable dose of epoetin alpha**\r\n\r\n\r\n**Instruction: For each scenario, select the most suitable dose of epoetin alpha from the list of answer options. Each option may be used once, more than once or not at all.**\u2028\u2028The sPmC for Eprex has been provided for you.\u2028[SmPC for Eprex](https://www.medicines.org.uk/emc/product/3442/smpc#gref)",
    "why": "50 IU/kg three times a week\r\n\r\nRationale:\r\n\r\nFor a patient with chronic renal failure and symptomatic anaemia undergoing haemodialysis, the SmPC for Eprex recommends an initial starting dose of 50 IU/kg three times weekly during the correction phase. This regimen ensures an effective response to treatment by promoting erythropoiesis while avoiding overtreatment, which could lead to complications such as hypertension or thromboembolic events.\r\n\r\nExplanation of Other Options:\r\n\r\nA. 50 IU/kg twice weekly\r\n\r\nThis dose is lower than the recommended frequency for haemodialysis patients. It may result in suboptimal correction of anaemia during the initial treatment phase.\r\n\r\nB. 75 IU/kg three times weekly\r\n\r\nAlthough this higher dose could be used in certain cases, it exceeds the standard starting dose for patients undergoing haemodialysis and may increase the risk of adverse effects.\r\n\r\nC. 100 IU/kg once weekly\r\n\r\nA once-weekly regimen is not appropriate during the correction phase, as more frequent dosing (three times weekly) is required to achieve target haemoglobin levels effectively.\r\n\r\nD. 150 IU/kg once every two weeks\r\n\r\nThis infrequent dosing schedule is unsuitable for correction phase treatment. Maintenance regimens can use longer intervals, but the correction phase requires regular dosing to achieve rapid results.\r\n\r\nE. 300 IU/kg once every four weeks\r\n\r\nThis dose is intended for different indications or as a maintenance dose in select cases. It is not suitable for patients in the correction phase of anaemia associated with chronic renal failure.\r\n\r\nF. 450 IU/kg once weekly\r\n\r\nThis dose is higher than required for the correction phase and is not aligned with the SmPC-recommended dosing for haemodialysis patients.\r\n\r\nG. 600 IU/kg once weekly\r\n\r\nThis dose is excessive and may be considered for alternative scenarios or unresponsive patients, but it is not the standard starting dose for haemodialysis-associated anaemia correction.\r\n\r\nNICE recommends the use of erythropoiesis-stimulating agents (ESAs), like epoetin alpha, for the management of anaemia in patients with chronic kidney disease (CKD), particularly those undergoing haemodialysis. The treatment aim is to maintain haemoglobin levels within the target range of 10\u201312 g/dL. Careful monitoring is essential to avoid overcorrection, which can increase the risk of cardiovascular events.\r\n\r\nFor correction-phase treatment, NICE aligns with the dosing guidance provided by the SmPC, recommending frequent administration (e.g., three times weekly) to restore haemoglobin levels effectively.\r\n\r\n\r\nFor more information watch BNF lesson Chapter 9 (Blood and Nutrition):\r\n\r\nhttps://preregshortcuts.com/preview-question/2432",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "50 IU/kg twice weekly",
        "answer_number": 1
      },
      {
        "text": "50 IU/kg three times a week.",
        "answer_number": 2
      },
      {
        "text": "75 IU/kg three times weekly",
        "answer_number": 3
      },
      {
        "text": "100 IU/kg once weekly",
        "answer_number": 4
      },
      {
        "text": "150 IU/kg once every two weeks",
        "answer_number": 5
      },
      {
        "text": "300 IU/kg once every four weeks",
        "answer_number": 6
      },
      {
        "text": "450 IU/kg once weekly",
        "answer_number": 7
      },
      {
        "text": "600 IU/kg once weekly",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2310,
    "bank": "clinicalTherapeutics",
    "title": "**Which NSAID is most likely to have caused this side effect?**",
    "text": "A 55-year-old woman with a history of chronic pain syndrome is prescribed a non-steroidal anti-inflammatory drug (NSAID) for her condition. After a few days of starting the medication, she notices blood in her urine and becomes concerned. She contacts your clinic for advice.",
    "why": "Tiaprofenic acid\r\n\r\nRationale:\r\n\r\nTiaprofenic acid is a non-steroidal anti-inflammatory drug (NSAID) that has been associated with severe cystitis and haematuria (blood in the urine). This reaction is unique to tiaprofenic acid among NSAIDs and has led to specific warnings from the Committee on Safety of Medicines (CSM). Patients taking tiaprofenic acid should be advised to stop treatment immediately and consult a healthcare professional if they develop urinary symptoms, such as:\r\n\r\nHaematuria (blood in the urine)\r\nDysuria (painful urination)\r\nUrgency and frequency\r\nNocturia (frequent urination at night)\r\nGiven this patient\u2019s recent NSAID use and new-onset haematuria, tiaprofenic acid is the most likely cause, and discontinuation is advised.\r\n\r\nExplanation of Other Options:\r\n\r\nA: Celecoxib\r\n\r\nCelecoxib is a COX-2 selective NSAID that has a lower risk of gastrointestinal bleeding, but it is not associated with haemorrhagic cystitis.\r\n\r\nB: Diclofenac\r\n\r\nDiclofenac is commonly used for pain and inflammation but does not typically cause urinary tract symptoms or haematuria.\r\n\r\nC: Ibuprofen\r\n\r\nIbuprofen is one of the safest NSAIDs in terms of urinary side effects and does not cause haemorrhagic cystitis.\r\n\r\nD: Naproxen\r\n\r\nNaproxen can cause gastrointestinal bleeding, but it is not linked to haemorrhagic cystitis or urinary symptoms.\r\n\r\nNSAIDs are widely used for pain management, but BNF and NICE guidelines highlight that tiaprofenic acid is uniquely associated with urinary tract irritation and haemorrhagic cystitis. The Committee on Safety of Medicines (CSM) has advised that tiaprofenic acid should not be prescribed to patients with urinary tract disorders and should be discontinued immediately if urinary symptoms develop. Patients should be monitored for signs of haematuria, dysuria, or urinary urgency, and alternative pain management options, such as paracetamol or alternative NSAIDs (e.g., ibuprofen, naproxen), should be considered.\r\n\r\nFor more information, please watch BNF Lesson Chapter 10 (Musculoskeletal System) at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Celecoxib",
        "answer_number": 1
      },
      {
        "text": "Diclofenac",
        "answer_number": 2
      },
      {
        "text": "Ibuprofen",
        "answer_number": 3
      },
      {
        "text": "Naproxen",
        "answer_number": 4
      },
      {
        "text": "Tiaprofenic acid",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2486,
    "bank": "clinicalMep",
    "title": "**Which of the following would be inappropriate advice to provide?**",
    "text": "The GP from the surgery next door calls you as he wishes to complete a requisition form for some morphine ampoules. He tells you that he will be making several house visits for different terminally ill patients and wants to ensure their pain is managed appropriately.",
    "why": "A. The doctor cannot requisition for schedule 2 and 3 controlled drugs.\r\n\r\nRationale:\r\n\r\nUnder the Medicines, Ethics, and Practice (MEP) guidelines and the Misuse of Drugs Regulations 2001, it is entirely legal for a doctor to requisition Schedule 2 and Schedule 3 controlled drugs (CDs) such as morphine. Morphine is commonly used for pain management in palliative care, and a requisition can be made if all legal requirements are fulfilled. Suggesting otherwise is incorrect and inappropriate.\r\n\r\nRequirements for a Controlled Drug Requisition:\r\n\r\nA controlled drug requisition must include the following:\r\n\r\nSignature of the requester.\r\nName, address, and profession/occupation of the person requisitioning the drug.\r\nTotal quantity of the drug to be supplied.\r\nPurpose for which the drug is required (this can be inferred if the drug is being used within the normal course of professional practice).\r\nStandardised requisition form (FP10CDF) for CDs in England.\r\n\r\nWhy the Other Options Are Incorrect:\r\n\r\nB. The doctor must sign the requisition himself as he is the recipient.\r\nThis is correct advice. The doctor requisitioning the CDs must sign the requisition form themselves, as per legal requirements.\r\n\r\nC. The doctor must state his profession/occupation on the requisition.\r\nThis is correct advice. The doctor must state their profession, as this is a legal requirement for all CD requisitions.\r\n\r\nD. The doctor must use a standardised NHS form when requesting the medication.\r\nThis is correct advice. In England, a standardised form (FP10CDF) must be used for requisitions of Schedule 2 and 3 CDs.\r\n\r\nE. The proposed use of the medicine must be stated on the requisition.\r\nWhile the explicit use does not have to be detailed in all cases, stating the purpose is considered good practice. For controlled drugs, the intended use is often implied (e.g., for professional medical use). This option is still correct advice when ensuring clarity on a requisition.\r\n\r\nA doctor can legally requisition Schedule 2 and 3 controlled drugs like morphine for legitimate medical purposes, provided all legal requirements are met. Controlled drug requisitions must be completed on a standardised form (FP10CDF in England), include the necessary details, and be signed by the requester. Misleading or incorrect advice about the requisition process could delay patient care and is inappropriate.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "The doctor cannot requisition for schedule 2 and 3 controlled drugs",
        "answer_number": 1
      },
      {
        "text": "The doctor must sign the requisition himself as he is the recipient",
        "answer_number": 2
      },
      {
        "text": "The doctor must state his profession/occupation on the requisition",
        "answer_number": 3
      },
      {
        "text": "The doctor must use a standardised NHS form when requesting the medication",
        "answer_number": 4
      },
      {
        "text": "The proposed use of the medicine must be stated on the requisition",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2488,
    "bank": "clinicalMep",
    "title": "**Which action is the most appropriate?**",
    "text": "Mr L comes into your pharmacy Monday morning with a bag of medicines. He explains that his mum passed away last week and he found some medicine in her house. He asks if he can leave it with you. Upon inspection you notice there are some Fentanyl patches in there.\u00a0\r\n -",
    "why": "E. Make a record in the controlled drug return register, but there is no need for an authorised witness.\r\n\r\nRationale:\r\n\r\nAccording to the Medicines, Ethics, and Practice (MEP) guidance, fentanyl patches are Schedule 2 Controlled Drugs (CDs). For patient-returned CDs, the following rules apply:\r\n\r\nA record of the return should be made in a CD return register (not the controlled drug register used for stock).\r\nDestruction of patient-returned CDs does not require an authorised witness but should ideally be carried out in the presence of another member of staff (e.g., another pharmacist or a pharmacy team member) to ensure accountability.\r\nThe patches must be denatured before disposal using an appropriate CD destruction kit to render them irretrievable.\r\nWhy the Other Options Are Incorrect:\r\n\r\nA. Make no record, and there is no need for an authorised witness.\r\nThis is incorrect because the receipt and destruction of returned Schedule 2 CDs must always be recorded in the CD return register to maintain an auditable trail.\r\n\r\nB. Make a record in the controlled drug register and have an authorised witness witness the destruction of the patches.\r\nThis is incorrect because the CD register is only for recording CD stock held in the pharmacy, not patient returns. Additionally, an authorised witness is only required for the destruction of expired pharmacy stock, not for patient-returned CDs.\r\n\r\nC. Make a record in the controlled drug register, but there is no need for an authorised witness.\r\nThis is incorrect because the CD register is not the correct place to record patient returns; the CD return register should be used instead.\r\n\r\nD. Make a record in your prescription register and have an authorised witness witness the destruction of the patches.\r\nThis is incorrect because the prescription register is for recording private prescriptions and supplies of certain CDs, not for the return and destruction of CDs.\r\n\r\nSummary:\r\n\r\nPatient returns of Schedule 2 Controlled Drugs, such as fentanyl patches, must be handled with care to ensure compliance with legal and professional standards. These returns should be recorded in the CD return register, and the medicines must be safely denatured before disposal. While an authorised witness is not required for patient-returned CDs, it is best practice to have another member of staff present during the destruction process to maintain accountability. Following these steps helps to prevent misuse and ensures the secure management of Controlled Drugs.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Make no record and there is no need for an authorised witness",
        "answer_number": 1
      },
      {
        "text": "Make a record in the controlled drug register and have an authorised witness, witness you destroy the patches",
        "answer_number": 2
      },
      {
        "text": "Make a record in the controlled drug register but there is no need for an authorised witness",
        "answer_number": 3
      },
      {
        "text": "Make a record in your prescription register and have an authorised witness, witness you destroy the patches",
        "answer_number": 4
      },
      {
        "text": "Make a record in the controlled drug return register but there is no need for an authorised witness",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2505,
    "bank": "clinicalMep",
    "title": "**Which of the following does not meet legal requirements of a prescription?**",
    "text": "Regulation 217 of the human medicines regulations states the legal requirements for prescriptions",
    "why": "c) Copies of electronic prescriptions can be sent via email\r\n\r\nRationale\r\n\r\nUnder Regulation 217 of the Human Medicines Regulations, copies of electronic prescriptions cannot be legally sent via email as they are not considered valid. Electronic prescriptions must be securely transmitted via the NHS Spine to a nominated pharmacy, ensuring a secure and authorised transfer of the prescription. Sending them via email is not a legally recognised or secure method of transmission.\r\n\r\nExplanation of the Other Options\r\n\r\na) Advanced electronic signatures that are uniquely linked to a signatory is acceptable for NHS electronic prescriptions\r\n\r\nThis is correct. Advanced electronic signatures that are securely linked to a signatory are acceptable for NHS electronic prescriptions, as they ensure authenticity and accountability.\r\n\r\nb) Carbon copies of prescriptions are permissible as long as they are signed in ink\r\n\r\nThis is correct. Carbon copies of prescriptions are legally valid once they are signed in indelible ink, ensuring the authenticity of the prescription.\r\n\r\nd) Prescription can be computer generated or typed\r\n\r\nThis is correct. Computer-generated or typed prescriptions are legally valid, provided they meet all other legal requirements (e.g., appropriate signatures and necessary details).\r\n\r\ne) Prescriptions need to be written in indelible ink\r\n\r\nThis is correct. Prescriptions must be written in indelible ink or computer-generated, ensuring the prescription cannot be altered after it is written.\r\n\r\nRegulation 217 outlines the legal requirements for prescriptions, ensuring they are authentic, secure, and legally valid. Key points include:\r\n\r\nElectronic prescriptions: Must be transmitted securely via the NHS Spine and cannot be sent via email.\r\nSignature requirements: Advanced electronic signatures and physical signatures in indelible ink are valid for prescriptions.\r\nCarbon copies: Carbon copies are permissible as long as they are signed in indelible ink to ensure authenticity.\r\nPrescription format: Prescriptions can be computer-generated or typed, provided they meet all other requirements.\r\nIndelible ink: Prescriptions must be written in indelible ink, ensuring that they cannot be altered after being written.\r\nBy adhering to these guidelines, pharmacies ensure prescriptions are legally valid, secure, and compliant with relevant regulations.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Advanced electronic signatures that is uniquely linked to a signatory is acceptable for NHS electronic prescriptions",
        "answer_number": 1
      },
      {
        "text": "Carbon copies of prescription are permissible as long as they are signed in ink",
        "answer_number": 2
      },
      {
        "text": "Copies of electronic prescriptions can be sent via email",
        "answer_number": 3
      },
      {
        "text": "Prescription can be computer generated or typed",
        "answer_number": 4
      },
      {
        "text": "Prescriptions need to be written in indelible ink",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2615,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most suitable treatment?**",
    "text": "A 28 year old pregnant female presents to the pharmacy with a headache with a gradual onset and progressively gets worse throughout the day. There is no photophobia or phonophobia. She explains to you the intensity of the headache sometimes worsens when she is stressed at work.",
    "why": "In this case, the most suitable treatment for the 28-year-old pregnant female with a headache is:\r\n\r\nParacetamol 500mg.\r\n\r\nRationale:\r\nSafety in Pregnancy: Paracetamol is considered the first-line analgesic for headaches during pregnancy. It has a well-established safety profile and is generally recommended for use in pregnant women.\r\n\r\nType of Headache: The description of the headache being gradual in onset and worsening with stress suggests a tension-type headache, which is commonly treated with paracetamol.\r\n\r\nOther Options:\r\n\r\nCo-codamol 8mg/500mg: While it can be effective, it contains codeine, which is generally avoided in early pregnancy unless absolutely necessary due to potential risks to the fetus.\r\nIbuprofen 200mg: NSAIDs like ibuprofen are usually avoided during pregnancy, particularly in the third trimester, due to the risk of complications.\r\nProchlorperazine 3mg: This medication is primarily used for nausea and vomiting, not for headache relief.\r\nSumatriptan 50mg: Triptans are generally not recommended during pregnancy due to limited safety data.\r\n\r\nAccording to the NICE guidelines, headaches during pregnancy are common and can be classified into primary and secondary headaches. The most prevalent type is tension-type headache, often exacerbated by stress and fatigue. NICE emphasizes the importance of thorough assessment to distinguish between these types and rule out any secondary causes that may require urgent intervention, such as pre-eclampsia. The guidelines recommend paracetamol as the first-line treatment for managing mild to moderate headaches in pregnant women, given its established safety profile. It is crucial for healthcare professionals to provide guidance on non-pharmacological interventions, such as maintaining hydration, proper posture, and stress reduction techniques, alongside medication when necessary. Additionally, the guidelines advise against the use of NSAIDs and codeine-containing medications unless absolutely essential, due to potential risks to both the mother and fetus.\r\n\r\nFor more information watch the OTC lesson on Chapter 4 Neurology (Headaches and migraines):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Co-codamol 8mg/500mg",
        "answer_number": 1
      },
      {
        "text": "Ibuprofen 200mg",
        "answer_number": 2
      },
      {
        "text": "Paracetamol 500mg",
        "answer_number": 3
      },
      {
        "text": "Prochlorperazine 3mg",
        "answer_number": 4
      },
      {
        "text": "Sumatriptan 50mg",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2602,
    "bank": "clinicalOtc",
    "title": "**Which of the following is a contraindication for the patient?**",
    "text": "A 23 year old female patient presents to the pharmacy requesting to purchase Pyrocalm 20mg tablets for the treatment of dyspepsia. She informs you she is HIV positive and takes nelfinavir.\r\n\r\nThe SmPC for pyrocalm 20mg tablets has been provided for you\r\n[SmPC for Pyrocalm 20mg](https://www.medicines.org.uk/emc/product/9154/smpc#gref)",
    "why": "She regularly takes nelfinavir.\r\n\r\nRationale:\r\n\r\nAccording to the Summary of Product Characteristics (SmPC) for Pyrocalm 20 mg tablets, which contain omeprazole, there is a significant drug interaction with nelfinavir, an antiretroviral medication used in the management of HIV. Proton pump inhibitors (PPIs), such as omeprazole, significantly reduce the plasma levels of nelfinavir, potentially reducing its therapeutic efficacy. Therefore, omeprazole and nelfinavir should not be used together, making the patient\u2019s regular use of nelfinavir a clear contraindication for the use of Pyrocalm.\r\n\r\nExplanation of Other Options:\r\n\r\nSymptoms lasting longer than 1 week is a common trigger for further medical evaluation, but it is not an absolute contraindication for PPIs.\r\nHypomagnesaemia and vitamin B12 deficiency are potential risks with long-term PPI use but not immediate contraindications.\r\nPrevious gastric ulcer is a condition often treated with PPIs, so it would not preclude their use.\r\nTherefore, the most significant contraindication in this case is the patient's regular use of nelfinavir, as outlined in the SmPC and supported by NICE recommendations.\r\n\r\nDyspepsia refers to a group of symptoms that typically include upper abdominal pain or discomfort, bloating, and indigestion. Initial management focuses on lifestyle changes such as weight reduction, reducing intake of alcohol, caffeine, and spicy foods, as well as stopping smoking. Pharmacological treatments for dyspepsia include antacids and proton pump inhibitors (PPIs) like omeprazole, which help reduce stomach acid and provide symptom relief. However, NICE emphasizes careful consideration of drug interactions, especially in patients on complex medication regimens, such as those taking nelfinavir for HIV. In such cases, PPIs like omeprazole should be avoided, and alternative therapies should be sought. Regular review and patient follow-up are recommended to ensure effective symptom control and to mitigate any risks related to long-term use of medications for dyspepsia.\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Her symptoms has lasted longer than 1 week",
        "answer_number": 1
      },
      {
        "text": "Pyrocalm\u00a0 can cause hypomagnesemia",
        "answer_number": 2
      },
      {
        "text": "Shes is at risk of vitamin B12 deficiency",
        "answer_number": 3
      },
      {
        "text": "She's had a previous gastric ulcer",
        "answer_number": 4
      },
      {
        "text": "She regularly takes nelfinavir",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2613,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the LEAST appropriate advice?**",
    "text": "A mother presents to the pharmacy with her 6 month old baby. She informs you her baby has a rash around the buttocks. After examination you inform the mother the baby has a nappy rash with candida albican involvement",
    "why": "Continue to use barrier creams whilst using antifungal cream on the infected rash.\r\n\r\nRationale:\r\n\r\nAntifungal Treatment: When Candida albicans is involved in a nappy rash, NICE guidelines recommend using an antifungal cream to treat the infection effectively. Barrier creams can be helpful for general nappy rash prevention, but they should not be used concurrently on the affected area while applying an antifungal cream, as they can create a barrier that may reduce the absorption and effectiveness of the antifungal treatment.\r\n\r\nAppropriate Care Advice:\r\n\r\nLeave the Nappy Off: Allowing the baby\u2019s skin to be exposed to air by leaving the nappy off as much as possible each day can help heal the rash, as it reduces moisture and promotes skin healing, which is in line with NICE recommendations.\r\nChange Nappies Promptly: Changing nappies as soon as they are soiled is crucial in preventing further irritation and moisture buildup, which is essential for managing nappy rash and is consistent with NICE advice.\r\nAvoid Soap as a Skin Cleanser: NICE advises against using soaps for cleansing the baby\u2019s skin, as they can be harsh and exacerbate irritation. Instead, water or a mild soap substitute should be used.\r\nThorough Washing of Reusable Nappies: Washing reusable nappies thoroughly is important to remove any residues that could irritate the skin or lead to further infection, which aligns with NICE's hygiene recommendations for nappy care.\r\n\r\nNICE Guidelines on Nappy Rash Management:\r\n\r\nNICE guidelines recommend keeping the baby's skin as dry as possible, frequently changing nappies, and using gentle cleansers. If Candida albicans is suspected, an antifungal cream should be applied, and barrier creams should be avoided on the affected area while the antifungal cream is being used to ensure effective absorption. Air exposure and good hygiene practices, including proper washing of reusable nappies, are emphasized as key steps in managing and preventing nappy rash.\r\n\r\nFor more information watch OTC lessons on skin:\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise to leave the nappy off for as long as possible each day",
        "answer_number": 1
      },
      {
        "text": "Advise to change nappies as soon as they are soiled",
        "answer_number": 2
      },
      {
        "text": "Avoid using a soap as a skin cleanser",
        "answer_number": 3
      },
      {
        "text": "Continue to use barrier creams whilst using anti fungal cream on the infected rash",
        "answer_number": 4
      },
      {
        "text": "Reusable nappies need to washed thoroughly to ensure there is no left over residue",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2616,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "A 31 year old male patient presents to the pharmacy with a frontal aching headache. He explains to you his headache worsens at work as he spends a lot of time on computers. There is no photophobia or phonophobia.",
    "why": "The most appropriate action in this case is:\r\n\r\nRefer patient to optician for routine eye check.\r\n\r\nRationale:\r\nThe patient's headache seems to be related to prolonged screen use, which may indicate eye strain or an issue with vision.\r\nThe absence of photophobia, phonophobia, or other alarming symptoms suggests that this is not a migraine or severe condition requiring urgent treatment or medication like Sumatriptan.\r\nCo-codamol could provide symptomatic relief, but it's not a long-term solution and might not address the underlying cause, which could be visual.\r\nProchlorperazine is used for nausea and vertigo, which are not indicated here.\r\n\r\n1. Initial Assessment:\r\nHistory Taking: The healthcare professional should gather a thorough history of the headache, including its duration, frequency, triggers, and associated symptoms. In this case, the patient mentions that the headache worsens while working on a computer and does not report photophobia (sensitivity to light) or phonophobia (sensitivity to sound).\r\nExclusion of Serious Conditions: The absence of severe symptoms, such as nausea, vomiting, or neurological deficits, suggests that this is likely a non-serious headache. This is consistent with tension-type headaches or headaches related to eye strain.\r\n2. Potential Causes:\r\nEye Strain: Spending long hours on a computer can lead to digital eye strain (also known as computer vision syndrome), which manifests as headaches, blurred vision, and discomfort. This may be particularly relevant in the patient's case, given the worsening of symptoms during work hours.\r\nTension-Type Headaches: These are the most common type of headache and are often triggered by stress, poor posture, and prolonged screen time, resulting in muscle tension in the neck and scalp.\r\n3. Management Recommendations:\r\nRefer for Routine Eye Check: Since the headache is aggravated by computer use, the most appropriate action is to refer the patient to an optician for a routine eye examination. This will help rule out vision problems that could be contributing to the headache, such as uncorrected refractive errors (e.g., myopia, hyperopia) or dry eyes.\r\nPain Relief: While selling analgesics like Co-codamol could provide symptomatic relief, it's not the best first-line approach here. NICE guidelines recommend addressing the underlying issue rather than just masking symptoms.\r\nAdvice on Ergonomics: The healthcare professional can also suggest ergonomic adjustments (like proper screen height, appropriate lighting, and regular breaks) to help alleviate symptoms related to prolonged screen use.\r\n4. Follow-Up:\r\nIf the headache persists after the eye check or if new symptoms develop, further assessment may be warranted to explore other potential causes or treatment options.\r\n\r\nFor more information watch the OTC lesson on Chapter 4 Neurology (headache and migraines)\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Refer patient to optician for routine eye check",
        "answer_number": 1
      },
      {
        "text": "Refer patient to urgent treatment centre",
        "answer_number": 2
      },
      {
        "text": "Sell Sumatriptan 50mg tablets",
        "answer_number": 3
      },
      {
        "text": "Sell Co-codamol 8mg/500mg tablets",
        "answer_number": 4
      },
      {
        "text": "Sell prochlorperazine 3mg buccal tablets",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2618,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "A 17 year old female presents to the pharmacy with a unilateral throbbing headache. Pain is moderate in severity. The patient also explains they have pins and needles sensation on the face.\u00a0\r\nShe has no allergies. She takes microgynon 30 tablets.",
    "why": "Advise the symptoms are caused by a side effect of the medication and see their GP as soon as possible.\r\n\r\nRationale:\r\nUnilateral Throbbing Headache: The patient's description of a unilateral throbbing headache, along with facial pins and needles sensation, raises concern for a potential migraine or another type of headache. However, the presence of facial pins and needles is particularly noteworthy, as it could indicate a neurological issue.\r\n\r\nMicrogynon 30: Although Microgynon (a combined oral contraceptive) can be associated with headaches, the symptoms the patient is experiencing suggest that they might be related to a more serious condition rather than a typical side effect.\r\n\r\nUrgent Referral: Given the neurological symptoms (pins and needles) and the nature of the headache, it is essential to refer the patient to their GP as soon as possible to rule out more serious conditions, such as a migraine with aura, transient ischemic attack (TIA), or other neurological concerns.\r\n\r\nOther Options:\r\n\r\nAdvise to see their GP as the dose of Microgynon may need to be reduced/increased: These options are not appropriate without a proper assessment of the underlying cause of the symptoms.\r\nSell Sumatriptan 50mg tablets: While Sumatriptan is used for treating migraines, it's crucial to confirm the diagnosis first and ensure the patient does not have contraindications, especially considering the neurological symptoms.\r\n\r\nThe patient's symptoms are suggestive of a migraine with aura, which is a serious condition that necessitates careful management. One of the rare but significant side effects of Microgynon 30 is an increased risk of blood clots, which is further compounded by the fact that migraine with aura itself is a recognized risk factor for blood clots and stroke, particularly in women using combined oral contraceptives. Consequently, Microgynon 30 is contraindicated for women who experience migraine with aura. Additionally, Sumatriptan 50mg tablets, which are often used to treat migraines, cannot be sold to individuals under the age of 18. Given these factors, it is crucial to refer the patient to their GP for a thorough evaluation and appropriate management of their symptoms to ensure their safety and wellbeing.\r\n\r\nAccording to the NICE guidelines, unilateral throbbing pain is often characteristic of migraine headaches, which are common among adolescents and can present with additional symptoms such as nausea, vomiting, and sensitivity to light or sound. Migraines may also occur with neurological symptoms, known as auras, which can include sensory disturbances like pins and needles. The guidelines highlight the importance of a thorough assessment to differentiate migraines from other types of headaches and to rule out secondary causes, particularly in younger patients. Treatment options for migraines typically include acute therapies such as triptans (e.g., Sumatriptan) for those who meet specific criteria, as well as non-pharmacological approaches. However, any unusual or new neurological symptoms, like facial paresthesia, should prompt immediate medical evaluation to ensure appropriate diagnosis and management, given the potential for more serious underlying conditions.\r\n\r\nFor more information watch the OTC lesson on Chapter 4 Neurology (Headaches and migraines):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the symptoms are caused by a side effect of the medication and see their GP as soon as possible",
        "answer_number": 1
      },
      {
        "text": "Advise to see their GP as the dose of microgynon may need to be reduced",
        "answer_number": 2
      },
      {
        "text": "Advise to see their GP as the dose of microgynon may need to be increased",
        "answer_number": 3
      },
      {
        "text": "Her symptoms are not caused by microgynon.",
        "answer_number": 4
      },
      {
        "text": "Sell sumatriptan 50mg tablets to treat her headache.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2567,
    "bank": "clinicalOtc",
    "title": "**Which one of the following is the most appropriate advice?**",
    "text": "A 25 year old female patient presents to the pharmacy requesting treatment for vaginal trush. The patient explains she has discomfort for 2 weeks and her discharge has a \u201cstrong smell\u201d. The patient has no other medical conditions and does not take any regular medications.",
    "why": "c) Refer to General Practitioner for further investigation\r\n\r\nRationale:\r\n\r\nThe patient\u2019s symptoms, particularly the \u201cstrong smell\u201d associated with her discharge, are atypical of vaginal candidiasis and may indicate bacterial vaginosis or another infection rather than thrush. Referral to a GP is appropriate for accurate diagnosis and tailored treatment. Vaginal thrush is typically characterised by thick, white, odourless discharge, itching, and irritation, whereas a foul-smelling discharge can indicate bacterial infection, which may require antibiotics. Referral ensures the patient receives the correct treatment based on the specific pathogen.\r\n\r\nExplanation of Other Options:\r\n\r\na) Advise the condition is self-limiting and provide self-care advice: While minor infections may resolve on their own, the duration and specific symptoms here warrant professional evaluation.\r\nb) Recommend using live yoghurt as a natural treatment: No evidence supports yogurt as a treatment for vaginal infections, and NICE guidelines do not recommend it.\r\nd) Sell Clotrimazole 500mg pessary for vaginal thrush: Clotrimazole is used to treat thrush, but due to the patient\u2019s symptoms, GP referral is more appropriate.\r\ne) Sell one fluconazole 150mg capsule for thrush: Fluconazole treats thrush, but referral is recommended here due to the unusual symptoms.\r\n\r\nAccording to NICE guidelines, vaginal candidiasis or thrush is an infection caused by Candida species, primarily Candida albicans. Symptoms typically include itching, soreness, redness, and a thick, white, odourless discharge. Diagnosis is often clinical but may require confirmation in recurrent cases or if symptoms suggest an alternative diagnosis, like bacterial vaginosis, which commonly causes a strong-smelling, greyish discharge.\r\n\r\nNICE recommends antifungal treatments for thrush, such as clotrimazole pessaries or fluconazole capsules. However, the guidelines highlight that any unusual symptoms, such as a foul odour or prolonged symptoms, should prompt further investigation by a GP to rule out other infections.\r\n\r\nFor more information please watch BNF lesson chapter 6 (Gynaecology):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the condition is self limiting and provide self care advice",
        "answer_number": 1
      },
      {
        "text": "Recommend using live yoghurt as a natural treatment",
        "answer_number": 2
      },
      {
        "text": "Refer to General Practitioner for further investigation",
        "answer_number": 3
      },
      {
        "text": "Sell Clotrimazole 500mg pessary for the treatment of vaginal thrush",
        "answer_number": 4
      },
      {
        "text": "Sell one fluconazole 150mg capsule for the treatment of vaginal thrush",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2153,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Antidotes** \u2028\u2028**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 30-year-old man who has overdosed on diazepam and is drowsy and unresponsive",
    "why": "Correct answer: \r\n\r\nD) Flumazenil\r\n\r\nRationale:\r\n\r\nFlumazenil is a benzodiazepine antagonist and is the specific antidote for benzodiazepine overdose, such as diazepam. It works by competitively inhibiting the action of benzodiazepines at the GABA-A receptor. It can rapidly reverse sedation and respiratory depression associated with benzodiazepines.\r\n\r\nHowever, caution is required: Flumazenil should not be used routinely, especially in patients with a history of seizures, benzodiazepine dependence, or co-ingestion of tricyclic antidepressants, as it may precipitate seizures or arrhythmias.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Acetylcysteine \r\n\r\nUsed in paracetamol overdose, not for benzodiazepines.\r\n\r\nB) Deferoxamine mesilate \r\n\r\nAntidote for iron poisoning.\r\n\r\nC) Dicobalt edetate \r\n\r\nUsed in cyanide poisoning, not indicated here.\r\n\r\nE) Glucagon \r\n\r\nUsed in beta-blocker or calcium channel blocker overdose.\r\n\r\nF) Naloxone hydrochloride \r\n\r\nOpioid antagonist, used in opioid overdose, not benzodiazepines.\r\n\r\nG) Phytomenadione (vitamin K1) \r\n\r\nAntidote for warfarin overdose.\r\n\r\nH) Sodium bicarbonate \r\n\r\nUsed in tricyclic antidepressant overdose, metabolic acidosis, or hyperkalaemia.\r\n\r\n\r\nIn benzodiazepine overdose (e.g. diazepam), Flumazenil is the specific antidote, but its use must be carefully assessed due to the risk of seizures, particularly in mixed overdoses or chronic benzodiazepine users. It is not routinely recommended unless clearly indicated and under specialist supervision.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Acetylcysteine",
        "answer_number": 1
      },
      {
        "text": "Deferoxamine mesilate",
        "answer_number": 2
      },
      {
        "text": "Dicobalt edetate",
        "answer_number": 3
      },
      {
        "text": "Flumazenil",
        "answer_number": 4
      },
      {
        "text": "Glucagon",
        "answer_number": 5
      },
      {
        "text": "Naloxone hydrochloride",
        "answer_number": 6
      },
      {
        "text": "Phytomenadione",
        "answer_number": 7
      },
      {
        "text": "Sodium bicarbonate",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2552,
    "bank": "clinicalMep",
    "title": "**What is the most appropriate action to take?**",
    "text": "A 23-year old female comes to the pharmacy with a prescription from their dentist. She informs you she has an abscess.\u00a0\r\nThe prescription has been presented below\u00a0\r\n![mepRxs](https://i.ibb.co/zGZVKy1/mepRxs.png)\r\n\r\nThe Dental Practitioners Formulary has been provided for this question\u00a0\r\n[Dental Practitioners Formulary](https://bnf.nice.org.uk/dental-practitioners-formulary/)",
    "why": "(C) Dispense amoxicillin and advise the patient to return to their dentist for a new prescription.\r\n\r\nRationale:\r\n\r\nDentists using an FP10D (NHS dental prescription form) are restricted to prescribing medications listed in the Dental Practitioners\u2019 Formulary (DPF). In this case, amoxicillin is appropriate and listed in the DPF for treating dental infections like abscesses. However, co-codamol is not listed in the DPF, and therefore cannot be dispensed under an NHS dental prescription. The correct action is to dispense the amoxicillin and advise the patient to return to their dentist for an alternative pain management prescription that complies with the DPF.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Dispense both medications without any further action:\r\nIncorrect. Since co-codamol is not in the DPF, it should not be dispensed on an NHS prescription from a dentist. This would be against NHS prescription guidelines.\r\n\r\n(B) Dispense amoxicillin only:\r\nPartially correct, but without advising the patient to consult the dentist for alternative pain management, this action would leave the patient without necessary guidance on addressing her pain appropriately.\r\n\r\n(D) Dispense an alternative medication that is listed in the DPF:\r\nIncorrect. Substituting medications without authorization from the prescriber is not permitted. The patient should consult the dentist for a new prescription instead.\r\n\r\n(E) Refuse to dispense both medications:\r\nIncorrect. Amoxicillin is listed in the DPF, and withholding it would delay necessary treatment for the abscess.\r\n\r\n\r\nThe DPF limits the medications that NHS dentists can prescribe. For prescriptions issued on FP10D forms, only drugs listed in the DPF should be dispensed. In this scenario, dispensing amoxicillin complies with the guidelines, while co-codamol does not. Patients requiring non-DPF medications for pain relief should be advised to return to their dentist for an alternative DPF-compatible prescription or consider obtaining a private prescription if appropriate. This approach aligns with MEP guidance on the handling of restricted NHS dental prescriptions.\r\n\r\nFor more information watch MEP lesson Chapter 3 (Underpinning knowledge: legislation and professional Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Dispense both medications without any further action.",
        "answer_number": 1
      },
      {
        "text": "Dispense amoxicillin only.",
        "answer_number": 2
      },
      {
        "text": "Dispense amoxicillin and advise the patient to return to their dentist for a new prescription.",
        "answer_number": 3
      },
      {
        "text": "Dispense an alternative medication that is listed in the DPF.",
        "answer_number": 4
      },
      {
        "text": "Refuse to dispense both medications .",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2553,
    "bank": "clinicalMep",
    "title": "**What is the most appropriate action to take?**",
    "text": "A patient presents to your community with a prescription. They explain to you they are visiting their family. You do not have a contract with the Ministry of Defence.\u00a0\r\n\r\nAn extract of the prescription has been provided for you.\r\n\r\n![mepRxs-3](https://i.ibb.co/KqdjTpv/mepRxs-3.png)",
    "why": "(D) Treat it as a private prescription and ask the patient to pay full costs before receiving the medicine.\r\n\r\nRationale:\r\n\r\nThe FMed296 form is a prescription issued by the Ministry of Defence (MOD) for military personnel. If presented at a non-contracted pharmacy, like in this case, the prescription should be treated as a private one. The patient is responsible for paying the full costs upfront, and they can later seek reimbursement from their military unit if eligible.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Advise the patient to return to their military base for a new prescription:\r\nNot required. The patient does not need a new prescription. They simply need to cover the costs themselves at a non-contracted pharmacy.\r\n\r\n(B) Dispense the medication without any further action:\r\nIncorrect. As the pharmacy is not contracted with the MOD, payment is required upfront, and the MOD will not cover direct costs in this situation.\r\n\r\n(C) Refuse to dispense the medication:\r\nUnnecessary. The prescription can be dispensed; however, it must be treated as a private prescription with upfront payment.\r\n\r\n(E) Send an invoice for services directly to the Ministry of Defence (MOD):\r\nIncorrect. Non-contracted pharmacies are not authorised to invoice the MOD directly. The patient must pay and handle reimbursement independently if eligible.\r\n\r\nIn the UK, prescriptions issued under FMed296 for MOD personnel are typically managed by contracted pharmacies. If a patient presents this prescription at a non-contracted pharmacy, it is treated as a private prescription, meaning the individual must pay the full cost of the medication upfront. This setup ensures that military personnel can still access necessary medicines, while maintaining clarity on payment responsibilities. The individual may pursue reimbursement directly through their military unit, contingent on their entitlements. This approach aligns with MEP guidance on handling MOD prescriptions outside contracted pharmacies.\r\n\r\nPlease for more information watch the MEP lesson on Chapter 2 (Professional and Legal Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the patient to return to their military base for a new prescription.",
        "answer_number": 1
      },
      {
        "text": "Dispense the medication without any further action.",
        "answer_number": 2
      },
      {
        "text": "Refuse to dispense the medication.",
        "answer_number": 3
      },
      {
        "text": "Treat it as a private prescription and ask the patient to pay full costs before receiving the medicine1.",
        "answer_number": 4
      },
      {
        "text": "Send an invoice for services directly to the Ministry of Defence (MOD)1",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2513,
    "bank": "clinicalMep",
    "title": "**Which of the following is INCORRECT regarding administration of Anaphylaxis**",
    "text": "Occasionally pharmacists need to administer adrenaline for the treatment of Anaphylaxis",
    "why": "D) Pharmacists require prescriptions for adrenaline prior to administration\r\n\r\nRationale:\r\n\r\nThis answer is incorrect because pharmacists do not require a prescription for adrenaline prior to administration in the case of an emergency such as anaphylaxis. Under the Human Medicines Regulations 2012, pharmacists can administer adrenaline in an emergency situation without the need for a prior prescription. The key requirement is that adrenaline is administered immediately to treat anaphylaxis, a life-threatening condition, which overrides the need for a prescription in urgent cases.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Adrenaline is a prescription-only medicine and is administered intramuscularly \u2013 This is correct. Adrenaline is indeed a prescription-only medicine (POM), and the recommended route of administration for anaphylaxis is intramuscularly (IM), typically into the anterolateral thigh.\r\n\r\nB) Pharmacists need to have training regarding recognising and treating Anaphylaxis \u2013 This is correct. Pharmacists should have appropriate training in recognising and managing anaphylaxis to ensure effective and timely intervention, including the administration of adrenaline when necessary.\r\n\r\nC) Pharmacists providing vaccination services must have access to an Anaphylaxis pack \u2013 This is correct. Pharmacists who provide vaccination services must have access to an anaphylaxis pack, including adrenaline, in case of an allergic reaction following a vaccination.\r\n\r\nE) Pharmacists who administered adrenaline also need to ensure an ambulance is called \u2013 This is correct. Following the administration of adrenaline for anaphylaxis, it is essential that an ambulance is called, as the patient may require further medical treatment and monitoring in a hospital setting.\r\n\r\n\r\nPharmacists are authorised to administer adrenaline in emergency situations such as anaphylaxis without requiring a prescription. The Human Medicines Regulations 2012 allow for the immediate administration of adrenaline in emergencies, particularly for the treatment of severe allergic reactions. Pharmacists must have appropriate training in recognising and managing anaphylaxis and should have access to an anaphylaxis pack when providing services like vaccinations. It is also essential that, after administering adrenaline, an ambulance is called to ensure the patient receives further care and observation. The overall goal is to ensure timely, safe, and effective treatment to prevent life-threatening consequences.\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal  issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Adrenaline is a prescription only medicine and is administered intramuscularly",
        "answer_number": 1
      },
      {
        "text": "Pharmacist need to have training regarding recognising and treating Anaphylaxis",
        "answer_number": 2
      },
      {
        "text": "Pharmacists providing vaccination services must have access to an Anaphylaxis pack",
        "answer_number": 3
      },
      {
        "text": "Pharmacists require prescriptions for adrenaline prior to administration",
        "answer_number": 4
      },
      {
        "text": "Pharmacists who administered adrenaline also need to ensure an ambulance is called",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2491,
    "bank": "clinicalMep",
    "title": "**Which of the following actions would be the most appropriate to take?**",
    "text": "A French patient comes in with a prescription for morphine sulphate 10mg/5ml oral solution 10mL to be given every 4 hours. She explains to you that she is travelling and didn\u2019t want to carry lots of bottles around so a registered EU doctor wrote these prescriptions. Your counter assistant translated the prescription fully for you and you are confident of the appropriateness. The prescription is dated within the past 28 days.",
    "why": "E. You are satisfied with the prescription and supply the morphine sulphate oral solution.\r\n\r\nRationale:\r\n\r\nAccording to the Medicines, Ethics, and Practice (MEP) guidelines, European Economic Area (EEA) professionals (such as doctors from France) are permitted to prescribe controlled drugs (CDs) within the UK, provided they comply with the necessary legal requirements outlined in the Human Medicines Regulations 2012 (Regulation 218).\r\n\r\nMorphine sulphate oral solution is a Schedule 5 controlled drug. Prescriptions for controlled drugs can be written by registered EEA doctors, as long as the prescription meets all the requirements, such as the correct prescription format, patient details, drug details, and appropriate dosage. A translation service like Language Line is an option if there are issues with understanding a non-English prescription, but since the prescription has already been translated by a reliable source (the counter assistant), this step is not necessary in this case.\r\n\r\nTherefore, the prescription is valid, and the most appropriate action is to supply the morphine sulphate oral solution.\r\n\r\nWhy the Other Options Are Incorrect:\r\n\r\nA. Refuse the supply as CD prescriptions must be written by a UK doctor.\r\nThis is incorrect because EEA doctors are allowed to prescribe controlled drugs in the UK, as per Regulation 218 of the Human Medicines Regulations 2012. There is no requirement for the prescription to be written by a UK doctor.\r\n\r\nB. Refuse the supply and request the patient make an appointment with a UK doctor to get a private prescription.\r\nThis is incorrect because the prescription from the EEA doctor is valid. There is no need to request a new prescription from a UK doctor, as long as all the prescription requirements have been met.\r\n\r\nC. Refuse the supply as you must not supply a prescription if it's not written in English.\r\nThis is incorrect. While it is important for prescriptions to be clear and understandable, a prescription written in a foreign language can be valid as long as it is properly translated. In this case, the translation has already been provided, so this is not a valid reason to refuse supply.\r\n\r\nD. Refuse the supply but supply another over-the-counter opiate such as co-codamol.\r\nThis is incorrect because supplying a different opiate (such as co-codamol) without proper medical authorisation would be inappropriate. The patient has a valid prescription for morphine sulphate, so it should be supplied as prescribed, not substituted with another medication.\r\n\r\nSummary:\r\n\r\nIn the UK, EEA doctors are authorised to prescribe controlled drugs such as morphine sulphate (a Schedule 5 controlled drug). The prescription must meet all legal requirements, including the correct format and details. If the prescription is in a foreign language, it can be valid as long as it is properly translated. Therefore, the prescription from the French doctor is legitimate, and the morphine sulphate oral solution should be supplied as prescribed.\r\n\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Refuse the supply as CD prescriptions must be written by a UK doctor.",
        "answer_number": 1
      },
      {
        "text": "Refuse the supply and request the patient make an appointment with a UK doctor to get a private prescription",
        "answer_number": 2
      },
      {
        "text": "Refuse the supply as you must not supply a prescription if its not written in English",
        "answer_number": 3
      },
      {
        "text": "Refuse the supply but supply another over the counter opiate such as co-codamol",
        "answer_number": 4
      },
      {
        "text": "You are satisfied with the prescription and supply the morphine sulphate oral solution.**",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2280,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following would require correction before initiation of treatment?**",
    "text": "A patient is to be initiated on lithium therapy after several treatment failures with other antipsychotics.",
    "why": "Correct Answer:\r\n\r\nD) Hyponatraemia\r\n\r\nRationale:\r\n\r\nLithium is a narrow therapeutic index drug, and sodium balance plays a crucial role in its excretion. Hyponatraemia increases lithium reabsorption in the kidneys, predisposing the patient to lithium toxicity. Therefore, sodium levels must be corrected before initiation to minimise this risk. NICE guidelines (2025) state that baseline renal function, electrolytes (including sodium), and thyroid function should be checked before starting lithium therapy.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Hypercalcaemia \r\n\r\n Lithium use can itself cause hypercalcaemia by affecting parathyroid hormone (PTH) regulation. However, pre-existing hypercalcaemia does not necessarily need correction before initiation. Monitoring is recommended.\r\n\r\nB) Hyperkalaemia \r\n\r\nLithium is primarily excreted by the kidneys, but it does not have a direct impact on potassium regulation in the same way it affects sodium. Although hyperkalaemia requires management, it is not a contraindication to lithium initiation.\r\n\r\nC) Hypermagnesaemia \r\n\r\nMagnesium levels do not significantly impact lithium metabolism or toxicity risk, so it is not a priority for correction before starting lithium.\r\n\r\nE) Hypophosphataemia \r\n\r\nLow phosphate levels do not influence lithium clearance or toxicity, so correction is not required before initiation.\r\n\r\nLithium and Sodium Balance:\r\n\r\n- Lithium competes with sodium for renal excretion. If sodium levels are low (hyponatraemia), lithium is retained, increasing the risk of toxicity.\r\n\r\n- Maintaining stable sodium intake and hydration is essential. Patients should be advised to avoid excessive sodium restriction or dehydration.\r\n\r\n- Routine monitoring of lithium levels, renal function, and electrolytes is essential throughout treatment.\r\n\r\nFor more information please watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Hypercalcaemia",
        "answer_number": 1
      },
      {
        "text": "Hyperkalaemia",
        "answer_number": 2
      },
      {
        "text": "Hypermagnesaemia",
        "answer_number": 3
      },
      {
        "text": "Hyponatraemia",
        "answer_number": 4
      },
      {
        "text": "Hypophosphataemia",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2249,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is an appropriate course of action?**",
    "text": "A 35-year-old man is admitted for minor day case surgery and a TTA is written for paracetamol 1g QDS 7/7, ibuprofen 400mg TDS 7/7, codeine 30mg 4hrly PRN 7/7 and tramadol 50mg QDS PRNP 7/7.\r\nHe has no known allergies and was taking levetiracetam 500mg BD pre-admission.",
    "why": "Correct Answer:\r\n\r\nD) Contact the doctor to stop the tramadol\u200b\r\n\r\nRationale:\r\n\r\nTramadol is associated with an increased risk of seizures and should be used with caution in patients with epilepsy. Given that the patient is already prescribed codeine, another opioid analgesic, adding tramadol may not provide additional benefit and could increase the risk of adverse effects. Therefore, it is appropriate to contact the doctor to discontinue tramadol in this patient's analgesic regimen.\u200b\r\n\r\nExplanation of Other Options:\r\n\r\nA) Contact the doctor to add in gastro-protection \r\n\r\nWhile NSAIDs like ibuprofen can cause gastrointestinal (GI) irritation, the need for gastro-protection should be evaluated based on individual risk factors such as age, history of GI ulcers, or concurrent use of other medications that increase GI risk. If the patient has no additional risk factors, routine gastro-protection may not be necessary.\u200b\r\n\r\nB) Contact the doctor to ensure you have a controlled drug (CD) prescription for the tramadol \r\n\r\nIn the UK, tramadol is classified as a Schedule 3 controlled drug, but it does not require the use of a controlled drug prescription form. However, certain prescription writing requirements must be met.\u200b\r\n\r\nC) Contact the doctor to stop the codeine \r\n\r\nCodeine is a commonly used opioid analgesic for moderate pain. There is no specific contraindication to its use in this patient, provided it is used appropriately.\u200b\r\n\r\n(E) Dispense the TTA ensuring that the patient has at least 7 days supply \r\n\r\nDispensing the take-home analgesia (TTA) as prescribed without addressing the potential risks associated with tramadol in a patient with epilepsy could lead to adverse outcomes.\u200b\r\n\r\nAnalgesic Use in Patients with Epilepsy:\r\n\r\nWhen prescribing analgesics to patients with epilepsy, it is crucial to consider the potential impact on seizure threshold. Tramadol has been associated with an increased risk of seizures and should be used with caution in this population. Alternative analgesics with a more favourable safety profile regarding seizure risk should be considered.\u200b\r\n\r\nFor more information, please watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Contact the Dr to add in gastro-protection",
        "answer_number": 1
      },
      {
        "text": "Contact the Dr to ensure you have a CD prescription for the tramadol",
        "answer_number": 2
      },
      {
        "text": "Contact the Dr to stop the codeine",
        "answer_number": 3
      },
      {
        "text": "Contact the Dr to stop the tramadol**",
        "answer_number": 4
      },
      {
        "text": "Dispense the TTA ensuring that the patient has a least 7 days supply",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2572,
    "bank": "clinicalOtc",
    "title": "Mrs H, a regular patient of yours, brings her 11-year-old child in to your pharmacy. She tells you that they have recently returned from a safari trip in Africa. Her son has come up in an itch with small bumps rash where the mosquitoes have bitten him. You note that the bites are across his legs and upon inspection find that the skin is intact and not infected.",
    "text": "**Theme: Dermatological preparations**\r\n\r\n\r\n**For each of the following scenarios select the best option for over-the-counter treatment. Each option may be used once, more than once or not at all.**",
    "why": "(g) Hydrocortisone 1% cream\r\n\r\nRationale:\r\n\r\nHydrocortisone 1% cream is the most suitable choice for this child\u2019s symptoms. It is a mild corticosteroid that effectively reduces inflammation and itching caused by mosquito bites, making it ideal for situations where the skin is intact and non-infected. This cream is appropriate for children over 10 and provides targeted relief for itchy, inflamed areas. Hydrocortisone offers a quicker and more effective response than other over-the-counter options, which are often less effective for multiple bites.\r\n\r\nExplanation of Other Options:\r\n\r\n(a) Aloe vera gel: Aloe vera has a soothing, cooling effect that can help alleviate mild skin irritation. However, it lacks the anti-inflammatory properties needed to fully relieve the persistent itching from multiple insect bites.\r\n\r\n(b) Aqueous calamine cream: Calamine is commonly used to relieve minor itchiness but does not match hydrocortisone\u2019s effectiveness for reducing inflammation and discomfort in cases of extensive bites.\r\n\r\n(c) Aveeno\u00ae lotion: While Aveeno provides moisturising benefits, it lacks anti-inflammatory effects, making it less suitable for relieving itching and inflammation from insect bites.\r\n\r\n(d) Dermol\u00ae wash: Dermol acts as an antimicrobial and emollient, which can help prevent skin infections but is not formulated to target itching relief from bites.\r\n\r\n(e) Diprobase\u00ae cream: Primarily a moisturiser, Diprobase is more suitable for dry skin conditions rather than addressing itching or inflammation from bites.\r\n\r\n(f) Eumovate\u00ae cream: Eumovate, a moderate-potency corticosteroid, is stronger than hydrocortisone and typically avoided for children without a professional recommendation.\r\n\r\n(h) Oilatum\u00ae Junior Bath Additive: This bath additive is beneficial for managing general dry or irritated skin but is not designed to alleviate the specific itching and inflammation caused by insect bites.\r\n\r\n\r\nAccording to NICE guidelines, managing insect bites, particularly in children, involves a combination of symptomatic relief, prevention of infection, and monitoring for any worsening of symptoms. For uncomplicated bites where the skin is intact and free from infection, a mild corticosteroid like hydrocortisone 1% cream is recommended to reduce localised itching and inflammation. This is generally safe for short-term use in children over 10 and provides effective relief from the discomfort caused by multiple bites, especially on exposed areas like the legs.\r\n\r\nIn cases where bites cause only mild irritation, cooling products such as aloe vera gel or aqueous calamine cream may be used for soothing. Emollient creams or lotions like Aveeno or Diprobase are helpful for dry skin but may not provide targeted relief for itching from bites. For young children or those with sensitive skin, it\u2019s essential to choose low-potency treatments and avoid stronger corticosteroids like Eumovate without a healthcare provider's recommendation.\r\n\r\nIf there are any signs of infection, such as redness, warmth, or pus at the bite sites, an antiseptic wash or consultation with a healthcare professional may be advised. Additional precautions, such as regular emollient use and avoiding scratching, can also help prevent worsening symptoms and skin breakdown.\r\n\r\n\r\n\r\n\r\n\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "Aloe vera gel",
        "answer_number": 1
      },
      {
        "text": "Aqueous calamine cream",
        "answer_number": 2
      },
      {
        "text": "Aveeno\u00ae lotion",
        "answer_number": 3
      },
      {
        "text": "Dermol\u00ae wash",
        "answer_number": 4
      },
      {
        "text": "Diprobase\u00ae cream",
        "answer_number": 5
      },
      {
        "text": "Eumovate\u00ae cream",
        "answer_number": 6
      },
      {
        "text": "Hydrocortisone 1% cream",
        "answer_number": 7
      },
      {
        "text": "Oilatum\u00ae Junior Bath Additive",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2489,
    "bank": "clinicalMep",
    "title": "**You inform the owner that the prescription can not be supplied, what makes the prescription incomplete about the prescription?**",
    "text": "The following questions relate to a prescription you receive from a pet\u2019s owner. You may find the prescription provided in the resource booklet useful for this question. It must be noted the date of supply is 24.03.17.\r\n\r\nA resource has been provided for this question \r\n\r\n![Screenshot-2024-01-08-at-09-55-55](https://i.ibb.co/Sw3Hb9v/Screenshot-2024-01-08-at-09-55-55.png)",
    "why": "E. The Vet\u2019s registration number is missing, so this must be added.\r\n\r\nRationale:\r\n\r\nAccording to the Veterinary Medicines Regulations 2013, as amended, a veterinary prescription must include all legally required details to ensure it is valid and compliant. One key legal requirement is the inclusion of the vet\u2019s registration number on prescriptions for Controlled Drugs (CDs), which allows traceability and accountability. If this detail is missing, the prescription is incomplete, and the pharmacy cannot proceed with the supply. The vet must amend and reissue the prescription to include the registration number.\r\n\r\nWhy the Other Options Are Incorrect:\r\n\r\nA. CD statement is incorrect; therefore, it must be taken back to the vet for correction.\r\nThis is incorrect because while CDs require specific statements (e.g., \"for the treatment of an animal under my care\"), there is no indication in this scenario that the CD statement is incorrect.\r\n\r\nB. Supply the prescription to the owner after making sure the dog lives at the address.\r\nThis is incorrect because even if the address is verified, the missing vet registration number renders the prescription invalid, and supply cannot proceed.\r\n\r\nC. The dosing instructions make this unable to supply for an animal.\r\nThis is incorrect. While veterinary prescriptions must have clear dosing instructions, this is not mentioned as an issue in the scenario.\r\n\r\nD. The medicine is not prescribed under the cascade, so that needs to be corrected before the supply is made.\r\nThis is incorrect. The cascade applies to prescribing unauthorised medicines for animals, but there is no suggestion in the scenario that this is relevant to the prescription.\r\n\r\nSummary:\r\n\r\nWhen dispensing veterinary prescriptions, it is essential to ensure compliance with the Veterinary Medicines Regulations 2013. For Controlled Drugs (CDs), the vet\u2019s registration number must be included on the prescription, among other legal requirements. If any mandatory detail is missing, the prescription cannot be supplied, and the issue must be corrected by the prescribing vet. Always verify veterinary prescriptions carefully to ensure they meet all legal and professional standards before supply.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "CD statement is incorrect therefore must be taken back to the vet for correction",
        "answer_number": 1
      },
      {
        "text": "Supply the prescription to the owner after making sure the dog lives at the address",
        "answer_number": 2
      },
      {
        "text": "The dosing instructions make this unable to supply for an animal",
        "answer_number": 3
      },
      {
        "text": "The medicine is not prescribed under the cascade so that needs to be corrected before the supply is made.",
        "answer_number": 4
      },
      {
        "text": "The Vet\u2019s registration number is missing so this must be added",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 974,
    "bank": "clinicalMep",
    "title": "**Which ONE of the following is correct regarding GPhC revalidation?**",
    "text": "You are the responsible pharmacist in your community pharmacy. You have a trainee pharmacist and you are explaining the requirements for revalidation.",
    "why": "The GPhC website states the following requirements for CPD: \tfour CPD records (two of which must be planned events)\r\none peer discussion record\r\none reflective account record",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Three CPD records, two of which must be planned, one peer discussion and one reflective account",
        "answer_number": 1
      },
      {
        "text": "Three CPD records, one of which must be planned and one peer discussion.",
        "answer_number": 2
      },
      {
        "text": "Four CPD records, two of which must be planned, one peer discussion record and one reflective account.",
        "answer_number": 3
      },
      {
        "text": "Four CPD records, one of which must be planned, one peer discussion record and one reflective account",
        "answer_number": 4
      },
      {
        "text": "Four CPD records none of which have to be planned and one reflective account",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 966,
    "bank": "clinicalMep",
    "title": "**Which of the following would require an authorised witness to allow denaturing of the controlled drug?**",
    "text": "Schedules 2, 3 and 4 (part 1) controlled drugs should be denatured prior to disposal",
    "why": "Only expired schedule 2 controlled drugs need to have an authorised witness for destruction",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Expired buprenophine 8mg sublingual tablets",
        "answer_number": 1
      },
      {
        "text": "Expired morphine sulfate 30mg capsules",
        "answer_number": 2
      },
      {
        "text": "Expired stock of temazepam 20mg tablets",
        "answer_number": 3
      },
      {
        "text": "Patient return of buprenophine 5mcg\u00a0 patches",
        "answer_number": 4
      },
      {
        "text": "Patient return of expired oxycodone 1mg/ml oral suspension",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 997,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely type of headache the student is experiencing?**",
    "text": "A university student has recently been suffering with a headache which feels like a tight-band around her head. It lasts for about an hour and is relieved by taking Paracetamol.",
    "why": "Tension headaches have the following symptoms: Dull and aching head pain\r\nTightness or pressure sensations\u00a0around the forehead. Tension headaches can be short lived or last for several days.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Cluster headache",
        "answer_number": 1
      },
      {
        "text": "Medication overuse headache",
        "answer_number": 2
      },
      {
        "text": "Migraine",
        "answer_number": 3
      },
      {
        "text": "Sinusitis",
        "answer_number": 4
      },
      {
        "text": "Tension headache",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2504,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a legal requirement on prescriptions?**",
    "text": "Regulation 217 of the human medicines regulations states the legal requirements for prescriptions",
    "why": "a) Date of birth\r\n\r\nRationale\r\n\r\nUnder Regulation 217 of the Human Medicines Regulations 2012, the date of birth is not a legal requirement on prescriptions. While the date of birth may be included in practice, especially to avoid confusion with similarly named patients, it is not a mandatory field under the regulations. However, if the patient is under 12 years of age, the age of the patient must be included on the prescription.\r\n\r\nExplanation of the Other Options\r\n\r\nb) Date of prescription\r\n\r\nThe date of prescription is a legal requirement. It must be included on the prescription to determine the validity period and ensure that the prescription is within the allowed timeframe for dispensing.\r\n\r\nc) Particulars of prescriber\r\n\r\nThe particulars of the prescriber (such as their name, address, and professional qualification) are legally required. This ensures that the prescription is legitimate and traceable to the prescriber.\r\n\r\nd) Patient name and address\r\n\r\nThe patient's name and address are legally required to identify the recipient of the prescribed medication. This is essential for the correct dispensation of the medication.\r\n\r\ne) Signature by appropriate practitioner\r\n\r\nExplanation: The signature of the appropriate practitioner (the prescriber) is a legal requirement to verify the authenticity of the prescription.\r\nSummary on Legal Requirements for Prescriptions\r\nRegulation 217 of the Human Medicines Regulations 2012 sets out clear legal requirements for prescriptions to ensure safety and proper dispensing. These include the date of prescription, details of the prescriber, patient's name and address, and the signature of the appropriate practitioner.\r\nWhile the date of birth is not mandatory, the age of a patient under 12 years is a legal requirement. Ensuring that these elements are present helps maintain legal compliance, traceability, and patient safety.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Date of birth",
        "answer_number": 1
      },
      {
        "text": "Date of prescription",
        "answer_number": 2
      },
      {
        "text": "Particulars of prescriber",
        "answer_number": 3
      },
      {
        "text": "Patient name and address",
        "answer_number": 4
      },
      {
        "text": "Signature by appropriate practitioner",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 968,
    "bank": "clinicalMep",
    "title": "**Which of the following would be the most appropriate activity during an absence of a responsible pharmacist?**",
    "text": "You are the pharmacist manager in your community pharmacy. You are currently on vacation and one of your pharmacy assistants has called you and explains the locum pharmacist is stuck in traffic and they do not expect to arrive for another 2 hours. They ask you what the team can do in the absence of a Responsible pharmacist.",
    "why": "Since there is no pharmacist, and therefore the RP has not signed in, the pharmacy needs to remained closed until they are on premises. Date checking is permitted without a RP. All other options are illegal under the Responsible Pharmacist Regulations 2008 as amended",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Accepting deliveries of controlled medicines",
        "answer_number": 1
      },
      {
        "text": "Date checking of medications in the dispensary",
        "answer_number": 2
      },
      {
        "text": "Hand out checked and bagged prescriptions",
        "answer_number": 3
      },
      {
        "text": "Sell General Sale List medicines",
        "answer_number": 4
      },
      {
        "text": "Sell Pharmacy medicines",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2381,
    "bank": "clinicalTherapeutics",
    "title": "**How many millilitres of the injection should the patient receive?**",
    "text": "A 66 year-old patient female is prescribed a dose of 0.5 mg/kg of morphine sulphate for moderate to severe pain after a road traffic accident. The patient weighs 70 kg and the available injection contains 10 mg/mL of morphine sulphate.",
    "why": "C. 3.5 mL\r\n\r\nRationale:\r\n\r\nTo calculate the volume of the injection, we can use the formula:\r\n\r\nvolume = (dose in mg) / (concentration in mg/mL)\r\n\r\nThe dose in mg is the product of the dose per kg and the patient's weight, which is:\r\n\r\ndose in mg = (0.5 mg/kg) x (70 kg)\r\ndose in mg = 35 mg\r\n\r\nSubstituting the values, we get:\r\n\r\nvolume = (35 mg) / (10 mg/mL)\r\nvolume = 3.5 mL\r\n\r\nTherefore, the patient should receive 3.5 mL of the injection.\r\n\r\nMorphine sulphate is an opioid analgesic used for managing moderate to severe pain. The dose is often calculated based on the patient\u2019s weight. Careful attention is required to avoid errors in dosing and preparation. Morphine sulphate injections are typically available in different concentrations, and the calculated dose must match the prescribed strength to ensure accurate administration.\r\n\r\nFor more information watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "0.35 mL",
        "answer_number": 1
      },
      {
        "text": "1.4 mL",
        "answer_number": 2
      },
      {
        "text": "3.5 mL",
        "answer_number": 3
      },
      {
        "text": "14 mL",
        "answer_number": 4
      },
      {
        "text": "35 mL",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2393,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate antibiotic option for her?**",
    "text": "A 20-year-old woman has been suffering from recurrent aphthous ulcers (canker sores) for the last 6 months. She has tried various topical treatments, such as corticosteroids, analgesics, and antiseptics, but they have not helped much. She has no other medical conditions or allergies. She asks for your advice on whether she should take an oral antibiotic to prevent further outbreaks of ulcers.\r\n\r\nA resource has been provided for this question.\u00a0\r\n[BNF Summary](https://bnf.nice.org.uk/treatment-summaries/oral-ulceration-and-inflammation/)",
    "why": "Doxycycline\r\n\r\nRationale:\r\n\r\nFor recurrent aphthous ulcers, doxycycline can be used as a mouthwash to reduce ulcer severity and frequency. According to the BNF, doxycycline dispersible tablets (100 mg) are recommended for recurrent aphthous ulceration. The dose is 100 mg four times a day for 3 days, to be dissolved in water and used as a mouthwash (not swallowed). This approach helps treat the condition locally while avoiding systemic side effects.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Amoxicillin\r\n\r\nAmoxicillin is not indicated for the treatment of recurrent aphthous ulcers. It is primarily used for bacterial infections, such as respiratory or urinary tract infections, not for managing non-infective conditions like canker sores.\r\n\r\nB. Clarithromycin\r\n\r\nClarithromycin is a macrolide antibiotic typically used for bacterial infections such as respiratory tract infections or Helicobacter pylori eradication. It is not appropriate for recurrent aphthous ulceration.\r\n\r\nD. Minocycline\r\n\r\nAlthough minocycline is part of the tetracycline group, it is not the first-line option for recurrent aphthous ulcers. Doxycycline is preferred due to its availability as a dispersible formulation for local use.\r\n\r\nE. Tetracycline\r\n\r\nTetracycline is another antibiotic in the same class as doxycycline, but it is not the recommended treatment for aphthous ulcers according to the BNF.\r\n\r\nNon-Antibiotic Options:\r\n\r\nTopical corticosteroids (e.g., hydrocortisone pellets or triamcinolone dental paste) are usually first-line treatments.\r\nAntiseptics (e.g., chlorhexidine mouthwash) can reduce the risk of secondary infection and provide symptomatic relief.\r\n\r\nAntibiotics in Refractory Cases:\r\n\r\nDoxycycline is used for its anti-inflammatory properties in addition to its antibacterial effects.\r\n\r\nLifestyle and Dietary Advice:\r\n\r\nEncourage stress reduction, avoidance of spicy or acidic foods, and maintenance of good oral hygiene to prevent ulcer recurrence.\r\n\r\nFor more Information please watch BNF lesson Chapter 12 ( Ear, Nose, and Oropharynx):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Amoxicillin",
        "answer_number": 1
      },
      {
        "text": "Clarithromycin",
        "answer_number": 2
      },
      {
        "text": "Doxycycline",
        "answer_number": 3
      },
      {
        "text": "Minocycline",
        "answer_number": 4
      },
      {
        "text": "Tetracycline",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2308,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is the most appropriate treatment?**",
    "text": "A 60-year-old man with a history of gout, severe renal impairment (eGFR 8.9mL/min/1.73m2, and a blood disorder presents to your clinic. He reports experiencing a gout flare-up and is seeking medication for relief.",
    "why": "Correct answer: \r\n\r\nC) Lifestyle modifications\r\n\r\nRationale:\r\n\r\n- This patient has severe renal impairment (eGFR <15) and a blood disorder, which limits safe pharmacological options for treating an acute gout flare.\r\n\r\n- NSAIDs like ibuprofen are contraindicated due to the risk of further nephrotoxicity.\r\n\r\n- Colchicine is not recommended in severe renal impairment and poses risk of bone marrow suppression, especially in blood disorders.\r\n\r\n- Allopurinol and febuxostat are used for urate-lowering, not for acute flare relief.\r\n\r\nTherefore, the safest and most appropriate option is lifestyle modifications, including:\r\n\r\n- Rest and elevation\r\n\r\n- Cold compress\r\n\r\n- Hydration\r\n\r\n- Avoiding alcohol and purine-rich foods\r\n\r\n- Urgent referral to a renal or rheumatology team is recommended for longer-term planning.\r\n\r\nExplanation of other options:\r\n\r\nA) Allopurinol \u2013 Incorrect\r\n\r\nUsed for long-term urate control, not suitable for acute flares. Should not be initiated or adjusted during a flare, especially without renal dose adjustment.\r\n\r\nB) Ibuprofen \u2013 Incorrect\r\n\r\nNSAIDs are first-line for gout flares in general, but contraindicated in severe renal impairment (eGFR <15) due to the risk of acute kidney injury.\r\n\r\nD) Febuxostat \u2013 Incorrect\r\n\r\nAlso used for chronic urate control, not for acute flares. Additionally, it's not recommended in patients with significant cardiovascular or haematological disorders.\r\n\r\nE) Colchicine \u2013 Incorrect\r\n\r\nColchicine is usually used for acute gout, but in severe renal impairment, the risk of toxicity is high. It should be avoided or used only with extreme caution under specialist advice.\r\n\r\nKey Point Summary:\r\n\r\nIn patients with severe renal impairment, both NSAIDs and colchicine are contraindicated for acute gout flare treatment.\r\nLifestyle measures are the safest approach until the patient can be assessed by a specialist.\r\n\r\nFor more information, please watch BNF Lesson Chapter 10 (Musculoskeletal System) at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Allopurinol",
        "answer_number": 1
      },
      {
        "text": "Colchicine",
        "answer_number": 2
      },
      {
        "text": "Febuxostat",
        "answer_number": 3
      },
      {
        "text": "Ibuprofen",
        "answer_number": 4
      },
      {
        "text": "Lifestyle modifications",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2566,
    "bank": "clinicalOtc",
    "title": "**What is the most likely causative organism of her condition?**",
    "text": "A 25-year-old woman presents to your pharmacy with a sore throat, fever, and malaise. She says she has been feeling unwell for the past three days and has difficulty swallowing. You examine her throat and see the white spots at the back of throat and swollen glands.",
    "why": "Streptococcus pyogenes\r\n\r\nRationale:\r\n\r\nThe most likely causative organism in this case is Streptococcus pyogenes, which is responsible for bacterial pharyngitis, commonly known as strep throat. The symptoms presented\u2014sore throat, fever, malaise, difficulty swallowing, swollen glands, and white spots at the back of the throat\u2014are all typical of a streptococcal infection. S. pyogenes infections can lead to pharyngitis, which is characterised by white patches on the tonsils, significant discomfort, and swollen lymph nodes, especially in the absence of other viral symptoms such as cough or runny nose.\r\n\r\nExplanation of Other Options:\r\n\r\nCandida albicans: This yeast causes oral thrush, which may present as white patches in the mouth or throat, especially in immunocompromised individuals or those on antibiotics. However, it is generally not accompanied by fever or swollen glands.\r\n\r\nEpstein-Barr virus: Although Epstein-Barr virus (EBV) can cause symptoms like a sore throat, fever, and swollen glands, it typically leads to infectious mononucleosis, which presents more gradually and often includes extreme fatigue. Swollen glands in EBV tend to be more generalised, and while white spots can be present, EBV is less likely to cause acute, localised throat pain as seen in strep throat.\r\n\r\nFusobacterium necrophorum: This bacterium is linked to Lemierre\u2019s syndrome, a rare complication following a sore throat that typically presents with high fever and neck swelling due to thrombophlebitis. It is less likely to be a primary cause of throat infection in this age group.\r\n\r\nHerpes simplex virus: Herpes simplex infections can cause a sore throat, fever, and swollen glands, but they are more often associated with painful ulcers or blisters rather than white patches and are typically localized to the lips or oral cavity.\r\n\r\nAccording to NICE guidelines, Streptococcus pyogenes (Group A Streptococcus) is a common cause of bacterial pharyngitis, particularly in children and young adults. Strep throat is characterised by sudden onset of sore throat, fever, tender and swollen lymph nodes, and white or yellow exudate on the tonsils. NICE recommends antibiotic treatment in cases where bacterial infection is confirmed or highly suspected, especially when symptoms are severe or persistent. First-line treatment typically includes penicillin or amoxicillin, but alternative antibiotics are available for those with allergies. Symptomatic care with hydration, rest, and analgesics is also recommended to relieve throat pain and fever.\r\n\r\nFor more information please watch BNF lesson chapter 2 (Respiratory):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Candida albicans",
        "answer_number": 1
      },
      {
        "text": "Epstein-Barr virus",
        "answer_number": 2
      },
      {
        "text": "Fusobacterium necrophorum",
        "answer_number": 3
      },
      {
        "text": "Herpes simplex virus",
        "answer_number": 4
      },
      {
        "text": "Streptococcus pyogenes",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2302,
    "bank": "clinicalTherapeutics",
    "title": "**How much of the stock solution (in ml) should the Pharmacist use?**",
    "text": "A Pharmacist needs to prepare 200ml of a 1% w/v solution of potassium permanganate from a 5% w/v stock solution.",
    "why": "40 ml\r\n\r\nRationale:\r\n\r\nThe pharmacist needs to prepare 200 ml of a 1% w/v potassium permanganate solution from a 5% w/v stock solution. This is a dilution calculation where we use the formula:\r\n\r\nC1 \u00d7 V1 = C2 \u00d7 V2\r\n\r\nWhere:\r\nC1 = 5% (stock solution concentration)\r\nV1 = ? (volume of stock solution required)\r\nC2 = 1% (final concentration needed)\r\nV2 = 200 ml (final total volume)\r\n\r\nRearrange the formula to solve for V1:\r\n\r\nV1 = (C2 \u00d7 V2) / C1\r\n\r\nV1 = (1 \u00d7 200) / 5\r\n\r\nV1 = 40 ml\r\n\r\nThus, the \r\npharmacist should take 40 ml of the 5% stock solution and dilute it to a total volume of 200 ml with water.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 10 ml\r\nThis would result in a much lower final concentration (0.25% w/v) instead of the required 1% w/v.\r\n\r\nB: 20 ml\r\nThis would give a final concentration of 0.5% w/v, which is only half of what is needed.\r\n\r\nD: 80 ml\r\nThis would result in a final concentration of 2% w/v, which is twice the required concentration and would lead to an overdose.\r\n\r\nE: 100 ml\r\nThis would give a final concentration of 2.5% w/v, which is much higher than needed and could lead to excessive oxidising effects, increasing the risk of tissue damage.\r\n\r\nPotassium Permanganate Dilution \r\n\r\nAccording to NICE guidelines (2025), potassium permanganate is an oxidising agent often used in dermatology for conditions such as wound debridement, infected eczema, and weeping ulcers. It should always be diluted correctly to avoid chemical burns and tissue irritation.\r\n\r\nThe recommended dilution for topical use is typically 0.01%\u20130.1% w/v, requiring further dilution from stock solutions. Miscalculations in dilution can lead to cytotoxic effects, causing tissue necrosis and worsening of the underlying condition. Healthcare professionals must follow the correct dilution guidelines and educate patients on safe use, including avoiding direct skin contact with concentrated solutions.\r\n\r\nFor further details, refer to BNF Lesson 13: Skin (Topical Preparations & Antiseptics) at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "10 ml",
        "answer_number": 1
      },
      {
        "text": "20 ml",
        "answer_number": 2
      },
      {
        "text": "40 ml",
        "answer_number": 3
      },
      {
        "text": "80 ml",
        "answer_number": 4
      },
      {
        "text": "100 ml",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2540,
    "bank": "clinicalMep",
    "title": "**Which of the following is a Schedule 2 Controlled medicine?**",
    "text": "There are different classifications of Controlled drugs",
    "why": "(d) Secobarbital\r\n\r\nRationale:\r\n\r\nSecobarbital is classified as a Schedule 2 Controlled Drug under the Misuse of Drugs Regulations. While most barbiturates fall under Schedule 3, secobarbital is an exception and is classified as Schedule 2 due to its potential for misuse and dependence. Schedule 2 drugs generally have higher restrictions, including requirements for secure storage, detailed record-keeping, and controlled dispensing protocols.\r\n\r\nOther Options Explained:\r\n\r\n(a) Gabapentin: Gabapentin is a Schedule 3 Controlled Drug. It is not classified as Schedule 2 because its risk profile is generally lower than drugs in Schedule 2.\r\n\r\n(b) Midazolam: Midazolam is classified as Schedule 3, commonly used for short-term sedation, and does not carry the same strict regulations as Schedule 2 drugs.\r\n\r\n(c) Sativex: Sativex, a cannabis-based product, is a Schedule 4 Part 1 Controlled Drug, allowing for its use under specific medical conditions without the tight restrictions of Schedule 2 drugs.\r\n\r\n(e) Temazepam: Temazepam is a Schedule 3 Controlled Drug used primarily for its sedative properties, requiring some controls but not as stringent as those for Schedule 2.\r\n\r\nThe Medicines, Ethics, and Practice (MEP) guide and NICE guidelines outline the classification of controlled drugs, which helps pharmacists comply with regulations regarding storage, dispensing, and record-keeping. Schedule 2 drugs, like secobarbital, have stricter controls due to their high potential for misuse, necessitating secured storage in a controlled drugs cabinet and logging each transaction in the controlled drugs register. Understanding the classification and associated legal obligations for each schedule ensures safe and compliant handling of controlled substances in pharmacy practice.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Gabapentin",
        "answer_number": 1
      },
      {
        "text": "Midazolam",
        "answer_number": 2
      },
      {
        "text": "Sativex",
        "answer_number": 3
      },
      {
        "text": "Secobarbital",
        "answer_number": 4
      },
      {
        "text": "Temazepam",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2244,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is most appropriate treatment?**",
    "text": "A patient whom has spent the past few years as a vegan has been feeling chronically tired, feeling sick and is obviously pale. The doctors order a full blood count which confirms that the patient has anaemia.\u00a0\u00a0\r\n\r\nThe results are as follows:\r\n\r\nHeamoglobin: 110g/L (130 \u2013 170g/L)\r\nMCV: 112fL\u00a0 (80-99 fL)\r\nMCH:\u00a0 36 pg (27-32pg)\r\nFerritin: 50ng/L (20-200ng/L)\r\nFolate: 4ng/L (3-13ng/L)\r\nB12: 97ng/L (200-800ng/L)",
    "why": "Correct Answer:\r\n\r\nE) Hydroxocobalamin\r\n\r\nRationale:\r\n\r\nThe patient presents with macrocytic anaemia, as indicated by a low haemoglobin (110 g/L) and an elevated mean corpuscular volume (MCV = 112 fL, normal range 80\u201399 fL). The most likely cause is vitamin B12 deficiency, confirmed by a low B12 level (97 ng/L, normal range: 200\u2013800 ng/L). Hydroxocobalamin is the first-line treatment for vitamin B12 deficiency in the UK, according to NICE guidelines (2025). It is administered intramuscularly and is preferred over oral cyanocobalamin, particularly in cases of malabsorption, neurological symptoms, or severe deficiency.\r\n\r\nThe patient has a normal ferritin level (50 ng/L, normal range: 20\u2013200 ng/L), indicating that iron deficiency is not the cause of anaemia. Although folate is at the lower end of the normal range, the primary deficiency in this case is vitamin B12. If folic acid were supplemented without correcting B12, it could mask the anaemia while allowing neurological damage to progress.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Epoetin alfa\r\n\r\nEpoetin alfa is an erythropoiesis-stimulating agent (ESA) used in anaemia associated with chronic kidney disease or chemotherapy. It does not correct B12 deficiency-related macrocytic anaemia, making it inappropriate for this case.\r\n\r\nB) Ferrous sulphate\r\n\r\nFerrous sulphate is used for iron deficiency anaemia. This patient has a normal ferritin level (50 ng/L), indicating that iron deficiency is not the cause of anaemia. Additionally, macrocytosis (high MCV) is not characteristic of iron deficiency, making ferrous sulphate inappropriate.\r\n\r\nC) Filgrastim\r\n\r\nFilgrastim is a granulocyte-colony stimulating factor (G-CSF) used to stimulate white blood cell production in neutropenic patients (e.g., post-chemotherapy or bone marrow disorders). It has no role in treating macrocytic anaemia due to vitamin B12 deficiency.\r\n\r\nD) Folic acid\r\n\r\nAlthough the patient's folate level is at the lower end of normal (4 ng/L, normal range: 3\u201313 ng/L), the more clinically significant deficiency is vitamin B12. Treating with folic acid alone could worsen neurological symptoms associated with B12 deficiency, making folic acid inappropriate as a primary treatment.\r\n\r\n\r\nVitamin B12 Deficiency and Macrocytic Anaemia:\r\n\r\nVitamin B12 is essential for red blood cell production and neurological function. Deficiency can result in megaloblastic anaemia, characterised by macrocytosis (high MCV), fatigue, pallor, glossitis, paraesthesia, and in severe cases, neurological complications such as peripheral neuropathy and cognitive impairment.\r\n\r\nThe most common causes of vitamin B12 deficiency include pernicious anaemia, vegan diets, gastrectomy, malabsorption disorders (e.g., Crohn\u2019s disease), and long-term use of proton pump inhibitors (PPIs) or metformin.\r\n\r\nNICE guidelines recommend:\r\n\r\nHydroxocobalamin 1 mg IM three times a week for two weeks, followed by maintenance therapy every 2\u20133 months for life if an ongoing deficiency is present.\r\nFolic acid should not be started without first correcting B12 deficiency, as it may mask anaemia while allowing neurological symptoms to progress.\r\nOral cyanocobalamin may be used only in dietary B12 deficiency but is not suitable for pernicious anaemia or malabsorption cases.\r\n\r\nFor more information, please watch BNF lesson Chapter 9 (Blood & Nutrition):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Epoetin alfa",
        "answer_number": 1
      },
      {
        "text": "Ferrous sulphate",
        "answer_number": 2
      },
      {
        "text": "Filgrastim",
        "answer_number": 3
      },
      {
        "text": "Folic acid",
        "answer_number": 4
      },
      {
        "text": "Hydroxocobalamin",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2378,
    "bank": "clinicalTherapeutics",
    "title": "**How much of the stock solution should you **",
    "text": "You need to prepare 250 mL of a 2% w/v solution of potassium chloride from a 15% w/v stock solution. use?",
    "why": "C. 33.33 mL\r\n\r\nTo solve this question, follow these steps:\r\n\r\nStep 1: Use the dilution formula to find the volume of the stock solution needed.\r\n\r\nThe dilution formula is:\r\n\r\nC\u2081V\u2081 = C\u2082V\u2082\r\n\r\nWhere:\r\n\r\nC\u2081 = Concentration of the stock solution = 15%\r\n\r\nV\u2081 = Volume of the stock solution (this is what we need to find)\r\n\r\nC\u2082 = Concentration of the final solution = 2%\r\n\r\nV\u2082 = Volume of the final solution = 250 mL\r\n\r\nStep 2: Rearrange the formula to solve for V\u2081 (volume of the stock solution):\r\n\r\nV\u2081 = (C\u2082 x V\u2082) / C\u2081\r\n\r\nStep 3: Substitute the given values into the formula:\r\n\r\nV\u2081 = (2% x 250 mL) / 15%\r\n\r\nV\u2081 = 33.33 mL",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "3.33 mL",
        "answer_number": 1
      },
      {
        "text": "16.67 mL",
        "answer_number": 2
      },
      {
        "text": "33.33 mL",
        "answer_number": 3
      },
      {
        "text": "83.33 mL",
        "answer_number": 4
      },
      {
        "text": "166.67 mL",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2587,
    "bank": "clinicalOtc",
    "title": "**Which of the following conditions is the most likely diagnosis?**",
    "text": "A 28-year-old patient visits your community pharmacy complaining of an itchy and scaly rash on their elbows and knees. Upon examination, you notice well-defined, silvery plaques with underlying erythema. The patient reports that their nails also appear pitted and discoloured.",
    "why": "Psoriasis\r\n\r\nRationale: \r\n\r\nThe most likely diagnosis is psoriasis, based on the presence of characteristic silvery plaques with underlying redness (erythema) on areas such as the elbows and knees. Nail involvement, including pitting and discolouration, is also a common sign of psoriasis.\r\n\r\nAtopic Dermatitis (Eczema) typically presents with dry, cracked, inflamed skin but is more common on flexural areas (inside the elbows, behind the knees) and doesn't usually feature silvery plaques.\r\nContact Dermatitis results from exposure to irritants or allergens and generally causes redness, itching, and blistering, rather than well-defined plaques with silvery scales.\r\nRosacea affects the face, causing redness, flushing, and visible blood vessels, and would not present with plaques or nail changes.\r\nUrticaria (Hives) typically presents as raised, itchy welts rather than scaly plaques.\r\n\r\nAccording to NICE guidelines, psoriasis is a chronic inflammatory skin condition that features well-demarcated, erythematous plaques covered with silvery scales, often found on the scalp, elbows, knees, and lower back. Nail involvement, such as pitting or discolouration, is also a common feature. Psoriasis can range in severity and may be associated with psoriatic arthritis in some patients.\r\n\r\nTreatment for psoriasis, as recommended by NICE, begins with topical therapies, including emollients to soothe the skin and prevent dryness, and topical corticosteroids or vitamin D analogues to reduce inflammation and plaque formation. For moderate-to-severe psoriasis, phototherapy or systemic treatments, such as methotrexate or biologic agents, may be necessary. Regular follow-up and referral to a dermatologist are advised for long-term management, particularly in more severe cases or when topical treatments are insufficient.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Atopic Dermatitis (Eczema)",
        "answer_number": 1
      },
      {
        "text": "Contact Dermatitis",
        "answer_number": 2
      },
      {
        "text": "Psoriasis",
        "answer_number": 3
      },
      {
        "text": "Rosacea",
        "answer_number": 4
      },
      {
        "text": "Urticaria (Hives)",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2526,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a legal requirement for a midwife supply order?**",
    "text": "Midwives can obtain certain Controlled drugs via midwife supply order",
    "why": "D. Signature of midwife\r\n\r\nRationale\r\n\r\nThe correct answer is Signature of midwife. A midwife supply order does not require the signature of the midwife. Instead, the order must include the signature of the appropriate medical officer\u2014either a doctor authorised by the local supervising authority or an appointee of a person with such authority. This signature requirement ensures proper authorisation and accountability for controlled drug supply.\r\n\r\nExplanation of Other Options\r\n\r\nA. Name of midwife \u2013 Legally required, as it identifies the midwife requesting the controlled drugs.\r\nB. Occupation of midwife \u2013 Required to verify the professional status of the requestor as a midwife.\r\nC. Purpose of midwife supply order \u2013 Necessary to specify the intended use for the controlled drugs.\r\nE. Total quantity of drug to be obtained \u2013 Required to indicate the exact amount of controlled drugs to be supplied.\r\n\r\nAccording to the Medicines, Ethics, and Practice (MEP) guidelines, midwife supply orders for controlled drugs must be properly documented and authorised. The legal requirements ensure appropriate control and minimise misuse by specifying key details like the midwife\u2019s name, occupation, purpose, and total quantity needed. However, the midwife\u2019s signature is not required; the authorisation signature must come from a designated medical officer. This system upholds both accountability and safety in the handling of controlled substances.\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Name of midwife",
        "answer_number": 1
      },
      {
        "text": "Occupation of midwife",
        "answer_number": 2
      },
      {
        "text": "Purpose of midwife supply order",
        "answer_number": 3
      },
      {
        "text": "Signature of midwife",
        "answer_number": 4
      },
      {
        "text": "Total quantity of drug to be obtained",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2565,
    "bank": "clinicalOtc",
    "title": "**What is the most appropriate advice to give him?**",
    "text": "A 60-year-old man visits your community pharmacy with a sore throat that has been bothering him for the past 3 weeks. He says he has been taking paracetamol 500mg four times a day, but it has not helped much. He also has a history of type 2 diabetes and takes metformin 1g twice daily. He has no fever, cough, or difficulty swallowing. He does not smoke or drink alcohol.",
    "why": "C) Refer him to his GP for further assessment.\r\n\r\nRationale: \r\n\r\nGiven the patient's persistent sore throat lasting over three weeks despite regular use of paracetamol, referral to his GP is warranted for further assessment. This is particularly important due to his age and medical history of type 2 diabetes, as it may complicate his condition or affect his immune response. Chronic throat symptoms can indicate an underlying issue that may require further investigation.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Lozenges containing benzocaine may provide temporary relief but will not address the underlying cause of the persistent sore throat.\r\nB) Gargling with salt water can be soothing but is unlikely to resolve ongoing symptoms and does not substitute for medical evaluation.\r\nD) Switching to ibuprofen may provide symptomatic relief, but again, it does not address the underlying issue and could mask symptoms that need evaluation.\r\nE) Continuing with paracetamol without seeking further advice is not appropriate given the duration of symptoms.\r\n\r\nAccording to NICE guidelines, the management of sore throat symptoms requires careful consideration, especially in older adults or those with pre-existing medical conditions. A sore throat that persists for more than three weeks warrants further investigation to rule out potential serious underlying conditions such as chronic infections, gastroesophageal reflux disease (GERD), or even malignancies. The guidelines emphasize the importance of assessing additional symptoms and risk factors, which can influence the decision to refer to a GP. In this patient's case, the combination of persistent symptoms and his history of diabetes increases the likelihood of complications, making a referral essential. Proper evaluation will enable targeted treatment and ensure any serious conditions are identified and managed appropriately, safeguarding the patient\u2019s health and well-being.\r\n\r\nFor more information please watch BNF lesson chapter 2 (Respiratory):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise him to take lozenges containing benzocaine as needed",
        "answer_number": 1
      },
      {
        "text": "Recommend him to gargle with salt water twice a day",
        "answer_number": 2
      },
      {
        "text": "Refer him to his GP for further assessment",
        "answer_number": 3
      },
      {
        "text": "Suggest him to switch to ibuprofen 400mg three times a day",
        "answer_number": 4
      },
      {
        "text": "Tell him to continue with paracetamol and wait for another week",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2562,
    "bank": "clinicalOtc",
    "title": "**What is the most suitable cough syrup to recommend in this scenario?**",
    "text": "A 35-year-old female with type 1 diabetes comes to your community pharmacy with a complaint of dry cough for the past week. She says she has no fever, chest pain, or weight loss. She has good glycaemic control and takes insulin glargine and insulin aspart. She does not smoke and works as a nurse. She asks you for a cough syrup to soothe her throat.",
    "why": "B) A cough syrup containing dextromethorphan\r\n\r\nRationale:\r\n\r\nDextromethorphan is an antitussive agent that effectively suppresses a dry cough by acting on the central nervous system. This makes it suitable for short-term relief in a patient with diabetes, as it has no known effects on blood glucose levels when taken as directed. Unlike syrups containing sugar or alcohol, dextromethorphan-based products avoid the risk of blood glucose fluctuations, making them safer for individuals with diabetes. Additionally, dextromethorphan does not interact with insulin, aligning with the patient\u2019s regimen of insulin glargine and insulin aspart for good glycaemic control.\r\n\r\nExplanation of Other Options:\r\n\r\nA) A cough syrup containing codeine: Codeine is an opioid antitussive that can effectively relieve cough, but it may cause drowsiness and has the potential for dependence, which makes it less suitable for a patient like this, who is seeking simple throat soothing.\r\nC) A cough syrup containing guaifenesin: Guaifenesin is an expectorant used to thin mucus, more suitable for productive coughs, whereas this patient\u2019s symptoms suggest a dry cough.\r\nD) A cough syrup containing sugar: Sugar-containing syrups should generally be avoided in diabetic patients, as they can cause blood glucose levels to spike.\r\nE) A cough syrup containing alcohol: Alcohol in cough syrups can dry out the throat and may interfere with blood glucose stability, which is especially unsuitable for someone managing type 1 diabetes.\r\n\r\nAccording to NICE guidelines, diabetic patients with a dry cough should avoid syrups with added sugars or alcohol, as these can cause fluctuations in blood glucose levels. Dextromethorphan, as a non-sedative antitussive without these additives, is recommended for dry cough relief in patients with diabetes. If a cough persists beyond three weeks, a further evaluation is advisable to rule out any underlying conditions.\r\n\r\n\r\nFor more information please watch BNF lesson chapter 2 (Respiratory):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "A cough syrup containing codeine",
        "answer_number": 1
      },
      {
        "text": "A cough syrup containing dextromethorphan",
        "answer_number": 2
      },
      {
        "text": "A cough syrup containing guaifenesin",
        "answer_number": 3
      },
      {
        "text": "A cough syrup containing sugar",
        "answer_number": 4
      },
      {
        "text": "A cough syrup containing alcohol",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2517,
    "bank": "clinicalMep",
    "title": "**Which of the following is INCORRECT regarding labelling medicinal products for emergency supplies at the request of a prescriber?**",
    "text": "Regulation 224 of the Human Medicines Regulations 2012 enables emergencies supplies on the request of a prescriber",
    "why": "E) The words \"emergency supply\"\r\n\r\nRationale:\r\n\r\nFor emergency supplies at the request of a prescriber, it is not required to label the product with the words \u201cemergency supply.\u201d This label notation is only mandatory for emergency supplies made at the patient's request. Including it for a prescriber request would be incorrect and unnecessary, as the prescriber has authorised the supply directly, which differs procedurally from a patient-initiated request.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Date of dispensing \u2013 This is a required element on the label for all emergency supplies. Recording the dispensing date is essential for tracking the timeline of medication provision and ensuring accurate record-keeping.\r\n\r\nB) Directions for use \u2013 Directions for use must be included to ensure the patient understands how to take the medication correctly. This guidance is crucial for safe and effective treatment adherence, especially in an emergency context.\r\n\r\nC) Name of medicine \u2013 The medicine\u2019s name is necessary on the label to avoid confusion and ensure the patient receives and recognises the correct medication. Proper labelling with the medicine name is a standard requirement for all dispensed medications.\r\n\r\nD) Name of patient \u2013 Including the patient\u2019s name on the label personalises the medication and prevents accidental administration to someone else. This is particularly important for patient safety and compliance.\r\n\r\n\r\nUnder Regulation 224 of the Human Medicines Regulations 2012, emergency supplies of prescription-only medicines (POMs) at the request of a prescriber must adhere to specific labelling standards to ensure patient safety and regulatory compliance. When a prescriber requests an emergency supply, the label must include essential details such as the date of dispensing, the medicine name, the patient\u2019s name, and directions for use. These elements promote clear communication and appropriate usage, enabling the patient to manage their treatment safely.\r\n\r\nThe words \u201cemergency supply\u201d are only legally required on labels for emergency supplies requested directly by a patient. Since a prescriber request implies professional oversight and responsibility, this additional notation is not needed. MEP and NICE guidelines reinforce these requirements, supporting pharmacists in delivering accurate, well-labelled medications while maintaining clear distinctions between patient- and prescriber-requested emergency supplies. This framework ensures safe, effective, and regulatory-compliant access to essential medications in urgent situations.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Date of dispensing",
        "answer_number": 1
      },
      {
        "text": "Directions for use",
        "answer_number": 2
      },
      {
        "text": "Name of medicine",
        "answer_number": 3
      },
      {
        "text": "Name of patient",
        "answer_number": 4
      },
      {
        "text": "The words \"emergency supply\"",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2549,
    "bank": "clinicalMep",
    "title": "**Which of the following makes the prescription legally not valid?\u00a0**",
    "text": "You receive a prescription for sevredol (morphine sulfate) 10mg tablets for a palliative care patient\u00a0\r\n\r\nHowever you realise you cannot dispense the prescription\u00a0\r\n\r\nAn extract of the prescription has been provided for you\u00a0\r\n![mepRxs-2](https://i.ibb.co/khcSv3Y/mepRxs-2.png)",
    "why": "Correct Answer: \r\n\r\nB) The dose is not legally suitable\r\n\r\nRationale:\r\n\r\nThis is a Schedule 2 Controlled Drug (morphine sulfate), and under Misuse of Drugs Regulations 2001 and MEP, the prescription must include a clear and unambiguous dose.\r\n\r\nThe phrase:\r\n\r\n\u201cTake every 4\u20136 hours when required\u201d\r\n\r\ndoes not specify the actual dose, such as \"Take 1 tablet every 4\u20136 hours when required\".\r\nWithout the specific number of tablets or quantity to take, the dose is not legally valid and cannot be dispensed.\r\n\r\nExplanation of Other Options:\r\n\r\nA) A nurse independent prescriber cannot prescribe Sevredol\r\n\r\nIncorrect \u2013 Nurse Independent Prescribers can prescribe Schedule 2 controlled drugs, including morphine sulfate, provided it is within their clinical competence and for legitimate medical need, such as palliative care (MEP Chapter 2).\r\n\r\nC) The prescription has expired\r\n\r\nIncorrect \u2013 Controlled Drug prescriptions are valid for 28 days from the date on the prescription. This prescription is marked \u201cTODAY'S DATE\u201d so it is still within the valid timeframe.\r\n\r\nD) The quantity is not written in words and figures\r\n\r\nIncorrect \u2013 In the extract, the quantity is written as:\r\n\r\n\u201cQuantity: 56 (fifty six)\u201d\r\nThis meets the legal requirement for Controlled Drugs, where the quantity must be written in both words and figures to prevent tampering.\r\n\r\nE) The prescription needs to be on a standardised form\r\n\r\nIncorrect \u2013 This is a standard FP10 prescription used in England by independent prescribers such as GPs, NIPs, and others.\r\n\r\nControlled drug prescriptions must meet certain legal wording and content requirements (e.g. dose, quantity, form, strength), but they do not need to be on a special or different form unless issued in specific settings (e.g. private prescriptions for Schedule 2/3 CDs must be on FP10PCD in England).\r\n\r\nIn this case, since it is an NHS prescription from a nurse independent prescriber, and not a private prescription, it does not need a different standardised form beyond the usual controlled drug legal content requirements.\r\n\r\nControlled Drug Prescription Requirements (MEP & Legal Framework):\r\n\r\n- Under MEP Chapter 2 and Misuse of Drugs Regulations 2001, a Schedule 2 Controlled Drug prescription must include:\r\n\r\n- The form and strength of the medicine\r\n\r\n- Clear dose (e.g. \"Take 1 tablet every 4\u20136 hours\")\r\n\r\n- Total quantity in words and figures\r\n\r\n- Valid prescriber details and signature\r\n\r\n- Dated within the last 28 days\r\n\r\n- Prescriptions lacking any of these legal requirements (especially an unambiguous dose) are not valid and must not be dispensed.\r\n\r\n\r\nPlease for more information watch the MEP lesson on Chapter 2 (Professional and Legal Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "A nurse independent prescriber cannot prescribe sevredol",
        "answer_number": 1
      },
      {
        "text": "The dose is not legally suitable",
        "answer_number": 2
      },
      {
        "text": "The prescription has expired",
        "answer_number": 3
      },
      {
        "text": "The quantity is not written in words and figures",
        "answer_number": 4
      },
      {
        "text": "The prescription needs to be on a standardised form",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2559,
    "bank": "clinicalOtc",
    "title": "**What is the most appropriate action to take?**",
    "text": "A 45-year-old female presents to your community pharmacy with a dry cough that has lasted a month. She says she has no fever, chest pain, or shortness of breath. She has a history of asthma and takes salbutamol inhaler as needed. She smokes 10 cigarettes per day and works as a receptionist in a busy office. She asks you for an over-the-counter cough suppressant to relieve her symptoms.",
    "why": "a) Advise her to see her GP as soon as possible\r\n\r\nRationale:\r\n\r\nFor a 45-year-old woman with a persistent dry cough lasting more than three weeks, the best course of action is to advise her to see her GP as soon as possible. Chronic cough, especially in a smoker, can be indicative of underlying conditions such as asthma complications, chronic obstructive pulmonary disease (COPD), or even early signs of lung disease. Although she is currently asymptomatic regarding chest pain or shortness of breath, her smoking habit and occupation in a busy office could exacerbate respiratory issues and may contribute to the persistence of her cough. Referral to a GP allows for further investigation, which may include spirometry, imaging, or adjustments to her asthma management.\r\n\r\nOver-the-counter (OTC) cough suppressants, like those containing codeine or dextromethorphan, may temporarily relieve symptoms but do not address the underlying cause. Frequent use of her salbutamol inhaler or increasing fluid intake could alleviate irritation but is not a substitute for medical evaluation, given the chronicity of her symptoms and her smoking history.\r\n\r\nExplanation of Other Options:\r\n\r\nb) Advise her to use her salbutamol inhaler more frequently: While this could relieve symptoms, it does not address the underlying cause of the persistent cough.\r\nc) Advise her to stop smoking and increase her fluid intake: Smoking cessation and hydration can improve respiratory health; however, due to the chronic nature of her cough, a GP assessment remains essential.\r\nd) Recommend a cough suppressant containing codeine: Codeine is an opioid-based cough suppressant and is not recommended due to potential dependency, especially in chronic cough cases.\r\ne) Recommend a cough suppressant containing dextromethorphan: Although dextromethorphan is suitable for dry cough, it does not address potential underlying causes that could require intervention.\r\n\r\nNICE guidelines recommend that patients with a persistent cough lasting more than three weeks, particularly if they smoke or have a history of respiratory conditions, should be evaluated by a GP. For smokers, chronic cough may be an early indicator of COPD or other respiratory issues. Referral is crucial to ensure accurate diagnosis and management, which may include smoking cessation support and adjustments to asthma therapy. Additionally, patient education on avoiding irritants, monitoring symptoms, and understanding asthma control can improve long-term respiratory health.\r\n\r\n\r\nFor more information please watch BNF lesson chapter 2 (Respiratory):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise her to see her GP as soon as possible",
        "answer_number": 1
      },
      {
        "text": "Advise her to use her salbutamol inhaler more frequently",
        "answer_number": 2
      },
      {
        "text": "Advise her to stop smoking and increase her fluid intake",
        "answer_number": 3
      },
      {
        "text": "Recommend a cough suppressant containing codeine",
        "answer_number": 4
      },
      {
        "text": "Recommend a cough suppressant containing dextromethorphan",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2626,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A father presents to the pharmacy for a 22 month old baby. He explains his daughter woke up with crusty sticky eyes this morning.\r\n\r\nA picture of the child\u2019s eyes has been presented below:\u00a0\r\n\r\n\r\n![conjunctivitis](https://i.ibb.co/sycYQ1J/conjunctivitis.jpg \"800x800\")",
    "why": "The child has bacterial conjunctivitis but the child is 22 months old therefore under the age of 2 so you cannot sell them OTC so a GP referral is needed.\r\n\r\nFor more information watch the OTC lesson on  Chapter 3 Opthalmology and Otology (Conjunctivitis):\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the condition is self limiting and there is no treatment available",
        "answer_number": 1
      },
      {
        "text": "Refer to the GP for antibiotic eye drops on prescription",
        "answer_number": 2
      },
      {
        "text": "Refer urgently to an eye specialist hospital",
        "answer_number": 3
      },
      {
        "text": "Sell chloramphenicol 0.5% eye drops",
        "answer_number": 4
      },
      {
        "text": "Sell chloramphenicol 1% eye ointment",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2146,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Signs a and Symptoms of toxicity** \r\n\r\n\u2028\u2028**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 33-year old male with hyperventilation, tinnitus and deafness",
    "why": "Correct answer: \r\n\r\nA) Aspirin\r\n\r\nRationale:\r\n\r\nAspirin toxicity (salicylate poisoning) presents with:\r\n\r\n- Hyperventilation \u2013 due to stimulation of the respiratory centre in the medulla\r\n\r\n- Tinnitus (ringing in the ears) \u2013 classic early sign of salicylate overdose\r\n\r\n- Deafness \u2013 due to cochlear toxicity from high salicylate levels\r\n\r\nThese symptoms typically occur in moderate to severe salicylate poisoning and may progress to metabolic acidosis, confusion, and even coma if untreated.\r\n\r\nExplanation of Other Options:\r\n\r\nB) Amitriptyline \u2013 Causes anticholinergic symptoms, seizures, arrhythmias, not hyperventilation or tinnitus\r\n\r\nC) Amlodipine \u2013 Causes hypotension and bradycardia, not tinnitus or deafness\r\n\r\nD) Bisoprolol \u2013 Causes bradycardia and hypotension, not hyperventilation\r\n\r\nE) Citalopram \u2013 Risk of QT prolongation and seizures in overdose, not tinnitus\r\n\r\nF) Fentanyl \u2013 Causes respiratory depression and pinpoint pupils, not hyperventilation\r\n\r\nG) Naproxen \u2013 NSAID, not associated with tinnitus or respiratory symptoms\r\n\r\nH) Paracetamol \u2013 Leads to hepatotoxicity, not typically associated with tinnitus or deafness\r\n\r\nAspirin overdose is classically associated with hyperventilation, tinnitus, and deafness due to its effects on the respiratory centre and cochlear nerve. These signs are key for early recognition of salicylate poisoning and require urgent management.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Aspirin",
        "answer_number": 1
      },
      {
        "text": "Amitriptyline",
        "answer_number": 2
      },
      {
        "text": "Amlodipine",
        "answer_number": 3
      },
      {
        "text": "Bisoprolol",
        "answer_number": 4
      },
      {
        "text": "Citalopram",
        "answer_number": 5
      },
      {
        "text": "Fentanyl",
        "answer_number": 6
      },
      {
        "text": "Naproxen",
        "answer_number": 7
      },
      {
        "text": "Paracetamol",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2545,
    "bank": "clinicalMep",
    "title": "**How many days left can the patient collect the prescription before it expires?**",
    "text": "You receive a prescription for a 26-year-old female of childbearing potential who has been prescribed isotretinoin for severe acne. The patient has dropped in the prescription to you and informed you she will collect it later. Today\u2019s date is the 11th December 2023\r\n\r\nAn extract of the prescription has been provided for you.\r\n![3](https://i.ibb.co/Mk8NsY0/3.png \"400x600\")",
    "why": "(b) 4 days\r\n\r\nRationale:\r\n\r\nPrescriptions for isotretinoin for women of childbearing potential, under the Pregnancy Prevention Programme (PPP), are valid for only 7 days from the date on the prescription due to the risk of teratogenicity. This strict 7-day timeframe aims to minimise the risk of pregnancy during treatment, as isotretinoin has a high risk of causing severe birth defects.\r\n\r\nIn this case:\r\n\r\nThe prescription date is 8th December.\r\nThe current date is 11th December.\r\nCounting from the date the prescription was written:\r\n\r\n8th, 9th, and 10th December have already passed.\r\nThe patient has 4 days remaining (11th, 12th, 13th, and 14th December) to collect the medication before the prescription expires.\r\nThus, the last day to dispense this prescription is 14th December.\r\n\r\n\r\nFor isotretinoin under PPP:\r\n\r\nPrescriptions are valid for 7 days from the date written.\r\nThe patient has 4 days left to collect the prescription before it becomes invalid.\r\n\r\nWatch MEP lesson on Chapter 2 (Professional and Legal Issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "3 days",
        "answer_number": 1
      },
      {
        "text": "4 days",
        "answer_number": 2
      },
      {
        "text": "5 days",
        "answer_number": 3
      },
      {
        "text": "24 days",
        "answer_number": 4
      },
      {
        "text": "28 days",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2422,
    "bank": "clinicalTherapeutics",
    "title": "A patient with chronic renal failure and symptomatic anaemia (haemoglobin 10.0 g/dL) who is on peritoneal dialysis and requires a starting dose for correction phase treatment.",
    "text": "**Theme: Most suitable dose of epoetin alpha**\r\n\r\n\r\n**Instruction: For each scenario, select the most suitable dose of epoetin alpha from the list of answer options. Each option may be used once, more than once or not at all.**\u2028\u2028The sPmC for Eprex has been provided for you.\u2028[SmPC for Eprex](https://www.medicines.org.uk/emc/product/3442/smpc#gref)",
    "why": "A. 50 IU/kg twice weekly\r\n\r\nRationale:\r\n\r\nFor a patient with chronic renal failure and symptomatic anaemia (haemoglobin 10.0 g/dL) on peritoneal dialysis, the SmPC for Eprex recommends:\r\n\r\nStarting dose: 50 IU/kg twice weekly during the correction phase.\r\n\r\nThis dosing schedule supports gradual haemoglobin correction while reducing the risk of rapid increases, which could lead to complications such as hypertension or thromboembolic events.\r\n\r\nB. 50 IU/kg three times a week\r\n\r\nSuitable for haemodialysis but not peritoneal dialysis, where twice-weekly dosing is preferred.\r\n\r\nC. 75 IU/kg three times weekly\r\n\r\nHigher than necessary for peritoneal dialysis patients during the correction phase.\r\n\r\nD. 100 IU/kg once weekly\r\n\r\nInfrequent and less effective than 50 IU/kg twice weekly.\r\n\r\nE. 150 IU/kg once every two weeks\r\n\r\nToo low and infrequent for effective correction phase treatment.\r\n\r\nF. 300 IU/kg once every four weeks\r\n\r\nExcessively spaced out and inappropriate for initiating anaemia correction.\r\n\r\nG. 450 IU/kg once weekly\r\n\r\nOverly high for peritoneal dialysis patients; not recommended during the correction phase.\r\n\r\nH. 600 IU/kg once weekly\r\n\r\nSignificantly higher than the recommended dose and associated with higher risks of adverse effects.Correction Phase:\r\n\r\nDuring the correction phase, epoetin alpha is administered at 50 IU/kg twice weekly in patients with chronic renal failure who are on peritoneal dialysis. The objective is to gradually raise haemoglobin to the target range (10\u201312 g/dL) without causing rapid increases, which could lead to complications.\r\n\r\nMaintenance Phase:\r\n\r\nOnce the target haemoglobin level is achieved, the dose and frequency may be adjusted to maintain stable levels.\r\n\r\nMonitoring:\r\n\r\nHaemoglobin: Regular monitoring is essential to avoid overcorrection, which can lead to adverse events such as hypertension or thromboembolism.\r\nBlood Pressure: Erythropoiesis-stimulating agents (ESAs) can increase blood pressure, requiring close monitoring.\r\n\r\nNICE guidelines recommend the use of epoetin alpha for treating anaemia in chronic renal failure, with specific dosing protocols tailored to the patient\u2019s dialysis modality and haemoglobin levels. For peritoneal dialysis patients, the correction-phase dose aligns with the SmPC recommendation of 50 IU/kg twice weekly.\r\n\r\nFor more information watch BNF lesson Chapter 9 (Blood and Nutrition):\r\n\r\nhttps://preregshortcuts.com/preview-question/2432",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "50 IU/kg twice weekly",
        "answer_number": 1
      },
      {
        "text": "50 IU/kg three times a week.",
        "answer_number": 2
      },
      {
        "text": "75 IU/kg three times weekly",
        "answer_number": 3
      },
      {
        "text": "100 IU/kg once weekly",
        "answer_number": 4
      },
      {
        "text": "150 IU/kg once every two weeks",
        "answer_number": 5
      },
      {
        "text": "300 IU/kg once every four weeks",
        "answer_number": 6
      },
      {
        "text": "450 IU/kg once weekly",
        "answer_number": 7
      },
      {
        "text": "600 IU/kg once weekly",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2266,
    "bank": "clinicalTherapeutics",
    "title": "**At what stage of the cycle of behavioural change is your patient?**",
    "text": "You are supporting a patient to stop smoking.\u00a0 They have been part of your smoking cessation scheme for the past month and you meet with them face-to-face once a fortnight to see how they are getting on and motivate them to continue.",
    "why": "Correct Answer:\r\n\r\n(A) Action\r\n\r\nRationale:\r\n\r\nThe cycle of behavioural change describes the stages a person goes through when modifying a behaviour, such as stopping smoking. According to NICE guidelines, the action stage refers to the phase where the individual has actively made changes to their behaviour and is working towards sustaining them.\r\n\r\nIn this scenario, the patient has been participating in the smoking cessation scheme for the past month, attending regular face-to-face meetings and receiving ongoing motivation. Since they have already stopped smoking and are actively maintaining this change, they are in the action stage, where they are making efforts to sustain their progress.\r\n\r\nExplanation of Other Options:\r\n\r\n(B) Contemplation \r\n\r\nThis stage occurs when a person is considering quitting but has not yet made a firm decision or taken any action. Since the patient has already started the cessation programme, they have moved beyond this stage.\r\n\r\n(C) Maintenance \r\n\r\nMaintenance refers to the long-term commitment to a behavioural change after sustaining it for an extended period (usually six months or more). Since the patient has only been in the programme for a month, they are not yet in the maintenance stage.\r\n\r\n(D) Preparation \r\n\r\nThe preparation stage occurs when the individual has decided to quit and is making plans (e.g., setting a quit date, gathering support, or choosing nicotine replacement therapy). Since the patient has already quit and is receiving ongoing support, they have moved past this stage.\r\n\r\n(E) Relapse \r\n\r\nRelapse occurs when an individual returns to smoking after quitting. There is no indication in the scenario that the patient has relapsed, so this stage is not applicable.\r\n\r\nNICE recommends that healthcare professionals use behavioural support interventions to help patients quit smoking. This includes:\r\n\r\n- Identifying the patient\u2019s stage in the behavioural change cycle to provide targeted interventions.\r\n\r\n- Providing face-to-face counselling to reinforce motivation and relapse prevention strategies.\r\n\r\n- Offering pharmacological support such as nicotine replacement therapy (NRT), varenicline, or bupropion if appropriate.\r\n\r\n- Encouraging long-term strategies for maintaining abstinence, such as self-monitoring, stress management, and social support.\r\n\r\nFor more information, please watch BNF lesson Chapter 4 (Central Nervous system):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Action",
        "answer_number": 1
      },
      {
        "text": "Contemplation",
        "answer_number": 2
      },
      {
        "text": "Maintenance",
        "answer_number": 3
      },
      {
        "text": "Preparation",
        "answer_number": 4
      },
      {
        "text": "Relapse",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2263,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following values is most likely to represent the patient's actual creatinine clearance?**",
    "text": "A 40-year-old female patient with renal impairment who is to be prescribed a drug which is metabolised primarily by the kidneys. To confirm that they have not made a dosing error, the consultant wants you to estimate the patient's creatinine clearance. The patient weighs 70 kg and her most recent serum creatinine value was 100 micromol/L.\r\n\r\nThe Cockcroft and Gault formula for estimating creatinine clearance is provided below:\u00a0\r\n\u00a0\r\n![creatitine-clearance-formula](https://i.ibb.co/RyFdnYg/creatitine-clearance-formula.png)",
    "why": "The key here is to estimate an answer as you will not have a calculator:\r\n\r\nEstimated Creatinine Clearance = \u00a0 (140 \u2013 40) \u00d7 70 \u00d7 1.04/100\r\n= (104 x 70) / 100\r\n= (7000 + 280) / 100\r\n= 7280 / 100\r\n= 72.8 mL/min (rounded to 73 mL/min)\r\n\r\nCreatinine Clearance and Drug Dosing \r\n\r\nCreatinine clearance is a key factor in dose adjustments for renally excreted drugs. NICE guidelines recommend:\r\n\r\nUsing Cockcroft-Gault or eGFR for drug dosing in patients with renal impairment.\r\nAdjusting doses of aminoglycosides, metformin, digoxin, and other nephrotoxic drugs in patients with CrCl <60 mL/min.\r\nMonitoring renal function regularly, especially in elderly patients and those on nephrotoxic medications.\r\n\r\nCreatinine Clearance and Drug Dosing \r\n\r\nCreatinine clearance is a key factor in dose adjustments for renally excreted drugs. NICE guidelines recommend:\r\n\r\n- Using Cockcroft-Gault or eGFR for drug dosing in patients with renal impairment.\r\n\r\n- Adjusting doses of aminoglycosides, metformin, digoxin, and other nephrotoxic drugs in patients with CrCl <60 mL/min.\r\n\r\n- Monitoring renal function regularly, especially in elderly patients and those on nephrotoxic medications.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "70 mL/min",
        "answer_number": 1
      },
      {
        "text": "70 mL/hour",
        "answer_number": 2
      },
      {
        "text": "73 mL/min",
        "answer_number": 3
      },
      {
        "text": "80 mL/min",
        "answer_number": 4
      },
      {
        "text": "100 mL/min",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2233,
    "bank": "clinicalTherapeutics",
    "title": "**How long will it take for the serum concentration to reach 5mg/L?**",
    "text": "A 48-year-old male patient is brought into Accident and Emergency as he has accidentally taken too many of his phenytoin capsules. Blood tests were carried out immediately after the patient was admitted. His peak phenytoin serum concentration is 40mg/L.\u00a0\r\nThe half life of phenytoin is 12 hours",
    "why": "Correct Answer: \r\n\r\nB) 36 hours\r\n\r\nRationale:\r\n\r\n- This is a classic half-life calculation based on first-order kinetics (used unless non-linear kinetics are specified in the question).\r\n\r\nThe concentration drops by half every 12 hours:\r\n\r\n- Draw out your table \u2028\u202840mg/L \u2014> 0 hours \u202820mg/L \u2014> 12 hours \u202810mg/L \u2014>  24 hours \u20285mg/L \u2014->  36 hours\r\n\r\n- So it takes 3 half-lives \u00d7 12 hrs = 36 hours to reduce the concentration from 40 mg/L to 5 mg/L.\r\n\r\n\r\nPhenytoin Elimination and Toxicity:\r\n\r\n- Phenytoin is a widely used anticonvulsant with non-linear pharmacokinetics at higher serum levels, meaning saturation of liver enzymes can occur, prolonging its elimination. \r\n- However, in exam scenarios, unless stated otherwise, it\u2019s appropriate to assume first-order kinetics for dose and time calculations. \r\n- Therapeutic serum levels of phenytoin are 10\u201320 mg/L, and concentrations >20 mg/L are associated with toxicity, including nystagmus, ataxia, confusion, and arrhythmias. \r\n- NICE and BNF recommend close monitoring, supportive care, and ECG/neurological assessment in overdose cases.\r\n\r\n\r\nFor more information please watch BNFChapter 4 (Central Nervous System) :\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "24 hours",
        "answer_number": 1
      },
      {
        "text": "36 hours",
        "answer_number": 2
      },
      {
        "text": "48 hours",
        "answer_number": 3
      },
      {
        "text": "60 hours",
        "answer_number": 4
      },
      {
        "text": "72 hours",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2485,
    "bank": "clinicalMep",
    "title": "**Which one of the following is the least appropriate action?**",
    "text": "Mr P bring his dog Lassie into the pharmacy. Lassie has been suffering from hay fever and the vet has prescribed Loratadine for him. You check over the prescription, label the medication and make a record in the vetinary prescription register.",
    "why": "Correct answer: \r\n\r\nA) Dispense the item and keep a record for 3 years\r\n\r\nRationale:\r\n\r\nAccording to the Veterinary Medicines Regulations (VMR) and RPS/MEP guidance, when a community pharmacist dispenses a veterinary prescription (e.g. POM-V or POM-VPS), the record of supply must be retained for 5 years, not 3.\r\n\r\nKeeping a record for only 3 years is insufficient and would be non-compliant with UK law \u2014 making it the least appropriate action in the list.\r\n\r\nExplanation of other options:\r\n\r\nB) Dispense and keep a record for 5 years \r\n\r\nThis meets the legal requirement under VMR 2013 (still current), which applies to both vets and pharmacists.\r\n\r\nC) Ensure the words \u201cunder the cascade\u201d are on the prescription \r\n\r\nOnly required when supplying a human medicine for an animal where no suitable veterinary product exists.\r\n\r\nD) Label must include the species of the animal\r\n\r\nHelps ensure appropriate use and traceability.\r\n\r\nE) Label must include the words \u201cfor animal treatment only\u201d \r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Dispense the item and keep a record for 3 years",
        "answer_number": 1
      },
      {
        "text": "Dispense the item and keep a record for 5 years",
        "answer_number": 2
      },
      {
        "text": "Ensure the words \u201cunder the cascade\u201d are on the prescription",
        "answer_number": 3
      },
      {
        "text": "The label must include the species of the animal",
        "answer_number": 4
      },
      {
        "text": "The label must include the word \u201cfor animal treatment only",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2479,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is the most appropriate intravenous antibiotic regimen to start for her infection?**",
    "text": "You are a pharmacist working in a hospital ward. A 25-year-old woman with cystic fibrosis is admitted with an acute exacerbation of pulmonary infection. She is currently taking the following medicines:\r\nKaftrio 100 mg/50 mg/75 mg tablets, two tablets twice daily\r\nAzithromycin 250 mg capsules, one capsule three times a week\r\nAlbuterol inhaler, two puffs as needed\r\nHypertonic saline nebuliser, 4 ml twice daily\r\nDornase alfa nebuliser, 2.5 mg once daily\r\nPancreatin 25,000 units capsules, two capsules with each meal and one with snacks\r\nOmeprazole 20 mg tablets, one tablet daily\r\nCalcium carbonate 500 mg tablets, two tablets twice daily\r\nVitamin D3 800 IU tablets, one tablet daily\r\nYou review her sputum culture results and find that she has a chronic infection with Pseudomonas aeruginosa that is sensitive to colistin, tobramycin, and ciprofloxacin.",
    "why": "E) Colistin 2 million units every 8 hours plus ciprofloxacin 400 mg every 12 hours\r\n\r\nRationale:\r\n\r\nAccording to NICE guidelines on cystic fibrosis, dual antibiotic therapy is preferred for treating acute pulmonary exacerbations caused by Pseudomonas aeruginosa. The rationale behind dual therapy is to use antibiotics with different mechanisms of action to optimize clinical outcomes and reduce the risk of bacterial resistance.\r\n\r\nColistin is a polymyxin antibiotic that disrupts the bacterial cell membrane, making it effective against Pseudomonas aeruginosa.\r\nCiprofloxacin is a fluoroquinolone that inhibits bacterial DNA synthesis, targeting the infection from a different angle.\r\nTogether, these antibiotics work synergistically and are often recommended in combination to treat serious infections in cystic fibrosis patients, especially those involving Pseudomonas aeruginosa. This regimen helps in achieving better bacterial eradication and preventing further resistance development.\r\n\r\nExplanation of other Options:\r\n\r\nA) Colistin 2 million units every 8 hours: While colistin is effective, the NICE guidelines recommend using two antibiotics to reduce resistance and improve treatment efficacy. Monotherapy is generally not preferred for acute infections caused by Pseudomonas aeruginosa.\r\n\r\nB) Tobramycin 10 mg/kg once daily: Tobramycin is an aminoglycoside and can interact with Kaftrio (a CF medication) to increase the risk of nephrotoxicity and ototoxicity. Additionally, tobramycin is not recommended as the sole antibiotic in this case, as it would not meet the guidelines' recommendation for dual therapy.\r\n\r\nC) Ciprofloxacin 400 mg every 12 hours: Ciprofloxacin alone is insufficient for treating acute exacerbations of pulmonary infections caused by Pseudomonas aeruginosa in cystic fibrosis patients. Dual therapy is recommended for more effective treatment.\r\n\r\nD) Colistin 2 million units every 8 hours plus tobramycin 10 mg/kg once daily: This combination is not ideal, as both colistin and tobramycin are nephrotoxic and ototoxic. Using these two antibiotics together increases the risk of adverse effects, particularly kidney and hearing damage.\r\n\r\nCystic fibrosis (CF) is a genetic disorder that often leads to chronic pulmonary infections, particularly caused by Pseudomonas aeruginosa. Management of acute pulmonary exacerbations in CF patients involves the use of intravenous antibiotics with different mechanisms of action to target the infection effectively and reduce the risk of antibiotic resistance.\r\n\r\nAccording to NICE guidelines, a dual therapy approach with two intravenous antibiotics is preferred when treating Pseudomonas aeruginosa infections in CF patients. This includes using antibiotics like colistin, a polymyxin that disrupts the bacterial cell membrane, and ciprofloxacin, a fluoroquinolone that inhibits bacterial DNA synthesis. The combination of these two antibiotics provides better clinical outcomes and reduces the chances of developing resistance compared to monotherapy.\r\n\r\nKey Points:\r\n\r\nColistin and ciprofloxacin are recommended as they have complementary mechanisms of action, ensuring comprehensive treatment.\r\nDual antibiotic therapy is recommended over monotherapy to prevent resistance and improve clinical outcomes.\r\nDoses and the choice of antibiotics should consider the patient's renal function and overall condition, as well as the potential for drug interactions, particularly with cystic fibrosis medications like Kaftrio.\r\nThe NICE guidelines advocate for careful monitoring of the patient\u2019s response to treatment, adjustment of doses as necessary, and use of dual therapy to avoid complications like nephrotoxicity or ototoxicity.\r\n\r\nFor further reading, you can consult the NICE Guidelines on Cystic Fibrosis for detailed recommendations on management and treatment protocols.\r\n\r\n\r\nFor more information please watch BNF lesson Chapter 5 (Infections):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Colistin 2 million units every 8 hours",
        "answer_number": 1
      },
      {
        "text": "Tobramycin 10 mg/kg once daily",
        "answer_number": 2
      },
      {
        "text": "Ciprofloxacin 400 mg every 12 hours",
        "answer_number": 3
      },
      {
        "text": "Colistin 2 million units every 8 hours plus tobramycin 10 mg/kg once daily",
        "answer_number": 4
      },
      {
        "text": "Colistin 2 million units every 8 hours plus ciprofloxacin 400 mg every 12 hours",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2530,
    "bank": "clinicalMep",
    "title": "**What is the last day the medicine can be used?**",
    "text": "You are preparing a prescription for ramipril 10mg capsules. You notice the medicine is short dated and has a use by date of 09/2024.",
    "why": "31st August 2024\r\n\r\nRationale:\r\n\r\nAccording to the 2025 Medicines, Ethics, and Practice (MEP) guidelines, a use-by date indicates that the product must be used before the stated month begins. This means the medication is safe to use up to 31st August 2024. After this date, the product may no longer meet the required standards for quality, safety, or efficacy and should not be used.\r\n\r\nExplanation of other options:\r\n\r\nA) 1st August 2024:\r\nThis is incorrect. The medication can still be used throughout August 2024, so the last safe date is 31st August 2024.\r\n\r\nC) 1st September 2024:\r\nThis is incorrect. The use-by date 09/2024 means the product should not be used during September. Therefore, it is no longer safe to use by 1st September 2024.\r\n\r\nD) 30th September 2024:\r\nThis is incorrect. A use-by date of 09/2024 does not mean the product can be used until the end of September. It must not be used from the start of September 2024.\r\n\r\nE) 1st October 2024:\r\nThis is incorrect. The medication must not be used beyond 31st August 2024, so using it in October would not comply with MEP guidance.\r\n\r\nMedicines Use-by Date Guidance:\r\n\r\nMedicines with a use-by date must be used before the stated month begins, ensuring they meet the required standards of quality, safety, and efficacy. For a product with a use-by date of 09/2024, the last day it can be used is 31st August 2024. It is essential for pharmacists to verify this when preparing prescriptions to ensure patient safety.\r\n\r\nFor more information, refer to Chapter 3 of the MEP or visit the link below:\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "1st August 2024",
        "answer_number": 1
      },
      {
        "text": "31st August 2024",
        "answer_number": 2
      },
      {
        "text": "1st September 2024",
        "answer_number": 3
      },
      {
        "text": "30th September 2024",
        "answer_number": 4
      },
      {
        "text": "1st October 2024",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 889,
    "bank": "clinicalOtc",
    "title": "**What is the most likely diagnosis and the most appropriate treatment for this patient?**",
    "text": "A 55-year-old woman presents to the pharmacy with a headache, fever, and a stiff neck. She has no known allergies and is not currently taking any medication. She asks you for advice on how to treat her condition.",
    "why": "The patient\u2019s symptoms of a headache, fever, and a stiff neck are consistent with meningitis, a serious infection of the membranes surrounding the brain and spinal cord. Meningitis can be life-threatening and requires immediate medical attention",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Cluster headache; oxygen therapy and triptans",
        "answer_number": 1
      },
      {
        "text": "Meningitis; immediate medical attention",
        "answer_number": 2
      },
      {
        "text": "Migraine; pain relievers and anti-nausea medication",
        "answer_number": 3
      },
      {
        "text": "Sinusitis; decongestants and pain relievers",
        "answer_number": 4
      },
      {
        "text": "Tension headache; pain relievers and relaxation techniques",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 1000,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A mother presents to the pharmacy with her 6 year old son with a rash on his face.\u00a0\r\nA photograph of the rash has been shown below\r\n![impetigo](https://i.ibb.co/82Sknzz/impetigo.jpg)",
    "why": "Impetigo is a highly contagious skin infection that is common in young children. It is caused by bacteria and typically presents as red sores around the mouth and nose that quickly burst and leave behind a yellow, crusty rash. Treating localized non-bullous infection with topical hydrogen peroxide for five days is the first line option then if it is not suitable then you refer for topical antibiotic treatment such as fusidic acid 2% or mupirocin",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the condition is self limiting and there is no treatment available",
        "answer_number": 1
      },
      {
        "text": "Sell crystacide (hydrogen peroxide) cream",
        "answer_number": 2
      },
      {
        "text": "Sell clotrimazole 1% cream",
        "answer_number": 3
      },
      {
        "text": "Refer to General practitioner for antibiotic treatment",
        "answer_number": 4
      },
      {
        "text": "Refer to accident and emergency",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2284,
    "bank": "clinicalTherapeutics",
    "title": "**Which statement best describes the use of hyoscine hydrobromide in this situation?**",
    "text": "An 8-year-old who has been prescribed hyoscine butyl bromide patches and topiramate tablets. The child has severe cerebral palsy resulting in hyper-salivation and epilepsy. The parent tells you that the hyoscine hydrobromide leaflet does not mention that it may be used for hyper-salivation. The topiramate tablets will be crushed and mixed in with soft food to allow easy administration.",
    "why": "Correct answer:\r\n\r\nA. The medicine is being used \u2018off label\u2019 as it is being used for an alternative indication\r\n\r\nRationale:\r\n\r\nThe term \u2018off-label\u2019 use refers to using a medicine outside of its licensed indication, route, dose, or age group, even though the medicine itself is licensed in the UK.\r\n\r\nHyoscine hydrobromide is licensed for motion sickness and as a premedication to reduce secretions before surgery.\r\nHowever, its use for hyper-salivation (sialorrhoea) in cerebral palsy is not explicitly mentioned in the product information leaflet, making this an off-label use.\r\nNICE recommends that off-label medicines can be prescribed in children when there is sufficient evidence to support their safety and efficacy.\r\nThe prescriber should ensure informed consent is obtained from the parent/carer before prescribing an off-label medicine.\r\n\r\nExplanation of Other Options:\r\n\r\nB. The medicine is \u2018unlicensed\u2019 because it is being used for a paediatric patient\r\n\r\nA medicine is not considered \u2018unlicensed\u2019 just because it is used in children. If the product is licensed but used outside the terms of its marketing authorisation, it is off-label, not unlicensed.\r\n\r\nC. The medicine is \u2018unlicensed\u2019 as it is not an authorised medicinal product in the UK\r\n\r\nHyoscine hydrobromide is a licensed medicinal product in the UK. \u2018Unlicensed\u2019 applies to medicines that have no UK marketing authorisation (e.g., imported medicines).\r\n\r\nD. The medicine is \u2018off label\u2019 because it is being used in a paediatric patient\r\n\r\nOff-label use occurs when a medicine is used outside its licence for any reason, not solely because it is prescribed to a child. The defining factor in this case is that it is being used for an unapproved indication (hyper-salivation).\r\n\r\nE. The medicine is \u2018unlicensed\u2019 because the formulation is classed as a \u2018special\u2019 item\r\n\r\n\u2018Specials\u2019 refer to medicines prepared specifically to meet an individual patient\u2019s needs when a licensed alternative is unavailable. Hyoscine hydrobromide does not fall under this category.\r\n\r\nOff-Label and Unlicensed Medicine Use in Paediatrics\r\n\r\nAccording to NICE Guidelines (2025) and the BNF for Children, off-label prescribing is common in paediatrics due to the lack of clinical trials in younger populations. Prescribers must:\r\n\r\n Assess the risk-benefit ratio before prescribing off-label medicines.\r\n Discuss off-label use with the child\u2019s parent/carer and obtain informed consent.\r\n Document the rationale for prescribing off-label medications.\r\n Follow guidelines from recognised bodies (e.g., NICE, MHRA, BNFC) when prescribing off-label medicines.\r\n\r\nFor more information please watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "The medicine is being used \u2018off label\u2019 as it being used for an alternative indication",
        "answer_number": 1
      },
      {
        "text": "The medicine is \u2018unlicensed\u2019 because it is being used for a paediatric patient",
        "answer_number": 2
      },
      {
        "text": "The medicine is \u2018unlicensed\u2019 as it is not an authorised medicinal product in the UK",
        "answer_number": 3
      },
      {
        "text": "The medicine is \u2018off label\u2019 because it is being used in a paediatric patient",
        "answer_number": 4
      },
      {
        "text": "The medicine is \u2018unlicensed\u2019 because the formulation is classed as a \u2018special\u2019 item",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2305,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following NSAIDs has the lowest risk of gastrointestinal effects?**",
    "text": "You are teaching your Trainee Pharmacist regarding gastrointestinal risks associated with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)",
    "why": "Ibuprofen 1200 mg daily\r\n\r\nRationale:\r\n\r\nAll non-steroidal anti-inflammatory drugs (NSAIDs) carry a risk of gastrointestinal (GI) toxicity, including gastritis, peptic ulcers, and GI bleeding. However, the level of risk varies among different NSAIDs.\r\n\r\nAccording to BNF and NICE guidelines, ibuprofen (\u22641200 mg daily) has the lowest GI risk among the non-selective NSAIDs. At higher doses (\u22652400 mg daily), ibuprofen\u2019s GI risk increases to an intermediate level.\r\n\r\nThe relative GI risk ranking of NSAIDs is:\r\n\r\nHigh risk: Piroxicam, ketoprofen, ketorolac\r\nIntermediate risk: Indometacin, diclofenac, naproxen\r\nLowest risk: Ibuprofen (\u22641200 mg daily)\r\nThus, ibuprofen at a dose of 1200 mg daily remains the safest NSAID option regarding GI toxicity.\r\n\r\nExplanation of Other Options:\r\n\r\nA: Diclofenac 150 mg daily\r\n\r\nDiclofenac has an intermediate GI risk and is also associated with cardiovascular risks, particularly at high doses.\r\n\r\nC: Indomethacin 200 mg daily\r\n\r\nIndomethacin is associated with a higher risk of GI toxicity compared to ibuprofen and should be used with caution, especially in elderly patients.\r\n\r\nD: Naproxen 1000 mg daily\r\n\r\nNaproxen has an intermediate GI risk but is preferred over diclofenac for patients with cardiovascular risks. However, it still poses a higher GI risk than ibuprofen.\r\n\r\nE: Piroxicam 20 mg daily\r\n\r\nPiroxicam has one of the highest risks for GI toxicity and should be avoided in patients at risk of peptic ulcers or GI bleeding unless no alternatives are suitable.\r\nParagraph on NSAID-Related Gastrointestinal Risks (Aligned with NICE and BNF Guidance):\r\nNSAIDs increase the risk of serious gastrointestinal complications, such as peptic ulceration, GI bleeding, and perforation, especially in elderly patients or those with a history of ulcers. According to BNF Chapter 10: Musculoskeletal System and NICE guidelines, ibuprofen (\u22641200 mg daily) is the least likely to cause serious GI side effects. Piroxicam, ketoprofen, and ketorolac have the highest risk and should be avoided unless absolutely necessary. Patients requiring long-term NSAID therapy should receive gastroprotection with a proton pump inhibitor (PPI) such as omeprazole or lansoprazole. COX-2 inhibitors (e.g., celecoxib) may also be considered for high GI risk patients, but their cardiovascular risks should be assessed before prescribing.\r\n\r\nFor more information, please watch BNF Lesson Chapter 10 (Musculoskeletal System) at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Diclofenac 150 mg daily",
        "answer_number": 1
      },
      {
        "text": "Ibuprofen 1200 mg daily",
        "answer_number": 2
      },
      {
        "text": "Indomethacin 200mg daily",
        "answer_number": 3
      },
      {
        "text": "Naproxen 1000 mg daily",
        "answer_number": 4
      },
      {
        "text": "Piroxicam 20mg daily",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2593,
    "bank": "clinicalOtc",
    "title": "**Which of the following is NOT a red flag referral?**",
    "text": "You are teaching your trainee pharmacist regarding red flag referral symptoms for dyspepsia",
    "why": "Abdominal discomfort\r\n\r\nRationale:\r\n\r\nAbdominal discomfort is a common symptom of dyspepsia and does not, on its own, constitute a red flag that necessitates urgent referral. Dyspepsia is often associated with upper gastrointestinal discomfort, bloating, or indigestion, and these symptoms can usually be managed with lifestyle changes and over-the-counter medications unless they are accompanied by more serious signs.\r\n\r\nExplanation of Other Options:\r\n\r\nAnaemia: Unexplained anaemia, especially if it is iron deficiency anaemia, is considered a red flag as it may indicate chronic gastrointestinal blood loss, possibly from ulcers, malignancies, or other serious GI conditions.\r\n\r\nDysphagia: Difficulty swallowing is a red flag that may suggest an obstructive lesion in the oesophagus, such as a tumour, or other serious disorders like oesophageal stricture or achalasia.\r\n\r\nMelaena: Black, tarry stools (melaena) are a red flag for gastrointestinal bleeding, most commonly from a duodenal or gastric ulcer. Immediate referral is necessary for further investigation.\r\n\r\nRadiating pain: Pain that radiates, particularly to the back or shoulder, can indicate more serious conditions such as perforated ulcers, pancreatitis, or even cardiac issues. This symptom requires urgent investigation to rule out life-threatening causes.\r\n\r\nNICE guidelines emphasize the importance of recognising red flag symptoms in patients presenting with dyspepsia, as these may indicate serious underlying conditions such as gastric or oesophageal cancer, ulcers, or significant gastrointestinal bleeding. Red flag symptoms include unintentional weight loss, persistent vomiting, anaemia, dysphagia, melaena, haematemesis, and unexplained or persistent abdominal pain, particularly if associated with radiation or severe onset. Any of these symptoms should prompt an urgent referral for further investigation and\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Abdominal discomfort",
        "answer_number": 1
      },
      {
        "text": "Anaemia",
        "answer_number": 2
      },
      {
        "text": "Dysphagia",
        "answer_number": 3
      },
      {
        "text": "Melaena",
        "answer_number": 4
      },
      {
        "text": "Radiating pain",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2607,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 66 year old male patient presents to the pharmacy requesting advice for this tongue. He informs you he was prescribed co-amoxiclav 500mg/125mg tablets for the treatment of a dental infection. He has no allergies and takes warfarin 3mg for the prevention of embolic stroke in atrial fibrillaton.\u00a0\r\nA photograph of the mans symptoms is below:\u00a0![oral-thrush](https://i.ibb.co/s5RTb5D/oral-thrush.jpg \"750x600\")",
    "why": "The most appropriate advice for the patient is:\r\n\r\nHe is experiencing a side effect of co-amoxiclav and whilst safe to continue taking it, he should see his GP for nystatin to be prescribed.\r\n\r\nRationale:\r\n\r\nThe patient\u2019s symptoms are consistent with oral thrush (candidiasis), a known side effect of antibiotic use, including co-amoxiclav. Antibiotics can disrupt the normal balance of bacteria and fungi in the mouth, leading to overgrowth of Candida species. This is particularly important in a patient who takes warfarin, as Daktarin (miconazole) oral gel can interact with warfarin and increase the risk of bleeding. Therefore, the safest and most effective treatment option is nystatin, which is recommended by NICE guidelines for managing oral thrush in patients on warfarin since it has fewer interactions.\r\n\r\nAdvising the patient to continue taking co-amoxiclav while seeking a prescription for nystatin is appropriate as stopping the antibiotic may interrupt treatment for the dental infection.\r\nDaktarin (miconazole) oral gel interacts with warfarin and should be avoided due to the increased risk of bleeding complications.\r\nStopping co-amoxiclav is unnecessary unless the patient develops severe allergic reactions or other significant adverse effects.\r\nThe symptoms are indeed a known side effect of co-amoxiclav, making the last option incorrect.\r\n\r\nNICE Guidance on Management of Oral Thrush\r\n\r\nAccording to NICE guidelines, the management of oral thrush in patients taking antibiotics or on anticoagulation therapy like warfarin includes:\r\n\r\nAntifungal Treatment: Nystatin suspension is often the preferred treatment for oral thrush in patients taking warfarin, as it has minimal systemic absorption and is less likely to interact with anticoagulant therapy.\r\n\r\nMaintaining Good Oral Hygiene: Patients should be advised to rinse their mouths after taking the antibiotic and maintain oral hygiene to reduce fungal growth.\r\n\r\nDietary Advice: Avoid sugary foods and beverages that may promote fungal growth, and encourage regular drinking of water to help cleanse the mouth.\r\n\r\nMonitoring INR Levels: Given the patient\u2019s use of warfarin, it is crucial that INR levels are monitored closely if any medication changes occur, including the addition of nystatin.\r\n\r\nAdditional Insights\r\n\r\nOral thrush is a common complication of antibiotic therapy, particularly broad-spectrum antibiotics like co-amoxiclav. Patients taking anticoagulants, such as warfarin, are at an increased risk of interactions with certain antifungal agents like miconazole, which can inhibit the metabolism of warfarin, raising INR levels and increasing the risk of bleeding.\r\n\r\nNICE guidelines emphasise the importance of selecting antifungal treatments with minimal interaction risks in such patients. Nystatin is effective and poses less risk, making it the preferred choice. If symptoms persist despite appropriate treatment, or if the patient experiences significant side effects from the antibiotic, further evaluation by a healthcare provider may be necessary. Regular communication between the patient, pharmacist, and GP can help ensure safe and effective management of both the dental infection and oral thrush.\r\n\r\nFor more information watch OTC lessons: \r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "He is experiencing a side effect of co-amoxiclav and whilst safe to continue taking it, he may wish to see his dentist for an alternative",
        "answer_number": 1
      },
      {
        "text": "He is experiencing a side effect of co-amoxiclav and whilst safe to continue taking it, sell Daktarin (miconazole) oral gel for treatment.",
        "answer_number": 2
      },
      {
        "text": "He is experiencing a side effect of co-amoxiclav and whilst safe to continue taking it, he should see his GP for nystatin to be prescribed.",
        "answer_number": 3
      },
      {
        "text": "Stop taking co-amoxiclav straight away and see her dentist as soon as possible",
        "answer_number": 4
      },
      {
        "text": "The symptoms are not known to be caused by co-amoxiclav",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2624,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 63 year old female patient presents to the pharmacy requesting advice for her eye. Her vision is blurred, with halo vision and is experiencing severe headaches.\u00a0\r\nShe informs you she has recently been in hospital with an asthma attack. She shows you her discharge letter which contains the following information.\u00a0\r\n\r\n*Reason for Admission and Presenting Complaint(s):* Life threatening acute asthma,\u00a0\r\nRelevant Investigations and Results:\r\n*PEFR < 33%*\r\n*Sp02: 89%*\r\n*(PaCO2): 5.9*\r\n*Heart rate: 112 bpm*\r\n*Procedures and Treatment:* nebulized salbutamol 5mg and nebulized ipratropium bromide 500 micrograms\r\n*Discharged medicines:* Salbutamol 100mcg/dose inhaler, beclometasone 100mcg/dose inhaler\r\n\r\nA picture of her eye has been provided below:\r\n![glaucoma](https://i.ibb.co/7vhmmH7/glaucoma.jpg \"750x500\")",
    "why": "Nebulised ipatropium has been known to cause acute glaucoma. The patients symptoms are classic symptoms of acute glaucoma.\r\n\r\n### Glaucoma \r\n\r\n**Definition**: \r\n- Glaucoma is a group of eye diseases causing progressive optic neuropathy, often associated with raised intraocular pressure (IOP).\r\n\r\n**Types**:\r\n1. **Primary Open-Angle Glaucoma (POAG)**:\r\n   - Most common type.\r\n   - Affects about 2% of people in the UK over 40 years.\r\n   - Usually insidious onset and chronic.\r\n   - Typically affects both eyes.\r\n   - Associated with raised IOP but can occur with normal IOP.\r\n\r\n2. **Primary Angle Closure Glaucoma (PACG)**:\r\n   - Affects about 0.4% of people in the UK over 40 years.\r\n   - Often asymptomatic chronic PACG.\r\n   - Acute angle closure is a medical emergency.\r\n\r\n**Risk Factors for Acute Angle Closure**:\r\n- Female, Asian, long-sighted, or older age.\r\n- Symptoms: painful red eye, blurred vision, headaches, nausea, halos around lights, semi-dilated pupil, tender eye.\r\n\r\n**Management**:\r\n- **Acute Angle Closure**:\r\n  - Immediate admission for ophthalmology assessment.\r\n  - If admission is delayed, start emergency treatment:\r\n    - Lie flat with face up.\r\n    - Administer pilocarpine drops (2% for blue eyes, 4% for brown eyes).\r\n    - Oral acetazolamide (500 mg) if no contraindications.\r\n    - Provide analgesia and anti-emetics as needed.\r\n\r\n- **Chronic Glaucoma**:\r\n  - Refer to optometrist or ophthalmologist.\r\n  - Treatment aims to reduce IOP to prevent vision loss.\r\n  - First-line treatment for IOP of 24mmHg or more, PACG, or at risk of visual impairment: 360\u00b0 selective laser trabeculoplasty.\r\n\r\n**Complications**:\r\n- Untreated glaucoma can lead to irreversible vision loss.\r\n\r\nFor more information watch the BNF lesson on  Chapter 11 (Eyes):\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "She should see her GP as the dose of her asthma treatment should have been reduced",
        "answer_number": 1
      },
      {
        "text": "She is experiencing a side effect of her asthma treatment and whilst safe to continue taking it, she may wish to see her GP for an alternative treatment",
        "answer_number": 2
      },
      {
        "text": "She should see her GP as the dose of her asthma treatment may need to be increased",
        "answer_number": 3
      },
      {
        "text": "Refer to accident and emergency as soon as possible",
        "answer_number": 4
      },
      {
        "text": "The symptoms are not known to be caused by her asthma treatment",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2571,
    "bank": "clinicalOtc",
    "title": "A 17-year-old female patient who presents with an itchy, red rash on her elbows and knees, which has been present for several weeks. She has a family history of atopic eczema and has already tried using E45 cream which improved the condition slightly, but it is still there and \u2018starting to bother\u2019 her.",
    "text": "**Theme: Dermatological preparations**\r\n\r\n**For each of the following scenarios select the best option for over-the-counter treatment. Each option may be used once, more than once or not at all.**",
    "why": "g) Hydrocortisone 1% cream\r\n\r\nRationale:\r\n\r\nHydrocortisone 1% cream is a mild corticosteroid and is appropriate for treating mild to moderate eczema flares in individuals over 10 years old, making it suitable for this 17-year-old. It is effective in reducing itching and inflammation on areas like the elbows and knees where the skin is intact but irritated. Since E45 cream provided only partial relief, hydrocortisone 1% is a reasonable next step for short-term use to help clear up the lingering rash.\r\n\r\nExplanation of Other Options:\r\n\r\na) Aloe vera gel: While it offers a soothing effect, aloe vera is generally inadequate for treating eczema-related inflammation.\r\nb) Aqueous calamine cream: Calamine can relieve mild itching but doesn\u2019t address eczema\u2019s underlying inflammation, making it less effective than hydrocortisone.\r\nc) Aveeno\u00ae lotion: Aveeno is an emollient that helps hydrate the skin but lacks the anti-inflammatory properties needed for treating an eczema flare.\r\nd) Dermol\u00ae wash: This is an antimicrobial and emollient wash that can be helpful for skin hydration and infection prevention, but it\u2019s not effective for reducing active inflammation.\r\ne) Diprobase\u00ae cream: While Diprobase is an effective emollient for daily use, it doesn\u2019t contain active ingredients to reduce inflammation.\r\nf) Eumovate\u00ae cream: Eumovate contains clobetasone butyrate, a moderate-potency corticosteroid. It is generally reserved for more severe or persistent cases that haven\u2019t responded to milder options. Pharmacists typically recommend hydrocortisone 1% before progressing to a higher-potency steroid.\r\nh) Oilatum\u00ae Junior Bath Additive: Oilatum is a bath emollient beneficial for hydration but is not intended to reduce localized inflammation from eczema.\r\n\r\n\r\nAccording to NICE guidelines, emollients are the foundation of eczema management to maintain skin hydration and support the barrier function. For mild flares, hydrocortisone 1% is suitable and effective, especially in individuals over the age of 10. Moderate potency corticosteroids, such as Eumovate, are recommended only if symptoms persist and milder corticosteroids prove ineffective. Eczema management also includes avoiding known triggers, using emollients regularly, and monitoring for signs of infection, such as redness, oozing, or increased pain. Regular follow-up and adjustments to treatment can help keep eczema under control and prevent future flares.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "Aloe vera gel",
        "answer_number": 1
      },
      {
        "text": "Aqueous calamine cream",
        "answer_number": 2
      },
      {
        "text": "Aveeno\u00ae lotion",
        "answer_number": 3
      },
      {
        "text": "Dermol\u00ae wash",
        "answer_number": 4
      },
      {
        "text": "Diprobase\u00ae cream",
        "answer_number": 5
      },
      {
        "text": "Eumovate\u00ae cream",
        "answer_number": 6
      },
      {
        "text": "Hydrocortisone 1% cream",
        "answer_number": 7
      },
      {
        "text": "Oilatum\u00ae Junior Bath Additive",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2299,
    "bank": "clinicalTherapeutics",
    "title": "**If the infusion runs continuously, how many vials of the medication will be needed for a 48-hour treatment?**",
    "text": "A 70-year-old male patient is prescribed an intravenous infusion of a heparin for the prevention of blood clots. Heparin is to be administered at a rate of 1000 units per hour. Each vial of the medication contains 5000 units of the drug.",
    "why": "10 vials\r\n\r\nRationale:\r\n\r\nThe patient is prescribed an intravenous infusion of heparin at a rate of 1000 units per hour for 48 hours. Each vial contains 5000 units of heparin.\r\n\r\nStep-by-step calculation:\r\n\r\nTotal dose required = Infusion rate \u00d7 Duration\r\nTotal dose required = 1000 units/hour \u00d7 48 hours\r\nTotal dose required = 48,000 units\r\n\r\nEach vial contains 5000 units, so the number of vials required is:\r\n\r\nNumber of vials = Total dose required / Units per vial\r\nNumber of vials = 48,000 / 5000\r\nNumber of vials = 9.6\r\n\r\nSince vials cannot be split in practice, the required amount must be rounded up to the next whole number:\r\n\r\nNumber of vials = 10\r\n\r\nThus, 10 vials of heparin are required for the 48-hour treatment.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 2 vials\r\n\r\nThis would provide only 10,000 units, which would last for 10 hours, far shorter than the required 48 hours of treatment.\r\n\r\nB: 4 vials\r\n\r\nThis would provide only 20,000 units, covering only 20 hours of treatment, which is insufficient.\r\n\r\nC: 8 vials\r\n\r\nThis would provide 40,000 units, covering 40 hours, which is 8 hours short of the required treatment duration.\r\n\r\nE: 12 vials\r\n\r\nThis would provide 60,000 units, which is more than needed, leading to potential wastage.\r\n\r\nHeparin Infusions\r\n\r\nAccording to NICE guidelines (2025), heparin infusions are commonly used for the prevention and treatment of venous thromboembolism (VTE), particularly in high-risk patients such as those with immobility, atrial fibrillation, or post-surgical status.\r\n\r\nKey considerations for heparin administration:\r\n\r\nWeight-based dosing may be required in therapeutic cases to optimise anticoagulation.\r\nActivated partial thromboplastin time (aPTT) monitoring should be conducted at regular intervals to prevent over-anticoagulation and bleeding risks.\r\nRenal function assessment is necessary, especially in elderly patients, as heparin clearance may be altered.\r\nAntidote availability: Protamine sulfate should be available for reversal of heparin in case of excessive anticoagulation or bleeding.\r\n\r\nFor further details, refer to BNF Lesson Chapter 2 (Cardiovascular System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "2 vials",
        "answer_number": 1
      },
      {
        "text": "4 vials",
        "answer_number": 2
      },
      {
        "text": "8 vials",
        "answer_number": 3
      },
      {
        "text": "10 vials",
        "answer_number": 4
      },
      {
        "text": "12 vials",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2528,
    "bank": "clinicalMep",
    "title": "**Which ONE of the following is a good example of Tallman lettering?**",
    "text": "Question:\r\n\r\nLook-Alike Sound-Alike (LASA) medications are medications which look similar in their appearance, or the names of the medication have either a similar spelling or phonetics. Tallman lettering is used to reduce the risk of LASA's.\r\n\r\n\r\nOptions:\r\n\r\nA) AlloPURinol v ATENolol\r\nB) AMlodipine v AMtriptyline\r\nC) CARbimazole v CARbamazepine\r\nD) PRopranolol v PREDnisolone\r\nE) QUEtiapine v QUInine",
    "why": "A) AlloPURinol v ATENolol\r\n\r\nRationale:\r\n\r\nTallman lettering is a method used in healthcare to minimise the risk of errors with Look-Alike Sound-Alike (LASA) medications. This technique capitalises certain letters in each drug name to visually distinguish one medication from another, particularly those with similar names or phonetics. This is especially useful in pharmacy settings to reduce medication errors during dispensing.\r\n\r\nIn Option A (AlloPURinol v ATENolol), the capitalised segments in each drug name (PUR and TEN) effectively highlight the differences between these two medications. This visual contrast helps distinguish Allopurinol (used to treat gout) from Atenolol (a beta-blocker for hypertension), supporting safe medication management.\r\n\r\nOther Options Explained:\r\nB) AMlodipine v AMtriptyline\r\n\r\nBoth names start with \"AM\" in uppercase, which could lead to confusion rather than clarity. Tallman lettering is most effective when the capitalised letters occur in unique parts of each drug name.\r\nC) CARbimazole v CARbamazepine\r\n\r\nHere, \"CAR\" is capitalised in both names, which does not help to distinguish these two medications effectively. As both names start with the same sequence, additional or differently placed capitalisation would be more appropriate.\r\nD) PRopranolol v PREDnisolone\r\n\r\nWhile there is some capitalisation, it is not positioned optimally. These names may still be difficult to differentiate quickly, as the beginning letters \"PR\" are similar.\r\nE) QUEtiapine v QUInine\r\n\r\nThough this option uses some capitalisation, the similarity of the letters \u201cQUE\u201d and \u201cQUI\u201d may still pose a risk. In contrast, Option A provides clearer separation in the middle of each name, making it easier to distinguish.\r\n\r\nTallman lettering is a safety measure in the pharmacy setting that capitalises parts of Look-Alike Sound-Alike (LASA) medication names to reduce the risk of dispensing errors. For example, AlloPURinol v ATENolol effectively uses Tallman lettering by capitalising the segments PUR and TEN, which are distinct parts of each name, enhancing the visual distinction. This strategy is especially beneficial in environments where quick differentiation is necessary to ensure patient safety.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "AlloPURinol v ATENolol",
        "answer_number": 1
      },
      {
        "text": "AMlodipine v AMtriptyline",
        "answer_number": 2
      },
      {
        "text": "CARbimazole v CARbamazepine",
        "answer_number": 3
      },
      {
        "text": "PRopranolol v PREDnisolone",
        "answer_number": 4
      },
      {
        "text": "QUEtiapine v QUInine",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2494,
    "bank": "clinicalMep",
    "title": "**Which one of the following best describes a mandatory activity that must be completed by pharmacy contractors on an annual basis as part of this?**",
    "text": "Clinical governance is defined as a systematic approach to maintaining and improving the quality of patient care within a health system.",
    "why": "A. Clinical audit\r\n\r\nRationale\r\n\r\nClinical governance is a fundamental framework in healthcare systems, encompassing various activities to ensure high standards of care. Community pharmacies must adhere to these standards through mandatory requirements such as clinical audits and other governance-related activities.\r\n\r\nA. Clinical audit (Correct):\r\n\r\nPharmacy contractors must conduct at least two clinical audits annually:\r\n\r\nOne nationally determined clinical audit, such as one defined by NHS England.\r\nOne locally chosen clinical audit, tailored to meet specific service needs.\r\nThese audits evaluate clinical practices and outcomes, identifying areas for improvement to enhance patient care.\r\n\r\nB. Clinical governance toolkit (Incorrect):\r\n\r\nWhile the toolkit is a resource that supports the implementation of clinical governance practices, completing it is not a mandatory annual requirement.\r\n\r\nC. Reaccreditation of services (Incorrect):\r\n\r\nReaccreditation may be required for specific advanced services but is not universally mandatory on an annual basis as part of clinical governance.\r\n\r\nD. Registering of premises (Incorrect):\r\n\r\nRegistering pharmacy premises is a legal requirement but is not a recurring annual activity tied to clinical governance.\r\n\r\nE. Unpublished patient survey (Incorrect):\r\n\r\nPharmacies must conduct an annual patient satisfaction survey, but its results must be published, making the phrase \"unpublished patient survey\" inaccurate.\r\n\r\nAs part of clinical governance, pharmacy contractors are required to complete two clinical audits annually\u2014one nationally mandated and one locally determined. These audits serve to review and improve clinical practices, ensuring high-quality patient care and compliance with healthcare standards.\r\n\r\nOther activities such as publishing patient survey results, maintaining up-to-date governance practices, and reaccreditation of services complement clinical governance but are not universally mandated annually. By adhering to these requirements, pharmacies uphold their commitment to safe, effective, and patient-centred care.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Clinical audit",
        "answer_number": 1
      },
      {
        "text": "Clinical governance toolkit",
        "answer_number": 2
      },
      {
        "text": "Reaccreditation of services",
        "answer_number": 3
      },
      {
        "text": "Registering of premises",
        "answer_number": 4
      },
      {
        "text": "Unpublished patient survey",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2151,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Antidotes** \r\n\r\n\u2028\u2028**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 40-year-old man who has accidentally ingested a large amount of iron tablets and is vomiting blood and has abdominal pain.",
    "why": "Correct answer: \r\n\r\nB) Deferoxamine mesilate\r\n\r\nRationale:\r\n\r\n- Deferoxamine mesilate is the antidote used in cases of acute iron poisoning, which commonly presents with vomiting, abdominal pain, gastrointestinal bleeding (e.g. vomiting blood), hypotension, and metabolic acidosis.\r\n\r\n- Deferoxamine acts as a chelating agent, binding free iron in the bloodstream to form a complex (ferrioxamine) that is then excreted in the urine. This reduces iron's toxic effects on the liver, gastrointestinal tract, and cardiovascular system.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Acetylcysteine \r\n\r\nUsed for paracetamol overdose.\r\n\r\nC) Dicobalt edetate \r\n\r\nUsed for cyanide poisoning.\r\n\r\nD) Flumazenil \r\n\r\nReverses benzodiazepine overdose.\r\n\r\nE) Glucagon \r\n\r\nUsed for beta-blocker or calcium channel blocker overdose.\r\n\r\nF) Naloxone hydrochloride \r\n\r\nUsed for opioid overdose.\r\n\r\nG) Phytomenadione \r\n\r\nVitamin K1; used for warfarin overdose.\r\n\r\nH) Sodium bicarbonate \r\n\r\nUsed in tricyclic antidepressant overdose or severe metabolic acidosis.\r\n\r\n\r\n\r\nIn suspected iron overdose, especially when symptoms include gastrointestinal bleeding, vomiting, and abdominal pain, the treatment of choice is Deferoxamine, a chelating agent that binds excess iron and facilitates its excretion. Prompt hospital referral is also essential.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Acetylcysteine",
        "answer_number": 1
      },
      {
        "text": "Deferoxamine mesilate",
        "answer_number": 2
      },
      {
        "text": "Dicobalt edetate",
        "answer_number": 3
      },
      {
        "text": "Flumazenil",
        "answer_number": 4
      },
      {
        "text": "Glucagon",
        "answer_number": 5
      },
      {
        "text": "Naloxone hydrochloride",
        "answer_number": 6
      },
      {
        "text": "Phytomenadione",
        "answer_number": 7
      },
      {
        "text": "Sodium bicarbonate",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 863,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate action to take?**",
    "text": "A 55-year-old woman comes to your pharmacy and asks for a shingles vaccine. She says she has rheumatoid arthritis and takes methotrexate and prednisolone regularly. She has no other medical conditions or allergies",
    "why": "he NHS shingles programme offers a free shingles vaccine to people who are at higher risk from shingles, including all adults turning 65, those aged 70 to 79 and those aged 50 and over with a severely weakened immune system\u00b9\u00b2. People with rheumatoid arthritis who take methotrexate and prednisolone are considered to have a severely weakened immune system, so they are eligible for the shingles vaccine from the age of 50\u00b2. There are two types of shingles vaccine given in the UK: Zostavax and Shingrix. Zostavax contains a weakened version of the virus that causes shingles, so it is not suitable for people with a severely weakened immune system. Shingrix is a non-live vaccine that does not contain the virus, so it is suitable for people with a severely weakened immune system\u00b9\u00b2. Therefore, the woman should be given the Shingrix vaccine for free as part of the NHS shingles programme. The pharmacy can provide the service, once signed up and service specifications are met so there is no need to refer her to her GP",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Give her the Zostavax vaccine for free as she is eligible for the NHS shingles programme.",
        "answer_number": 1
      },
      {
        "text": "Give her the Shingrix vaccine for free as she is eligible for the NHS shingles programme.",
        "answer_number": 2
      },
      {
        "text": "Give her the Zostavax vaccine and charge her for it as she is not eligible for the NHS shingles programme.",
        "answer_number": 3
      },
      {
        "text": "Give her the Shingrix vaccine and charge her for it as she is not eligible for the NHS shingles programme.",
        "answer_number": 4
      },
      {
        "text": "Refer her to her GP for the shingles vaccine as she is not eligible for a pharmacy service.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2611,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the LEAST appropriate self advice for onychomycosis?**",
    "text": "A 23 year old male patient presents to the pharmacy with onychomycosis on his left big toe.\u00a0\r\nHe has purchased amorolfine 5% nail lacquer and would like some self care advice.",
    "why": "The LEAST appropriate self-care advice for a patient with onychomycosis is:\r\n\r\nWear well-fitting occlusive shoes.\r\n\r\nRationale: \r\n\r\nAccording to NICE guidelines, it's important to avoid wearing occlusive shoes when managing fungal infections such as onychomycosis, as they can trap moisture and heat, providing a favorable environment for fungal growth. Instead, footwear should be non-occlusive, allowing air circulation to keep the feet cool and dry. The other self-care options listed are appropriate and align with NICE recommendations for managing fungal infections.\r\n\r\nAvoid trauma to the nails if possible: Protecting nails from injury is crucial as trauma can worsen the infection or allow fungi to penetrate the nail further.\r\nKeep his toenails short and filed down: This practice reduces the fungal load and aids the effectiveness of topical treatments like amorolfine.\r\nMaintain good foot hygiene: Washing and thoroughly drying feet, especially between the toes, helps reduce moisture and fungal growth.\r\nWear cotton absorbent socks: These socks help absorb moisture and keep the feet dry, creating an unfavorable environment for fungal organisms.\r\nSelf-Care Advice for Athlete's Foot According to NICE Guidelines\r\nWhile managing onychomycosis, NICE guidelines also provide comprehensive self-care advice for athlete's foot, another common fungal infection:\r\n\r\nWear well-fitting, non-occlusive footwear: This helps keep the feet cool and dry, reducing moisture accumulation.\r\nConsider replacing old footwear: Old shoes may harbor fungal spores, so replacing them helps prevent reinfection.\r\nMaintain good foot hygiene: Wearing different shoes every 2\u20133 days allows each pair to dry fully, minimizing the risk of fungal growth.\r\nWear cotton, absorbent socks: These socks keep the feet dry and comfortable by absorbing excess moisture.\r\nAvoid scratching the affected skin: Scratching can spread the infection to other body parts or individuals.\r\nDry feet thoroughly after washing, especially between the toes, to reduce moisture retention.\r\nDo not share towels and wash them frequently to minimize the spread of the infection.\r\nWear protective footwear in communal areas like showers, locker rooms, and gyms to lower the risk of acquiring or transmitting fungal infections.\r\nChildren with athlete's foot do not need to be excluded from school or nursery.\r\n\r\nBoth onychomycosis and athlete\u2019s foot are commonly caused by similar fungal organisms, and preventing these infections relies heavily on maintaining good foot hygiene and choosing appropriate footwear. While antifungal treatments play a crucial role, effective prevention strategies are equally important in managing these infections and reducing recurrence. By following these NICE-recommended self-care tips, patients can significantly enhance the efficacy of treatments and promote overall foot health.\r\n\r\nFor more information watch OTC lesson on Chapter 8 Dermatology:\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Avoid trauma to the nails if possible",
        "answer_number": 1
      },
      {
        "text": "Keep his toenails short and filed down",
        "answer_number": 2
      },
      {
        "text": "Maintain good feet hygiene",
        "answer_number": 3
      },
      {
        "text": "Wear cotton absorbent socks",
        "answer_number": 4
      },
      {
        "text": "Wear well fitting occlusive shoes",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2487,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate action to take?**",
    "text": "Mrs K comes into your pharmacy on Saturday morning. She explains that she is visiting her daughter from out of town and has forgotten her medicine. She tells you that she is currently taking phenobarbital tablets at a dose of 80mg each night for epilepsy. She says that she usually receives the Actavis brand and shows you an empty box which is dated within the past month and is clearly labelled with the dose instructions.",
    "why": "B. Explain that you can make a supply which is limited to only 5 days\u2019 worth of treatment.\r\n\r\nRationale:\r\n\r\nUnder the Medicines, Ethics, and Practice (MEP) guidelines, an emergency supply of a controlled drug is permitted in specific circumstances. For Schedule 3 controlled drugs, such as phenobarbital (when prescribed for epilepsy), the pharmacist can supply no more than 5 days\u2019 worth of treatment.\r\n\r\nThis supply is permissible because:\r\n\r\nPhenobarbital is the only Schedule 3 CD permitted for emergency supply under these conditions, provided the pharmacist is satisfied of its necessity.\r\nThe patient must provide evidence of prior use (e.g., a labelled box or verbal confirmation).\r\nThe pharmacist must make a record of the supply, including the patient\u2019s GP details, the medicine details, and the rationale for the emergency supply.\r\n\r\nWhy the Other Options Are Incorrect:\r\n\r\nA. Explain that you can make a supply if she furnishes a prescription within 72 hours.\r\nThis is incorrect because phenobarbital does not require the patient to furnish a prescription within 72 hours for an emergency supply. This requirement applies to some other CDs under specific conditions.\r\n\r\nC. Explain that you cannot make a supply as controlled drugs fall outside of emergency supply rules.\r\nThis is incorrect because phenobarbital, when used for epilepsy, is specifically allowed under emergency supply rules despite being a Schedule 3 controlled drug.\r\n\r\nD. Supply the drug for a 30-day duration and make a record detailing this alongside her doctor\u2019s details.\r\nThis is incorrect because only a 5-day supply is permitted for Schedule 3 controlled drugs under emergency supply rules. A 30-day supply applies only to certain prescription-only medicines, not controlled drugs.\r\n\r\nE. Supply the drug and make a record detailing her general practitioner\u2019s name and registration number.\r\nThis is incorrect because while a record must be made, the supply is limited to 5 days for phenobarbital, not an unrestricted amount. Additionally, there is no requirement to record the GP's registration number.\r\n\r\n\r\nEmergency supply regulations allow pharmacists to provide a maximum of 5 days' worth of Schedule 3 controlled drugs, such as phenobarbital, for epilepsy. This exception ensures that patients can access essential medications for a chronic condition when unexpected circumstances arise. Pharmacists must exercise professional judgment, ensure the supply is appropriate, and document all necessary details, including the patient\u2019s GP information and rationale for the supply.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Explain that you can make a supply if she furnishes a prescription within 72 hours",
        "answer_number": 1
      },
      {
        "text": "Explain that you can make a supply which is limited to only 5 days\u2019 worth of treatment",
        "answer_number": 2
      },
      {
        "text": "Explain that you cannot make a supply as controlled drugs fall outside of emergency supply rules",
        "answer_number": 3
      },
      {
        "text": "Supply the drug for a 30-day duration and make a record detailing this alongside her doctor\u2019s details",
        "answer_number": 4
      },
      {
        "text": "Supply the drug and make a record detailing her general practitioner\u2019s name and registration number",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2144,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Signs a and Symptoms of toxicity** \r\n\r\n\u2028\u2028**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 45-year old female who has hepatic necrosis, which may lead to liver failure, encephalopathy, coma, and death.",
    "why": "Correct answer: \r\n\r\nH) Paracetamol\r\n\r\n\r\nRationale:\r\n\r\n- Paracetamol overdose is one of the most common causes of acute liver failure in the UK. It leads to:\r\n\r\n- Hepatic necrosis due to accumulation of the toxic metabolite NAPQI when glutathione stores are depleted\r\n\r\n- Clinical progression can include liver failure, hepatic encephalopathy, coagulopathy, coma, and death if untreated\r\n\r\n- Early administration of acetylcysteine (NAC) is crucial to prevent liver damage and improve survival\r\n\r\nExplanation of Other Options:\r\n\r\nA) Aspirin \u2013 May cause salicylate toxicity, metabolic acidosis, tinnitus, but not hepatic necrosis\r\n\r\nB) Amitriptyline \u2013 Can lead to anticholinergic effects, seizures, and cardiac arrhythmias, not liver failure\r\n\r\nC) Amlodipine \u2013 Overdose causes hypotension and reflex tachycardia, no hepatic necrosis\r\n\r\nD) Bisoprolol \u2013 Beta-blocker toxicity can cause bradycardia and hypotension, not liver damage\r\n\r\nE) Citalopram \u2013 May cause serotonin syndrome and QT prolongation, not associated with hepatic necrosis\r\n\r\nF) Fentanyl \u2013 Causes respiratory depression and CNS effects, no liver involvement\r\n\r\nG) Naproxen \u2013 NSAID toxicity may cause renal issues and GI bleeding, not hepatic necrosis\r\n\r\n\r\nSummary:\r\n\r\nParacetamol overdose is life threatening due to its risk of acute hepatic failure. It requires prompt treatment with acetylcysteine, ideally within 8 hours of ingestion, to prevent irreversible liver damage, encephalopathy, and death. Regular monitoring of ALT, INR, bilirubin, and renal function is essential in suspected toxicity cases.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 8,
    "weighting": 3,
    "answers": [
      {
        "text": "Aspirin",
        "answer_number": 1
      },
      {
        "text": "Amitriptyline",
        "answer_number": 2
      },
      {
        "text": "Amlodipine",
        "answer_number": 3
      },
      {
        "text": "Bisoprolol",
        "answer_number": 4
      },
      {
        "text": "Citalopram",
        "answer_number": 5
      },
      {
        "text": "Fentanyl",
        "answer_number": 6
      },
      {
        "text": "Naproxen",
        "answer_number": 7
      },
      {
        "text": "Paracetamol",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2467,
    "bank": "clinicalTherapeutics",
    "title": "**What is Nutriflex peri solution for infusion used for?**",
    "text": "A 50-year-old male patient is admitted to the hospital. The junior doctor would like to initiate Nutriflex peri solution for infusion. The patient's weight is 80 kg.\r\n\r\nThe SmPC for Nutriflex Peri Solution has been provided for this question. [SmPC for Nutriflex](https://www.medicines.org.uk/emc/product/15206/smpc#gref)",
    "why": "C. To provide nutrition\r\n\r\nRattionale\r\n\r\nNutriflex Peri solution is a parenteral nutrition product used when oral or enteral feeding is insufficient or impossible. According to the Summary of Product Characteristics \r\n\r\n(SmPC), it contains:\r\n\r\nAmino acids: Essential for protein synthesis.\r\nElectrolytes: To maintain fluid balance.\r\nGlucose: Provides energy.\r\nCalories: Supports metabolic needs.\r\n\r\nThe infusion is administered intravenously to ensure the patient receives necessary nutrients for physiological maintenance and recovery, especially in cases of malnutrition or inability to consume adequate food orally.\r\n\r\nRationale for Incorrect Options\r\n\r\nA. To treat hypertension: Nutriflex Peri does not manage or treat high blood pressure.\r\nB. To treat diabetes: While it contains glucose, it is not a treatment for diabetes. In fact, its glucose content requires careful monitoring in diabetic patients.\r\nD. To treat cancer: Nutriflex Peri has no anticancer properties.\r\nE. To treat anaemia: It does not contain haematinics like iron or erythropoietin, which are necessary for treating anaemia.\r\n\r\nAdditional Notes\r\n\r\nNutriflex Peri is typically used under medical supervision, and the infusion rate is based on individual metabolic demands. Monitoring for potential side effects, such as hyperglycaemia, electrolyte imbalances, or infection, is essential.\r\n\r\nSmPC Key Information:\r\n\r\nMaximum infusion rate: 2 ml/kg/hour.\r\nThe product should not be administered at excessive rates due to the risk of metabolic derangements.\r\n\r\nNutriflex Peri is typically used under medical supervision, with close monitoring to prevent complications such as:\r\n\r\nHyperglycaemia.\r\nElectrolyte imbalances.\r\nInfections at the infusion site.\r\n\r\nThe infusion rate and dosage are based on individual patient needs, determined by weight and metabolic demand.\r\n\r\n\r\nFor more information please watch BNF lesson Chapter 9 (Blood and Nutrition)\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "To treat hypertension",
        "answer_number": 1
      },
      {
        "text": "To treat diabetes",
        "answer_number": 2
      },
      {
        "text": "To provide nutrition",
        "answer_number": 3
      },
      {
        "text": "To treat cancer",
        "answer_number": 4
      },
      {
        "text": "To treat anemia",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2374,
    "bank": "clinicalTherapeutics",
    "title": "**According to the BNF, what is the most likely cause of his blurred vision?**",
    "text": "A 45-year-old man has been using fluticasone nasal spray twice daily for the last 6 weeks to treat his allergic rhinitis. He comes to the pharmacy complaining of blurred vision in his right eye. He says he has no history of eye problems or diabetes. He asks for your advice on what he should do.",
    "why": "B. Central serous chorioretinopathy\r\n\r\nRationale:\r\n\r\nFluticasone is a corticosteroid, and one of its rare but serious side effects is central serous chorioretinopathy (CSCR). This condition involves the accumulation of fluid beneath the retina, which can lead to blurred vision, distorted vision, or reduced central vision. The BNF states that patients presenting with visual disturbances after corticosteroid use should be referred to an ophthalmologist for evaluation.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Cataract:\r\n\r\nCataracts can develop as a side effect of long-term corticosteroid use. However, the onset of symptoms like blurred vision is typically gradual and occurs after extended use, not within six weeks.\r\n\r\nC. Diabetic retinopathy:\r\n\r\nDiabetic retinopathy is associated with diabetes mellitus. The patient has no history of diabetes, making this an unlikely cause of their symptoms.\r\n\r\nD. Glaucoma:\r\n\r\nGlaucoma is another potential long-term side effect of corticosteroid use, causing increased intraocular pressure. However, acute blurred vision from glaucoma would likely present with additional symptoms, such as eye pain or halos around lights, which are not mentioned here.\r\n\r\nE. Macular degeneration:\r\n\r\nMacular degeneration is an age-related condition that commonly affects those over 50 years old. The patient is only 45, and this condition is unrelated to corticosteroid use.\r\n\r\nAdditional Information:\r\n\r\n\r\nAccording to NICE guidelines, corticosteroids should be used with caution, and patients should be informed about the potential for side effects, including visual disturbances. NICE recommends that any patient experiencing blurred vision or other visual changes while on corticosteroids be promptly referred to an ophthalmologist for further investigation and management. CSCR may resolve spontaneously in some cases, but ongoing corticosteroid use should be reviewed and possibly discontinued to prevent further complications.\r\n\r\nFor more information please watch BNF lesson Chapter 11 (Eyes):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Cataract",
        "answer_number": 1
      },
      {
        "text": "Central serous chorioretinopathy",
        "answer_number": 2
      },
      {
        "text": "Diabetic retinopathy",
        "answer_number": 3
      },
      {
        "text": "Glaucoma",
        "answer_number": 4
      },
      {
        "text": "Macular degeneration",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2268,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is NOT usually recommended as a potential technique to help dislodge an airway obstruction in a 7-year-old child?**",
    "text": "You are working as a Pharmacist Manager in your local community pharmacy. You are refreshing your first-aid knowledge",
    "why": "Correct Answer:\r\n\r\nD) Putting your finger in to remove it\r\n\r\nRationale:\r\n\r\nFor a 7-year-old child with airway obstruction, first-aid guidance prioritises effective techniques that encourage spontaneous clearance while minimising further complications. Blind finger sweeps (putting your finger in the mouth to remove an object) are not usually recommended, as they may:\r\n\r\n- Push the object further down the airway, worsening the obstruction.\r\n- Cause soft tissue injury in the mouth or throat.\r\n- Trigger gagging or vomiting, increasing the risk of aspiration.\r\n\r\nInstead, NICE guidelines recommend:\r\n\r\n- Encouraging coughing (if the child is still able to breathe and make noise).\r\n- Performing five sharp back blows if the obstruction does not clear.\r\n- Giving abdominal thrusts if back blows are ineffective.\r\n- Seeking emergency help (999) if the obstruction is not relieved.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Encouraging coughing \r\n\r\nRecommended as the first response in partial airway obstruction. If the child can cough effectively, they should be encouraged to do so to clear the blockage.\r\n\r\n(B) Giving five sharp back blows \r\n\r\nIf coughing is ineffective, NICE guidelines advise delivering up to five back blows between the shoulder blades using the heel of the hand.\r\n\r\n(C) Giving abdominal thrusts \r\n\r\nIf back blows fail, abdominal thrusts (Heimlich manoeuvre) should be used in children over 1 year of age. The child should be standing or sitting, and the thrust should be applied by placing a fist above the navel and pulling inwards and upwards.\r\n\r\n(E) Getting the child to pick it out themselves \r\n\r\nIf the object is visible and reachable, the child can carefully remove it themselves. However, forced removal is discouraged unless the obstruction is obvious and can be extracted safely.\r\n\r\nAirway Obstruction in Children \r\n\r\nChoking is a medical emergency that requires immediate and appropriate intervention. In children aged over 1 year, the recommended first-aid sequence is:\r\n\r\n1) Encourage coughing if the child is conscious and able to breathe.\r\n\r\n2) If ineffective, give up to five back blows between the shoulder blades.\r\n\r\n3) If the obstruction persists, perform abdominal thrusts (up to five attempts).\r\n\r\n4) If the blockage is not cleared, repeat the cycle of back blows and abdominal thrusts while seeking emergency help (999).\r\n\r\n5) If the child becomes unresponsive, begin CPR (30:2 compression-to-breath ratio) while awaiting medical assistance.\r\n\r\nFor more information, please watch BNF lesson Chapter 3 (Respiratory System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Encouraging coughing",
        "answer_number": 1
      },
      {
        "text": "Giving five sharp back blows",
        "answer_number": 2
      },
      {
        "text": "Giving abdominal thrusts",
        "answer_number": 3
      },
      {
        "text": "Putting your finger in to remove it",
        "answer_number": 4
      },
      {
        "text": "Getting the child to pick it out themselves",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2229,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate equivalent dose of fentanyl patches for this patient?**",
    "text": "A 70-year-old woman with chronic obstructive pulmonary disease (COPD) and osteoarthritis has been taking morphine modified-release tablets 30 mg twice daily and morphine 10 mg/5mL oral solution, 5mL TDS for breakthrough pain. She has been experiencing respiratory depression, sedation and confusion as side effects of morphine. Her pain specialist decides to switch her to fentanyl transdermal patches.\u00a0\r\n\r\n\r\n![fentanyl](https://i.ibb.co/wwf2hGd/fentanyl.png \"800x700\")",
    "why": "Correct Answer: \r\n\r\nC) 37.5 micrograms/hour\r\n\r\nRationale:\r\n\r\nStep-by-step opioid conversion:\r\n\r\nTotal daily oral morphine:\r\n\r\nMR morphine: 30 mg \u00d7 2 = 60 mg\r\n\r\nOral solution: 10 mg \u00d7 3 = 30 mg\r\n\r\n\u2192 Total: 90 mg/day\r\n\r\nFrom the provided fentanyl conversion chart:\r\n\r\n90 mg oral morphine/day \u2248 fentanyl 37.5 micrograms/hour\r\n\r\nThis is the correct equivalent transdermal patch dose.\r\n\r\nFentanyl transdermal patches are used in patients with stable opioid requirements, particularly when oral opioids are not tolerated due to side effects such as nausea, sedation, or respiratory depression. \r\nWhen switching from oral morphine to fentanyl, equi-analgesic tables such as those in the BNF, palliative care formularies, and NICE-endorsed guidance are used. \r\nFentanyl patches deliver medication continuously over 72 hours, and full analgesic effect is reached within 12\u201324 hours of application. \r\nPatients should be monitored closely during this period, with oral morphine available for breakthrough pain.\r\n\r\n\r\nFor more information, please watch BNF lesson chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "12 micrograms/hour",
        "answer_number": 1
      },
      {
        "text": "25 micrograms/hour",
        "answer_number": 2
      },
      {
        "text": "37.5 micrograms/hour",
        "answer_number": 3
      },
      {
        "text": "50 micrograms/hour",
        "answer_number": 4
      },
      {
        "text": "75 micrograms/hour",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 1013,
    "bank": "clinicalTherapeutics",
    "title": "A 55-year-old man who has chronic alcohol dependence has been diagnosed with Wernicke's encephalopathy and has been prescribed a high-dose infusion to prevent further neurological damage.",
    "text": "**Theme: Vitamins and Supplements**\u2028\u2028\r\n\r\n**For each of the following clinical scenarios, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "why": "Correct answer: \r\n\r\nE. Vitamin B1\r\n\r\nRationale:\r\n\r\nWernicke\u2019s encephalopathy is a serious neurological emergency caused by thiamine (vitamin B1) deficiency, commonly seen in patients with chronic alcohol misuse. Symptoms include confusion, ataxia, and ophthalmoplegia. Without prompt treatment, it can progress to Korsakoff\u2019s syndrome, causing irreversible memory damage. High-dose parenteral thiamine (e.g. Pabrinex\u00ae) is required urgently to prevent permanent neurological impairment.\r\n\r\nExplanation of other options:\r\n\r\nA. Calcium\r\n\r\nUsed in cases like hypocalcaemia, osteoporosis, or post-parathyroidectomy. Not relevant to Wernicke\u2019s encephalopathy.\r\n\r\nB. Iron\r\n\r\nTreats iron-deficiency anaemia. Although alcoholics may have anaemia, this is not the cause of the acute neurological picture.\r\n\r\nC. Folic acid\r\n\r\nCan be deficient in alcoholism but does not cause Wernicke\u2019s encephalopathy and is not the immediate treatment priority.\r\n\r\nD. Magnesium\r\n\r\nOften co-administered with thiamine in alcohol misuse because magnesium deficiency can impair thiamine utilisation, but it is not the primary treatment for Wernicke\u2019s.\r\n\r\nF. Vitamin B12\r\n\r\nDeficiency leads to peripheral neuropathy and subacute combined degeneration of the spinal cord, not Wernicke\u2019s encephalopathy.\r\n\r\nG. Vitamin D\r\n\r\nDeficiency is common in alcoholics but related to bone health, not neurological emergencies.\r\n\r\nH. Zinc\r\n\r\nMay be depleted in chronic alcohol use, but again not involved in acute neurological syndromes like Wernicke\u2019s.\r\n\r\n\r\nWernicke\u2019s encephalopathy is a medical emergency caused by vitamin B1 (thiamine) deficiency, especially in patients with chronic alcohol dependence. Prompt IV thiamine is essential to prevent progression to Korsakoff\u2019s syndrome, which causes irreversible cognitive damage. Oral supplementation is insufficient in acute cases.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Calcium",
        "answer_number": 1
      },
      {
        "text": "Iron",
        "answer_number": 2
      },
      {
        "text": "Folic acid",
        "answer_number": 3
      },
      {
        "text": "Magnesium",
        "answer_number": 4
      },
      {
        "text": "Vitamin B1",
        "answer_number": 5
      },
      {
        "text": "Vitamin B12",
        "answer_number": 6
      },
      {
        "text": "Vitamin D",
        "answer_number": 7
      },
      {
        "text": "Zinc",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 1011,
    "bank": "clinicalTherapeutics",
    "title": "A 25-year-old woman who is 12 weeks pregnant has been diagnosed with microcytic anemia\u00a0 and has been prescribed a supplement to prevent complications for herself and her baby.",
    "text": "**Theme: Vitamins and Supplements**\r\n\r\n\u2028\u2028**For each of the following clinical scenarios, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "why": "Correct answer: \r\n\r\nB. Iron\r\n\r\nRationale:\r\n\r\nMicrocytic anaemia in pregnancy is most commonly due to iron deficiency, which causes small (microcytic), pale (hypochromic) red blood cells. Pregnant women are at increased risk due to higher iron demands for fetal development and maternal blood volume expansion. Iron supplementation is essential to prevent complications such as preterm delivery, low birth weight, and maternal fatigue. Oral iron (e.g. ferrous sulfate) is the first-line treatment unless contraindicated.\r\n\r\nExplanation of other options:\r\n\r\nA. Calcium\r\n\r\nImportant for fetal bone development but not indicated for anaemia.\r\n\r\nC. Folic acid\r\n\r\nUsed to prevent neural tube defects and treat megaloblastic anaemia, not microcytic anaemia.\r\n\r\nD. Magnesium\r\n\r\nUsed in pre-eclampsia and certain cardiac or muscular conditions, but not anaemia.\r\n\r\nE. Vitamin B1\r\n\r\nUsed in Wernicke\u2019s encephalopathy and alcohol misuse, not in pregnancy-related anaemia.\r\n\r\nF. Vitamin B12\r\n\r\nDeficiency leads to macrocytic anaemia, not microcytic anaemia.\r\n\r\nG. Vitamin D\r\n\r\nImportant in calcium metabolism and bone health, but not related to red cell production.\r\n\r\nH. Zinc\r\n\r\nImportant for immune and cellular function, but not indicated in anaemia management.\r\n\r\nIron-deficiency anaemia is the most common cause of microcytic anaemia in pregnancy. It should be corrected with iron supplements to support maternal health and fetal growth, reducing the risk of complications such as preterm labour and developmental delays.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Calcium",
        "answer_number": 1
      },
      {
        "text": "Iron",
        "answer_number": 2
      },
      {
        "text": "Folic acid",
        "answer_number": 3
      },
      {
        "text": "Magnesium",
        "answer_number": 4
      },
      {
        "text": "Vitamin B1",
        "answer_number": 5
      },
      {
        "text": "Vitamin B12",
        "answer_number": 6
      },
      {
        "text": "Vitamin D",
        "answer_number": 7
      },
      {
        "text": "Zinc",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 973,
    "bank": "clinicalMep",
    "title": "**Which of the following does NOT need to be recorded in the pharmacy record?**",
    "text": "The pharmacy record is an important document under the Responsible Pharmacist regulations 2008 (as amended)",
    "why": "The reason for the temporary absence is a professional requirement, not a legal requirement. Time of when absence has started and ended is a legal requirement.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Date of Responsible pharmacist duty",
        "answer_number": 1
      },
      {
        "text": "Responsible pharmacist name",
        "answer_number": 2
      },
      {
        "text": "Responible pharmacist registration number",
        "answer_number": 3
      },
      {
        "text": "Reason for temporary absence.",
        "answer_number": 4
      },
      {
        "text": "Time of Responsible pharmacist duty",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 985,
    "bank": "clinicalOtc",
    "title": "**Which of the following would be the LEAST appropriate advice?**",
    "text": "A 42 year old female patient presents to the pharmacy requesting advice regarding insomnia.",
    "why": "The rationale is that exercise can stimulate the body and make it harder to fall asleep if done too close to bedtime. Exercise can also raise the body temperature, which may interfere with the natural cooling process that occurs before sleep. Therefore, it is recommended to avoid exercise at least 4 hours before bed",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Avoid watching TV or using your phone/computer before bedtime",
        "answer_number": 1
      },
      {
        "text": "Keep a sleep diary to identify what encourages sleep and what to avoid",
        "answer_number": 2
      },
      {
        "text": "Regular exercise which can be carried out up to an hour before bedtime",
        "answer_number": 3
      },
      {
        "text": "Try aromatherapy to promote a feeling of relaxation using camomile oil",
        "answer_number": 4
      },
      {
        "text": "You can advise the patient to have a warm milky drink before bedtime",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2424,
    "bank": "clinicalTherapeutics",
    "title": "A patient who is scheduled for major elective orthopaedic surgery (haemoglobin 10.5 g/dL)",
    "text": "**Theme: Most suitable dose of epoetin alpha**\r\n\r\n\r\n**Instruction: For each scenario, select the most suitable dose of epoetin alpha from the list of answer options. Each option may be used once, more than once or not at all.**\u2028\u2028The sPmC for Eprex has been provided for you.\u2028[SmPC for Eprex](https://www.medicines.org.uk/emc/product/3442/smpc#gref)",
    "why": "600 IU/kg once weekly\r\n\r\nRationale:\r\n\r\nAccording to the SmPC for Eprex (epoetin alfa), the recommended dose for patients undergoing major elective orthopaedic surgery with mild anaemia (e.g., haemoglobin 10.5 g/dL) is:\r\n\r\n600 IU/kg administered subcutaneously once weekly for three weeks prior to surgery (on days -21, -14, and -7) and on the day of surgery (day 0).\r\nThis regimen is designed to optimise haemoglobin levels, reducing the need for blood transfusions during surgery. It is effective for managing mild preoperative anaemia in patients at risk of significant blood loss.\r\n\r\nExplanation of Other Options:\r\n\r\nA. 50 IU/kg twice weekly\r\n\r\nUsed for anaemia in chronic kidney disease (CKD) patients on dialysis. It is not appropriate for pre-surgical optimisation.\r\n\r\nB. 50 IU/kg three times a week\r\n\r\nSuitable for some CKD patients but not indicated for pre-surgical anaemia management.\r\n\r\nC. 75 IU/kg three times weekly\r\n\r\nThis dose may apply in some anaemia scenarios but is not the correct regimen for pre-surgical haemoglobin optimisation.\r\n\r\nD. 100 IU/kg once weekly\r\n\r\nToo low to achieve the necessary haemoglobin optimisation within three weeks before surgery.\r\n\r\nE. 150 IU/kg once every two weeks\r\n\r\nThis dosing interval is too infrequent for surgical preparation.\r\n\r\nF. 300 IU/kg once every four weeks\r\n\r\nThis dose is used in long-term anaemia management but is not suitable for rapid haemoglobin optimisation.\r\n\r\nG. 450 IU/kg once weekly\r\n\r\nThis is an alternative regimen that may be used in specific settings, but the SmPC recommends 600 IU/kg weekly for this scenario.\r\n\r\n\r\nPre-Surgical Use:\r\n\r\nEpoetin alfa is used to optimise haemoglobin levels in patients with mild anaemia, reducing the need for transfusion during surgery.\r\n\r\nSafety Considerations:\r\n\r\nMonitor haemoglobin levels regularly to avoid exceeding 12 g/dL, which increases the risk of thromboembolic events.\r\nAdminister with caution in patients with cardiovascular disease or a history of thromboembolism.\r\n\r\nAlternative Regimens:\r\n\r\nFor patients with shorter preparation times before surgery, higher doses such as 300 IU/kg every day for 10 days before surgery may be used.\r\n\r\nAlways consult the SmPC for specific dosing recommendations.\r\nIndividualise treatment based on haemoglobin levels, timing of surgery, and patient-specific risk factors.\r\nMonitor closely to ensure safe and effective haemoglobin optimisation.\r\n\r\nFor more information please watch BNF lesson chapter 9 (Blood and Nutrition):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 8,
    "weighting": 3,
    "answers": [
      {
        "text": "50 IU/kg twice weekly",
        "answer_number": 1
      },
      {
        "text": "50 IU/kg three times a week.",
        "answer_number": 2
      },
      {
        "text": "75 IU/kg three times weekly",
        "answer_number": 3
      },
      {
        "text": "100 IU/kg once weekly",
        "answer_number": 4
      },
      {
        "text": "150 IU/kg once every two weeks",
        "answer_number": 5
      },
      {
        "text": "300 IU/kg once every four weeks",
        "answer_number": 6
      },
      {
        "text": "450 IU/kg once weekly",
        "answer_number": 7
      },
      {
        "text": "600 IU/kg once weekly",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2625,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 22 year old male patient presents to the pharmacy with a painful eyelid. He informs you there has been no changes in vision. He has had the symptoms for the past 3 days.\r\nA picture of the eyelid has been provided below:\r\n\r\n\r\n![stye](https://i.ibb.co/mqk6XHM/stye.jpg \"600x600\")",
    "why": "The patient has a stye which is self limiting. The patient can use a warm compress to release the pus in the stye.\r\n\r\nA **stye** (hordeolum) is an acute infection or inflammation of the eyelid margin, usually caused by a staphylococcal infection. There are two types:\r\n\r\n- **External Stye**: Located on the eyelid margin, often from an infected eyelash follicle or associated gland.\r\n- **Internal Stye**: Found on the conjunctival surface of the eyelid, caused by an infection of a Meibomian gland.\r\n\r\n**Risk Factors**: Chronic blepharitis, acne rosacea.\r\n\r\n**Symptoms**: Painful, localized swelling (papule or furuncle) near the eyelid margin, typically unilateral but can be bilateral. Symptoms usually resolve within 5\u20137 days once the stye drains or ruptures.\r\n\r\n**Complications**: May include infective conjunctivitis, Meibomian cyst formation, or rarely, periorbital or orbital cellulitis.\r\n\r\n**Assessment**:\r\n- Determine the timescale of symptoms, previous episodes, and associated risk factors.\r\n- Examine for typical features, check for complications, and rule out atypical diagnoses (e.g., malignant eyelid tumour).\r\n\r\n**Management**:\r\n- Reassure patients that styes are usually self-limiting and serious complications are rare.\r\n- For severe cases with periorbital or orbital cellulitis, arrange emergency hospital admission.\r\n- Urgent referral to an ophthalmologist if a malignant tumour is suspected.\r\n- Advise self-care measures: apply warm compresses, avoid eye makeup and contact lenses until healed.\r\n- Manage underlying conditions (blepharitis, acne rosacea) to reduce recurrence.\r\n- Prescribe topical antibiotics only if there are signs of infective conjunctivitis.\r\n\r\n**For Painful External Styes**:\r\n- Consider plucking the affected eyelash to facilitate drainage.\r\n- Incision and drainage may be performed by a trained healthcare professional if appropriate.\r\n\r\n**Referral to Ophthalmologist**:\r\n- If the stye does not improve with primary care management.\r\n- If an internal stye is particularly large and painful.\r\n\r\nFor more information watch the OTC lesson on  Chapter 3 Opthalmology and Otology:\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the symptoms are self limiting",
        "answer_number": 1
      },
      {
        "text": "Refer patient to GP",
        "answer_number": 2
      },
      {
        "text": "Refer to eye specialist in hospital",
        "answer_number": 3
      },
      {
        "text": "Sell chloramphenicol 1% eye ointment",
        "answer_number": 4
      },
      {
        "text": "Sell sodium cromoglicate 2% eye drops.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2306,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate action to take?**",
    "text": "A 35-year-old woman with asthma has been taking ibuprofen 400 mg three times a day for her menstrual cramps. She notices that her asthma symptoms have worsened since she started the ibuprofen, and she needs to use her salbutamol inhaler more frequently. She also complains of mild dyspepsia.",
    "why": "Advise her to stop the ibuprofen and switch to paracetamol 1 g four times a day\r\n\r\nRationale:\r\n\r\nThis patient has asthma exacerbation following the use of ibuprofen, a non-steroidal anti-inflammatory drug (NSAID). NSAIDs are contraindicated in patients with asthma who have a history of bronchospasm or worsening asthma symptoms induced by NSAIDs or aspirin.\r\n\r\nNSAID-induced asthma occurs due to inhibition of cyclooxygenase-1 (COX-1), leading to increased production of leukotrienes, which cause bronchoconstriction and respiratory symptoms. Given her increased need for salbutamol, it is safest to stop ibuprofen immediately and switch to paracetamol, which does not affect prostaglandin synthesis and is unlikely to trigger asthma.\r\n\r\nExplanation of Other Options:\r\n\r\nB: Advise her to continue the ibuprofen and add a proton pump inhibitor for gastroprotection\r\n\r\nThis does not address the worsening asthma symptoms. While a PPI may help with dyspepsia, ibuprofen should still be stopped to prevent further respiratory deterioration.\r\n\r\nC: Advise her to reduce the dose of ibuprofen to 200 mg three times a day and monitor her asthma symptoms\r\n\r\nReducing the dose does not eliminate the risk of NSAID-induced bronchospasm. Even low doses can trigger severe reactions in sensitive individuals.\r\n\r\nD: Advise her to stop the ibuprofen and switch to a COX-2 inhibitor such as celecoxib 200 mg once a day\r\n\r\nCOX-2 inhibitors (e.g., celecoxib) have a lower risk of causing asthma exacerbations compared to non-selective NSAIDs, but they are not completely safe. NICE and BNF do not recommend COX-2 inhibitors as first-line options for NSAID-sensitive asthma patients.\r\n\r\nE: Advise her to stop the ibuprofen and switch to naproxen 500 mg twice a day with a proton pump inhibitor\r\n\r\nNaproxen is also a non-selective NSAID and is just as likely to worsen asthma symptoms as ibuprofen. It should be avoided in NSAID-sensitive asthma.\r\n\r\nNSAID-induced asthma is a well-recognised phenomenon where NSAIDs (e.g., ibuprofen, aspirin, naproxen) can trigger bronchospasm in susceptible individuals. According to BNF Chapter 3: Respiratory System, NSAIDs should be avoided in patients with asthma who have a history of NSAID-induced exacerbations. NICE guidelines recommend that paracetamol should be the first-line analgesic for pain management in NSAID-sensitive asthmatics, as it does not affect prostaglandin pathways and does not trigger bronchoconstriction. COX-2 inhibitors (e.g., celecoxib) may be better tolerated but are not routinely recommended unless absolutely necessary. Patients should be monitored for worsening respiratory symptoms when taking any new medication, especially NSAIDs.\r\n\r\nFor more information, please watch BNF Lesson Chapter 3 (Respiratory System) at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise her to stop the ibuprofen and switch to paracetamol 1 g four times a day",
        "answer_number": 1
      },
      {
        "text": "Advise her to continue the ibuprofen and add a proton pump inhibitor for gastroprotection",
        "answer_number": 2
      },
      {
        "text": "Advise her to reduce the dose of ibuprofen to 200 mg three times a day and monitor her asthma symptoms",
        "answer_number": 3
      },
      {
        "text": "Advise her to stop the ibuprofen and switch to a COX-2 inhibitor such as celecoxib 200 mg once a day",
        "answer_number": 4
      },
      {
        "text": "Advise her to stop the ibuprofen and switch to naproxen 500 mg twice a day with a proton pump inhibitor",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2321,
    "bank": "clinicalTherapeutics",
    "title": "Which of the following is the most common side effect of this medication?",
    "text": "A 40-year-old male patient has been diagnosed with gout. He has been prescribed allopurinol.",
    "why": "Gastrointestinal disturbances\r\n\r\nRationale:\r\n\r\nAllopurinol, a xanthine oxidase inhibitor, is used in the management of gout to lower uric acid levels by inhibiting uric acid production. The most common side effects associated with allopurinol are gastrointestinal disturbances, including nausea, vomiting, and diarrhoea. These are generally mild and resolve with continued use or dose adjustment.\r\n\r\nPatients should be counselled on the possibility of these side effects and encouraged to take the medication after meals to reduce gastrointestinal discomfort. Severe side effects such as hypersensitivity reactions (e.g., allopurinol hypersensitivity syndrome) are rare but require immediate medical attention.\r\n\r\nExplanation of Other Options:\r\n\r\nA: Bradycardia\r\n\r\nBradycardia is not commonly associated with allopurinol use. It is more typically linked to medications such as beta-blockers or digoxin.\r\n\r\nC: Hyperkalemia\r\n\r\nHyperkalemia is not a common side effect of allopurinol. It is usually associated with conditions like chronic kidney disease or medications such as ACE inhibitors and potassium-sparing diuretics.\r\n\r\nD: Hypertension\r\n\r\nHypertension is not commonly caused by allopurinol. If anything, some studies suggest a potential modest benefit of allopurinol in lowering blood pressure in patients with gout.\r\n\r\nE: Hypoglycemia\r\n\r\nHypoglycemia is not a side effect of allopurinol. It is commonly associated with diabetes medications such as insulin or sulfonylureas.\r\n\r\nAllopurinol is a first-line therapy for the long-term management of gout and other hyperuricaemic conditions. According to NICE CKS: Gout and the BNF, common side effects of allopurinol include gastrointestinal disturbances such as nausea and diarrhoea. Rare but serious adverse effects include allopurinol hypersensitivity syndrome (AHS), which presents with skin rash, fever, and multi-organ involvement. To minimise the risk of hypersensitivity, treatment should begin with a low dose (e.g., 100 mg daily) and be titrated according to serum urate levels and renal function.\r\n\r\nPatients should be counselled to:\r\n\r\nTake allopurinol with food to reduce gastrointestinal upset.\r\nReport any symptoms of rash, fever, or other signs of hypersensitivity immediately.\r\nMaintain good hydration to reduce the risk of uric acid kidney stones.\r\nRegular monitoring of renal function and serum urate levels is essential to ensure safe and effective treatment.\r\n\r\nFor more information please watcH BNF lesson Chapter 10 (Muscoloskeletal System)\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Bradycardia",
        "answer_number": 1
      },
      {
        "text": "Gastrointestinal disturbances",
        "answer_number": 2
      },
      {
        "text": "Hyperkalemia",
        "answer_number": 3
      },
      {
        "text": "Hypertension",
        "answer_number": 4
      },
      {
        "text": "Hypoglycemia",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2377,
    "bank": "clinicalTherapeutics",
    "title": "**How much of the stock solution should you use?**",
    "text": "You needs to prepare 100 mL of a 0.5% w/v solution of sodium chloride from a 10% w/v stock solution.",
    "why": "B. 5 mL\r\n\r\nTo solve this question, follow these steps:\r\n\r\nStep 1: Identify the formula for dilution, which is:\r\n\r\nC\u2081V\u2081 = C\u2082V\u2082\r\n\r\nWhere:\r\n\r\nC\u2081 = concentration of the stock solution (10%)\r\n\r\nV\u2081 = volume of the stock solution to use (unknown)\r\n\r\nC\u2082 = concentration of the final solution (0.5%)\r\n\r\nV\u2082 = volume of the final solution (100 mL)\r\n\r\nStep 2: Substitute the given values into the equation:\r\n\r\n(10%) x (V\u2081) = (0.5%) x (100 mL)\r\n\r\nStep 3: Solve for V\u2081:\r\n\r\nV\u2081 = (0.5%) x (100 mL) / (10%)\r\n\r\nV\u2081 = 5 mL\r\n\r\nTherefore, the pharmacist should use 5 mL of the stock solution.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "0.5 mL",
        "answer_number": 1
      },
      {
        "text": "5 mL",
        "answer_number": 2
      },
      {
        "text": "10 mL",
        "answer_number": 3
      },
      {
        "text": "50 mL",
        "answer_number": 4
      },
      {
        "text": "100 mL",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2563,
    "bank": "clinicalOtc",
    "title": "**What is the most appropriate product to recommend in this scenario?**",
    "text": "A mother presents to your community pharmacy with her 4-year-old daughter with a complaint of ear pain and fever for the past two days. She also has a runny nose, sneezing, and cough. She has no other medical conditions or allergies and goes to nursery. She asks you for a product to relieve her ear pain and fever.",
    "why": "A) A product containing paracetamol and a saline nasal spray\r\n\r\nRationale: \r\n\r\nIn this case, recommending paracetamol for pain and fever relief along with a saline nasal spray to ease nasal congestion is the safest and most appropriate option. Paracetamol is suitable for children and effectively reduces fever and discomfort associated with acute otitis media (AOM), while saline nasal spray helps clear nasal passages without the risks of other decongestant medications.\r\n\r\nExplanation of Other Options:\r\n\r\nB) A product containing ibuprofen and pseudoephedrine is not suitable for a child this age, as pseudoephedrine is generally recommended for children over 6 years and may cause side effects in younger children.\r\nC) A product containing acetylcysteine and guaifenesin, typically used for mucolytic purposes, is not recommended in this scenario as it does not specifically address pain or fever and has limited use in treating AOM symptoms.\r\nD) A product containing oseltamivir is used to treat viral infections like influenza and is not indicated for this child\u2019s symptoms.\r\nE) A product containing amoxicillin may be considered for bacterial infections but is not immediately necessary, as many cases of AOM in children are viral and resolve on their own.\r\n\r\nThe child\u2019s symptoms\u2014ear pain, fever, runny nose, sneezing, and cough\u2014suggest acute otitis media (AOM), which is an inflammation of the middle ear commonly triggered by infections following a cold or flu. AOM is frequent in young children and typically resolves within a week, with most children improving within three days without antibiotics. NICE guidelines recommend symptomatic management first, reserving antibiotics for more severe or persistent cases due to the low risk of complications. Sympathomimetic decongestants are generally unsuitable for children of this age group: phenylephrine is indicated for those over 12 years, and pseudoephedrine and xylometazoline are recommended only for children over six years. Providing adequate pain relief and symptomatic support while avoiding unnecessary medications supports optimal care for AOM in young children.\r\n\r\n\r\n\r\n\r\nFor more information please watch BNF lesson chapter 2 (Respiratory):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "A product containing paracetamol and a saline nasal spray",
        "answer_number": 1
      },
      {
        "text": "A product containing ibuprofen and pseudoephedrine",
        "answer_number": 2
      },
      {
        "text": "A product containing acetylcysteine and guaifenesin",
        "answer_number": 3
      },
      {
        "text": "A product containing oseltamivir",
        "answer_number": 4
      },
      {
        "text": "A product containing amoxicillin",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2584,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 17 year old male presents to the pharmacy. He informs you he has suffered with eczema since childhood. He informs you he has a flare up of his eczema and lesions inside the elbows are weeping and have a yellow crust.",
    "why": "Advise to see his GP as soon as possible for treatment\r\n\r\nRationale:\r\n\r\nThe presence of weeping lesions with a yellow crust suggests a possible secondary bacterial infection, commonly caused by Staphylococcus aureus in individuals with eczema. When eczema becomes infected, immediate medical attention is required, as a GP can prescribe appropriate treatment such as oral antibiotics or stronger topical corticosteroids. The patient should avoid using over-the-counter hydrocortisone or other topical treatments without medical advice as these may worsen the infection.\r\n\r\nThe other options are less appropriate because:\r\n\r\nOintments are more moisturising than creams, but they should not be used on weeping or infected skin as they can trap moisture and bacteria, worsening the infection.\r\nHydrocortisone 1% cream is not suitable for use on infected eczema without medical advice, as it could exacerbate the infection.\r\nChlorophenamine (an antihistamine) may help reduce itching, but it does not address the underlying infection, which is the primary concern in this case.\r\nUsing a lotion on broken skin is not recommended as lotions are more watery and can irritate broken or weeping skin, potentially leading to further discomfort and infection.\r\n\r\nNICE guidelines recommend that patients with infected eczema should be referred to a healthcare provider for appropriate treatment. Signs of infection include weeping lesions, yellow crusts, or an unusual smell. Treatment typically involves antibiotics and appropriate topical corticosteroids to manage inflammation and infection. Infected eczema should not be self-treated with over-the-counter emollients, corticosteroids, or antihistamines without consulting a healthcare professional. Managing infection early can prevent complications and further skin damage.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise to use an ointment rather than a cream as ointments are more moisturising",
        "answer_number": 1
      },
      {
        "text": "Advise to see his GP as soon as possible for treatment",
        "answer_number": 2
      },
      {
        "text": "Advise to purchase hydrocortisone 1% cream to reduce inflammation",
        "answer_number": 3
      },
      {
        "text": "Advise to purchase chlorphenamine 4mg tablets to help reduce itchiness",
        "answer_number": 4
      },
      {
        "text": "Advise to use a lotion on areas where the skin is broken",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2295,
    "bank": "clinicalTherapeutics",
    "title": "A 17-year-old asplenic patient requires this as an annual vaccination to help protect his immune system from infection",
    "text": "**Theme: Vaccines and immunisations**\r\n** For each of the following scenarios choose the vaccination which needs to be administered and/or which best applies**",
    "why": "Influenza vaccine\r\n\r\nRationale:\r\n\r\nAsplenic patients (those without a functioning spleen) are at increased risk of infections, particularly from encapsulated bacteria such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae.\r\n\r\nAnnual influenza vaccination is recommended for asplenic patients because:\r\n\r\nInfluenza infection can predispose patients to secondary bacterial infections, including pneumococcal and meningococcal infections, which are particularly dangerous in asplenic individuals.\r\n\r\nAnnual administration is necessary as the influenza virus strains change each year.\r\nInfluenza itself can lead to severe complications in immunocompromised patients.\r\nThus, the influenza vaccine should be administered annually to help protect the patient.\r\n\r\nExplanation of Other Options:\r\n\r\nA: BCG vaccine\r\nThe BCG vaccine protects against tuberculosis (TB) but is not specifically recommended for asplenic patients unless they fall into a high-risk category for TB exposure.\r\n\r\nB: Hepatitis B vaccine\r\nThe hepatitis B vaccine is recommended for patients at risk of bloodborne virus exposure (e.g., healthcare workers, IV drug users) but is not specifically required for asplenic patients.\r\n\r\nD: Meningococcal B vaccine\r\nAlthough the MenB vaccine is recommended for asplenic patients, it is not an annual vaccine. Instead, it is part of the primary immunisation schedule for these individuals.\r\n\r\nE: Meningococcal quadrivalent ACWY\r\nAsplenic patients should receive MenACWY vaccination; however, it is not an annual requirement but part of routine booster schedules.\r\n\r\nF: Pneumococcal conjugate vaccine\r\nThis is crucial for asplenic patients, as they are at high risk for pneumococcal infections. However, pneumococcal vaccination is typically given every 5 years, not annually.\r\n\r\nG: Rotavirus vaccine\r\nThe rotavirus vaccine is a live oral vaccine given to infants to prevent severe diarrhoea but is not relevant to this case.\r\n\r\nH: Tetanus immunoglobulin\r\nTetanus immunoglobulin is administered in cases of high-risk wounds in non-immunised individuals and is unrelated to asplenia.\r\n\r\nVaccination Recommendations for Asplenic Patients \r\n\r\nAccording to NICE guidelines, patients with asplenia or splenic dysfunction should receive the following vaccinations due to their increased risk of severe infections:\r\n\r\n-Haemophilus influenzae type B (Hib) with Meningococcal C (MenC) \u2013 if not previously received.\r\n-Meningococcal ACWY conjugate vaccine (MenACWY) \u2013 booster doses may be needed.\r\n-Meningococcal B vaccine (MenB) \u2013 part of routine immunisation for asplenic individuals.\r\n-Pneumococcal vaccines (both conjugate and polysaccharide types) \u2013 essential to prevent pneumococcal disease.\r\n-Annual Influenza Vaccine \u2013 required every year to reduce the risk of secondary bacterial infections following flu.\r\n-Additionally, asplenic patients should receive prophylactic antibiotics (e.g., daily penicillin V) for life, particularly in childhood or if they have a history of severe infections.\r\n\r\nFor more Information please watch BNF lesson Chapter 5 (Infections):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "BCG vaccine",
        "answer_number": 1
      },
      {
        "text": "Hepatitis B vaccine",
        "answer_number": 2
      },
      {
        "text": "Influenza vaccine",
        "answer_number": 3
      },
      {
        "text": "Meningococcal B vaccine",
        "answer_number": 4
      },
      {
        "text": "Meningococcal quadrivalent ACWY",
        "answer_number": 5
      },
      {
        "text": "Pneumococcal conjugate vaccine",
        "answer_number": 6
      },
      {
        "text": "Rotavirus vaccine",
        "answer_number": 7
      },
      {
        "text": "Tetanus immunoglobulin",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2246,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following could be an appropriate diuretic for this patient?**",
    "text": "The patient is currently taking ramipril 2.5mg BD, metaprolol, furosemide 40mg OD and simvastatin. Over the past few days their potassium levels have been decreasing and the prescribers wish to initiate another diuretic. Their current potassium is 3.1mcg/L (normal range 3.5 \u2013 5.1mcg/L) and their eGFR is 57mL/min.",
    "why": "Correct Answer:\r\n\r\nE) Spironolactone\r\n\r\nRationale:\r\n\r\nThe patient has hypokalaemia (potassium 3.1 mcg/L, normal range 3.5 \u2013 5.1 mcg/L) and requires a diuretic that will not exacerbate potassium loss. Spironolactone is a potassium-sparing diuretic, meaning it helps retain potassium and can counteract the potassium-lowering effects of furosemide, a loop diuretic known to promote potassium excretion. Given that the patient\u2019s eGFR is 57 mL/min, spironolactone can be safely used; however, it should be prescribed with caution in individuals with worsening renal function due to the risk of hyperkalaemia. \r\nRegular monitoring of potassium and renal function is necessary, particularly because the patient is also on an ACE inhibitor (ramipril), which can increase potassium levels when combined with spironolactone.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Bendroflumethiazide\r\n\r\nBendroflumethiazide is not appropriate as it is a thiazide diuretic, which can increase potassium excretion and worsen the patient\u2019s existing hypokalaemia. Thiazide diuretics are also less effective when eGFR falls below 30 mL/min. Although this patient's eGFR is 57 mL/min, spironolactone is still the better choice to address the low potassium levels.\r\n\r\nB) Bumetanide\r\n\r\nBumetanide is a loop diuretic, similar to furosemide, which enhances potassium excretion. Using bumetanide alongside furosemide would further lower potassium levels, putting the patient at increased risk of cardiac arrhythmias. This makes bumetanide an inappropriate choice for this patient.\r\n\r\nC) Indapamide\r\n\r\nIndapamide is a thiazide-like diuretic, which can contribute to potassium loss and worsen hypokalaemia. Although indapamide is sometimes used for hypertension, it is not suitable for a patient who already has low potassium levels and is taking another potassium-lowering diuretic (furosemide).\r\n\r\nD) Mannitol\r\n\r\nMannitol is an osmotic diuretic, used mainly for cerebral oedema and acute kidney injury prevention rather than for routine diuresis. It does not play a role in managing fluid retention, heart failure, or hypertension and is therefore an inappropriate option in this scenario.\r\n\r\nE) Spironolactone\r\n\r\nSpironolactone is the correct answer because it is a potassium-sparing diuretic, meaning it prevents excessive potassium loss while still helping with fluid retention. It is especially beneficial in patients with heart failure, hypertension, or those at risk of further hypokalaemia. \r\nHowever, it must be used cautiously in patients with eGFR <45 mL/min due to the risk of hyperkalaemia, so potassium and renal function should be monitored regularly.\r\n\r\nDiuretics and Potassium Balance:\r\n\r\nDiuretics are commonly used to manage hypertension, heart failure, and fluid retention, but their effects on potassium balance must be carefully considered. \r\nLoop diuretics such as furosemide and bumetanide cause significant potassium loss, increasing the risk of hypokalaemia, which can lead to arrhythmias and muscle weakness. \r\nSimilarly, thiazide and thiazide-like diuretics such as bendroflumethiazide and indapamide also promote potassium excretion, making them unsuitable choices in patients with existing hypokalaemia. \r\nIn contrast, potassium-sparing diuretics such as spironolactone and eplerenone help retain potassium by blocking aldosterone, which prevents excessive potassium excretion in the kidneys. \r\nHowever, these agents must be used with caution in patients with renal impairment, as they increase the risk of hyperkalaemia. \r\nNICE guidelines recommend monitoring serum potassium and renal function regularly in patients prescribed potassium-sparing diuretics, particularly if co-prescribed with ACE inhibitors or ARBs, as these also increase potassium levels.\r\n\r\nFor more information, please watch BNF lesson Chapter 2 (Cardiovascular System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Bendroflumethiazide",
        "answer_number": 1
      },
      {
        "text": "Bumetinide",
        "answer_number": 2
      },
      {
        "text": "Indapamide",
        "answer_number": 3
      },
      {
        "text": "Mannitol",
        "answer_number": 4
      },
      {
        "text": "Spironolactone",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2609,
    "bank": "clinicalOtc",
    "title": "**What is the most likely diagnosis?**",
    "text": "A 45-year-old woman presents to your pharmacy with a complaint of multiple small ulcers in her mouth. She says she has been having them for the past 5 days, and they are very painful and interfere with her eating and speaking. She has tried various over-the-counter products, such as bonjela, orabase, and corsodyl mouthwash, but none of them have helped. She also says she has no other medical conditions or allergies, and she does not smoke or drink alcohol. She asks you for your advice on what else she can do to treat her mouth ulcers.\r\n\r\nYou examine her mouth and see multiple pin point ulcers at the front of the mouth and at the sides of the tongue.",
    "why": "The most likely diagnosis for the patient is:\r\n\r\nHerpetiform ulcers\r\n\r\nRationale:\r\n\r\nHerpetiform ulcers are characterised by multiple small ulcers with irregular edges and a red border, typically occurring in clusters. Unlike cold sores, which are caused by the herpes simplex virus, herpetiform ulcers are associated with an immune-mediated process and are often recurrent. These ulcers can last for several weeks and may also be a cutaneous manifestation of coeliac disease, a gluten-sensitive enteropathy.\r\n\r\nThe other options are less likely to be the cause of the patient's symptoms due to differing clinical features:\r\n\r\nCanker sores (aphthous ulcers) usually appear as larger, single ulcers or in small groups and typically heal within two weeks.\r\nCold sores are caused by herpes simplex virus and generally present as blisters on the lips or around the mouth.\r\nOral lichen planus is a chronic inflammatory condition that presents with white lace-like patches, red areas, or ulcers on the oral mucosa.\r\nOral cancer typically presents as a single, persistent, painless ulcer with indurated edges, which is not consistent with the current presentation.\r\n\r\nNICE Guidance on Management of Herpetiform Ulcers\r\n\r\nAccording to NICE guidelines and supported by the book Community Pharmacy by Rutter, management strategies for herpetiform ulcers include:\r\n\r\nTopical Treatments: The use of a topical steroid mouthwash can help reduce inflammation and pain associated with the ulcers.\r\n\r\nOral Rinses: Antiseptic mouthwashes, such as chlorhexidine, may help maintain oral hygiene and reduce the risk of secondary infection.\r\n\r\nPain Relief: Over-the-counter analgesics (e.g., paracetamol or ibuprofen) can assist in managing discomfort.\r\n\r\nAvoidance of Irritants: Patients should avoid spicy, acidic, or abrasive foods to minimise irritation and pain during the healing process.\r\n\r\nHydration and Nutrition: Encourage the intake of soft foods and adequate hydration to support healing, especially as eating can be painful.\r\n\r\nAdditional Insights\r\n\r\nHerpetiform ulcers can arise from various triggers, including stress, hormonal changes, or certain food intolerances, and are particularly noted as a cutaneous manifestation of coeliac disease. They typically recur and can be more severe than standard canker sores.\r\n\r\nPatients should be advised to review their symptoms after two weeks of treatment; if there is no improvement or if there are signs of infection, malignancy, or systemic disease, a referral to a GP or dentist is warranted for further evaluation.\r\n\r\nEducating the patient on good oral hygiene practices and the importance of managing stress can be beneficial in preventing future outbreaks. This comprehensive approach ensures that patients receive not only symptomatic relief but also guidance on maintaining their overall oral health and addressing any underlying conditions effectively.\r\n\r\nFor more information watch OTC lesson on Chapter 8 Dermatology:\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Canker sores",
        "answer_number": 1
      },
      {
        "text": "Cold sores",
        "answer_number": 2
      },
      {
        "text": "Herpetiform ulcers",
        "answer_number": 3
      },
      {
        "text": "Oral lichen planus",
        "answer_number": 4
      },
      {
        "text": "Oral cancer",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2531,
    "bank": "clinicalMep",
    "title": "**Which of the following is INCORRECT regarding maintaining controlled drugs registers in the pharmacy?**",
    "text": "A controlled drugs register must be maintained in the pharmacy to record the receipt and supply of schedule 2 controlled drugs.",
    "why": "D) Registers must be retained for 2 years after the first entry\r\n\r\nRationale: \r\n\r\nAccording to the Misuse of Drugs Regulations 2001, the legal requirement is to retain controlled drugs registers for 2 years after the last entry made, not the first. This ensures that the records are available for inspection or audit and that any controlled drugs transactions are fully traceable.\r\n\r\nExplanation of other options:\r\n\r\nA) Copies of registers must be shown to an inspector upon request: This is correct. Pharmacists must make their controlled drugs registers available to authorised persons (such as inspectors) for inspection as per the regulations. This ensures accountability and compliance with the law.\r\n\r\nB) Records can be kept in their original form: This is correct. Controlled drugs registers can be kept either in paper form or electronically, as long as they are accurate and easily accessible.\r\n\r\nC) Registers must be kept at the premises: This is correct. Controlled drugs registers must be kept on-site at the pharmacy where the controlled drugs are stored. This is necessary for regular access and auditing.\r\n\r\nE) Registers must be retained for 2 years after the last entry: This is correct. The legal retention period is two years from the last entry in the register, allowing sufficient time for auditing and inspection.\r\n\r\n\r\nPharmacies are required to maintain a register of all Schedule 2 controlled drugs (CDs), documenting their receipt, supply, and any other movement. This register must be kept at the pharmacy premises and available for inspection by authorities. The records must be retained for two years from the last entry, which ensures the traceability and accountability of controlled drug transactions. Electronic and paper records are both acceptable, provided they are accurate and accessible. This is in line with the Misuse of Drugs Regulations 2001 (as amended), which set out the requirements for the handling of controlled substances to ensure their proper use and prevent misuse.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Copies of registers must be shown to an inspector upon request",
        "answer_number": 1
      },
      {
        "text": "Records can\u00a0 be kept in their original form",
        "answer_number": 2
      },
      {
        "text": "Registers must be kept at the premises",
        "answer_number": 3
      },
      {
        "text": "Registers must be retained for 2 years after the first entry",
        "answer_number": 4
      },
      {
        "text": "Registers must be retained for 2 years after the last entry",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2580,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the patient's symptoms?**",
    "text": "A 59 year old female patient presents to the pharmacy with a rash. She explains she has had symptoms for the past few weeks and has not seen any improvement. Her rash is on her elbows, knees and scalp.\r\nA picture of the rash has been shown below:\u00a0\r\n![psoriasis](https://i.ibb.co/qJc5tP9/psoriasis.jpg \"650x500\")",
    "why": "d) Psoriasis\r\n\r\nRationale:\r\n\r\nPsoriasis is the most likely diagnosis based on the patient\u2019s symptoms and presentation. This chronic skin condition commonly presents with well-defined, scaly, red plaques on extensor surfaces like the elbows, knees, and scalp. The persistent nature of the symptoms and the specific areas affected align closely with plaque psoriasis, the most prevalent form of this condition.\r\n\r\nExplanation of Options\r\n\r\na) Atopic eczema\r\n\r\nWhile eczema can affect various areas of the body, it typically involves the flexural regions (e.g., inner elbows, behind the knees) and is associated with intense itching. Additionally, atopic eczema often presents with a history of allergies or asthma and is not typically localized to the extensor areas like psoriasis.\r\n\r\nb) Acne vulgaris\r\n\r\nAcne vulgaris is a skin condition that primarily affects the face, chest, and back, presenting with blackheads, whiteheads, and sometimes pustules. It does not manifest as red, scaly plaques on the elbows, knees, or scalp, making it an unlikely cause in this case.\r\n\r\nc) Pityriasis versicolor\r\n\r\nPityriasis versicolor is a fungal skin infection that causes small, flaky patches, often lighter or darker than surrounding skin. It generally affects the trunk, shoulders, and back, not areas like the elbows and knees, making it less likely in this scenario.\r\n\r\ne) Rosacea\r\n\r\nRosacea is typically confined to the face, presenting with persistent redness, visible blood vessels, and occasionally pustules. It does not affect the scalp, elbows, or knees, ruling it out as a probable cause for this patient\u2019s symptoms.\r\n\r\n\r\nPsoriasis is a chronic, immune-mediated skin condition characterised by recurrent flares of red, scaly plaques, most commonly on the elbows, knees, and scalp. According to NICE guidelines, the initial management of psoriasis focuses on topical treatments to control symptoms and reduce inflammation. Emollients are often used to maintain skin hydration, and topical corticosteroids and vitamin D analogues are recommended to reduce scaling and soothe inflammation.\r\n\r\nFor patients with more extensive or severe psoriasis, NICE advises considering phototherapy or systemic treatments, such as methotrexate or biologics, to control symptoms. Lifestyle factors, including managing stress, smoking cessation, and avoiding potential triggers (e.g., infections, skin trauma) are emphasised to help prevent flare-ups. NICE also highlights the importance of patient education on the chronic nature of psoriasis, setting realistic expectations, and ensuring adherence to treatment to improve overall quality of life. Regular follow-ups to monitor response to therapy are also advised for optimal management.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Atopic eczema",
        "answer_number": 1
      },
      {
        "text": "Acne vulgaris",
        "answer_number": 2
      },
      {
        "text": "Pityriasis versicolor",
        "answer_number": 3
      },
      {
        "text": "Psoriasis",
        "answer_number": 4
      },
      {
        "text": "Rosacea",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2551,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropiate action?\u00a0**",
    "text": "It is a Saturday morning in your local community pharmacy. You receive a prescription for a 31 year old female patient from Greece. She explains to you she is in the UK working for 6 months so her doctor has postdated a number of prescriptions for her\u00a0\r\n\r\nAn extract of the prescription is below:\u00a0\r\n![Screenshot-2024-01-08-at-11-08-28](https://i.ibb.co/YfJtxVM/Screenshot-2024-01-08-at-11-08-28.png)\r\n\r\nAn extract of the BNF has been provided for you.\u00a0\r\n[Tretinoin BNF extract](https://bnf.nice.org.uk/drugs/tretinoin-specialist-drug/medicinal-forms/)",
    "why": "(C) Refer the patient to NHS 111 for a prescription with a UK license.\r\n\r\nRationale:\r\n\r\nThe prescription provided meets the legal requirements set out under Regulation 218 of the Human Medicines Regulations 2012 for overseas prescriptions. However, Retin-A 0.1% cream is not available in the UK under this brand name or as a direct equivalent. Therefore, it cannot be dispensed as prescribed. The best course of action is to refer the patient to NHS 111, where they can receive guidance on how to obtain a UK-licensed equivalent of tretinoin cream. This ensures the patient can access the treatment they need while following UK legal and regulatory guidelines.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Advise the patient to return to their doctor and request a new prescription of Retin-A:\r\nIncorrect. This would be impractical, as the patient\u2019s doctor is based in Greece, and Retin-A is unlikely to be prescribed with a UK license there. NHS 111 is a more suitable option for obtaining UK-licensed medication.\r\n\r\n(B) Provide an emergency supply of Retin-A 0.1% cream and request a new prescription from their doctor in Greece:\r\nIncorrect. Retin-A is not available in the UK market, and an emergency supply can only be given if the medicine is obtainable in the UK. An emergency supply would not be appropriate in this case.\r\n\r\n(D) Refuse to dispense the prescription because it does not meet legal requirements:\r\nIncorrect. The prescription is legally valid, but the medication is unavailable in the UK. Referring the patient to NHS 111 for a UK-licensed equivalent is a more suitable response.\r\n\r\n(E) The prescription meets all legal requirements therefore dispense the prescription:\r\nIncorrect. While the prescription is legally valid, Retin-A is unavailable in the UK. Dispensing it as prescribed is not possible.\r\n\r\nOverseas prescriptions are permissible if they meet specific legal requirements, such as including the prescriber's qualifications, address, and clear instructions. However, overseas medications not marketed in the UK cannot be dispensed under these prescriptions. In such cases, referring patients to NHS 111 for a licensed UK equivalent is the recommended course of action, as per MEP guidelines, ensuring patient safety and compliance with UK medicine regulations.\r\n\r\nPlease for more information watch the MEP lesson on Chapter 2 (Professional and Legal Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the patient to return to their doctor and request a new prescription of Retin-A.",
        "answer_number": 1
      },
      {
        "text": "Provide an emergency supply of Retin- A 0.1% cream and request a new prescription from their doctor in Greece",
        "answer_number": 2
      },
      {
        "text": "Refer the patient to NHS 111 for a prescription with a UK license",
        "answer_number": 3
      },
      {
        "text": "Refuse to dispense the prescription because it not does not meet legal requirements",
        "answer_number": 4
      },
      {
        "text": "The prescription meets all legal requirements therefore dispense the prescription",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2561,
    "bank": "clinicalOtc",
    "title": "**What is the most likely diagnosis in this scenario?**",
    "text": "A 25-year-old male walks into your community pharmacy with a sudden onset of sharp chest pain on the right side and difficulty breathing. He says he has no history of lung disease or chest injury. He is a non-smoker and works as a software engineer. He asks you for some painkillers and an inhaler to relieve his symptoms.",
    "why": "d) Spontaneous pneumothorax\r\n\r\nRationale: \r\n\r\nThe most likely diagnosis in this scenario is a spontaneous pneumothorax. A spontaneous pneumothorax, often occurring without an obvious cause, typically affects young, tall, thin males and can result in the sudden trapping of air between the lung and chest wall, causing the lung to partially collapse. Symptoms usually include a sudden, sharp, and stabbing chest pain that worsens with inhalation, as well as shortness of breath and, in some cases, rapid heart rate.\r\n\r\nIn this case, the patient\u2019s presentation\u2014sudden onset of sharp, one-sided chest pain and difficulty breathing without prior lung disease or injury\u2014aligns closely with typical symptoms of spontaneous pneumothorax. This condition is a medical emergency, requiring referral to an A&E or immediate hospital assessment, where imaging can confirm the diagnosis and appropriate treatment can be initiated.\r\n\r\nExplanation of Other Options:\r\n\r\na) Acute bronchitis: Usually associated with cough and phlegm production, not sudden sharp chest pain or severe difficulty breathing.\r\nb) Aspiration pneumonia: Typically presents with fever, cough, and breathlessness but is usually linked to recent inhalation of food or liquid.\r\nc) Pneumonia: Commonly causes fever, productive cough, and difficulty breathing rather than sudden onset of sharp chest pain.\r\ne) Tuberculosis: Often presents as a chronic condition with a persistent cough, night sweats, fever, and weight loss, rather than an acute onset of chest pain and shortness of breath.\r\n\r\nAccording to NICE guidelines, a spontaneous pneumothorax typically requires emergency medical attention to confirm the diagnosis and determine the severity. Imaging, such as a chest X-ray, helps assess the extent of lung collapse. Treatment may range from observation for small pneumothoraces to more urgent interventions, such as needle aspiration or chest tube placement, for larger pneumothoraces. Immediate referral is advised for any sudden-onset, sharp chest pain with difficulty breathing, as early intervention can prevent complications and promote recovery.\r\n\r\nFor more information please watch BNF lesson chapter 2 (Respiratory):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Acute bronchitis",
        "answer_number": 1
      },
      {
        "text": "Aspiration pneumonia",
        "answer_number": 2
      },
      {
        "text": "Pneumonia",
        "answer_number": 3
      },
      {
        "text": "Spontaneous pneumothorax",
        "answer_number": 4
      },
      {
        "text": "Tuberculosis",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2145,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Signs a and Symptoms of toxicity** \r\n\r\n\u2028\u2028**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 28-year old male with respiratory depression, euphoria and reduced level of consciousness",
    "why": "Correct answer: \r\n\r\nF) Fentanyl\r\n\r\nRationale:\r\n\r\n- Fentanyl is a potent synthetic opioid analgesic. In overdose or misuse, it can cause:\r\n\r\n- Respiratory depression \u2013 the most life-threatening effect, due to opioid-induced suppression of the brainstem respiratory centres\r\n\r\n- Euphoria \u2013 common in opioid intoxication due to central dopaminergic reward pathway activation\r\n\r\n- Reduced level of consciousness \u2013 sedation, stupor or coma may occur, especially with high doses or mixed use with other CNS depressants\r\n\r\n- These signs are classic features of opioid toxicity and warrant urgent administration of naloxone.\r\n\r\n\r\nExplanation of Other Options:\r\n\r\nA) Aspirin \r\n\r\nCan cause tinnitus, hyperventilation, and metabolic acidosis, but not euphoria or reduced consciousness early on\r\n\r\nB) Amitriptyline \r\n\r\nCauses anticholinergic effects, seizures, and cardiac arrhythmias\r\n\r\nC) Amlodipine \r\n\r\nMay cause hypotension and reflex tachycardia, but not euphoria or respiratory depression\r\n\r\nD) Bisoprolol \r\n\r\nCan cause bradycardia and hypotension, but not euphoria\r\n\r\nE) Citalopram \r\n\r\nRisk of serotonin syndrome and QT prolongation, not respiratory depression or euphoria\r\n\r\nG) Naproxen \r\n\r\nNSAID, not associated with CNS depression or euphoria\r\n\r\nH) Paracetamol \r\n\r\nCauses hepatotoxicity in overdose, but not euphoria or reduced consciousness unless liver failure progresses\r\n\r\n\r\nFentanyl toxicity presents with the classic triad of opioid overdose:\r\n\r\nrespiratory depression, CNS depression (reduced consciousness), and euphoria or pinpoint pupils. Rapid identification and naloxone administration are critical to reverse these effects and prevent fatality.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 6,
    "weighting": 3,
    "answers": [
      {
        "text": "Aspirin",
        "answer_number": 1
      },
      {
        "text": "Amitriptyline",
        "answer_number": 2
      },
      {
        "text": "Amlodipine",
        "answer_number": 3
      },
      {
        "text": "Bisoprolol",
        "answer_number": 4
      },
      {
        "text": "Citalopram",
        "answer_number": 5
      },
      {
        "text": "Fentanyl",
        "answer_number": 6
      },
      {
        "text": "Naproxen",
        "answer_number": 7
      },
      {
        "text": "Paracetamol",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2387,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is incorrect regarding Xalatan (latanoprost) eye drops?**",
    "text": "A 40-year-old woman with a history of severe asthma and recurrent herpes simplex keratitis visits the pharmacy for a prescription of Xalatan (latanoprost) eye drops. She has been diagnosed with ocular hypertension and has been advised to use latanoprost once daily in the evening. She asks you about the possible side effects and precautions of using latanoprost.",
    "why": "E) Latanoprost should be stored in the refrigerator before opening and at room temperature after opening.\r\n\r\nRationale\r\n\r\nAccording to the British National Formulary (BNF), Xalatan (latanoprost) eye drops should be stored at room temperature (not in the refrigerator) before and after opening. This is the correct guideline for Xalatan, although some generic versions of latanoprost may have different storage instructions, which may include refrigeration before opening.\r\n\r\nExplanation of other options\r\n\r\nA) Latanoprost may cause eye irritation, increased eyelash growth, and changes in eye colour\r\n\r\nThis is correct. Common side effects of latanoprost include eye irritation, increased eyelash growth, and changes in iris colour, which can be permanent.\r\n\r\nB) Latanoprost should be used with caution in patients with a history of herpetic keratitis\r\n\r\nThis is true. Latanoprost should be used cautiously in patients with a history of herpetic keratitis, as it may trigger or worsen an outbreak, particularly in those with recurrent herpes simplex keratitis.\r\n\r\nC) Latanoprost should be avoided in patients with severe or uncontrolled asthma\r\n\r\nThis is correct. Latanoprost can potentially exacerbate asthma in patients with severe or uncontrolled asthma, so it should be avoided in these cases.\r\n\r\nD) Latanoprost should be applied at least 15 minutes before or after wearing contact lenses\r\n\r\nThis is accurate. Latanoprost contains benzalkonium chloride, which can be absorbed by soft contact lenses and may cause irritation. It is recommended that latanoprost be applied at least 15 minutes before or after wearing contact lenses.\r\n\r\nLatanoprost is a prostaglandin analogue commonly used for the treatment of ocular hypertension and glaucoma. By increasing the outflow of aqueous humor from the eye, it effectively lowers intraocular pressure. NICE guidelines recommend latanoprost for managing these conditions, but they also advise caution in specific patient populations. For example, patients with a history of herpetic keratitis should be monitored closely, and it is generally avoided in patients with severe or uncontrolled asthma due to the potential for exacerbating symptoms. The guidelines also emphasize proper administration techniques to avoid potential side effects, such as eye irritation and changes in eye colour, and to ensure the safe use of contact lenses.\r\n\r\nFor more information watch BNF lesson Chapter 11 (Eyes):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Latanoprost may cause eye irritation, increased eyelash growth, and changes in eye colour",
        "answer_number": 1
      },
      {
        "text": "Latanoprost should be used with caution in patients with a history of herpetic keratitis",
        "answer_number": 2
      },
      {
        "text": "Latanoprost should be avoided in patients with severe or uncontrolled asthma",
        "answer_number": 3
      },
      {
        "text": "Latanoprost should be stored in the refrigerator before opening and at room temperature after opening",
        "answer_number": 4
      },
      {
        "text": "Latanoprost should be applied at least 15 minutes before or after wearing contact lenses",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2238,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Medical emergencies**\r\n\r\n**Instruction: For the following scenarios select the correct dose and product that should be utilised in each of the following medical emergencies. Each option may be used once, more than once, or not at all**",
    "text": "A one-year-old child who is febrile and has presented to hospital undergoing a convulsive seizure which has lasted longer than five minutes.",
    "why": "Correct Answer:\r\n\r\nE) 5 mg diazepam rectal tube\r\n\r\nRationale:\r\n\r\nA seizure lasting more than five minutes is considered a prolonged convulsion and must be treated as an emergency to reduce the risk of status epilepticus and brain injury.\r\n\r\nAccording to NICE guidelines (NG158) and Resuscitation Council UK, the first-line treatment for prolonged convulsive seizures in children includes:\r\n\r\n- Rectal diazepam\r\n- Buccal midazolam (depending on availability and setting)\r\n\r\nFor a child aged 1 year, the appropriate dose of rectal diazepam is 5 mg, as per the BNF for Children. It is administered via a pre-filled rectal tube and works as a rapid-onset anticonvulsant.\r\n\r\nExplanation of Other Options:\r\n\r\nA) 150 micrograms adrenaline (1 mg/mL) \r\n\r\nUsed in anaphylaxis for children under 6, not seizures.\r\n\r\nB) 500 micrograms adrenaline (1 mg/mL) \r\n\r\nUsed in anaphylaxis for children aged 6\u201312, not relevant here.\r\n\r\nC) 1 mg glucagon injection \r\n\r\nUsed for severe hypoglycaemia, not febrile seizures.\r\n\r\nD) 2 mg chlorphenamine syrup \r\n\r\nUsed for mild allergic reactions, not seizures.\r\n\r\nF) 20 mg isosorbide mononitrate \r\n\r\nUsed in angina, not paediatric emergencies.\r\n\r\nG) 300 mg aspirin dispersible tablet \r\n\r\nContraindicated in children due to Reye\u2019s syndrome risk.\r\n\r\nH) 55\u2013110 mL Lucozade\u00ae \r\n\r\nUsed for mild hypoglycaemia, not seizures.\r\n\r\nEmergency Management of Febrile Seizures in Children:\r\n\r\n- According to NICE guidelines on epilepsies and convulsive status epilepticus, any seizure lasting more than five minutes in a child must be treated immediately to prevent progression to status epilepticus. \r\n\r\n- In children aged 6 months to 10 years, rectal diazepam (or buccal midazolam) is the recommended first-line treatment. The correct dose for a 1-year-old is 5 mg via rectal tube, delivered promptly in a clinical setting. \r\n\r\n- Febrile seizures are often triggered by infections, and while most resolve spontaneously, prolonged ones require urgent intervention. Caregivers and healthcare professionals must be trained in recognising signs of prolonged seizures and administering rescue medication safely and swiftly.\r\n\r\nFor more information, please watch BNF lesson Chapter 4 (Central Nervous System):\r\n  \r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "150 micrograms (0.15 mL) of adrenaline (1 mg/mL)",
        "answer_number": 1
      },
      {
        "text": "500 micrograms (0.5 mL) of adrenaline (1 mg/mL)",
        "answer_number": 2
      },
      {
        "text": "1 mg glucagon injection",
        "answer_number": 3
      },
      {
        "text": "2 mg chlorphenamine syrup (4mg/5mL)",
        "answer_number": 4
      },
      {
        "text": "5 mg diazepam rectal tube",
        "answer_number": 5
      },
      {
        "text": "20 mg of isosorbide mononitrate",
        "answer_number": 6
      },
      {
        "text": "300mg aspirin dispersible tablet",
        "answer_number": 7
      },
      {
        "text": "55 \u2013 110 mL of Lucozade\u00ae energy drink",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2496,
    "bank": "clinicalMep",
    "title": "**Which one of the following is NOT a legal requirement for recording the receipt/supply of controlled medicines?**",
    "text": "Schedule 2 controlled drugs need to be entered in to the Controlled Drugs register once received or supplied in the pharmacy",
    "why": "Correct Answer: \r\n\r\nE) Whether ID was requested\r\n\r\nRationale:\r\n\r\n- The Misuse of Drugs Regulations 2001 and Home Office guidance outline the legal requirements for entries in the Controlled Drugs Register (CDR) when receiving or supplying Schedule 2 controlled drugs.\r\n\r\n- While good practice encourages some additional entries (like running balances or checking ID), only specific fields are legally mandatory.\r\n\r\n- \"Whether ID was requested\" is not one of the legal requirements and is therefore the correct answer to this question.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Date of supply - required\r\n\r\nLegally must be recorded to document when the controlled drug was supplied or received.\r\n\r\nB) Patient address \u2013 required\r\n\r\nFor supplies, the address of the person receiving the controlled drug must be entered.\r\n\r\nC) Patient name \u2013 required\r\n\r\nEssential for identifying the recipient and ensuring traceability.\r\n\r\nD) Running balance of controlled medicine \u2013  Not legally required, but strongly recommended\r\n\r\nAlthough not mandatory by law, the running balance is considered best practice (as per NICE, CQC, GPhC) to enhance accountability and safety.\r\n\r\nE) Whether ID was requested \u2013 Not required\r\n\r\nThere is no legal requirement to record whether or not ID was requested or verified. Though advisable in certain cases (e.g. when someone unknown is collecting), it does not need to be documented in the register.\r\n\r\n\r\n- The Controlled Drugs Register is a legal document used to record the receipt and supply of Schedule 2 controlled drugs.\r\n\r\n- According to the Misuse of Drugs Regulations 2001, the mandatory legal entries include:\r\n\r\n- Date of transaction (supply or receipt)\r\n\r\n- Name and address of the patient (for supply)\r\n\r\n- Details of the person or supplier received from (for receipt)\r\n\r\n- Quantity supplied or received\r\n\r\n- Form and strength of the controlled drug\r\n\r\n- Name of the prescriber (if applicable)\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Date of supply",
        "answer_number": 1
      },
      {
        "text": "Patient address",
        "answer_number": 2
      },
      {
        "text": "Patient name",
        "answer_number": 3
      },
      {
        "text": "Running balance of controlled medicine",
        "answer_number": 4
      },
      {
        "text": "Whether ID was requested",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 995,
    "bank": "clinicalOtc",
    "title": "**Which one of the following is NOT correct regarding the sale of the Maloff Protect?**",
    "text": "A 37 year old man presents to the pharmacy requesting to purchase Maloff Protect (atovaquone and proguanil hydrochloride). He explains he is travelling to Tanzania in 2 weeks. The patient does not have any medical conditions or regular medications.",
    "why": "Correct Answer: \r\n\r\nA) Chemoprophylaxis should commence 1 week prior to entering a malaria-endemic area, continue during the period of the stay and continue for 7 days after leaving the area.\r\n\r\nRationale:\r\n\r\n- The statement in option A is incorrect, which makes it the correct answer to this question.\r\n\r\n- Maloff Protect (atovaquone and proguanil hydrochloride) should be taken as follows:\r\n\r\n- Start 1\u20132 days before entering a malaria-endemic area\r\n\r\n- Continue during the stay\r\n\r\n- Continue for 7 days after leaving the area\r\n\r\n- Starting 1 week before travel, as stated in option A, is incorrect. That guidance applies to mefloquine, not to Maloff Protect.\r\n\r\nExplanation of Other Options:\r\n\r\nB) Chemoprophylaxis should commence 1\u20132 days prior, this is correct and matches the SmPC and BNF guidance for atovaquone/proguanil.\r\n\r\nC) It can only be sold to those over 18 years. Maloff Protect is only licensed for OTC sale to adults aged 18 and over.\r\n\r\nD) Important to take the tablets at the same time each day. Consistency improves protection and adherence.\r\n\r\nE) Must be taken with food.Taking with food, especially fatty food, improves absorption of atovaquone.\r\n\r\nMaloff Protect (atovaquone with proguanil) is a licensed OTC antimalarial for adults travelling to malaria-endemic areas. It should be:\r\n\r\n- Started 1\u20132 days before travel\r\n\r\n- Taken daily during travel\r\n\r\n- Continued for 7 days after leaving the endemic area\r\n\r\n- The medication should always be taken with food and at the same time each day. It is not licensed for sale to those under 18. Misunderstanding start times (e.g. using mefloquine guidance instead) can result in poor protection.\r\n\r\n\r\nFor more information, please watch BNF lesson Chapter 5 (Infection):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Chemoprophylaxis should commence 1 week prior to entering a malaria-endemic area, continue during the period of the stay and continue for 7 days  after leaving the area.",
        "answer_number": 1
      },
      {
        "text": "Chemoprophylaxis should commence 1-2 days prior to entering a malaria-endemic area, continue during the period of the stay and continue for 1 week\u00a0 after leaving the area.",
        "answer_number": 2
      },
      {
        "text": "It can only be sold to those over 18 years.",
        "answer_number": 3
      },
      {
        "text": "It is important to advise patient to take the tablets at the same each day to ensure the protection is effective.",
        "answer_number": 4
      },
      {
        "text": "You need to take Maloff protect with food",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 976,
    "bank": "clinicalMep",
    "title": "**Which of the following schedules of Controlled drugs do you need to retain the invoice for a minimum of 2 years?**",
    "text": "Invoices for some controlled medicines needs to be retained in the pharmacy",
    "why": "Schedule 3 and 5 CD invoices must be retained for 2 years minimum under the Misuse of Drugs Regulations 2001 as amended. Invoices for schedule 2 CDs are often retained for good practice and useful for balance checks",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Schedule 2 and 3",
        "answer_number": 1
      },
      {
        "text": "Schedule 2 and 4",
        "answer_number": 2
      },
      {
        "text": "Schedule 3 and 4",
        "answer_number": 3
      },
      {
        "text": "Schedule 3 and 5",
        "answer_number": 4
      },
      {
        "text": "Schedule 4 and 5",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2223,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Electrolyte abnormalities** \r\n**For each of the following scenarios, select the most likely electrolyte abnormality from the list of options.**",
    "text": "A 65-year-old man with chronic kidney disease and pneumonia has a serum potassium concentration of 6.5 mmol/L and a serum creatinine concentration of 200 micromol/L. He is taking ramipril 5 mg once daily and trimethoprim 200 mg twice daily. He complains of having muscle weakness, palpitations, and chest pain.",
    "why": "Hyperkalaemia is a common side effect of trimethoprim, which can inhibit the renal tubular secretion of potassium and mimic the effects of amiloride. Ramipril, an angiotensin-converting enzyme inhibitor, can also cause hyperkalaemia by reducing the aldosterone-mediated renal excretion of potassium. Muscle weakness, palpitations, and chest pain are some of the symptoms of hyperkalaemia.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Hypercalcaemia (Ca2+ > 2.6 mmol/L)",
        "answer_number": 1
      },
      {
        "text": "Hyperkalaemia (K+ > 5.3 mmol/L)",
        "answer_number": 2
      },
      {
        "text": "Hypermagnesaemia (Mg2+ > 1.0 mmol/L)",
        "answer_number": 3
      },
      {
        "text": "Hypernatraemia (Na+ > 145 mmol/L)",
        "answer_number": 4
      },
      {
        "text": "Hypocalcaemia (Ca2+ < 2.2 mmol/L)",
        "answer_number": 5
      },
      {
        "text": "Hypokalaemia (K+ < 3.5 mmol/L)",
        "answer_number": 6
      },
      {
        "text": "Hypomagnesaemia (Mg2+ < 0.7 mmol/L)",
        "answer_number": 7
      },
      {
        "text": "Hyponatraemia (Na+ < 135 mmol/L)",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 880,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT an appropriate practitioner?**",
    "text": "Prescription only medicines can only be prescribed by an appropriate practitioner",
    "why": "Chiropractors are not listed as an appropriate prescriber as listed under Regulation 214 of the Human Medicines Regulations 2012 as amended.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Community practitioner nurse prescribers",
        "answer_number": 1
      },
      {
        "text": "Chiropractor independent prescriber",
        "answer_number": 2
      },
      {
        "text": "Optometrist independent prescribers",
        "answer_number": 3
      },
      {
        "text": "Podiatrist independent prescriber",
        "answer_number": 4
      },
      {
        "text": "Paramedic independent prescriber",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2619,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 31 year old patient presents to the pharmacy with a headache. She informs you she has been having the headache for a few months. She tells you she takes paracetamol and ibuprofen however she always has a headache after taking analgesics.",
    "why": "This is because the patient is experiencing a medicine induced headache. This is where the nociceptors are turned on rather than off when taking analgesics. This is caused by overusing the analgesics. Treatment is to withdraw from the analgesics. Medicine induced headaches are a referral to the patient's GP.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise to purchase 8mg/500mg co-codamol for headache",
        "answer_number": 1
      },
      {
        "text": "Advise to purchase sumatriptan 50mg tablet for headache",
        "answer_number": 2
      },
      {
        "text": "Advise to see her GP to withdraw from analgesics",
        "answer_number": 3
      },
      {
        "text": "Advise to see her GP to investigate cause of headache",
        "answer_number": 4
      },
      {
        "text": "Advise to see urgent medical advice",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 970,
    "bank": "clinicalMep",
    "title": "**Which of the following is the LEAST appropriate in terms of the nature of entering into the controlled drugs register?**",
    "text": "A controlled drugs register must be maintained in the pharmacy to record the receipt and supply of schedule 2 controlled drugs.",
    "why": "You must cross out in the CD register, any errors must be amended using an astertix and noting the error either at the bottom or the side of the CD register.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Amendments signed by the responsible pharmacist",
        "answer_number": 1
      },
      {
        "text": "Crossing out errors in the register",
        "answer_number": 2
      },
      {
        "text": "Entries are made in a chronological order",
        "answer_number": 3
      },
      {
        "text": "Entered promptly (same day or following day)",
        "answer_number": 4
      },
      {
        "text": "Must be indelible (ink or computerised)",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 883,
    "bank": "clinicalMep",
    "title": "**What is the minimum time period you should keep the Responsible Pharmacist record for?**",
    "text": "You have taken over as a Pharmacist manager in your community pharmacy. The previous manager kept excessive amounts of paperwork therefore you are decluttering and organising your files.",
    "why": "The Responsible Pharmacist record must be kept for at least 5 years, this can be written, electronic or both",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "6 months",
        "answer_number": 1
      },
      {
        "text": "1 year",
        "answer_number": 2
      },
      {
        "text": "2 years",
        "answer_number": 3
      },
      {
        "text": "5 years",
        "answer_number": 4
      },
      {
        "text": "10 years",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 971,
    "bank": "clinicalMep",
    "title": "**What is the last day the medicine can be used?**",
    "text": "You are preparing a prescription for Fentanyl 25mcg patches. You notice the medicine is short dated and has an expiry date 11/2023",
    "why": "An expiry date of 11/2023 means last day you can use it is the last day of that month",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "30th November 2023",
        "answer_number": 1
      },
      {
        "text": "31st October 2023",
        "answer_number": 2
      },
      {
        "text": "1st November 2023",
        "answer_number": 3
      },
      {
        "text": "1st December 2023",
        "answer_number": 4
      },
      {
        "text": "1st October 2023",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2492,
    "bank": "clinicalMep",
    "title": "**Regarding this mechanism of supply, which of the following is correct?**",
    "text": "Salbutamol inhalers can be supplied to schools without a prescription for administration in an emergency by trained persons using a signed order.",
    "why": "B. A signed order must be signed by the head teacher.\r\n\r\nRationale\r\n\r\nThe mechanism for supplying salbutamol inhalers to schools without a prescription is regulated under legislation to ensure these devices are available for emergencies, such as severe asthma attacks in pupils.\r\n\r\nA. Appropriately headed paper is legally required (Incorrect):\r\n\r\nHeaded paper is not a legal requirement, though it is a professional recommendation to help validate the authenticity of the signed order.\r\n\r\nB. A signed order must be signed by the head teacher (Correct):\r\n\r\nLegally, the signed order must be authorised and signed by a person with management responsibility, typically the head teacher or principal of the school. This ensures accountability and proper oversight of the supply process.\r\n\r\nC. A spacer device should be provided with each supply of an inhaler (Incorrect):\r\n\r\nWhile spacer devices can improve the effectiveness of salbutamol delivery, there is no legal requirement to supply a spacer with each inhaler under this mechanism. Schools are responsible for ensuring they have the appropriate devices for use.\r\n\r\nD. The signed order must be retained for 5 years from the date of supply, and a POM register entry made only (Incorrect):\r\n\r\nIt is true that the signed order must be retained for 2 years (not 5 years) and that an entry must be made in the Prescription-Only Medicine (POM) register. This ensures accurate record-keeping and accountability.\r\n\r\nE. Ventolin\u00ae branded inhalers are approved for supply via this mechanism (Incorrect):\r\n\r\nBoth branded (e.g., Ventolin\u00ae) and generic salbutamol inhalers are approved for supply under this mechanism. There is no restriction to specific brands.\r\n\r\nSchools can obtain salbutamol inhalers without a prescription to be used in emergencies for pupils diagnosed with asthma or prescribed an inhaler. The supply must follow specific legal requirements, including:\r\n\r\nA signed order authorised by the head teacher or principal.\r\nRetention of the signed order for 2 years, with an appropriate entry in the POM register.\r\nThe supply can include either generic or branded inhalers, but a spacer device is not mandatory.\r\nWhile appropriately headed paper is not a legal requirement, its use is encouraged to maintain professional standards and ensure clarity. This policy ensures rapid access to lifesaving treatment in emergencies while maintaining robust record-keeping and oversight.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Appropriately headed paper is legally required",
        "answer_number": 1
      },
      {
        "text": "A signed order must be signed by the head teacher",
        "answer_number": 2
      },
      {
        "text": "A spacer device should be provided with each supply of an inhaler",
        "answer_number": 3
      },
      {
        "text": "The signed order must be retained for 5 years from the date of supply, and a POM register entry made only",
        "answer_number": 4
      },
      {
        "text": "Ventolin\u00ae branded inhalers are approved for supply via this mechanism",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2509,
    "bank": "clinicalMep",
    "title": "**Which of the following is INCORRECT regarding legal requirements or EEA/Switzerland prescriptions?**",
    "text": "Regulation 218 of the Human Medicines Regulations states the legal requirements for EEA or Switzerland prescriptions",
    "why": "a) Medicines which are not MHRA approved in the UK are acceptable\r\n\r\nRationale\r\n\r\nThis statement is incorrect because medicines prescribed on EEA/Swiss prescriptions must be approved by the UK\u2019s Medicines and Healthcare products Regulatory Agency (MHRA). Medicines that are not MHRA-approved cannot be legally dispensed in the UK, even if prescribed by a valid EEA/Swiss prescriber.\r\n\r\nExplanation of the Other Options\r\n\r\nb) Only Schedule 4 and 5 Controlled Drugs can be prescribed\r\n\r\nThis is correct. EEA and Swiss prescribers can legally prescribe only Schedule 4 and 5 Controlled Drugs. They are not allowed to prescribe Controlled Drugs from Schedules 1, 2, or 3.\r\n\r\nc) Patients' full first name, surname, and date of birth are needed\r\n\r\nThis is correct. The prescription must include the patient's full name and date of birth to ensure accurate identification and to meet legal requirements.\r\n\r\nd) Prescriptions are valid for 6 months unless the medicine is a Schedule 4 Controlled Drug\r\n\r\nThis is correct. Prescriptions issued by EEA or Swiss prescribers are valid for 6 months unless they involve Schedule 4 Controlled Drugs, in which case they are valid for 28 days from the date of issue.\r\n\r\ne) Prescribers' direct contact details, including email address and telephone number\r\n\r\nThis is correct. The prescription must include the prescriber's direct contact details (such as email address and telephone number) to allow the dispensing pharmacist to verify the prescription if needed. This ensures authenticity and compliance with the legal framework.\r\n\r\nRegulation 218 of the Human Medicines Regulations 2012 outlines the requirements for accepting prescriptions issued by EEA or Swiss healthcare professionals. Key points include:\r\n\r\nMedicine Approval: Only medicines approved by the UK\u2019s MHRA can be dispensed.\r\nControlled Drugs: Only Schedule 4 and 5 Controlled Drugs can be prescribed by EEA/Swiss prescribers.\r\nValidity: Prescriptions are generally valid for 6 months, except for Schedule 4 Controlled Drugs, which are valid for 28 days.\r\nPatient and Prescriber Details: Prescriptions must include the patient\u2019s full name and date of birth as well as the prescriber's name, qualifications, contact details, and work address.\r\nPharmacists must carefully assess the validity and compliance of EEA/Swiss prescriptions before dispensing, ensuring patient safety and adherence to UK law.\r\n\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Medicines which are not MHRA approved in the UK are acceptable",
        "answer_number": 1
      },
      {
        "text": "Only Schedule 4 and 5 Controlled drugs can be prescribed",
        "answer_number": 2
      },
      {
        "text": "Patients full first name, surname and date of birth are needed",
        "answer_number": 3
      },
      {
        "text": "Prescriptions are valid for 6 months unless the medicine is a Schedule 4 Controlled Drug",
        "answer_number": 4
      },
      {
        "text": "Prescribers direct contact details including email address and telephone number",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2575,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the child's symptoms?**",
    "text": "A 67 year old female approaches you with her granddaughter who is 5 years old. Her granddaughter is presenting with red sores around her mouth which are yellow and crusty. She has no other symptoms and has only had it for a few days.\u00a0\u00a0\r\n\r\n![impetigo](https://i.ibb.co/LtKRsxK/impetigo.jpg \"700x500\")",
    "why": "e) Impetigo\r\n\r\nRationale:\r\n\r\nThe child's symptoms of red sores around the mouth that are yellow and crusty strongly indicate impetigo, which is a common bacterial skin infection in children. Impetigo typically presents as red sores that burst, ooze, and then develop a yellow crust, particularly around the nose and mouth. The causative agents are usually Staphylococcus aureus or Streptococcus pyogenes.\r\n\r\na) Acne: This condition usually appears as comedones (blackheads and whiteheads) and does not cause crusty sores.\r\nb) Chicken pox: This viral infection causes an itchy rash with fluid-filled blisters all over the body, not localised yellow crusts around the mouth.\r\nc) Cold sore: Caused by the herpes simplex virus, cold sores present as painful, fluid-filled blisters on the lips but do not typically crust over in the same manner as impetigo.\r\nd) Eczema: This chronic condition results in dry, red, itchy patches of skin rather than the crusty lesions associated with impetigo.\r\n\r\nImpetigo is a highly contagious superficial skin infection commonly seen in children, characterised by the appearance of vesicular lesions that can rupture and crust over, typically presenting as golden or honey-coloured scabs. It usually affects exposed areas of the body, especially the face, arms, and legs. The infection can occur after skin trauma, such as cuts or insect bites, but can also develop without any obvious preceding injury.\r\n\r\nThe primary pathogens responsible for impetigo are Staphylococcus aureus and Streptococcus pyogenes. The condition can spread rapidly in settings such as schools and daycare centres, making good hygiene practices essential in controlling outbreaks.\r\n\r\nImpetigo can be classified into two types: non-bullous impetigo, which is more common and involves the formation of small blisters that quickly rupture, and bullous impetigo, which features larger fluid-filled blisters. Treatment typically involves topical antibiotics, such as mupirocin or fusidic acid, for localised cases, while oral antibiotics may be required for extensive infections or when there is a risk of complications.\r\n\r\nManagement also includes educating caregivers on hygiene measures to prevent spread, such as regular hand-washing, avoiding sharing towels or bedding, and keeping the affected area covered. Children with impetigo should stay home from school or daycare until they have been on antibiotics for at least 48 hours or until the lesions are crusted and dry.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Acne",
        "answer_number": 1
      },
      {
        "text": "Chicken pox",
        "answer_number": 2
      },
      {
        "text": "Cold Sore",
        "answer_number": 3
      },
      {
        "text": "Eczema",
        "answer_number": 4
      },
      {
        "text": "Impetigo",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2628,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the man\u2019s symptoms?**",
    "text": "A 79-year-old male patient presents to the pharmacy. He explains his eyes often has a burning sensation and often his vision is blurred which improves when blinking. He has heart failure and takes the following medication\r\n\r\nBumetanide 1mg tablets\u00a0\r\nRamipril 10mg tablets\u00a0\r\nBisoprolol 5mg tablets\u00a0\r\nSpironolactone 25mg tablets",
    "why": "Burning sensation, blurred vision that improves with blinking, and advanced age are common symptoms of dry eye syndrome.\r\nMedications such as diuretics (Bumetanide), ACE inhibitors (Ramipril), beta-blockers (Bisoprolol), and potassium-sparing diuretics (Spironolactone) can contribute to dry eye symptoms as a side effect.\r\nDry eye is a common condition, especially in the elderly, and it can be exacerbated by medications that affect tear production or composition.\r\n\r\n- Dry eye disease (keratoconjunctivitis sicca) is a chronic condition involving loss of tear film homeostasis, leading to reduced tear production or instability, with discomfort and visual symptoms.\r\n  \r\n- **Two main types:**\r\n  - **Evaporative dry eye** (more common) \u2014 caused by increased tear evaporation due to a deficient lipid layer.\r\n  - **Aqueous deficient dry eye** \u2014 due to reduced tear secretion from the lacrimal glands.\r\n\r\n- **Causes include:**\r\n  - Meibomian gland dysfunction, blepharitis, age-related changes, Sj\u00f6gren\u2019s syndrome, rosacea, reduced blinking, environmental factors, and iatrogenic causes (contact lens use, medications, or post-surgery).\r\n\r\n- **Complications:**\r\n  - Impacts daily activities, causes anxiety and depression, and may lead to corneal damage or severe visual loss (rare).\r\n\r\n- **Symptoms:**\r\n  - Eye irritation, dryness, transient blurring, watery eyes, mild redness, or mucous discharge.\r\n\r\n- **Assessment:**\r\n  - Symptom history, impact on quality of life, possible causes, ocular history, medication, visual acuity, and examination for lid issues or inflammation.\r\n\r\n- **Management:**\r\n  - Provide information and support, suggest lifestyle adjustments (warm compresses, lid hygiene), reduce contributing drug use, manage any related conditions, recommend tear substitutes, and arrange follow-up if needed.\r\n\r\n- **Referral to specialist:**\r\n  - For red flag symptoms, suspected serious underlying cause, uncertain diagnosis, systemic conditions (e.g. Sj\u00f6gren\u2019s), abnormal lid anatomy, or unresponsive symptoms after 4\u201312 weeks.\r\n\r\nFor more information watch the OTC lesson on  Chapter 3 Opthalmology and Otology (Dry Eye):\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Episcleritis",
        "answer_number": 1
      },
      {
        "text": "Keratitis",
        "answer_number": 2
      },
      {
        "text": "Keratoconjunctivitis sicca",
        "answer_number": 3
      },
      {
        "text": "Subconjunctival haemorrhage",
        "answer_number": 4
      },
      {
        "text": "Uveitis",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2533,
    "bank": "clinicalMep",
    "title": "**How many days of missed treatment means a patient would be \u201coff script\u201d?**",
    "text": "You are the responsible pharmacist in a community pharmacy running a supervised methadone clinic. One of your clients regularly misses their collection.",
    "why": "B. 3 consecutive days\r\n\r\nRationale:\r\n\r\nAccording to the guidelines for supervised methadone dispensing, if a patient misses three consecutive days of treatment, they would be considered \"off script.\" This is based on the principle that missing multiple doses of methadone increases the risk of opioid overdose due to the loss of tolerance, which can lead to significant harm.\r\n\r\nExplanation of Other Options:\r\n\r\nA. 2 consecutive days:\r\nThis is incorrect because the \"off script\" criteria are specifically related to missing three consecutive days of treatment. Missing two days alone does not trigger this classification.\r\n\r\nC. 3 unconsecutive days:\r\nThis is incorrect. It is the consecutive missed days that are the primary concern for determining when a patient is \"off script,\" as the gap between doses can significantly affect the risk of harm.\r\n\r\nD. 4 consecutive days:\r\nThis is incorrect. While missing more than three days would also indicate a high risk, the point at which the patient is officially considered \"off script\" is after missing three consecutive days, not four.\r\n\r\nE. 5 consecutive days:\r\nThis is incorrect for the same reason as option D. The critical threshold is three consecutive days, and while missing five days would definitely place the patient at risk, the official point of being \"off script\" occurs after three days.\r\n\r\n\r\nIn the context of supervised methadone dispensing, the key risk is that a patient who misses three consecutive days of methadone treatment may lose their tolerance to opioids. If a patient misses three consecutive doses, their risk of overdose upon resuming treatment is significantly increased. As a result, patients in this situation are considered \"off script,\" and alternative actions, such as consulting the prescriber or re-evaluating the patient's treatment plan, would be necessary to ensure their safety. The guidelines emphasise the importance of continuity in methadone administration to prevent withdrawal and overdose risks.\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "2 consecutive days",
        "answer_number": 1
      },
      {
        "text": "3 consecutive days",
        "answer_number": 2
      },
      {
        "text": "3 unconsecutive days",
        "answer_number": 3
      },
      {
        "text": "4 consecutive days",
        "answer_number": 4
      },
      {
        "text": "5 consecutive days",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2291,
    "bank": "clinicalTherapeutics",
    "title": "You receive a hospital pharmacy outpatient prescription for a 16-year-old patient with cystic fibrosis who has been seen by the ENT specialist due to nasal polyps. He has been prescribed a sinus rinse as well as some Flixonase\u00ae 400 microgram nasules for use in each nostril.",
    "text": "**Theme: Eye, ear, nose and oropharynx\r\n\r\n\r\n\r\n**For each of the following scenarios select the dose that best corresponds to the counselling required to be given for an initial dose of the products mentioned. Each option may be used once, more than once or not all.**",
    "why": "6 drops OD\r\n\r\nRationale:\r\n\r\nFlixonase\u00ae 400 microgram nasules (fluticasone propionate) are used for the treatment of nasal polyps, particularly in patients with cystic fibrosis, as they help reduce inflammation and polyp size.\r\n\r\nEach Flixonase nasule contains 12 drops.\r\nThe usual dosing regimen is 6 drops in each nostril once daily (OD).\r\nThe nasules should be used after a sinus rinse to maximise absorption.\r\nThus, the correct dosing instruction is 6 drops OD.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 1 drop TDS\r\n\r\nIncorrect; 1 drop is too low a dose, and TDS is not the recommended frequency for Flixonase nasules.\r\n\r\nB: 1 drop QDS\r\n\r\nIncorrect; 1 drop per dose is too little, and QDS dosing is not recommended for Flixonase nasules.\r\n\r\nC: 1 drop every 2 hours\r\n\r\nIncorrect; Flixonase is not used frequently throughout the day.\r\n\r\nD: 2 drops BD\r\n\r\nIncorrect; while BD dosing could be an alternative regimen, 6 drops OD is the standard recommendation.\r\n\r\nE: 1 spray OD\r\n\r\nIncorrect; Flixonase nasal spray and Flixonase nasules have different dosing regimens. The nasules contain a liquid formulation, not a spray.\r\n\r\nF: 1 spray TDS\r\n\r\nIncorrect; Flixonase nasules are not administered as a spray.\r\n\r\nH: 7 drops BD\r\n\r\nIncorrect; BD dosing is not standard, and 7 drops exceed the usual recommendation of 6 drops per nostril OD.\r\n\r\nNasal Polyps and Cystic Fibrosis \r\n\r\nAccording to NICE guidelines (2025) and BNF recommendations, the treatment of nasal polyps in cystic fibrosis includes:\r\n\r\nFirst-line pharmacological treatment:\r\n\r\nIntranasal corticosteroids (e.g., Flixonase\u00ae 400 microgram nasules) \u2013 6 drops per nostril once daily.\r\nNasal saline rinses should be used before steroid application to improve drug penetration.\r\n\r\nSurgical intervention:\r\n\r\nPolypectomy may be required if symptoms persist despite medical therapy.\r\n\r\nFollow-up and monitoring:\r\n\r\nAssess symptom improvement in 4\u20136 weeks.\r\nMonitor for systemic steroid side effects if used long term.\r\n\r\nFor more information please watch BNF Lesson ( Chapter 12) ENT:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "1 drop TDS",
        "answer_number": 1
      },
      {
        "text": "1 drop QDS",
        "answer_number": 2
      },
      {
        "text": "1 drop every 2 hours",
        "answer_number": 3
      },
      {
        "text": "2 drops BD",
        "answer_number": 4
      },
      {
        "text": "1 spray OD",
        "answer_number": 5
      },
      {
        "text": "1 spray TDS",
        "answer_number": 6
      },
      {
        "text": "6 drops OD",
        "answer_number": 7
      },
      {
        "text": "7 drops BD",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2633,
    "bank": "clinicalOtc",
    "title": "**What is the most likely causative organism of the infant's condition?**",
    "text": "A 6-month-old infant is brought to the pharmacy by their mother. The infant has a history of eczema and has not received the first two doses of the 6-in-1 vaccine. The mother says that the infant has had a runny nose and a mild cough for the past two weeks, and recently developed episodes of severe coughing followed by a whooping sound and vomiting. The infant is feeding poorly and has a temperature of 38.2\u00b0C. On examination, you notice that the infant has a red face and watery eyes during the coughing fits. The infant is not drooling or having difficulty breathing.",
    "why": "The infant has classic symptoms of whooping cough (pertussis), which is a  highly infectious bacterial infection caused by bacterium Bordetella pertussis\u00b9. Whooping cough has three phases of symptoms:\r\n\r\nCatarrhal phase (1\u20132 weeks): Resembles a common cold with symptoms like runny nose, malaise, and mild cough. Fever is rare.\r\n\r\nParoxysmal phase (around 1 week): Characterised by intense coughing fits followed by a 'whoop' sound (less common in adults and infants) or vomiting. Infants may experience apnea.\r\n\r\nConvalescent phase (2\u20133 weeks): Gradual improvement, though coughing may recur with future infections.\r\n\r\nVaccination or prior infection can result in milder symptoms but does not offer lifelong protection. Infants under six months are at higher risk of severe illness and death.\r\n\r\nWhooping cough is suspected if a person has had a cough for 14 days or more, with symptoms like paroxysmal cough, inspiratory 'whoop', vomiting after coughing, or unexplained apnea in infants, especially if they had contact with a confirmed case.\r\n\r\nManagement includes:\r\n\r\nAdmitting severe cases, particularly infants.\r\nAntibiotics within 14 days of cough onset (or 21 days for close contacts).\r\nSymptomatic relief and managing close contacts.\r\nEnsuring vaccinations are up to date.\r\nExclusion from nursery, school, or work is advised until 48 hours of antibiotic treatment or 14\u201321 days without treatment, depending on the case.\r\n\r\nFor more information watch the OTC lesson on  Chapter 1 Paediatrics (Whooping Cough):\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Bordetella pertussis",
        "answer_number": 1
      },
      {
        "text": "Haemophilus influenzae type b",
        "answer_number": 2
      },
      {
        "text": "Mycoplasma pneumoniae",
        "answer_number": 3
      },
      {
        "text": "Respiratory syncytial virus",
        "answer_number": 4
      },
      {
        "text": "Streptococcus pneumoniae",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2568,
    "bank": "clinicalOtc",
    "title": "**Which of the following would be the most appropriate course of action?**",
    "text": "A 32-year-old woman presents to your pharmacy with which she describes as 'a burning, acidic sensation' after eating. Upon consultation, you discover the woman also feels sick and is burping a lot. She is eating and drinking normally, and does not have any other symptoms, but is 34 weeks pregnant.\u00a0\r\n\r\nShe does not smoke and has tried both diet and lifestyle modifications, as suggested by her midwife, for the last week, but the symptoms have persisted. She has not yet tried any medication, and does not take any other regular medication.",
    "why": "d) Advise her to take Gaviscon\u00ae liquid and see her GP if her symptoms do not improve\r\n\r\nRationale:\r\n\r\nFor a pregnant woman at 34 weeks experiencing symptoms of acid reflux and heartburn, Gaviscon\u00ae liquid is a safe, effective, and first-line treatment option. Gaviscon contains alginates and antacids, which provide a soothing barrier on the stomach contents, reducing reflux symptoms without systemic absorption, making it safe during pregnancy. If her symptoms do not improve, a GP consultation is recommended for further assessment and potential prescription options.\r\n\r\nExplanation of Other Options:\r\n\r\na) Advise her to eat smaller and more regular meals: Although smaller, frequent meals can help manage heartburn, she has already tried lifestyle and dietary modifications per her midwife's advice. Additional medication is now warranted to relieve her persistent symptoms.\r\nb) Advise her to purchase ranitidine tablets and see her GP if her symptoms do not improve: Ranitidine is not recommended as a first-line OTC treatment for pregnant women due to limited availability and safety concerns in pregnancy. Prescription antacids should only be considered if other measures are ineffective.\r\nc) Advise her to take Nexium\u00ae tablets and see her GP if her symptoms do not improve: Nexium\u00ae (esomeprazole) is a proton pump inhibitor (PPI) and is typically reserved for use under medical supervision in pregnancy due to its systemic effects. It is not recommended as a first-line OTC treatment without GP guidance.\r\ne) Advise her to see her GP to confirm the diagnosis and prescribe an appropriate drug: While a GP visit may be needed if symptoms persist, an OTC option like Gaviscon is safe and suitable as a first-line option before consulting a GP.\r\n\r\nNICE guidelines suggest managing heartburn and acid reflux in pregnancy initially with dietary and lifestyle changes, such as smaller, frequent meals and avoiding triggers. For women who continue to experience symptoms despite these measures, antacids or alginate-containing products like Gaviscon are recommended as safe, non-systemic options to alleviate discomfort. If symptoms persist, a healthcare provider may evaluate the need for further treatment.\r\n\r\nFor more information please watch BNF lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise her to eater smaller and more regular meals",
        "answer_number": 1
      },
      {
        "text": "Advise her to purchase ranitidine tablets and see her GP if her symptoms do not improve",
        "answer_number": 2
      },
      {
        "text": "Advise her to take Nexium\u00ae tablets and see her GP if her symptoms do not improve",
        "answer_number": 3
      },
      {
        "text": "Advise her to take Gaviscon\u00ae liquid and see her GP if her symptoms do not improve",
        "answer_number": 4
      },
      {
        "text": "Advise her to see her GP to confirm the diagnosis and prescribe an appropriate drug",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2394,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate treatment option for him?**",
    "text": "A 60-year-old man has been taking warfarin for the last 6 months to prevent thromboembolism due to his atrial fibrillation. He comes to the pharmacy with symptoms of oral thrush, such as white patches on his tongue and cheeks, soreness, and difficulty swallowing. He says he has not changed his diet or oral hygiene habits recently. He asks for your advice on what he can use to treat his infection.",
    "why": "E. Nystatin oral suspension\r\n\r\nRationale:\r\n\r\nNystatin oral suspension is an effective and safe treatment for oral thrush. It is a topical antifungal that works locally without significant systemic absorption. This makes it ideal for patients taking warfarin, as it does not interfere with the metabolism of warfarin or increase the INR, thereby avoiding the risk of bleeding.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Chlorhexidine mouthwash\r\n\r\nAlthough chlorhexidine can reduce bacterial load in the oral cavity, it has no antifungal activity and is therefore ineffective for treating oral thrush.\r\n\r\nB. Fluconazole oral capsules\r\n\r\nFluconazole is a systemic antifungal effective against oral thrush. However, it has a major interaction with warfarin, as it inhibits CYP450 enzymes, increasing warfarin levels and raising the INR, which significantly heightens the risk of bleeding.\r\n\r\nC. Hydrogen peroxide gargle\r\n\r\nHydrogen peroxide is a mild antiseptic but has no antifungal properties. It is not suitable for the treatment of oral thrush.\r\n\r\nD. Miconazole oral gel\r\n\r\nMiconazole is a topical antifungal effective for oral thrush. However, it strongly interacts with warfarin by inhibiting CYP450 enzymes, leading to elevated warfarin levels and an increased risk of bleeding.\r\n\r\nOral thrush (oral candidiasis) is a common condition caused by Candida species. It often presents as white patches on the tongue and inside the cheeks, which may be sore or bleed when scraped. NICE guidelines recommend topical antifungal treatments like Nystatin or Miconazole as first-line therapy. However, in patients on warfarin, Nystatin is preferred due to its lack of systemic absorption and absence of interactions with warfarin. It is important to counsel patients on proper oral hygiene and to complete the course of antifungal treatment to prevent recurrence.\r\n\r\nFor more information watch BNF lesson Chapter 5 (Infections):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Chlorhexidine mouthwash",
        "answer_number": 1
      },
      {
        "text": "Fluconazole oral capsules",
        "answer_number": 2
      },
      {
        "text": "Hydrogen peroxide gargle",
        "answer_number": 3
      },
      {
        "text": "Miconazole oral gel",
        "answer_number": 4
      },
      {
        "text": "Nystatin oral suspension",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 969,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "You receive a prescription, on a saturday afternoon for morphine sulfate (zomorph) 10mg capsules, at a dose of one capsule every 12 hours, quantity 120 capsules.",
    "why": "A. Amend the prescription indelibly so the prescription is compliant with the regulations.\r\n\r\nRationale:\r\n\r\nUnder the Misuse of Drugs Regulations 2001 (as amended), a pharmacist is permitted to make technical amendments to a prescription for Schedule 2 and 3 controlled drugs (e.g., morphine sulfate) in certain situations. The pharmacist can amend the prescription indelibly if:\r\n\r\nEither the quantity in words or the quantity in figures is missing (but not both).\r\nThere are minor typographical errors.\r\nIn this scenario, the prescription does not include the quantity written in words, but it does include the quantity in figures (120 capsules). This means the pharmacist can correct the prescription to comply with the regulations without requiring a new prescription.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Amend the prescription indelibly so the prescription is compliant with the regulations\r\n\r\nPharmacists have the authority to amend a Schedule 2 or 3 controlled drug prescription for minor technical details, such as adding the quantity in words. This ensures the prescription complies with legal requirements and allows the pharmacist to supply the medication.\r\n\r\nB. Explain the quantity is not written in words and figures therefore you cannot dispense the prescription\r\n\r\nIf only one of these is missing, the pharmacist can amend the prescription themselves. Refusing to dispense in this case is unnecessary and would cause undue delay for the patient.\r\n\r\nC. Provide 5 days\u2019 worth of medication as an emergency supply\r\n\r\nEmergency supply provisions do not apply to Schedule 2 controlled drugs (except phenobarbital for epilepsy). Morphine sulfate cannot be supplied as an emergency without a valid prescription.\r\n\r\nD. Refer to NHS 111 for a new prescription\r\n\r\nNHS 111 does not issue prescriptions directly; they may arrange out-of-hours GP services. However, this step is unnecessary because the pharmacist can legally amend the prescription.\r\n\r\nE. Refer to the general practitioner for a new prescription\r\n\r\nThis would be an unnecessary delay since the pharmacist is authorised to make technical amendments to the prescription under the law.\r\n\r\nUnder the Misuse of Drugs Regulations 2001 (as amended):\r\n\r\nA pharmacist can correct technical details, such as the quantity in words or minor errors, on a Schedule 2 or 3 controlled drug prescription, provided it is indelibly amended.\r\nEmergency supply provisions do not apply to Schedule 2 controlled drugs (except phenobarbital for epilepsy).\r\nPrescriptions for controlled drugs must comply with all legal requirements to be valid, but pharmacists can take action to ensure compliance without involving the prescriber unnecessarily.\r\n\r\nFor more information watch MEP lesson Chapter 3 (Underpinning Knowledge : legislation and professional Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Amend the prescription indelibly so the prescription is compliant with the regulations.",
        "answer_number": 1
      },
      {
        "text": "Explain the quantity is not written in words and figures therefore you cannot dispense the prescription",
        "answer_number": 2
      },
      {
        "text": "Provide 5 days worth of medication as an emergency supply.",
        "answer_number": 3
      },
      {
        "text": "Refer to NHS 111 for a new prescription",
        "answer_number": 4
      },
      {
        "text": "Refer to the general practitioner for a new prescription",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2278,
    "bank": "clinicalTherapeutics",
    "title": "**In which of the following situations would use of this medicine be inappropriate?**",
    "text": "A 25-year old female patient who wears contact lenses and has been initiated on isotretinoin. Their blood test results are shown below:\r\n\r\nLDL  1.9 mmol/L  (<3mmol/L)\r\nALT   42 units/L   (7 \u2013 56 units/L)\r\nTotal bilirubin  0.7 mg/dL (0.3 - 1.9 mg/dL)",
    "why": "Correct Answer:\r\n\r\nA. Acne where topical antibiotics have failed\r\n\r\nRationale:\r\n\r\nIsotretinoin is reserved for severe cases of acne that have not responded to conventional treatments. NICE guidelines  suggest that isotretinoin should be used for:\r\n\r\n- Severe nodulocystic or conglobate acne\r\n- Acne leading to extensive scarring\r\n- Acne causing significant psychological distress\r\n\r\nIf topical antibiotics have failed, other treatments such as oral antibiotics (e.g., lymecycline, doxycycline) or hormonal therapies should be trialled first. Isotretinoin is not the first-line therapy due to its serious risks, including teratogenicity (birth defects), adverse effects on liver function, and potential mental health issues.\r\n\r\nExplanation of Other Options:\r\n\r\nB. Acne resulting in extensive scarring \u2013 Isotretinoin is appropriate for this condition as it is a severe form of acne that requires aggressive treatment to prevent further scarring.\r\n\r\nC. Acne associated with psychological problems \u2013 This is another indication for isotretinoin, as severe acne can significantly affect the patient's mental health. If topical or oral antibiotics have failed, isotretinoin can be considered for these patients.\r\n\r\nD. Conglobate acne \u2013 Isotretinoin is commonly used for conglobate acne, a severe, cystic form of acne that can lead to scarring.\r\n\r\nE. Severe acne \u2013 Isotretinoin is recommended for severe acne that has not responded to other treatments, such as oral antibiotics or hormonal therapies.\r\n\r\nIsotretinoin is a vitamin A derivative used for severe acne, especially when other treatments fail. It works by reducing sebaceous gland size, decreasing sebum production, and preventing the formation of acne lesions.\r\n\r\nKey Considerations:\r\n\r\n- Pregnancy Prevention: It is teratogenic, and strict pregnancy prevention is required during treatment.\r\n\r\n- Monitoring: Regular lipid levels and liver function tests are necessary to monitor for side effects.\r\n\r\n- Psychiatric Monitoring: There is a potential for depression and suicidal thoughts, so monitoring is critical.\r\n\r\nFor more information please watch BNF lesson Chapter 13 (Skin):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Acne where topical antibiotics have failed",
        "answer_number": 1
      },
      {
        "text": "Acne resulting in extensive scarring",
        "answer_number": 2
      },
      {
        "text": "Acne associated with psychological problems",
        "answer_number": 3
      },
      {
        "text": "Conglobate acne",
        "answer_number": 4
      },
      {
        "text": "Severe acne",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2149,
    "bank": "clinicalTherapeutics",
    "title": "A 20 year old man with nausea, vomiting, agitation, tremor, nystagmus and sinus tachycardia.",
    "text": "**Theme: Signs and Symptoms of toxicity** \u2028\u2028\r\n\r\n**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "why": "Correct Answer: \r\n\r\nE) Citalopram\r\n\r\nRationale:\r\n\r\nThe symptoms described, nausea, vomiting, agitation, tremor, nystagmus, and sinus tachycardia, are consistent with serotonin toxicity (serotonin syndrome), which is a known risk with SSRI overdose such as citalopram.\r\n\r\nCitalopram in overdose can lead to:\r\n\r\n- CNS excitation: agitation, tremor, anxiety\r\n\r\n- Autonomic instability: tachycardia, sweating, nausea\r\n\r\n- Neuromuscular changes: hypereflexia, tremor, clonus\r\n\r\n- In severe cases: seizures, QT prolongation\r\n\r\nExplanation of Other Options:\r\n\r\nA. Aspirin\r\nWould present with tinnitus, hyperventilation, metabolic acidosis, not tremor or nystagmus.\r\n\r\nB. Amitriptyline\r\nCauses anticholinergic effects (dry mouth, urinary retention, delirium), arrhythmias, seizures, and coma, but not typically tremor or nystagmus.\r\n\r\nC. Amlodipine\r\nCauses hypotension, reflex tachycardia, and flushing, but not tremor, agitation, or CNS toxicity.\r\n\r\nD. Bisoprolol\r\nCan cause bradycardia, hypotension, and fatigue in overdose. It does not match the hyperactive symptoms listed.\r\n\r\nF. Fentanyl\r\nWould cause CNS depression, respiratory depression, and miosis (pinpoint pupils), opposite of the symptoms here.\r\n\r\nG. Naproxen\r\nA non-steroidal anti-inflammatory; overdose typically causes GI upset and, in large doses, renal impairment or CNS depression, not agitation or tremor.\r\n\r\nH. Paracetamol\r\nEarly symptoms include nausea, vomiting, but no CNS excitation. Late toxicity affects the liver, not the CNS.\r\n\r\n\r\n\r\n- Citalopram is an SSRI antidepressant. In overdose, it can cause serotonin syndrome \u2014 a triad of:\r\n\r\n- Cognitive effects (agitation, confusion)\r\n\r\n- Autonomic instability (tachycardia, nausea)\r\n\r\n- Neuromuscular symptoms (tremor, hyperreflexia)\r\n\r\n- This condition can be life-threatening and requires immediate medical attention. This question aligns with BNF and NICE toxicology guidance on SSRI overdose symptoms.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Aspirin",
        "answer_number": 1
      },
      {
        "text": "Amitriptyline",
        "answer_number": 2
      },
      {
        "text": "Amlodipine",
        "answer_number": 3
      },
      {
        "text": "Bisoprolol",
        "answer_number": 4
      },
      {
        "text": "Citalopram",
        "answer_number": 5
      },
      {
        "text": "Fentanyl",
        "answer_number": 6
      },
      {
        "text": "Naproxen",
        "answer_number": 7
      },
      {
        "text": "Paracetamol",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2355,
    "bank": "clinicalTherapeutics",
    "title": "**According to the NICE guidelines and BNF, what should be the maximum duration of treatment with this potent corticosteroid?**",
    "text": "A 35-year-old patient with scalp psoriasis has been prescribed a potent corticosteroid.",
    "why": "D. 56\r\n\r\nRationale: \r\n\r\nAccording to the NICE guidelines and BNF, potent corticosteroids should not be applied for more than 8 weeks (56 days) at any one site, such as the scalp. Prolonged use beyond this duration increases the risk of adverse effects, including:\r\n\r\nSkin atrophy: Thinning of the skin.\r\n\r\nTachyphylaxis: Reduced efficacy due to overuse.\r\n\r\nSystemic absorption: Risk of side effects extending beyond the skin.\r\n\r\nManagement Recommendations:\r\n\r\nUse potent corticosteroids for up to 8 weeks (56 days).\r\n\r\nIf symptoms persist, take a 4-week treatment break to reduce risks and reassess the treatment plan.\r\n\r\nConsider non-steroidal alternatives, such as:\r\n\r\nVitamin D analogues (e.g., calcipotriol).\r\n\r\nCoal tar preparations or other topical treatments.\r\n\r\nEnsure that treatment is reviewed regularly by a healthcare professional to monitor progress and prevent complications.\r\n\r\n\r\nFor more information watch BNF lesson Chapter 13 (Skin):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "7",
        "answer_number": 1
      },
      {
        "text": "14",
        "answer_number": 2
      },
      {
        "text": "28",
        "answer_number": 3
      },
      {
        "text": "56",
        "answer_number": 4
      },
      {
        "text": "84",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2510,
    "bank": "clinicalMep",
    "title": "**Which of the following is INCORRECT regarding military prescriptions?**",
    "text": "Small military medical centres can outsource their dispensing to designated community pharmacies.",
    "why": "a) Military prescriptions do not have a designated prescription form\r\n\r\nRationale\r\n\r\nMilitary prescriptions do have a designated prescription form known as FMed 296. This form is used by military medical centres and is specific to prescriptions issued within the Ministry of Defence (MOD). The statement that military prescriptions do not have a designated form is therefore incorrect.\r\n\r\nExplanation of the Other Options\r\n\r\nb) Military prescriptions presented to a non-contracted pharmacy should be treated as private prescriptions\r\n\r\nThis is correct. If a pharmacy does not have a contract with the MOD and is presented with a military prescription (e.g., FMed 296), it must treat the prescription as a private prescription. The patient will pay for the medication and can subsequently claim reimbursement from the MOD.\r\n\r\nc) Non-contracted pharmacies charge the patient for an appropriate fee\r\n\r\nThis is correct. When a military prescription is handled by a non-contracted pharmacy, the pharmacy charges the patient as they would for any private prescription.\r\n\r\nd) Pharmacies with a dispensing contract directly invoice the military of defence\r\n\r\nThis is correct. Pharmacies with a dispensing contract with the MOD are reimbursed directly by the MOD for the prescriptions they dispense.\r\n\r\ne) Prescriptions for Schedule 2 and 3 Controlled Drugs must be written on FP10PCD or equivalent\r\n\r\nThis is correct. Controlled Drugs (CDs) in Schedules 2 and 3 must be written on the appropriate designated form (e.g., FP10PCD or an MOD-equivalent prescription form) to meet legal requirements for dispensing.\r\n\r\n\r\nMilitary prescriptions are issued on the designated FMed 296 form. Military sites often have dispensing doctors, but where this is not available, community pharmacies may be used to dispense medicines.\r\n\r\nContracted pharmacies: Pharmacies with a contract with the MOD invoice the MOD directly for reimbursement.\r\nNon-contracted pharmacies: If the pharmacy does not have a contract, prescriptions should be treated as private prescriptions, and the patient is charged accordingly. The patient can then seek reimbursement from the MOD.\r\nControlled Drugs: Prescriptions for Schedule 2 and 3 Controlled Drugs must comply with the legal requirements for CDs, including being written on an FP10PCD or equivalent designated form.\r\nPharmacists must be aware of these distinctions to ensure compliance with MOD requirements and the Human Medicines Regulations.\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Military prescriptions do not have a designated prescription form",
        "answer_number": 1
      },
      {
        "text": "Military prescriptions presented to a non contracted pharmacy should be treated as private prescriptions",
        "answer_number": 2
      },
      {
        "text": "Non contracted pharmacies charge the patient for appropriate fee",
        "answer_number": 3
      },
      {
        "text": "Pharmacies with a dispensing contract directly invoice the military of defence",
        "answer_number": 4
      },
      {
        "text": "Prescriptions for Schedule 2 and 3 Controlled drugs must be written on FP10PCD or equivalent",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2627,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the woman\u2019s symptoms?**",
    "text": "A 56 year old presents to the pharmacy requesting advice regarding her left eye. She informs you she often wears contact lenses. She has been experiencing severe pain in the eye, slightly blurred vision and photophobia. Upon examination you notice limbal redness.",
    "why": "**Keratitis** is an inflammation of the cornea caused by infections, trauma, or contact lens-related issues. Symptoms include severe eye pain, blurred vision, photophobia (sensitivity to light), and limbal redness (redness at the corneal-sclera border).\r\n\r\n**Risk factors for keratitis:**\r\n- Contact lens use, particularly with poor cleaning habits or extended wear, increases the risk. Improper daily cleaning, disinfection, and use of contaminated lens cases are common causes.\r\n  \r\n**Acanthamoeba keratitis**, a severe and painful infection, is particularly linked to soft lenses (especially reusable or extended wear). This condition can occur if lenses come into contact with tap water or are improperly disinfected, and requires prompt specialist treatment to prevent vision loss.\r\n\r\n**Prevention** involves strict compliance with lens care, avoiding tap water exposure, and limiting extended lens wear.\r\n\r\nCheck Image\r\nhttps://ibb.co/99g9xR0\r\n\r\nFor more information watch the OTC lesson on  Chapter 3 Opthalmology and Otology (Whooping Cough):\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Episcleritis",
        "answer_number": 1
      },
      {
        "text": "Keratitis",
        "answer_number": 2
      },
      {
        "text": "Keratoconjunctivitis sicca",
        "answer_number": 3
      },
      {
        "text": "Subconjunctival haemorrhage",
        "answer_number": 4
      },
      {
        "text": "Uveitis",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2451,
    "bank": "clinicalTherapeutics",
    "title": "A 70-year-old man with advanced Parkinson's disease has severe dysphagia and a nasojejunal (NJ) tube in place. He was previously taking co-careldopa (Sinemet) controlled release tablets four times a day, but they cannot be crushed and administered via the tube. His consultant would still like him to remain on levodopa and carbidopa and he asks you what is the most appropriate alternative formulation for the patient.",
    "text": "**Theme: Management of Parkinson's disease with swallowing difficulties or feeding tubes in situ**\r\n\r\n**For each of the following scenarios, select the best alternative medicine option from the list above. Each option may be used once, more than once or not at all.**",
    "why": "Co-careldopa (Sinemet) standard release tablets\r\n\r\nThese tablets can be dispersed in water and administered via the NJ tube. They should be given immediately after dispersion as they degrade upon exposure to air, and settling can occur, which may reduce the dose. The dose and frequency may need to be adjusted, as levodopa is mainly absorbed in the jejunum, and its effect can be unpredictable when administered via an NJ tube.\r\n\r\nRationale\r\n\r\nLevodopa is primarily absorbed in the small intestine, making the NJ tube an appropriate route for its administration. Since co-careldopa (Sinemet) standard release tablets can be dispersed and administered via the tube, this formulation allows the patient to continue their treatment effectively despite their swallowing difficulties. The consultant's preference for levodopa and carbidopa therapy is thus met.\r\n\r\nExplanation of Other Options\r\n\r\nA. Apomorphine (APO-go) subcutaneous infusion\r\n\r\nApomorphine is not a direct substitute for levodopa and carbidopa. It is typically used as a rescue therapy for patients with severe motor fluctuations in advanced Parkinson's disease. It is inappropriate as a first-line alternative in this scenario.\r\n\r\nB. Co-beneldopa (Madopar) capsules\r\n\r\nCapsules cannot be administered via an NJ tube as they must not be crushed. This formulation does not resolve the patient's dysphagia or allow for proper administration.\r\n\r\nC. Co-beneldopa (Madopar) dispersible tablets\r\n\r\nWhile these dispersible tablets are suitable for patients with mild swallowing difficulties, they are not as ideal for NJ tube administration as co-careldopa, which was the patient\u2019s original therapy.\r\n\r\nD. Co-careldopa (Sinemet) controlled release tablets\r\n\r\nControlled release tablets must not be crushed, making them unsuitable for administration via an NJ tube. This formulation also provides slower symptom relief, which may not be ideal for the patient.\r\n\r\nF. Levodopa/carbidopa/entacapone (Stalevo) tablets\r\n\r\nStalevo is not suitable for NJ tube administration as the tablets must not be crushed or dispersed. Additionally, entacapone is an adjunctive therapy and not strictly required for all patients.\r\n\r\nG. Ropinirole (Requip) tablets\r\n\r\nRopinirole is a dopamine agonist, not a substitute for levodopa and carbidopa. While it can be used to manage Parkinson\u2019s symptoms, it does not fulfill the consultant's preference for maintaining levodopa therapy.\r\n\r\nH. Rotigotine (Neupro) transdermal patch\r\n\r\nRotigotine is a transdermal dopamine agonist, which bypasses the swallowing process entirely. However, it is not a direct replacement for levodopa and carbidopa therapy.\r\n\r\nAccording to NICE guidelines, Parkinson\u2019s disease management should focus on ensuring continuity of effective treatment despite complications such as swallowing difficulties. Levodopa remains the cornerstone of therapy in moderate to advanced stages of the disease. For patients unable to swallow, alternative routes such as dispersible tablets administered via feeding tubes or non-oral formulations may be used, with careful consideration of bioavailability and administration timing. Adjustments in dose and frequency may be required to maintain symptom control.\r\n\r\nFor more information watch BNF lesson (Chapter 4) Central Nervous System:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Apomorphine (APO-go) subcutaneous infusion",
        "answer_number": 1
      },
      {
        "text": "Co-beneldopa (Madopar) capsules",
        "answer_number": 2
      },
      {
        "text": "Co-beneldopa (Madopar) dispersible tablets",
        "answer_number": 3
      },
      {
        "text": "Co-careldopa (Sinemet) controlled release tablets",
        "answer_number": 4
      },
      {
        "text": "Co-careldopa (Sinemet) standard release tablets",
        "answer_number": 5
      },
      {
        "text": "Levodopa/carbidopa/entacapone (Stalevo) tablets",
        "answer_number": 6
      },
      {
        "text": "Ropinirole (Requip) tablets",
        "answer_number": 7
      },
      {
        "text": "Rotigotine (Neupro) transdermal patch",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2544,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "You receive a prescription for a 27-year-old male who has been prescribed fentanyl patches for pain relief after a road traffic accident.\u00a0\r\n\r\nAn extract of the prescription has been provided for you.\r\n\r\n![1](https://i.ibb.co/0C4XFdW/1.png \"400x600\")",
    "why": "(b) Amend the quantity of the prescription to meet all legal requirements and then dispense the prescription\r\n\r\nRationale:\r\n\r\nUnder the Misuse of Drugs Regulations 2001, Schedule 2 controlled drugs, like fentanyl, have strict prescription requirements, including having the quantity written in both words and figures. However, if either the words or figures are missing (but not both), pharmacists have the authority to make a technical amendment. This involves completing the missing part, signing, and including their full name and GPhC number to validate the correction.\r\n\r\nOther Options Explained:\r\n\r\n(a) Advise the patient to return to their GP for a new prescription: This is not necessary unless both words and figures for the quantity are missing. A pharmacist can amend the prescription if only one part is absent.\r\n\r\n(c) Contact the GP surgery to specify which brand of fentanyl patch is needed: This step would only be required if the prescription specified a brand-related issue. In this case, no brand-related clarification is necessary.\r\n\r\n(d) Provide an emergency supply and request a new prescription from the GP: Emergency supply is not permitted for Schedule 2 controlled drugs like fentanyl, making this option inappropriate.\r\n\r\n(e) The prescription meets all legal requirements therefore dispense the prescription: This option assumes no amendments are needed, but if either the words or figures for the quantity are missing, it does not meet the requirements until corrected.\r\n\r\nAccording to the Medicines, Ethics, and Practice (MEP) guide and NICE guidelines, prescriptions for Schedule 2 controlled drugs such as fentanyl must meet specific requirements. The prescription must include the total quantity written in both words and figures, ensuring clarity and preventing potential misuse or errors. If one part of the quantity (either words or figures) is missing, pharmacists can amend this detail, provided they add their signature, full name, and registration number.\r\n\r\nNote:\r\n\r\nEmergency supplies are strictly prohibited for Schedule 2 controlled substances (except phenobarbital for epilepsy), and dispensing without correct quantity information is unlawful. These guidelines ensure that prescriptions for controlled drugs meet rigorous standards for both patient safety and legal compliance.\r\n\r\nWatch MEP lesson on Chapter 2 (Professional and Legal Issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the patient to return to their GP for a new prescription",
        "answer_number": 1
      },
      {
        "text": "Amend the quantity of the prescription to meet all legal requirements and then dispense the prescription",
        "answer_number": 2
      },
      {
        "text": "Contact the GP surgery to specify which brand of fentanyl patch is needed.",
        "answer_number": 3
      },
      {
        "text": "Provide an emergency supply and request a new prescription from the GP.",
        "answer_number": 4
      },
      {
        "text": "The prescription meets all legal requirements therefore dispense the prescription",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2557,
    "bank": "clinicalMep",
    "title": "A community nurse practitioner is considering prescribing a controlled drug for a palliative care patient during a home visit.",
    "text": "**Theme: Controlled drug prescribing**\r\n\r\n**Instruction: For each of the scenarios below, select the most appropriate answer option from the list above. Each option may be used once, more than once, or not at all.**",
    "why": "A. Cannot prescribe controlled drugs in Schedules 2-5\r\n\r\nRationale:\r\n\r\nCommunity nurse practitioners do not have prescribing authority for any controlled drugs listed in Schedules 2-5, even for palliative care. According to the MEP, only independent prescribers, with additional qualifications and authority, can prescribe specific controlled drugs. Therefore, the community nurse practitioner must refer the patient to a prescriber with appropriate authority.\r\n\r\nExplanation of Other Options:\r\n\r\nB. Can only prescribe oral diazepam, lorazepam, temazepam, and dihydrocodeine\r\nIncorrect. This limitation applies to specific prescribers like supplementary prescribers or those with limited qualifications, not to community nurse practitioners.\r\n\r\nC. Can only prescribe oral diazepam, lorazepam, temazepam, dihydrocodeine, oxycodone, IV and oral morphine, and fentanyl patches\r\nIncorrect. This describes the scope of advanced nurse practitioners with specific training, not community nurse practitioners.\r\n\r\nD. Can prescribe Schedule 2-5 controlled drugs and does not need a standardised form for private prescriptions for Schedules 2 and 3\r\nIncorrect. Independent prescribers may prescribe Schedule 2-5 controlled drugs but still require standardised private forms for Schedules 2 and 3.\r\n\r\nE. Can prescribe any controlled drug listed in Schedules 2-5 for the treatment of addiction\r\nIncorrect. Only doctors who are specifically licensed can prescribe controlled drugs for addiction treatment.\r\n\r\nF. Can prescribe Schedules 2-5 for any medical condition within their competence, except diamorphine, cocaine, and dipipanone for addiction treatment\r\nIncorrect. This applies only to independent prescribers with advanced qualifications and does not include community nurse practitioners.\r\n\r\nG. Schedule 2 and 3 controlled drugs only\r\nIncorrect. This authority applies to certain advanced prescribers but does not extend to community nurse practitioners, who are not authorised to prescribe any controlled drugs.\r\n\r\nH. Schedule 4 and 5 controlled medicines only\r\nIncorrect. Community nurse practitioners cannot prescribe controlled drugs in any schedule, including Schedules 4 and 5.\r\n\r\n\r\nAccording to the MEP, prescribing authority for controlled drugs varies by practitioner type and requires specific qualifications and regulatory approval. Only independent prescribers and those with advanced qualifications are permitted to prescribe certain controlled drugs within specific guidelines. Community nurse practitioners are not authorised to prescribe any controlled drugs, even in palliative care, as they must refer patients to qualified prescribers for controlled medications.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Cannot prescribe controlled drugs \u00a0Schedule 2-5 controlled drugs",
        "answer_number": 1
      },
      {
        "text": "Can only prescribe oral diazepam, lorazepam, temazepam and dihydrocodeine.",
        "answer_number": 2
      },
      {
        "text": "Can only prescribe oral diazepam, lorazepam, temazepam and dihydrocodeine and oxycodone. As well as IV and oral morphine and fentanyl patches. .",
        "answer_number": 3
      },
      {
        "text": "Can prescribe schedule 2 - 5 controlled drugs and does not need a standardised form for private prescriptions for schedule 2 and 3",
        "answer_number": 4
      },
      {
        "text": "Can prescribe any controlled drug listed in schedules 2-5 for the treatment of addiction",
        "answer_number": 5
      },
      {
        "text": "Schedules 2-5 for any medical condition within their competence, except diamorphine, cocaine and dipipanone for the treatment of addiction1.",
        "answer_number": 6
      },
      {
        "text": "Schedule 2 and 3 controlled drugs only.",
        "answer_number": 7
      },
      {
        "text": "Schedule 4 and 5 controlled medicines only",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2631,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the causative species for croup?**",
    "text": "You are the responsible pharmacist and you teaching trainee pharmacists about Croup.",
    "why": "Croup is commonly caused by parainfluenza viruses, particularly types 1 and 2.\r\n\r\nCroup (laryngotracheobronchitis) is a common respiratory illness in children aged 6 months to 3 years, usually caused by viruses like parainfluenza types 1 or 3. It is characterised by a sudden onset of a seal-like barking cough, often with hoarseness, stridor, and breathing difficulties. Symptoms tend to worsen at night and with agitation. \r\n\r\nBefore the cough starts, non-specific upper respiratory symptoms like cough, runny nose, and fever may occur for 12 to 72 hours. The clinical features arise due to inflammation and swelling of the upper airways, causing narrowing of the subglottic region.\r\n\r\nCroup severity is classified as:\r\n- **Mild:** Barking cough without stridor or chest recession at rest.\r\n- **Moderate:** Barking cough with stridor and chest recession, but no agitation or lethargy.\r\n- **Severe:** Barking cough with stridor, chest recession, and agitation or lethargy.\r\n- **Impending respiratory failure:** Increasing airway obstruction, chest wall and abdominal movement issues, fatigue, pallor, cyanosis, and a drop in consciousness.\r\n\r\nMild cases can be managed at home and typically resolve within 48 hours, though some may last up to a week. Parents are advised to give paracetamol or ibuprofen for fever and pain, and seek urgent medical help if symptoms worsen. \r\n\r\nHospital admission is required for children with chronic lung or heart disease, immunodeficiency, fast breathing (over 60 breaths/minute), high fever, or poor fluid intake. Children with moderate or severe croup, or those at risk of respiratory failure, should also be hospitalised.\r\n\r\nAll children with croup should receive a single dose of oral dexamethasone (0.15 mg/kg). For those too unwell for oral treatment, nebulised budesonide or intramuscular dexamethasone are alternative options.\r\n\r\nFor more information watch the OTC lesson on  Chapter 1 Paediatrics (Croup and paedriatics quiz):\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Bordetella pertussis",
        "answer_number": 1
      },
      {
        "text": "Human papilloma virus (HPV)",
        "answer_number": 2
      },
      {
        "text": "Parainfluenza virus (PIV)",
        "answer_number": 3
      },
      {
        "text": "Staphylococcus pyogenes",
        "answer_number": 4
      },
      {
        "text": "Varicella zoster virus (VZV)",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2518,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a criteria to enable emergency supplies at patient request?**",
    "text": "Regulation 225 of the Human Medicines Regulations enables emergency supplies at the request of a patient",
    "why": "E) Prescription must be obtained within 72 hours\r\n\r\nRationale:\r\n\r\nFor an emergency supply at the request of a patient, there is no legal requirement that a prescription be obtained within 72 hours. This criterion applies only when an emergency supply is requested by a prescriber, not by the patient. At a patient\u2019s request, the pharmacist may provide an emergency supply if specific conditions are met, but there is no time limit for obtaining a subsequent prescription.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Maximum 5 days supply for Schedule 4 Controlled drugs \u2013 This is a correct requirement. For Schedule 4 Part I controlled drugs (such as Clobazam), an emergency supply at a patient\u2019s request can only cover a maximum of 5 days. This regulation helps control the availability of these drugs while addressing immediate patient needs in a limited capacity.\r\n\r\nB) Pharmacist is satisfied there is an immediate need \u2013 This criterion is essential for emergency supplies. The pharmacist must be convinced that the patient has an urgent requirement for the medication, making an immediate supply necessary to maintain their health or prevent adverse effects from an interrupted treatment.\r\n\r\nC) Pharmacist to interview the patient \u2013 A direct interview with the patient is required for an emergency supply at the patient\u2019s request. This interaction allows the pharmacist to assess the patient\u2019s condition, determine the necessity of the medication, and ensure safe dispensing based on the patient\u2019s history.\r\n\r\nD) POM requested must have been used as previous treatment \u2013 The medication requested for an emergency supply must be one that the patient has previously been prescribed, ensuring that the patient is familiar with the medication and its effects. This requirement also supports continuity in treatment, reducing the risk of adverse reactions to unfamiliar medications.\r\n\r\n\r\nRegulation 225 of the Human Medicines Regulations 2012 governs emergency supplies of prescription-only medicines (POMs) at a patient\u2019s request, enabling pharmacists to provide urgent medication under specific conditions. The key criteria for patient-requested emergency supplies include that the pharmacist is satisfied there is an immediate need, the medicine has been previously prescribed for the patient, and an interview is conducted to assess the situation. For Schedule 4 Part I controlled drugs, only a maximum of 5 days\u2019 supply can be issued, ensuring adherence to controlled substance regulations.\r\n\r\nUnlike emergency supplies requested by a prescriber, there is no statutory requirement for obtaining a prescription within a certain time frame when an emergency supply is at the patient\u2019s request. These guidelines are designed to balance access to essential medications with regulatory control, supporting pharmacists in making safe, compliant decisions when addressing urgent patient needs.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Maximum 5 days supply for Schedule 4 Controlled drugs",
        "answer_number": 1
      },
      {
        "text": "Pharmacist is satisfied there is an immediate need",
        "answer_number": 2
      },
      {
        "text": "Pharmacist to interview the patient",
        "answer_number": 3
      },
      {
        "text": "POM requested must have been used as previous treatment",
        "answer_number": 4
      },
      {
        "text": "Prescription must be obtained within 72 hours",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2248,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following would be the most appropriate course of action?**",
    "text": "Mrs O, a 65-year-old lady has been admitted to hospital following a fall at home, upon questioning she mentions that she has been started on some new medication by her GP in the last week to help with pain following a sprain injury to her wrist and she hasn\u2019t been feeling herself since.\r\nShe is currently prescribed:\r\nParacetamol 1 g QDS\r\nTramadol 50mg \u2013 100mg QDS\r\nIbuprofen 400mg TDS",
    "why": "Correct Answer:\r\n\r\nC) Recommend holding the tramadol and reviewing the NSAID; add gastro-protection if the NSAID is to continue\r\n\r\nRationale:\r\n\r\nMrs. O, a 65-year-old patient, presents with a recent fall after being started on paracetamol, tramadol, and ibuprofen for pain management. Given her symptoms of \"not feeling herself,\" the most likely culprit is tramadol, which is known to cause dizziness, sedation, and confusion, all of which increase fall risk in older adults.\r\n\r\nAdditionally, ibuprofen (NSAID) poses a significant gastrointestinal (GI) bleeding risk in individuals over 65. If ibuprofen must be continued, gastro-protection with a proton pump inhibitor (PPI) like omeprazole is recommended to reduce GI complications.\r\n\r\nKey Considerations:\r\n\r\n1. Tramadol:\r\n\r\n- Risk of falls: Tramadol lowers the seizure threshold, causes sedation, and increases fall risk in older adults.\r\n- Action: Hold tramadol and assess if stopping it improves her symptoms.\r\n\r\n2. Ibuprofen (NSAID):\r\n\r\n- High GI risk in elderly patients: NSAIDs increase the risk of gastric ulcers and GI bleeding, especially in patients over 65 years old.\r\n- Action: If NSAIDs must be continued, gastro-protection with a PPI (e.g., omeprazole) should be added.\r\n\r\n3. Paracetamol:\r\n\r\n- Safe and effective for mild to moderate pain.\r\n- Action: Continue paracetamol as it poses minimal risk.\r\n\r\nExplanation of Other Options:\r\n\r\nA) No intervention required \r\n\r\nThe fall and \"not feeling herself\" could be linked to tramadol's side effects. Leaving the regimen unchanged could result in another fall.\r\n\r\nB) Recommend adding in omeprazole or famotidine \r\n\r\nGastro-protection addresses the NSAID risk, but it does not address the fall risk from tramadol.\r\n\r\nD) Recommend stopping the ibuprofen \r\n\r\nStopping NSAIDs may reduce GI risk, but it does not address tramadol\u2019s CNS effects, which may have contributed to the fall.\r\n\r\nE) Stop all medication \r\n\r\nParacetamol is safe and effective for pain relief, so stopping all medication is unnecessary.\r\n\r\nPain Management in Older Adults:\r\n\r\n- Opioids (e.g., tramadol):\r\n\r\nShould be used with caution in elderly patients due to increased sensitivity to side effects like sedation and dizziness, which increase fall risk.\r\n\r\n- NSAIDs (e.g., ibuprofen):\r\n\r\nShould only be used when necessary and at the lowest effective dose.\r\nPatients over 65 should be co-prescribed a PPI (e.g., omeprazole) to prevent GI bleeding.\r\n\r\n- Paracetamol:\r\n\r\nFirst-line analgesic for mild to moderate pain due to its favorable safety profile in older adults.\r\n\r\nBy holding tramadol and reviewing NSAID use, we reduce the risk of further falls and prevent GI complications, ensuring safe and effective pain management.\r\n\r\nFor more information, please watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "No intervention required",
        "answer_number": 1
      },
      {
        "text": "Recommend adding in omeprazole or famotidine",
        "answer_number": 2
      },
      {
        "text": "Recommend holding the tramadol and reviewing the NSAID and add gastro-protection if the NSAID is to continue",
        "answer_number": 3
      },
      {
        "text": "Recommend stopping the ibuprofen",
        "answer_number": 4
      },
      {
        "text": "Stop all medication",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2522,
    "bank": "clinicalMep",
    "title": "**Which of the following medicines CANNOT be prescribed?**",
    "text": "Physiotherapist independent prescribers can prescribe certain Controlled medicines",
    "why": "E) Oxycodone injection\r\n\r\nRationale:\r\n\r\nPhysiotherapists who are independent prescribers are authorised to prescribe certain controlled medicines. However, there are restrictions on injectable forms of certain drugs. Oxycodone, for example, can only be prescribed by independent prescribers for oral formulations, not for injectable forms. Therefore, physiotherapists are unable to prescribe injectable oxycodone.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Dihydrocodeine tablets \u2013 Physiotherapists can prescribe this oral form of dihydrocodeine, a controlled medicine used for pain relief.\r\n\r\nB) Fentanyl patches \u2013 Fentanyl patches are a strong opioid prescribed for pain management, and physiotherapists can prescribe them in their patch form.\r\n\r\nC) Lorazepam tablets \u2013 Lorazepam, a benzodiazepine, can be prescribed by physiotherapists for managing anxiety or sleep disorders.\r\n\r\nD) Morphine injection \u2013 Physiotherapists can prescribe injectable morphine for pain management, making it an acceptable option for prescription.\r\n\r\n\r\nThe Medicines, Ethics and Practice (MEP) guidelines specify that while physiotherapists can prescribe certain controlled drugs, they are restricted from prescribing injectable versions of certain medications, such as oxycodone. It is important to be aware of these prescribing limits to ensure compliance with regulations and patient safety.\r\n\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Dihydrocodeine tablets",
        "answer_number": 1
      },
      {
        "text": "Fentanyl patches",
        "answer_number": 2
      },
      {
        "text": "Lorazepam tablets",
        "answer_number": 3
      },
      {
        "text": "Morphine injection",
        "answer_number": 4
      },
      {
        "text": "Oxycodone injection",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2152,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Antidotes** \u2028\u2028**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 60-year-old woman who has taken too much warfarin and has a high INR and bleeding gums.",
    "why": "Correct answer: \r\n\r\nG) Phytomenadione\r\n\r\nRationale:\r\n\r\n- Phytomenadione (vitamin K1) is the specific antidote for warfarin overdose. It is used to reverse the effects of warfarin when there is evidence of bleeding (e.g. bleeding gums, bruising) or when the INR is significantly elevated.\r\n\r\n- Vitamin K helps to restore the synthesis of clotting factors (II, VII, IX, and X), which are inhibited by warfarin. The route and dose depend on the severity of bleeding and INR level (oral, IV, or subcutaneous may be used).\r\n\r\nExplanation of Other Options:\r\n\r\nA) Acetylcysteine \r\n\r\nAntidote for paracetamol overdose, not anticoagulants.\r\n\r\nB) Deferoxamine mesilate \r\n\r\nUsed for iron poisoning.\r\n\r\nC) Dicobalt edetate \r\n\r\nAntidote for cyanide poisoning.\r\n\r\nD) Flumazenil \r\n\r\nAntidote for benzodiazepine overdose.\r\n\r\nE) Glucagon \r\n\r\nUsed for beta-blocker or calcium channel blocker overdose.\r\n\r\nF) Naloxone hydrochloride \r\n\r\nAntidote for opioid overdose.\r\n\r\nH) Sodium bicarbonate \r\n\r\nUsed in tricyclic antidepressant overdose or severe metabolic acidosis.\r\n\r\n\r\nIn warfarin toxicity with bleeding or high INR, phytomenadione (vitamin K1) is the first-line treatment to reverse anticoagulation. Hospital admission may also be needed depending on the severity, and in cases of major bleeding, prothrombin complex concentrate (PCC) may be considered alongside vitamin K.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "Acetylcysteine",
        "answer_number": 1
      },
      {
        "text": "Deferoxamine mesilate",
        "answer_number": 2
      },
      {
        "text": "Dicobalt edetate",
        "answer_number": 3
      },
      {
        "text": "Flumazenil",
        "answer_number": 4
      },
      {
        "text": "Glucagon",
        "answer_number": 5
      },
      {
        "text": "Naloxone hydrochloride",
        "answer_number": 6
      },
      {
        "text": "Phytomenadione",
        "answer_number": 7
      },
      {
        "text": "Sodium bicarbonate",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 977,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate action to take?**",
    "text": "A 10-year-old boy with a history of peanut allergy is on a school trip to a farm. He accidentally eats a biscuit that contains peanut butter and develops symptoms of anaphylaxis, such as wheezing, swelling, and rash. His teacher finds his adrenaline auto-injector (Emerade 300 micrograms) in his backpack, but notices that it has expired 3 months ago. She runs into your community pharmacy asking for help.",
    "why": "Under the Human Medicines Regulations 2012, pharmacists can administer adrenaline for emergency treatment of anaphylaxis.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Administer adrenaline auto-injector from your pharmacy and call 999.",
        "answer_number": 1
      },
      {
        "text": "Do not use the expired adrenaline auto-injector and call 999",
        "answer_number": 2
      },
      {
        "text": "Do not use the expired adrenaline auto-injector and give antihistamines instead",
        "answer_number": 3
      },
      {
        "text": "Use the expired adrenaline auto-injector and call 999",
        "answer_number": 4
      },
      {
        "text": "Use the expired adrenaline auto-injector and wait for the symptoms to subside",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2608,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate product for her?**",
    "text": "A 60-year-old woman comes to your pharmacy with a complaint of dry mouth. She says she has been feeling thirsty and having difficulty swallowing and speaking for the past few months. She also has a sore tongue and cracked lips. She has type 2 diabetes and hypertension, for which she takes metformin and lisinopril. She has no other medical conditions or allergies. She asks you to recommend something that can relieve her symptoms.",
    "why": "The most appropriate product for the patient is:\r\n\r\nBiotene Oralbalance gel\r\n\r\nRationale:\r\n\r\nBiotene Oralbalance gel is a saliva substitute that is specifically designed to relieve symptoms of dry mouth (xerostomia). It helps to lubricate the oral mucosa, alleviating dryness, and improving swallowing and speaking. This makes it suitable for the patient\u2019s symptoms of dryness, sore tongue, and cracked lips, which are common in individuals with type 2 diabetes and those taking medications like lisinopril that may contribute to dry mouth as a side effect.\r\n\r\nBonjela gel is primarily intended for mouth ulcers and would not effectively relieve the overall dryness of the mouth.\r\nCorsodyl mouthwash contains chlorhexidine, which may help with oral hygiene but could exacerbate dryness and is not recommended for alleviating xerostomia.\r\nDifflam spray is an anti-inflammatory mouth spray primarily used for sore throats and mouth pain but does not address dryness.\r\nOrajel mouth ulcer gel is indicated for pain relief from mouth ulcers and would not provide moisture or relief for dry mouth symptoms.\r\n\r\nNICE Guidance on Management of Dry Mouth\r\n\r\nAccording to NICE guidelines, the management of xerostomia includes:\r\n\r\nSaliva Substitutes: Products like Biotene Oralbalance gel are recommended as they provide moisture and lubrication, helping to relieve the symptoms associated with dry mouth.\r\n\r\nHydration: Advising the patient to sip water regularly and avoid caffeinated or alcoholic drinks that may contribute to dehydration and worsen dry mouth symptoms.\r\n\r\nGood Oral Hygiene: Maintaining oral hygiene by brushing with fluoride toothpaste and avoiding sugary foods can help prevent complications like dental caries, which patients with dry mouth are at higher risk for.\r\n\r\nAvoidance of Irritants: The patient should avoid spicy or acidic foods that may further irritate the sore tongue and cracked lips.\r\n\r\nAdditional Insights\r\n\r\nDry mouth (xerostomia) is a common issue, especially in individuals with diabetes and those taking certain medications, such as antihypertensives like lisinopril. It is important to address the underlying cause while providing symptomatic relief. In this case, Biotene Oralbalance gel serves as an effective solution for temporary relief. If symptoms persist, referral to a GP may be necessary for further evaluation and adjustment of medication if needed.\r\n\r\nEducating patients on the importance of regular dental check-ups is also crucial, as dry mouth increases the risk of oral infections, dental caries, and other complications. Incorporating saliva substitutes and lifestyle changes into daily routines can significantly improve the patient\u2019s quality of life.\r\n\r\nFor more information watch OTC lessons:\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Biotene Oralbalance gel",
        "answer_number": 1
      },
      {
        "text": "Bonjela gel",
        "answer_number": 2
      },
      {
        "text": "Corsodyl mouthwash",
        "answer_number": 3
      },
      {
        "text": "Difflam spray",
        "answer_number": 4
      },
      {
        "text": "Orajel mouth ulcer gel",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2382,
    "bank": "clinicalTherapeutics",
    "title": "**How many millilitres of the injection should the patient receive?**",
    "text": "A patient is prescribed a dose of 40 mg/m2 of doxorubicin for chemotherapy. The patient has a body surface area of 1.8 m2^ and the available injection contains 2 mg/mL of doxorubicin.",
    "why": "E. 36 mL\r\nRationale\r\nTo calculate the required volume of the injection:\r\n\r\nDetermine the total dose in milligrams:\r\nDose (mg) = Dose per m\u00b2 \u00d7 Body Surface Area (m\u00b2)\r\nDose (mg) = 40 mg/m\u00b2 \u00d7 1.8 m\u00b2 = 72 mg\r\n\r\nCalculate the volume to be administered:\r\nVolume (mL) = Dose (mg) \u00f7 Concentration (mg/mL)\r\nVolume (mL) = 72 mg \u00f7 2 mg/mL = 36 mL\r\n\r\nTherefore, the patient requires 36 mL of the injection.\r\n\r\nDoxorubicin is an anthracycline chemotherapeutic agent used to treat various cancers. Dosage is based on body surface area to ensure appropriate systemic exposure. It is essential to calculate the correct dose and volume to minimise the risk of toxicity and ensure efficacy. Doxorubicin is typically administered intravenously and requires close monitoring due to its potential for cardiotoxicity and other adverse effects.\r\n\r\nFor more information watch BNF lesson Chapter 8 (Malignant disease and Immunosupression):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "14.4 mL",
        "answer_number": 1
      },
      {
        "text": "16 mL",
        "answer_number": 2
      },
      {
        "text": "18 mL",
        "answer_number": 3
      },
      {
        "text": "20 mL",
        "answer_number": 4
      },
      {
        "text": "36 mL",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 975,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a legally acceptable dose?**",
    "text": "Controlled Drug prescriptions for Schedule 2 and 3 require doses which are legally acceptable",
    "why": "There is no quantity of the medicine formulation stated in the directions to be taken twice a day, therefore not a legally defined dose. A legally acceptable dose would be \u201cTake one tablet twice a day\u201d",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Apply one patch every 3 days",
        "answer_number": 1
      },
      {
        "text": "Take one tablet when required",
        "answer_number": 2
      },
      {
        "text": "Take twice a day",
        "answer_number": 3
      },
      {
        "text": "Take one tablet four times a day",
        "answer_number": 4
      },
      {
        "text": "Two ampoules to be given over 24 hours",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 972,
    "bank": "clinicalMep",
    "title": "**What is the maximum time period a pharmacist can be absent during the pharmacy business hours?**",
    "text": "Under the responsible pharmacist regulations (2008) allows a pharmacist to be absent from the pharmacy",
    "why": "Under the Responsible Pharmacist Regulations 2008 as amended, the maximum absence duration is 2 hours.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "1 hour",
        "answer_number": 1
      },
      {
        "text": "2 hours",
        "answer_number": 2
      },
      {
        "text": "3 hours",
        "answer_number": 3
      },
      {
        "text": "4 hours",
        "answer_number": 4
      },
      {
        "text": "5 hours",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2508,
    "bank": "clinicalMep",
    "title": "**Which of the following medicines CANNOT be prescribed by a dentist on a NHS prescription?**",
    "text": "You are teaching your trainee pharmacist about NHS dental prescriptions and their restrictions in prescribing.\u00a0\r\n\r\nAn extract of the Dental Practitioners Formulary has been provided for you.\u00a0\r\n\r\nhttps://bnf.nice.org.uk/dental-practitioners-formulary/",
    "why": "b) Co-codamol tablets\r\n\r\nRationale\r\n\r\nCo-codamol tablets are not listed in the Dental Practitioners Formulary (DPF), which defines the medicines that dentists can legally prescribe on the NHS. If a medication is not included in the DPF, dentists are not authorised to prescribe it on an NHS prescription, although they may do so privately if appropriate.\r\n\r\nExplanation of the Other Options\r\n\r\na) Aciclovir cream\r\n\r\nThis is included in the DPF and can be prescribed by dentists for treating conditions like cold sores (herpes labialis) or oral herpetic infections.\r\n\r\nc) Dihydrocodeine tablets\r\n\r\nDihydrocodeine is listed in the DPF and can be prescribed by dentists for short-term pain management when NSAIDs or paracetamol are insufficient.\r\n\r\nd) Lidocaine spray\r\n\r\nLidocaine spray is part of the DPF and is commonly used for topical anaesthesia in dental procedures or to relieve oral discomfort.\r\n\r\ne) Temazepam tablets\r\n\r\nTemazepam tablets are listed in the DPF for use as a sedative in dental practice, particularly for anxious patients undergoing dental procedures.\r\n\r\nThe Dental Practitioners Formulary (DPF) is a section of the British National Formulary (BNF) that outlines the medicines dentists can prescribe on the NHS. Dentists are restricted to prescribing drugs listed in the DPF, which ensures prescribing remains relevant to dental practice. Key considerations:\r\n\r\nPrescriptions must align with the treatment of dental conditions.\r\nMedications outside the DPF cannot be prescribed on the NHS but may be issued privately.\r\nDentists can prescribe Schedule 2, 3, and 4 Controlled Drugs within the DPF, adhering to legal and clinical guidelines.\r\nPharmacists should verify that dental prescriptions comply with the DPF to ensure legality and appropriateness.\r\n\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Aciclovir cream",
        "answer_number": 1
      },
      {
        "text": "Co-codamol tablets",
        "answer_number": 2
      },
      {
        "text": "Dihydrocodeine tablets",
        "answer_number": 3
      },
      {
        "text": "Lidocaine spray",
        "answer_number": 4
      },
      {
        "text": "Temazepam tablets",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 979,
    "bank": "clinicalMep",
    "title": "A prescription for isotretinoin for a 18 year old child bearing potential female patient and under the pregnancy prevention programme.",
    "text": "**Theme: Timeframes**\r\n\r\n**For the following descriptions, please select the most suitable validity of prescriptions from or after the appropriate date, from the list. Each option may be used once, more than once or not at all.**",
    "why": "Prescriptions for oral retinoids under the preganancy prevention programme are valid for 7 days.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "7 days",
        "answer_number": 1
      },
      {
        "text": "28 days",
        "answer_number": 2
      },
      {
        "text": "30 days",
        "answer_number": 3
      },
      {
        "text": "6 months",
        "answer_number": 4
      },
      {
        "text": "2 years",
        "answer_number": 5
      },
      {
        "text": "5 years",
        "answer_number": 6
      },
      {
        "text": "7 years",
        "answer_number": 7
      },
      {
        "text": "10 years",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2292,
    "bank": "clinicalTherapeutics",
    "title": "You look at a 33-year-old secretary who comes in asking for \u2018something for an eye infection\u2019.\u00a0 The right eye has a purulent and sticky discharge, whilst the left eye is watery. You decide it is appropriate to sell her some chloramphenicol 0.5% eye drops.",
    "text": "**Theme: Eye, ear, nose and oropharynx\r\n\r\n\r\n\r\n**For each of the following scenarios select the dose that best corresponds to the counselling required to be given for an initial dose of the products mentioned. Each option may be used once, more than once or not all.**",
    "why": "1 drop every 2 hours\r\n\r\nRationale:\r\n\r\nChloramphenicol 0.5% eye drops are used for bacterial conjunctivitis, which presents with purulent and sticky discharge in one eye, as described in this case. \r\nThe initial dosing frequency depends on the severity of infection and the risk of ocular complications.\r\n\r\nSevere bacterial conjunctivitis requires 1 drop every 2 hours during waking hours for the first 48 hours to ensure rapid bacterial eradication.\r\nOnce improvement is observed, the dosing frequency can be reduced to QDS and should continue for 48 hours after symptoms resolve to prevent recurrence.\r\nThus, the correct initial dose is 1 drop every 2 hours.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 1 drop TDS\r\n\r\nToo infrequent for an initial dose in bacterial conjunctivitis, leading to suboptimal bacterial eradication.\r\n\r\nB: 1 drop QDS\r\n\r\nQDS dosing is appropriate after the first 48 hours, but for initial treatment, more frequent application is needed.\r\n\r\nD: 2 drops BD\r\n\r\nBD dosing is insufficient for treating an active bacterial infection.\r\n\r\nE: 1 spray OD\r\n\r\nNot applicable, as chloramphenicol eye drops are not administered via spray.\r\n\r\nF: 1 spray TDS\r\n\r\nIncorrect formulation; chloramphenicol is not available as an eye spray.\r\n\r\nG: 6 drops OD\r\n\r\nIncorrect frequency; applying multiple drops once daily would not maintain adequate drug levels for bacterial eradication.\r\n\r\nH: 7 drops BD\r\n\r\nToo infrequent, as bacterial infections require regular administration to prevent recurrence and resistance.\r\n\r\n\r\nBacterial Conjunctivitis \r\n\r\nAccording to NICE guidelines (2025) and BNF recommendations, the treatment of bacterial conjunctivitis includes:\r\n\r\nFirst-line choice:\r\n\r\nChloramphenicol 0.5% eye drops: 1 drop every 2 hours for 48 hours, then reduce to QDS for 5 days.\r\nChloramphenicol 1% eye ointment: Used at night if using drops during the day or TDS-QDS if used alone.\r\nCounselling points:\r\n\r\nWash hands before and after application to prevent contamination.\r\nDo not wear contact lenses during treatment.\r\nComplete the full course even if symptoms improve early.\r\n\r\nReferral criteria:\r\n\r\nSevere pain, photophobia, or vision changes (indicating possible keratitis or iritis).\r\nSymptoms lasting >2 weeks despite treatment.\r\n\r\n\r\nFor further information please watch BNF Lesson (Chapter 11) The Eye at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "1 drop TDS",
        "answer_number": 1
      },
      {
        "text": "1 drop QDS",
        "answer_number": 2
      },
      {
        "text": "1 drop every 2 hours",
        "answer_number": 3
      },
      {
        "text": "2 drops BD",
        "answer_number": 4
      },
      {
        "text": "1 spray OD",
        "answer_number": 5
      },
      {
        "text": "1 spray TDS",
        "answer_number": 6
      },
      {
        "text": "6 drops OD",
        "answer_number": 7
      },
      {
        "text": "7 drops BD",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2543,
    "bank": "clinicalMep",
    "title": "**Which of the following is INCORRECT regarding controlled drugs requisition?**",
    "text": "Standardised controlled drug requisition forms are a legal requirement for a professional to obtain schedule 1, 2 and 3 controlled drugs.",
    "why": "(c) Faxed controlled drug requisition forms are legally acceptable\r\n\r\nRationale:\r\n\r\nThe statement is incorrect because faxed or photocopied requisition forms for controlled drugs are not legally acceptable. For the requisition to be valid, it must be a physical, original document. Accepting faxed or copied requisitions could compromise security and accountability measures surrounding controlled drug distribution.\r\n\r\nOther Options Explained:\r\n\r\n(a) A Home Office license is needed to be in possession of Schedule 1 controlled medicines: This is correct. Possession of Schedule 1 drugs is generally prohibited unless the person has a Home Office license, as these drugs have no recognised therapeutic use in the UK.\r\n\r\n(b) A standardised form is not needed if a hospital pharmacy receives a requisition from a ward within the same legal entity: This is also correct. Hospital pharmacies can receive controlled drug requisitions from wards within the same entity without a standardised form.\r\n\r\n(d) In an emergency, a dentist can be supplied with a Schedule 2 or 3 controlled drug if the requisition will be supplied within 24 hours: This is correct. In an emergency, dentists or doctors can obtain Schedule 2 or 3 drugs if they provide a requisition within 24 hours.\r\n\r\n(e) Pharmacists are not able to requisition Schedule 1 controlled medicines: This is correct. Schedule 1 drugs require a Home Office license for possession, and pharmacists are not authorised to requisition these drugs without one.\r\n\r\nAccording to Medicines, Ethics, and Practice (MEP) guidelines, requisition forms for Schedule 2 and 3 controlled drugs must generally be submitted on a standardised, signed form and must be the original document rather than a faxed or photocopied version. For Schedule 1 drugs, Home Office licensing is necessary, as these drugs have no therapeutic use in the UK. Additionally, emergency provisions allow doctors and dentists to obtain Schedule 2 or 3 controlled drugs immediately, provided they submit a requisition within 24 hours. Pharmacists play a critical role in ensuring that all requisition requirements for controlled drugs are strictly met.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "A home office license is needed to be in possession of schedule 1 controlled medicines",
        "answer_number": 1
      },
      {
        "text": "A standarised form is not needed if a hospital pharmacy recieved a requisition from a ward within the same legal entity",
        "answer_number": 2
      },
      {
        "text": "Faxed controlled drug requistition forms are legally acceptable",
        "answer_number": 3
      },
      {
        "text": "In an emergency a dentist can be supplied with a schedule 2 or 3 controlled drug if the requisition will be supplied within 24 hours.",
        "answer_number": 4
      },
      {
        "text": "Pharmacists are not able to requisit schedule 1 controlled medicines",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2296,
    "bank": "clinicalTherapeutics",
    "title": "**How many capsules should be dispensed to the patient for the entire course of treatment?**",
    "text": "A 60-year-old male patient has been prescribed oral amoxicillin for a respiratory infection. The recommended dose is 500mg four times daily for 10 days. The capsules available are 250mg capsules.",
    "why": "80 capsules\r\n\r\nRationale:\r\n\r\nThe patient has been prescribed oral amoxicillin at a dose of 500 mg four times daily (QDS) for 10 days. The available capsule strength is 250 mg per capsule.\r\n\r\nStep-by-step calculation:\r\n\r\n1. Determine how many capsules are needed per dose:\r\n\r\n500 mg required per dose \u00f7 250 mg per capsule = 2 capsules per dose\r\n\r\n2. Calculate the total number of capsules needed per day:\r\n\r\n2 capsules per dose \u00d7 4 doses per day = 8 capsules per day\r\n\r\n3.Determine the total number of capsules for the full 10-day course:\r\n\r\n8 capsules per day \u00d7 10 days = 80 capsules\r\n\r\nThus, the patient will need 80 capsules to complete the course.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 20 capsules\r\n\r\nThis would only cover 2.5 days of treatment, leading to an incomplete course and potential antibiotic resistance.\r\n\r\nB: 40 capsules\r\n\r\nThis would last for 5 days, which is half the required duration, increasing the risk of treatment failure.\r\n\r\nC: 60 capsules\r\n\r\nThis would only cover 7.5 days, which is insufficient to complete the 10-day course.\r\n\r\nE: 100 capsules\r\n\r\nThis exceeds the required amount and would result in extra unused medication, potentially leading to inappropriate self-medication or antimicrobial resistance risks.\r\n\r\nAmoxicillin Use \r\n\r\nAccording to NICE guidelines (2025), amoxicillin is a broad-spectrum penicillin commonly used for respiratory tract infections (RTIs), otitis media, and urinary tract infections (UTIs).\r\n\r\nThe standard dose for moderate respiratory infections is 500 mg every 8 hours for 5 to 10 days, depending on severity.\r\nShorter courses (5 days) may be sufficient for mild cases, whereas severe or persistent infections may require 10 days.\r\nMicrobial resistance is a growing concern, and delayed antibiotic prescribing may be considered for self-limiting infections.\r\nPenicillin allergy assessment is essential, as cross-reactivity with cephalosporins may occur.\r\nMonitoring renal function is advised in older adults, as amoxicillin is primarily renally excreted.\r\n\r\nFor more Information please watch BNF lesson Chapter 5 (Infections):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "20 capsules",
        "answer_number": 1
      },
      {
        "text": "40 capsules",
        "answer_number": 2
      },
      {
        "text": "60 capsules",
        "answer_number": 3
      },
      {
        "text": "80 capsules",
        "answer_number": 4
      },
      {
        "text": "100 capsules",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2386,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is the most appropriate first line treatment?\u00a0**",
    "text": "A 50-year-old woman visits the pharmacy for a routine eye check-up. She has no symptoms or complaints, but her intraocular pressure (IOP) is measured at 24 mmHg in both eyes. She has no history of glaucoma or other eye diseases. She asks for your advice on what eye drops she can use to lower her IOP and prevent glaucoma.",
    "why": "D. Latanoprost\r\n\r\nRationale:\r\n\r\nLatanoprost, a topical prostaglandin analogue, is recommended as the first-line pharmacological treatment for reducing intraocular pressure (IOP) and preventing glaucoma. It is effective in lowering IOP and has a well-established safety profile for patients with elevated IOP but no other symptoms or complications. In cases where latanoprost is not tolerated, other prostaglandin analogues or beta-blockers like timolol can be used as alternatives.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Brimonidine\r\n\r\nThis is a sympathomimetic that can lower IOP by reducing the production of aqueous humor and increasing its outflow. However, it is not the first-line treatment due to its potential side effects, such as ocular irritation and dry mouth, and its limited efficacy compared to prostaglandin analogues.\r\n\r\nB. Cyclopentolate\r\n\r\nThis is an antimuscarinic used to induce pupil dilation for diagnostic purposes, not for lowering IOP. It is not used for glaucoma or elevated IOP.\r\n\r\nC. Dorzolamide\r\n\r\nThis is a carbonic anhydrase inhibitor used to reduce IOP, typically in combination with other treatments. It is second-line after prostaglandin analogues.\r\n\r\nE. Timolol\r\n\r\nThis is a beta-blocker used to reduce IOP by decreasing aqueous humor production. It is effective but typically used second-line after prostaglandin analogues, as they tend to be better tolerated and more effective in the long term.\r\n\r\nFor the treatment of elevated intraocular pressure (IOP) and prevention of glaucoma, prostaglandin analogues, such as latanoprost, are considered the first-line therapy due to their ability to reduce IOP effectively by enhancing aqueous humor outflow. They are preferred over other treatments like beta-blockers (e.g., timolol) or carbonic anhydrase inhibitors (e.g., dorzolamide) because of their superior efficacy and lower incidence of systemic side effects. If prostaglandin analogues are not tolerated, other medications or surgical options may be considered, but latanoprost remains the preferred choice according to current clinical guidelines.\r\n\r\nFor more information watch BNF lesson Chapter 11 (Eyes):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Brimonidine",
        "answer_number": 1
      },
      {
        "text": "Cyclopentolate",
        "answer_number": 2
      },
      {
        "text": "Dorzolamide",
        "answer_number": 3
      },
      {
        "text": "Latanoprost",
        "answer_number": 4
      },
      {
        "text": "Timolol",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2148,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Signs a and Symptoms of toxicity** \r\n\r\n\u2028\u2028**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 61-year old male with bradycardia, hypotension and syncope",
    "why": "Correct answer: \r\n\r\nD) Bisoprolol\r\n\r\nRationale:\r\n\r\nBradycardia, hypotension, and syncope are classic signs of beta-blocker toxicity, particularly with drugs like bisoprolol. Beta-blockers slow the heart rate and reduce cardiac output, which in overdose or heightened sensitivity can lead to dangerously low heart rate (bradycardia), low blood pressure (hypotension), and fainting (syncope).\r\n\r\nExplanation of Other Options:\r\n\r\nA) Aspirin \u2013 Causes metabolic acidosis, tinnitus, hyperventilation, not bradycardia\r\n\r\nB) Amitriptyline \u2013 Can cause tachycardia, seizures, and arrhythmias, not bradycardia\r\n\r\nC) Amlodipine \u2013 Can cause hypotension, but typically with reflex tachycardia, not bradycardia and syncope\r\n\r\nE) Citalopram \u2013 May cause QT prolongation and seizures, not primary bradycardia\r\n\r\nF) Fentanyl \u2013 Can cause respiratory depression, but not typically bradycardia and syncope as primary features\r\n\r\nG) Naproxen \u2013 NSAID, not associated with bradycardia or hypotension\r\n\r\nH) Paracetamol \u2013 Mainly causes hepatic toxicity, not cardiovascular symptoms\r\n\r\n\r\nBisoprolol, a beta-blocker, is the most likely cause of bradycardia, hypotension, and syncope in this scenario. In toxicity, beta-blockers depress the cardiac conduction system, which can lead to life-threatening cardiovascular effects.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Aspirin",
        "answer_number": 1
      },
      {
        "text": "Amitriptyline",
        "answer_number": 2
      },
      {
        "text": "Amlodipine",
        "answer_number": 3
      },
      {
        "text": "Bisoprolol",
        "answer_number": 4
      },
      {
        "text": "Citalopram",
        "answer_number": 5
      },
      {
        "text": "Fentanyl",
        "answer_number": 6
      },
      {
        "text": "Naproxen",
        "answer_number": 7
      },
      {
        "text": "Paracetamol",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2541,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT an example of home office approved wording?**",
    "text": "The home office has approved specific wording for instalment prescriptions which allows pharmacists a degree of flexibility when supplying either methadone or buprenorphine to a patient.",
    "why": "(a) Consult the prescriber if two or more consecutive days of a prescription have been missed.\r\n\r\nRationale:\r\n\r\nThe Home Office has established specific, approved wording for instalment prescriptions to provide pharmacists with flexibility when supplying controlled drugs like methadone or buprenorphine. This wording is important for ensuring continuity in patient treatment while also maintaining necessary oversight. One of these approved phrases is \u201cConsult the prescriber if three or more consecutive days of a prescription have been missed.\u201d The option \u201cConsult the prescriber if two or more consecutive days of a prescription have been missed\u201d is incorrect because it does not follow the approved guidance, which specifically states three or more consecutive days.\r\n\r\nOther Options Explained:\r\n\r\n(b) Dispense daily doses in separate containers: This is correct and is an approved phrase to support patient adherence by helping to clarify daily doses.\r\n\r\n(c) If an instalment collection day has been missed, please still dispense the amount due for any remaining day(s) of that instalment: This is correct and is approved wording, allowing for flexibility if a collection is missed.\r\n\r\n(d) Please dispense instalments due on a pharmacy closed days on a prior suitable day: This is correct. This phrase is approved, as it accounts for pharmacy closures and allows for dispensing the instalment early.\r\n\r\n(e) Supervised consumption on collection days: This is correct and approved, indicating that the patient\u2019s dose should be supervised by the pharmacist upon collection.\r\n\r\nThe Medicines, Ethics, and Practice (MEP) guide emphasises that controlled drug prescriptions for instalments, especially for drugs like methadone and buprenorphine used in opioid dependency, must comply with Home Office-approved wording to maintain safety and continuity in patient treatment. Approved phrases help manage missed doses, reinforce daily adherence, and accommodate pharmacy closures. For missed doses, the guidance specifies consulting the prescriber after three missed days, as missing three consecutive doses could indicate a disruption in the patient\u2019s treatment plan that requires intervention. This level of structure ensures that the pharmacist has clear protocols to follow while still maintaining flexibility to support the patient's needs and safety.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Consult the prescriber if two or more consecutive days of a prescription have been missed.",
        "answer_number": 1
      },
      {
        "text": "Dispense daily doses in separate containers",
        "answer_number": 2
      },
      {
        "text": "If an instalment collection day has been missed, please still dispense the amount due for any remaining day(s) of that instalment.",
        "answer_number": 3
      },
      {
        "text": "Please dispense instalments due on a pharmacy closed days on a prior suitable day",
        "answer_number": 4
      },
      {
        "text": "Supervised consumption on collection days",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 964,
    "bank": "clinicalMep",
    "title": "**Which of the following requirements is NOT necessary for the prescription to be considered legally valid?**",
    "text": "A patient presents a prescription at the pharmacy for estradiol 50mcg patches.",
    "why": "The correct answer is E. According to the provided information, a valid prescription must fulfill several requirements to be considered legally valid. These include being signed in ink by an appropriate practitioner or having an advanced electronic signature (Option A), containing the prescriber's address (Option B), being dated and having a specified validity period (Option C), and featuring the patient's name, address, and age if applicable (Option D). However, it is not a legal requirement for the prescription to include the patient's NHS number.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "The prescription must be signed in ink by an appropriate practitioner or possess an advanced electronic signature.",
        "answer_number": 1
      },
      {
        "text": "The prescription must contain the address of the prescriber.\u00a0.",
        "answer_number": 2
      },
      {
        "text": "The prescription must be dated and remains valid for up to six months from the appropriate date, or 28 days for Schedule 2, 3, or 4 Controlled Drugs.",
        "answer_number": 3
      },
      {
        "text": "The prescription must include the patient's name, address, and age (if under 12 years old).",
        "answer_number": 4
      },
      {
        "text": "The prescription must feature the patient's NHS number",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2237,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Electrolyte imbalances**\r\n\r\n\r\n\r\n**Instruction: For each of the following patients, select the most likely electrolyte imbalances they are experiencing from the list of options. Each option may be used once, more than once, or not at all**",
    "text": "Mr J presents to hospital via an ambulance feeling fatigued and with an abnormal heart rhythm. Upon arrival an ECG and bloods are undertaken. The ECG shows widened QRS intervals and Mr J is quickly started on calcium gluconate to stabilise the myocardium. Once the blood results are back it is decided to start him on calcium polystyrene sulfonate resin as a result of the findings.",
    "why": "Correct Answer:\r\n\r\nB) Hyperkalaemia\r\n\r\nRationale:\r\n\r\nMr J is showing clinical signs of hyperkalaemia, a dangerous elevation in serum potassium levels that can cause:\r\n\r\n- Fatigue\r\n\r\n- Cardiac arrhythmias\r\n\r\n- ECG changes such as widened QRS complexes, peaked T-waves, and prolonged PR interval\r\n\r\n- The immediate use of calcium gluconate confirms this diagnosis, as it is administered to protect the myocardium from the depolarising effects of excess potassium \u2014 but it does not lower potassium levels.\r\n\r\n- To actively lower serum potassium, calcium polystyrene sulphonate resin (Kayexalate or Resonium) is used. It works by binding potassium in the gut, helping eliminate it via faeces.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Hypercalcaemia \r\n\r\nWould not cause widened QRS or be treated with calcium gluconate and potassium-binding resins.\r\n\r\nC) Hypernatraemia \r\n\r\nPresents with confusion, thirst, and neurological symptoms, not typically ECG changes.\r\n\r\nD) Hypocalcaemia \r\n\r\nWould be treated with calcium gluconate, but no reason to use potassium resin.\r\n\r\nE) Hypokalaemia \r\n\r\nCauses flattened T-waves and muscle weakness, not widened QRS or calcium gluconate treatment.\r\n\r\nF) Hypomagnesaemia \r\n\r\nCan lead to arrhythmias, but not typically treated with calcium polystyrene sulfonate.\r\n\r\nG) Hyponatraemia \r\n\r\nLeads to confusion, seizures, and low serum sodium \u2014 no indication for potassium-binding resin.\r\n\r\nH) Hypophosphataemia \r\n\r\nUnrelated to ECG changes or treatment with calcium-based potassium resins.\r\n\r\nHyperkalaemia Management:\r\n\r\nHyperkalaemia is a medical emergency requiring urgent treatment to prevent life-threatening arrhythmias. \r\nAccording to the NICE guidelines acute and chronic hyperkalaemia, the first step is cardiac membrane stabilisation using intravenous calcium gluconate. This protects the heart but does not lower potassium levels. Subsequent steps include shifting potassium into cells (e.g. insulin with glucose, beta-agonists), and removal from the body, such as via resins like calcium polystyrene sulphonate or renal replacement therapy in severe or refractory cases. Monitoring ECG changes and repeating blood potassium levels is critical in guiding further treatment.\r\n\r\nFor more information please watch BNF lesson Chapter 9 (Blood & Nutrition):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Hypercalcaemia",
        "answer_number": 1
      },
      {
        "text": "Hyperkalaemia",
        "answer_number": 2
      },
      {
        "text": "Hypernatraemia",
        "answer_number": 3
      },
      {
        "text": "Hypocalcaemia",
        "answer_number": 4
      },
      {
        "text": "Hypokalaemia",
        "answer_number": 5
      },
      {
        "text": "Hypomagnesaemia",
        "answer_number": 6
      },
      {
        "text": "Hyponatraemia",
        "answer_number": 7
      },
      {
        "text": "Hypophosphataemia",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2307,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most likely diagnosis?**",
    "text": "A 45-year-old man presents to your clinic with a 2-week history of lower back pain radiating down his left leg. The pain is described as a sharp, burning sensation that is worse when sitting or standing for long periods.",
    "why": "Sciatica\r\n\r\nRationale:\r\n\r\nThis patient presents with sharp, burning pain radiating down the left leg, which worsens with prolonged sitting or standing. This is a classic presentation of sciatica, a condition caused by compression or irritation of the sciatic nerve, often due to lumbar disc herniation at L4-L5 or L5-S1.\r\n\r\nA positive Straight Leg Raise (SLR) test (pain reproduced when lifting the affected leg while lying down) is a key clinical finding in sciatica. The condition is often self-limiting, and treatment focuses on pain management, physiotherapy, and maintaining mobility.\r\n\r\nExplanation of Other Options:\r\n\r\nA: Hip osteoarthritis\r\n\r\nHip osteoarthritis causes gradual onset of joint stiffness and pain, typically worsened by movement but not radiating down the leg in a sharp, burning pattern.\r\n\r\nB: Muscular dystrophy\r\n\r\nMuscular dystrophy is a genetic disorder causing progressive muscle weakness rather than acute onset radiating pain.\r\n\r\nC: Rheumatoid arthritis\r\n\r\nRheumatoid arthritis (RA) typically affects multiple joints symmetrically, especially the small joints of the hands and feet, and does not usually present as unilateral lower back pain radiating to the leg.\r\n\r\nD: Sacroiliac joint dysfunction\r\n\r\nSacroiliac joint dysfunction can cause lower back pain, but it usually presents as localised pain in the sacroiliac region rather than sharp, burning pain radiating down the leg.\r\n\r\nSciatica is a common cause of lower back pain radiating down the leg, often due to lumbar disc herniation or nerve root compression. According to NICE NG59: Low Back Pain and Sciatica, first-line management includes analgesia (paracetamol, NSAIDs), physiotherapy, and maintaining physical activity. Opioids are not routinely recommended. In severe or persistent cases, referral for imaging (MRI) and specialist assessment may be required, particularly if there are red flag symptoms such as bladder dysfunction, saddle anaesthesia, or progressive weakness, which suggest cauda equina syndrome, a medical emergency.\r\n\r\nFor more information, please watch BNF Lesson Chapter 10 (Musculoskeletal System) at:\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Hip osteoarthritis",
        "answer_number": 1
      },
      {
        "text": "Muscular dystrophy",
        "answer_number": 2
      },
      {
        "text": "Rheumatoid arthritis",
        "answer_number": 3
      },
      {
        "text": "Sacroiliac joint dysfunction",
        "answer_number": 4
      },
      {
        "text": "Sciatica",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2586,
    "bank": "clinicalOtc",
    "title": "**Which of the following would NOT require a referral?**",
    "text": "You are teaching your trainee Pharmacist regarding herpes simplex labialis",
    "why": "A 34-year-old pregnant female who requires aciclovir 5% cream for a cold sore\r\n\r\nRationale: \r\n\r\nA 34-year-old pregnant female with a typical cold sore does not require a referral if she is only seeking to purchase aciclovir 5% cream, which is safe to use during pregnancy for topical treatment. Pregnancy is not a contraindication for topical aciclovir use in the case of herpes simplex labialis, and it can be managed in a pharmacy setting.\r\n\r\nOn the other hand, the other patients would require referral for the following reasons:\r\n\r\nA 65-year-old patient with a sore for 3 weeks: This indicates a chronic or non-healing sore, which may require investigation for underlying conditions, such as malignancy or a resistant infection.\r\nA 23-year-old patient with cold sores inside their mouth: Herpes simplex labialis typically affects the lips and surrounding areas. Sores inside the mouth are not common for typical cold sores and could indicate another condition, such as herpetic gingivostomatitis or an oral ulcer, which requires referral.\r\nAn 18-year-old patient with a cold sore that has spread to the face: This suggests a more extensive or complicated infection, potentially requiring antiviral medication beyond topical treatment or further medical assessment.\r\nA 48-year-old patient with severe and widespread lesions: Widespread or severe lesions may indicate a more serious form of herpes simplex infection or an immunocompromised state, and these patients should be referred for systemic treatment and further investigation.\r\n\r\n\r\nAccording to NICE guidelines, herpes simplex labialis (cold sores) usually presents as a recurrent, self-limiting viral infection that can be managed with topical antiviral agents, such as aciclovir 5% cream. Most cases resolve within 10\u201314 days, and treatment is aimed at reducing the duration and severity of symptoms. Referral is warranted for patients who have chronic, non-healing sores, widespread infections, involvement of the oral mucosa, or if they are immunocompromised. Safe use of topical antiviral treatments in pregnant women is well-established, making them suitable candidates for over-the-counter management unless the infection is severe or atypical.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "A 34 year old pregnant female who requires aciclovir 5% cream for cold sore.",
        "answer_number": 1
      },
      {
        "text": "A 65 year old patient with a sore on his lip for the past 3 weeks",
        "answer_number": 2
      },
      {
        "text": "A 23 year old patient with cold sores inside their mouth",
        "answer_number": 3
      },
      {
        "text": "A 18 year old patient with a cold sore which has spread on to the face",
        "answer_number": 4
      },
      {
        "text": "A 48 year old patient with severe and widespread lesions",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2357,
    "bank": "clinicalTherapeutics",
    "title": "**which of the following would be the most appropriate first line treatment for this patient?**",
    "text": "A 35-year-old patient has been diagnosed with flexural psoriasis.",
    "why": "D. Topical corticosteroids\r\n\r\nRationale:\r\n\r\nFlexural psoriasis primarily affects areas of thin skin, such as the groin, armpits, and under the breasts. These areas are prone to irritation and sensitivity, making the treatment approach different from that of plaque psoriasis on thicker skin.\r\n\r\nTopical corticosteroids are the first-line treatment for flexural psoriasis:\r\n\r\nEfficacy: Corticosteroids reduce inflammation and itching, providing quick relief from symptoms.\r\n\r\nStrength: Only mild to moderate potency corticosteroids (e.g., Eumovate\u00ae cream) are recommended for thin skin to avoid thinning or atrophy.\r\n\r\nDiscontinuation: Treatment should be stopped once symptoms have resolved to minimise the risk of adverse effects.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Phototherapy\r\n\r\nPhototherapy is not typically used as a first-line treatment for flexural psoriasis due to the difficulty of adequately exposing these areas to UV light.\r\n\r\nB. Systemic or biologic therapy\r\n\r\nThese are reserved for severe or refractory psoriasis cases that fail to respond to topical treatments. Flexural psoriasis is usually mild and can be managed with topical therapy alone.\r\n\r\nC. Topical calcineurin inhibitors\r\n\r\nWhile calcineurin inhibitors such as tacrolimus (Protopic\u00ae) or pimecrolimus (Elidel\u00ae) are useful alternatives, they are generally considered off-label for psoriasis and are used only if topical corticosteroids are unsuitable or ineffective.\r\n\r\nE. Vitamin D analogues\r\n\r\nVitamin D analogues such as calcipotriol (Curatoderm\u00ae) are effective in psoriasis but can cause irritation in flexural areas. They may be used as second-line treatment if corticosteroids are unsuitable or overuse is a concern.\r\n\r\nMild Topical Corticosteroids for Flexural Psoriasis:\r\n\r\nThese are the first choice due to their effectiveness and safety profile for thin, sensitive skin.\r\n\r\nDiscontinuation Once Symptoms Resolve:\r\n\r\nProlonged use of corticosteroids on thin skin can lead to atrophy, striae, and other complications.\r\n\r\nSecond-Line Options:\r\n\r\nVitamin D analogues or calcineurin inhibitors can be used if steroids are contraindicated or excessive use is a concern.\r\n\r\nThis approach ensures effective symptom relief while minimising potential side effects.\r\n\r\nFor more information watch BNF lesson Chapter 13 (Skin):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Phototherapy",
        "answer_number": 1
      },
      {
        "text": "Systemic or biologic therapy",
        "answer_number": 2
      },
      {
        "text": "Topical calcineurin inhibitors",
        "answer_number": 3
      },
      {
        "text": "Topical corticosteroids",
        "answer_number": 4
      },
      {
        "text": "Vitamin D analogues",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2597,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of his diarrhoea?**",
    "text": "A 22 year old male presents to the pharmacy with abdominal discomfort and bouts of bloody diarrhoea where each bowel movement is urgent.",
    "why": "Ulcerative colitis\r\n\r\nRationale:\r\n\r\nThe symptoms described\u2014abdominal discomfort, bloody diarrhoea, and urgent bowel movements\u2014are characteristic of ulcerative colitis, a chronic inflammatory bowel disease (IBD). Ulcerative colitis typically affects the colon and rectum, leading to inflammation, ulceration, and bleeding in the bowel. These symptoms align with a flare-up of this condition, which often presents in young adults.\r\n\r\nExplanation of Other Options:\r\n\r\nColorectal cancer: While colorectal cancer can cause changes in bowel habits and sometimes bleeding, it usually presents with more subtle, gradual symptoms, such as weight loss and non-specific abdominal discomfort. Bloody diarrhoea with urgency is more typical of an inflammatory condition like ulcerative colitis.\r\n\r\nIrritable bowel syndrome (IBS): IBS can cause abdominal discomfort and changes in bowel habits, but it is not typically associated with bloody diarrhoea or urgent bowel movements. The presence of blood suggests an inflammatory or structural issue, which is not common in IBS.\r\n\r\nGastro-enteritis: Gastro-enteritis usually presents with non-bloody diarrhoea, nausea, vomiting, and abdominal cramps. Bloody diarrhoea is more indicative of a more severe inflammatory or infectious condition, like ulcerative colitis or bacterial dysentery.\r\n\r\nMalabsorption syndrome: This can cause diarrhoea and weight loss, but bloody stools are not a common feature. The urgency and presence of blood in the stool point towards an inflammatory condition rather than malabsorption.\r\n\r\n\r\nUlcerative colitis is a chronic condition that leads to inflammation and ulceration of the colon, resulting in symptoms like bloody diarrhoea, abdominal pain, and urgency to defecate. According to NICE guidelines, management of ulcerative colitis depends on disease severity. Mild-to-moderate cases can often be managed with aminosalicylates like mesalazine, while more severe cases may require corticosteroids or immunosuppressants. Early diagnosis and appropriate treatment are essential to manage symptoms and prevent complications. Regular monitoring and tailored therapy are crucial for long-term disease control.\r\n\r\n\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Colorectal cancer",
        "answer_number": 1
      },
      {
        "text": "Irritable bowel syndrome",
        "answer_number": 2
      },
      {
        "text": "Gastro-enteritis",
        "answer_number": 3
      },
      {
        "text": "Malabsorption syndrome",
        "answer_number": 4
      },
      {
        "text": "Ulcerative colitis",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2294,
    "bank": "clinicalTherapeutics",
    "title": "A child is admitted to hospital with a dog bite, the registrar asks for your advice in the supply of this vaccine",
    "text": "**Theme: Vaccines and immunisations**\r\n** For each of the following scenarios choose the vaccination which needs to be administered and/or which best applies**",
    "why": "Tetanus immunoglobulin\r\n\r\nRationale:\r\n\r\nA dog bite poses a risk of tetanus infection due to potential contamination with Clostridium tetani, a spore-forming bacterium that thrives in deep or puncture wounds.\r\n\r\nTetanus immunoglobulin (TIG) is recommended if the wound is high-risk and the patient is inadequately vaccinated or if their last tetanus booster was over 10 years ago.\r\nIf the child is not fully vaccinated, a tetanus-containing vaccine (e.g., DTaP, Td/IPV booster) should be given alongside TIG.\r\nThus, tetanus immunoglobulin is the most appropriate intervention following an animal bite.\r\n\r\nExplanation of Other Options:\r\n\r\nA: BCG vaccine\r\nThe BCG vaccine protects against tuberculosis (TB) and is unrelated to dog bites.\r\n\r\nB: Hepatitis B vaccine\r\nThe hepatitis B vaccine is administered to prevent bloodborne transmission (e.g., via needlestick injuries) but is not relevant for dog bites.\r\n\r\nC: Influenza vaccine\r\nThe influenza vaccine is given annually to protect against seasonal flu and has no role in dog bite management.\r\n\r\nD: Meningococcal B vaccine\r\nThe MenB vaccine is given to protect against meningococcal disease and is not indicated for a dog bite.\r\n\r\nE: Meningococcal quadrivalent ACWY\r\nThe MenACWY vaccine is provided for meningitis prevention but is not relevant in this case.\r\n\r\nF: Pneumococcal conjugate vaccine\r\nThe pneumococcal vaccine protects against Streptococcus pneumoniae infections (e.g., pneumonia, meningitis) and is not related to dog bites.\r\n\r\nG: Rotavirus vaccine\r\nThe rotavirus vaccine is given to infants to prevent viral gastroenteritis and is not applicable for this case.\r\n\r\nTetanus Management \r\n\r\nAccording to NICE guidelines, tetanus-prone wounds include:\r\n\r\n-Animal bites (including dog bites)\r\n-Puncture wounds with soil, faeces, or saliva contamination\r\n-Crush injuries or deep wounds with devitalised tissue\r\n\r\nManagement of dog bites includes:\r\n\r\n1. Wound cleaning: Immediate irrigation with saline to reduce infection risk.\r\n\r\n2. Tetanus prophylaxis:\r\n\r\n-If fully vaccinated (\u22655 doses): No booster needed unless the last dose was over 10 years ago.\r\n\r\n-If uncertain/incompletely vaccinated: Give tetanus booster (Td/IPV) + Tetanus immunoglobulin (TIG).\r\n\r\n3. Rabies prophylaxis: Considered if the bite occurred in a rabies-endemic area.\r\n\r\n4.Antibiotic prophylaxis: Co-amoxiclav is the first-line antibiotic for infected or high-risk bites.\r\n\r\nFor more Information please watch BNF lesson Chapter 14 (Vaccine):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 8,
    "weighting": 3,
    "answers": [
      {
        "text": "BCG vaccine",
        "answer_number": 1
      },
      {
        "text": "Hepatitis B vaccine",
        "answer_number": 2
      },
      {
        "text": "Influenza vaccine",
        "answer_number": 3
      },
      {
        "text": "Meningococcal B vaccine",
        "answer_number": 4
      },
      {
        "text": "Meningococcal quadrivalent ACWY",
        "answer_number": 5
      },
      {
        "text": "Pneumococcal conjugate vaccine",
        "answer_number": 6
      },
      {
        "text": "Rotavirus vaccine",
        "answer_number": 7
      },
      {
        "text": "Tetanus immunoglobulin",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2261,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most likely diagnosis based on the blood results?**",
    "text": "A patient who presents to hospital with a three-month history of feeling chronically tired.\u00a0 He has been feeling sick for the last week and is pale in colour.\u00a0\r\n\r\nThe medical team order haematinics, which come back as follows:\u00a0\r\n\r\n- Haemoglobin 110 g/L (130 \u2013 170 g/L\r\n\r\n- MCV 110 g/L (130 \u2013 170 g/L)\r\n\r\n- MCH 36 pg (27-32 pg)\r\n\r\n- Ferritin 50 ng/L (20-200 ng/L)\r\n\r\n- Folate 4 ng/L (3-13 ng/L)\r\n\r\n- B12 97 ng/L (200-800 ng/L)",
    "why": "Correct Answer:\r\n\r\nC) Pernicious Anaemia\r\n\r\nRationale:\r\n\r\nThe patient's low haemoglobin (110 g/L) and elevated mean corpuscular volume (MCV) of 110 fL indicate macrocytic anaemia. The key findings that support vitamin B12 deficiency are:\r\n\r\n- Severely low B12 level (97 ng/L, normal: 200\u2013800 ng/L)\r\n- Normal ferritin (50 ng/L, normal: 20\u2013200 ng/L), ruling out iron-deficiency anaemia\r\n- Low folate (4 ng/L, normal: 3\u201313 ng/L)\r\n\r\nThe most likely cause of vitamin B12 deficiency is pernicious anaemia, an autoimmune condition that leads to impaired absorption of B12 due to intrinsic factor deficiency.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Haemoglobinopathy \r\n\r\nHaemoglobinopathies (e.g., sickle cell disease, thalassaemia) typically present with microcytic anaemia (low MCV) rather than macrocytosis.\r\n\r\n(B) Methaemoglobinaemia \r\n\r\nMethaemoglobinaemia is a functional haemoglobin disorder where oxygen delivery is impaired, leading to cyanosis and hypoxia. It does not cause macrocytic anaemia.\r\n\r\n(D) Sickle Cell Anaemia \r\n\r\nSickle cell anaemia is a genetic haemoglobinopathy that presents with normocytic or microcytic anaemia, not macrocytosis.\r\n\r\n(E) Thalassaemia \r\n\r\nInherited disorder affecting haemoglobin synthesis. It causes microcytic anaemia (low MCV), which contradicts the patient\u2019s high MCV.\r\n\r\nPernicious Anaemia \r\n\r\nPernicious anaemia is a leading cause of vitamin B12 deficiency, which leads to macrocytic anaemia and neurological complications if untreated.\r\n\r\nNICE 2025 recommends the following approach:\r\n\r\n- Diagnosis: Confirmed by low B12 levels and positive intrinsic factor/parietal cell antibodies.\r\n\r\nTreatment:\r\n\r\n- Hydroxocobalamin 1 mg IM three times a week for two weeks.\r\n\r\n- Maintenance: 1 mg IM every three months for life if pernicious anaemia is confirmed.\r\n\r\n- Oral cyanocobalamin is not recommended for pernicious anaemia due to malabsorption.\r\n\r\n- Folic acid supplementation: Only after B12 correction, if folate deficiency is also present.\r\n\r\n- Monitoring: Regular full blood count (FBC) and neurological assessment to ensure adequate response.\r\n\r\nFor more information, please watch BNF lesson Chapter 9 (Nutrition and Blood):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Haemoglobinopathy",
        "answer_number": 1
      },
      {
        "text": "Methaemoglobinaemia",
        "answer_number": 2
      },
      {
        "text": "Pernicious anaemia",
        "answer_number": 3
      },
      {
        "text": "Sickle cell anaemia",
        "answer_number": 4
      },
      {
        "text": "Thalassaemia",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 988,
    "bank": "clinicalOtc",
    "title": "A 31-year old woman with blood on her tissue after passing a bowel movement and complaining of soreness around the perianal area",
    "text": "**Theme: Gastroenterology conditions**\u2028\u2028\r\n\r\n**Instruction: select the most appropriate gastroenterology condition correlating with the symptoms associated with each patient. Each option may be used once, more than once or not at all**",
    "why": "The most suitable condition for the patient described is haemorrhoids. Haemorrhoids, also known as piles, are swollen veins in the lower part of the anus and rectum. When the walls of these blood vessels stretch, the veins bulge and become irritated, especially when you defecate. Haemorrhoids can develop inside the rectum (internal haemorrhoids) or under the skin around the anus (external haemorrhoids). One of the most common symptoms of haemorrhoids is bleeding during bowel movements, which can be seen on toilet paper or in the toilet bowl. Other symptoms include itching, discomfort, and soreness around the anus",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Bowel Obstruction",
        "answer_number": 1
      },
      {
        "text": "Constipation",
        "answer_number": 2
      },
      {
        "text": "Carcinoma",
        "answer_number": 3
      },
      {
        "text": "Diarrhoea",
        "answer_number": 4
      },
      {
        "text": "Haemorrhoids",
        "answer_number": 5
      },
      {
        "text": "Heartburn",
        "answer_number": 6
      },
      {
        "text": "Irritable bowel syndrome",
        "answer_number": 7
      },
      {
        "text": "Stomach Ulcer",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2420,
    "bank": "clinicalTherapeutics",
    "title": "A patient with chronic renal failure and symptomatic anaemia (haemoglobin 8.5 g/dL) who is not on dialysis and requires a starting dose for correction phase treatment.",
    "text": "**Theme: Most suitable dose of epoetin alpha**\r\n\r\n\r\n**Instruction: For each scenario, select the most suitable dose of epoetin alpha from the list of answer options. Each option may be used once, more than once or not at all.**\u2028\u2028The sPmC for Eprex has been provided for you.\u2028[SmPC for Eprex](https://www.medicines.org.uk/emc/product/3442/smpc#gref)",
    "why": "50 IU/kg three times a week\r\n\r\nRationale:\r\n\r\nIn patients with chronic renal failure who are not on dialysis, the SmPC for Eprex recommends an initial starting dose of 50 IU/kg three times weekly during the correction phase. This regimen provides sufficient stimulation of erythropoiesis to correct anaemia effectively while reducing the risks of overtreatment, such as hypertension or thromboembolism. Regular monitoring of haemoglobin levels is essential to ensure efficacy and safety.\r\n\r\nExplanation of Other Options:\r\n\r\nA. 50 IU/kg twice weekly\r\n\r\nThis dose is lower than the recommended frequency for non-dialysis patients during the correction phase and may not adequately address anaemia in this scenario.\r\n\r\nB. 75 IU/kg three times weekly\r\n\r\nWhile this dose may be suitable for some patients, it exceeds the standard starting dose and could increase the risk of adverse effects, such as elevated blood pressure.\r\n\r\nC. 100 IU/kg once weekly\r\n\r\nThis dose and frequency are inappropriate for the correction phase, as it does not provide adequate stimulation for anaemia management in patients with a haemoglobin of 8.5 g/dL.\r\n\r\nD. 150 IU/kg once every two weeks\r\n\r\nThis dose and frequency are too infrequent for effective correction-phase treatment, as anaemia requires more consistent management during the initial stages.\r\n\r\nE. 300 IU/kg once every four weeks\r\n\r\nThis schedule is typically used for maintenance therapy or other indications. It is not suitable for the correction phase in non-dialysis patients with chronic renal failure.\r\n\r\nF. 450 IU/kg once weekly\r\n\r\nThis higher dose exceeds the standard starting dose for correction-phase treatment and may increase the risk of complications, especially in non-dialysis patients.\r\n\r\nG. 600 IU/kg once weekly\r\n\r\nThis dose is excessive and not recommended as an initial starting dose in the correction phase of anaemia associated with chronic renal failure.\r\n\r\nNICE recommends the use of erythropoiesis-stimulating agents (ESAs), such as epoetin alpha, for managing anaemia in chronic kidney disease (CKD), including patients not on dialysis. The target haemoglobin level is typically 10\u201312 g/dL, and therapy should be initiated when levels fall significantly below this range, particularly if symptoms of anaemia are present.\r\n\r\nFor the correction phase, more frequent dosing (e.g., three times weekly) is advised to restore haemoglobin levels effectively. NICE emphasises the importance of individualised therapy, regular monitoring of haemoglobin levels, and vigilance to avoid overcorrection, which can lead to cardiovascular complications.\r\n\r\nFor more information watch BNF lesson Chapter 9 (Blood and Nutrition):\r\n\r\nhttps://preregshortcuts.com/preview-question/2432",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "50 IU/kg twice weekly",
        "answer_number": 1
      },
      {
        "text": "50 IU/kg three times a week.",
        "answer_number": 2
      },
      {
        "text": "75 IU/kg three times weekly",
        "answer_number": 3
      },
      {
        "text": "100 IU/kg once weekly",
        "answer_number": 4
      },
      {
        "text": "150 IU/kg once every two weeks",
        "answer_number": 5
      },
      {
        "text": "300 IU/kg once every four weeks",
        "answer_number": 6
      },
      {
        "text": "450 IU/kg once weekly",
        "answer_number": 7
      },
      {
        "text": "600 IU/kg once weekly",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2560,
    "bank": "clinicalOtc",
    "title": "**What is the most likely cause of his symptoms?**",
    "text": "A 65-year-old male comes to your community pharmacy with a complaint of coughing up pink frothy sputum for the past two days. He says he has a history of high blood pressure and atrial fibrillation and takes apixiban, ramipril, and bisoprolol. He also reports feeling short of breath, sweaty, and having chest pain. He asks you for a cough medicine to ease his symptoms.",
    "why": "c) Congestive heart failure\r\n\r\nRationale:\r\n\r\nThe most likely cause of this patient\u2019s symptoms is congestive heart failure (CHF). Coughing up pink frothy sputum is a classic sign of pulmonary edema, a complication often associated with worsening heart failure. In CHF, the heart\u2019s reduced ability to pump blood effectively can lead to fluid buildup in the lungs, causing pink frothy sputum, shortness of breath, chest pain, and sweating. These symptoms suggest an urgent medical need, as pulmonary edema in the context of CHF requires prompt treatment and hospital referral.\r\n\r\nThe patient\u2019s medical history, including high blood pressure and atrial fibrillation, increases his susceptibility to CHF. His medications\u2014apixaban (an anticoagulant), ramipril (an ACE inhibitor), and bisoprolol (a beta-blocker)\u2014help manage these conditions. However, the sudden worsening of symptoms indicates a likely CHF exacerbation, requiring immediate intervention with treatments such as oxygen therapy, diuretics to manage fluid overload, and close monitoring.\r\n\r\nExplanation of Other Options:\r\n\r\na) Acute bronchitis: Characterized by a productive cough, often with yellow or green sputum, usually following a viral infection. It does not typically produce pink frothy sputum.\r\nb) Aspiration pneumonia: Caused by inhaling a foreign substance, leading to lung inflammation and fever, but not associated with frothy or pink sputum.\r\nd) Lung cancer: Typically causes a persistent, chronic cough that may be blood-stained, along with weight loss, but is not commonly linked to sudden pink frothy sputum.\r\ne) Pulmonary embolism: Often presents with sudden chest pain, breathlessness, and may cause bloody, rather than frothy, sputum.\r\n\r\nAccording to NICE guidelines, symptoms such as pink frothy sputum and shortness of breath in a patient with CHF indicate acute pulmonary edema, necessitating urgent hospital referral. Immediate management includes oxygen support to alleviate hypoxia, diuretics to reduce lung fluid, and, if indicated, vasodilators to lower cardiac workload. Long-term CHF management typically involves medications to reduce fluid retention, enhance heart function, and manage blood pressure, as well as routine monitoring to prevent exacerbations. Educating patients on symptom recognition and lifestyle modifications, such as reducing sodium intake and monitoring fluid status, is crucial for ongoing CHF management.\r\n\r\nFor more information please watch BNF lesson chapter 2 (Respiratory):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Acute bronchitis",
        "answer_number": 1
      },
      {
        "text": "Aspiration pneumonia",
        "answer_number": 2
      },
      {
        "text": "Congestive heart failure",
        "answer_number": 3
      },
      {
        "text": "Lung cancer",
        "answer_number": 4
      },
      {
        "text": "Pulmonary embolism",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2610,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 45 year old diabetic male presents to the pharmacy with a problem with his feet.\u00a0\r\nA picture of the patient's feet is presented below:\u00a0\r\n![fungalnail2](https://i.ibb.co/PDPhtzn/fungalnail2.jpg \"750x600\")",
    "why": "Patients with more than 2 nails affected and diabetic patients need to be referred.The most appropriate advice for the patient is:\r\n\r\n\"Advise to see his GP as soon as possible.\"\r\n\r\nRationale: \r\n\r\nFor a diabetic patient presenting with a foot problem, it is crucial to prioritise proper assessment and management due to the increased risk of complications associated with diabetes, such as peripheral neuropathy and poor circulation. Fungal nail infections (onychomycosis) in diabetic patients can escalate quickly if left untreated and may lead to more severe complications like cellulitis or ulceration.\r\n\r\nAdvise the condition is self-limiting: This is not appropriate because fungal infections in diabetic patients are not typically self-limiting and require medical intervention.\r\nAdvise to purchase amorolfine 5% nail lacquer: While this is a suitable option for non-diabetic patients with mild fungal infections, it is insufficient for a diabetic patient who may need more thorough evaluation and management.\r\nAdvise to go to accident and emergency: This is not necessary unless the patient shows signs of severe infection, such as fever, spreading redness, or an open wound.\r\nSupply terbinafine 250mg tablets: Oral antifungals may be necessary, but they should only be supplied after proper assessment and prescription by a healthcare professional, especially considering potential contraindications or drug interactions in diabetic patients.\r\n\r\nNICE Guidance for Diabetic Foot Health\r\n\r\nNICE guidelines emphasise that any foot issue in diabetic patients should be taken seriously and assessed promptly by a healthcare professional, as they are at a higher risk for complications. Diabetic patients with foot infections or ulcers should receive comprehensive management, including monitoring of blood glucose levels, appropriate antifungal or antibacterial treatment, and wound care if necessary.\r\n\r\nImportant Advice for Diabetic Patients with Foot Problems\r\nEarly Intervention: Diabetic individuals should seek medical advice immediately if they notice any changes in their feet, such as redness, swelling, infection, or abnormal nail appearance.\r\n\r\nFoot Hygiene and Care: Regularly inspect and clean feet, ensuring they are dried properly, particularly between the toes. Moisturisers may be used to prevent dry and cracked skin, but they should not be applied between the toes to avoid excess moisture.\r\nFootwear: Properly fitted shoes are essential to prevent trauma and reduce the risk of injury. Diabetic patients are also advised to wear cotton socks that allow feet to breathe.\r\nSpecialist Referral: Diabetic patients may be referred to a podiatrist or diabetic foot clinic for further evaluation and management, especially if the infection does not respond to initial treatments.\r\n\r\nBy following NICE guidelines and seeking timely medical advice, diabetic patients can minimise the risk of complications and maintain foot health effectively.\r\n\r\nFor more information watch BNF lesson chapter 6 Endocrine system\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the condition is self limiting",
        "answer_number": 1
      },
      {
        "text": "Advise to purchase amorolfine 5% nail lacquer.",
        "answer_number": 2
      },
      {
        "text": "Advise to see his GP as soon as possible",
        "answer_number": 3
      },
      {
        "text": "Advise to go to accident and emergency",
        "answer_number": 4
      },
      {
        "text": "Supply terbinafine 250mg tablets",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2588,
    "bank": "clinicalOtc",
    "title": "**What is the most likely diagnosis and the most appropriate treatment for this patient?**",
    "text": "A 50-year-old man presents to the pharmacy with a rash on his arms and legs, accompanied by itching and redness. He informs you he works as a cleaner.  He has no known allergies and is not currently taking any medication. He asks you for advice on how to treat his condition. ![acd2-Watermarked-Wy-JXYXRlcm1hcmtl-ZCJd](https://i.ibb.co/hYg4h12/acd2-Watermarked-Wy-JXYXRlcm1hcmtl-ZCJd.jpg \"650x500\")",
    "why": "Contact dermatitis; topical corticosteroids\r\n\r\nRationale: \r\n\r\nThe most likely diagnosis in this case is contact dermatitis due to the patient's occupation as a cleaner, which increases exposure to irritants and allergens, such as cleaning agents. The patient's symptoms of itching, redness, and a rash on the arms and legs are typical signs of contact dermatitis.\r\n\r\nEczema is less likely since the symptoms appear to be triggered by an external factor, and the patient has no history of atopic conditions.\r\nHives are generally raised, itchy welts rather than a red, inflamed rash.\r\nPsoriasis tends to cause thick, silvery scales on the skin, not just redness and itching.\r\nScabies causes intense itching, particularly at night, and is usually associated with small burrows in the skin.\r\n\r\nAccording to NICE guidelines, contact dermatitis is an inflammatory skin reaction that occurs when the skin is exposed to irritants or allergens. There are two types: irritant contact dermatitis, caused by substances that physically damage the skin, and allergic contact dermatitis, triggered by an immune response to specific allergens. \r\nSymptoms include redness, itching, swelling, and dry or cracked skin, usually in areas frequently exposed to the irritant or allergen.\r\n\r\nNICE recommends using topical corticosteroids as the first-line treatment to reduce inflammation and soothe symptoms. Additionally, emollients should be used regularly to maintain the skin's moisture barrier and prevent further irritation. It is essential for the patient to identify and avoid the causative irritant or allergen for long-term management. If symptoms persist or are severe, referral to a specialist may be necessary.**Image reference: DermnetNZ.org**\r\n\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Contact dermatitis; topical corticosteroids",
        "answer_number": 1
      },
      {
        "text": "Eczema; emollients and topical corticosteroids",
        "answer_number": 2
      },
      {
        "text": "Hives; antihistamines",
        "answer_number": 3
      },
      {
        "text": "Psoriasis; topical corticosteroids",
        "answer_number": 4
      },
      {
        "text": "Scabies; permethrin cream",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2385,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following eye drops are used to identify the foreign bodies or damage in eyes?\u00a0**",
    "text": "A 45-year-old man presents to the pharmacy with symptoms of blurred vision, eye pain, and photophobia. He says he has a history of recurrent herpes simplex virus (HSV) infection and suspects that he has a corneal ulcer.",
    "why": "B. Fluorescein sodium\r\n\r\nRationale:\r\n\r\nFluorescein sodium is a yellow-green dye that is commonly used in eye examinations to identify damage to the corneal epithelium. It stains areas of the cornea where the epithelium is damaged, helping to detect corneal ulcers, abrasions, or foreign bodies. The dye can be observed under a cobalt blue light, which enhances its fluorescence, making it easy to visualize areas of injury or foreign material in the eye.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Chloramphenicol\r\n\r\nThis is an antibiotic used for treating eye infections, particularly bacterial conjunctivitis, not for identifying damage or foreign bodies in the eye.\r\n\r\nC. Keterolac\r\n\r\nThis is a nonsteroidal anti-inflammatory drug (NSAID) used for reducing inflammation and pain in eye conditions, such as after cataract surgery. It does not identify foreign bodies or corneal damage.\r\n\r\nD. Lidocaine\r\n\r\nThis is a local anesthetic used for numbing the eye during procedures, but it does not help in identifying damage or foreign bodies in the eye.\r\n\r\nE. Olopatadine\r\n\r\nThis is an antihistamine used to treat allergic conjunctivitis. It does not have a role in identifying corneal damage or foreign bodies.\r\n\r\nFluorescein sodium is a crucial diagnostic tool in ophthalmology for detecting corneal damage, such as ulcers or abrasions, as well as identifying foreign bodies in the eye. \r\nThe dye stains the damaged areas of the cornea, making them visible under a cobalt blue light, allowing clinicians to assess the extent of the damage. It is commonly used in combination with other diagnostic tools and is particularly valuable in the assessment of corneal ulcers, especially in patients with a history of recurrent herpes simplex virus infections.\r\n\r\nFor more information watch BNF lesson Chapter 11 (Eyes):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Chloramphenicol",
        "answer_number": 1
      },
      {
        "text": "Fluorescein sodium",
        "answer_number": 2
      },
      {
        "text": "Keterolac",
        "answer_number": 3
      },
      {
        "text": "Lidocaine",
        "answer_number": 4
      },
      {
        "text": "Olopatadine",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2525,
    "bank": "clinicalMep",
    "title": "**Which of the following Controlled medicines can be obtained via a midwife supply order?**",
    "text": "Midwives can obtain certain Controlled drugs via midwife supply order",
    "why": "E. Pethidine\r\n\r\nRationale\r\n\r\nThe correct answer is E. Pethidine. According to the Medicines, Ethics, and Practice (MEP) guidelines, midwives can obtain pethidine, along with diamorphine and morphine, for the purpose of childbirth. These controlled substances are authorised for use in labour and delivery settings to manage pain.\r\n\r\nExplanation of Other Options\r\n\r\nA. Fentanyl \u2013 Fentanyl is not listed as one of the controlled drugs midwives can obtain via a supply order for childbirth.\r\nB. Lorazepam \u2013 Lorazepam is not authorised for midwife supply orders; it is typically used for anxiety or seizures and is not specific to childbirth.\r\nC. Midazolam \u2013 Similar to lorazepam, midazolam is not approved for midwives to obtain via supply orders for childbirth. It is typically used in sedation or anaesthesia.\r\nD. Oxycodone \u2013 Oxycodone is not available through midwife supply orders for childbirth, as its use in this context is not specified.\r\n\r\n\r\nMidwives are authorised to obtain specific controlled drugs through a midwife supply order, but the drugs must be related to childbirth and pain management. Pethidine, diamorphine, and morphine are the approved medications for midwives to use for pain relief during labour. This restriction helps maintain control over the use of high-risk medications while ensuring they are available for critical situations in childbirth.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Fentanyl",
        "answer_number": 1
      },
      {
        "text": "Lorazepam",
        "answer_number": 2
      },
      {
        "text": "Midazolam",
        "answer_number": 3
      },
      {
        "text": "Oxycodone",
        "answer_number": 4
      },
      {
        "text": "Pethidine",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2523,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most suitable duration of treatment to be prescribed?**",
    "text": "You receive a prescription for temazepam 10mg tablets",
    "why": "B. 30\r\n\r\nRationale\r\n \r\nThe correct answer is 30. According to good practice guidelines and the Misuse of Drugs Regulations, it is generally considered appropriate to prescribe a maximum of 30 days of treatment for Schedule 2 and Schedule 3 controlled drugs, such as temazepam. This ensures that there is proper oversight and monitoring of the patient's use of the medication, which helps to mitigate risks of misuse and dependence.\r\n\r\nExplanation of Other Options\r\n\r\nA. 28 \u2013 Incorrect. While some controlled drugs can be prescribed for 28 days, 30 days is generally the recommended duration for treatment, as it allows for a complete course without encouraging excess supply.\r\nC. 56 \u2013 Incorrect. Prescribing for 56 days would be considered excessive for a Schedule 3 controlled drug like temazepam, and may raise concerns regarding potential misuse.\r\nD. 60 \u2013 Incorrect. Similar to 56 days, prescribing for 60 days would not align with best practices for controlled substances.\r\nE. 84 \u2013 Incorrect. 84 days of temazepam would be far beyond the appropriate prescribing duration for a controlled drug and could increase the risk of misuse.\r\n\r\n\r\nFor Schedule 2 and Schedule 3 controlled drugs, including temazepam, it is considered best practice to prescribe no more than 30 days of treatment at a time. This helps ensure the patient is regularly reviewed and reduces the potential for misuse or dependence. The Misuse of Drugs Regulations and clinical guidelines provide that prescribing larger quantities may increase the risk of medication misuse or overdose.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "28",
        "answer_number": 1
      },
      {
        "text": "30",
        "answer_number": 2
      },
      {
        "text": "56",
        "answer_number": 3
      },
      {
        "text": "60",
        "answer_number": 4
      },
      {
        "text": "84",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 864,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate equivalent dose of buprenorphine patches for this patient?**",
    "text": "A 65-year-old man with advanced prostate cancer has been taking morphine modified-release tablets 30 mg twice daily and morphine 10 mg/5mL oral solution, 2.5mL fives times a day for breakthrough pain. He has been experiencing constipation, nausea and drowsiness as side effects of morphine. His palliative care team decides to switch him to buprenorphine transdermal patches.\u00a0An extract has been provided for this question\r\n\r\n![Screenshot-2023-11-29-at-17-21-42.png](https://i.ibb.co/HC6VVwm/Screenshot-2023-11-29-at-17-21-42.png \"650x500\")",
    "why": "Determine the total daily morphine equivalent dose in mg/day. In this case, it is 30mg x 2 + 5mg x 5 = 85 mg/day.\r\nChoose the nearest available patch strength and frequency of application.\r\nTherefore, the most appropriate initial dose of buprenorphine patches for this patient is 35 micrograms/hour.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "5 micrograms/hour",
        "answer_number": 1
      },
      {
        "text": "10 micrograms/hour",
        "answer_number": 2
      },
      {
        "text": "20 micrograms/hour",
        "answer_number": 3
      },
      {
        "text": "35 micrograms/hour",
        "answer_number": 4
      },
      {
        "text": "52.5 micrograms/hour",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2390,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most likely consequence of using xylometazoline nasal drops in children under 6 years of age?**",
    "text": "A 4-year-old boy is brought to the pharmacy by his mother with symptoms of nasal congestion, runny nose, and sneezing. She says he has had a cold for the last 3 days and she has been giving him xylometazoline nasal drops twice a day, as recommended by her friend. She asks for your advice on whether this is safe and effective for her son.\r\n\r\nA resource has been provided for this question.\u00a0\r\nhttps://bnf.nice.org.uk/drugs/xylometazoline-hydrochloride/",
    "why": "A) Associated risk with agitated psychosis, ataxia and hallucinations\r\n\r\nRationale:\r\n\r\nXylometazoline is a sympathomimetic decongestant that can have serious side effects, particularly in children under 6 years of age. The BNF specifically highlights the increased risk of severe adverse effects such as agitated psychosis, ataxia, hallucinations, and even death in young children. This is why its use is contraindicated in children under 6 years. While cardiovascular effects such as hypertension and tachycardia are also possible, the primary concern and the most serious risk associated with its use in this age group are the neuropsychiatric effects mentioned above.\r\n\r\nExplanation of Other Options:\r\n\r\nB) Increased risk of systemic adverse effects such as hypertension and tachycardia\r\n\r\nAlthough xylometazoline can lead to systemic side effects like hypertension and tachycardia, these are more common in older children and adults rather than in children under 6. The more concerning risks in this age group are the neuropsychiatric effects like agitated psychosis.\r\n\r\nC) Increased risk of nasal bleeding and infection\r\n\r\nThis is a potential side effect of prolonged use of nasal decongestants, but it is not the primary concern in children under 6 years. The main risks in this age group are associated with neuropsychiatric and systemic cardiovascular effects.\r\n\r\nD) No significant effect on the nasal symptoms\r\n\r\nXylometazoline is effective in reducing nasal congestion and improving symptoms, but in children under 6, the risks of serious side effects outweigh the benefits, which is why it is contraindicated.\r\n\r\nE) Reduced nasal congestion and improved breathing\r\n\r\nWhile xylometazoline does reduce nasal congestion and improve breathing, the severe side effects in young children, such as agitated psychosis and hallucinations, make it inappropriate for use in this age group.\r\n\r\nXylometazoline, a nasal decongestant, is effective for relieving nasal congestion, but its use in children under 6 years old is contraindicated due to serious risks, including neuropsychiatric effects such as agitated psychosis, ataxia, and hallucinations. The NICE guidelines recommend avoiding decongestants in this age group, as the potential for harm outweighs the benefit of nasal decongestion. Alternative treatments should be considered for young children, and decongestants should only be used under the guidance of healthcare professionals, with careful consideration of the age and potential risks.\r\n\r\n\r\nFor more information watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Associated risk with agitated psychosis, ataxia and hallucinations",
        "answer_number": 1
      },
      {
        "text": "Increased risk of systemic adverse effects such as hypertension and tachycardia",
        "answer_number": 2
      },
      {
        "text": "Increased risk of nasal bleeding and infection",
        "answer_number": 3
      },
      {
        "text": "No significant effect on the nasal symptoms",
        "answer_number": 4
      },
      {
        "text": "Reduced nasal congestion and improved breathing",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2234,
    "bank": "clinicalTherapeutics",
    "title": "**What advice is most appropriate to give with regards to the latanoprost eye drops?**",
    "text": "Whilst in hospital, the patient is referred to an ophthalmic specialist who initiates latanoprost 0.005% w/v eye drops at a dose of 1 drop into the left eye each day to help better manage his glaucoma.",
    "why": "Correct Answer:\r\n\r\nB) May cause harmless pigmentation of the iris\r\n\r\nRationale:\r\n\r\n- Latanoprost is a prostaglandin analogue used to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. \r\n\r\n- A well-known side effect is increased brown pigmentation of the iris, especially in patients with mixed-colour irises (e.g., green-brown, blue-brown). This pigmentation is usually harmless and permanent but should be explained to the patient as it may change the appearance of the eye over time.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Best applied in the morning \r\n\r\nProstaglandin analogues like latanoprost are usually applied in the evening because intra-ocular pressure is often higher at night and they are more effective when dosed then.\r\n\r\nC) May be administered whilst wearing contact lens \r\n\r\nLatanoprost contains benzalkonium chloride, a preservative that can be absorbed by contact lenses and cause irritation. Contact lenses should be removed before use and can be reinserted 15 minutes after administration.\r\n\r\nD) Should be used 2 minutes apart from another eye drop \r\n\r\nWhen more than one eye drop is required, they should be spaced at least 5 minutes apart, not 2, to ensure proper absorption and avoid washout.\r\n\r\nE) Should not be used alongside timolol \r\n\r\nLatanoprost can be safely used with timolol (a beta-blocker eye drop) and in fact, combination products like latanoprost/timolol are available and commonly prescribed for better IOP control.\r\n\r\nLatanoprost Use in Glaucoma:\r\n\r\n- Latanoprost is a first-line treatment for open-angle glaucoma, reducing intraocular pressure by increasing uveoscleral outflow. It is typically administered once daily at night. \r\n\r\n- One of the most important counselling points is that it can cause increased brown pigmentation of the iris, which is permanent but not harmful. \r\n\r\n- Patients should also be advised that it may cause mild stinging and should not be used while wearing contact lenses due to preservative absorption. \r\n\r\n- When using multiple eye drops, they should be spaced at least 5 minutes apart. Latanoprost is often used alone or in combination with timolol to achieve optimal pressure control.\r\n\r\nFor more information please watch BNF lesson Chapter 11 (Eye):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Best applied in the morning",
        "answer_number": 1
      },
      {
        "text": "May cause harmless pigmentation of the iris",
        "answer_number": 2
      },
      {
        "text": "May be administered whilst wearing contact lens",
        "answer_number": 3
      },
      {
        "text": "Should be used 2 minutes apart from another eye drop",
        "answer_number": 4
      },
      {
        "text": "Should not be used alongside timolol",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 962,
    "bank": "clinicalMep",
    "title": "**What are the legal requirements for you to be absent from the pharmacy for this period?**",
    "text": "You are the Responsible Pharmacist (RP) in charge of your local community pharmacy that operates from 9 am to 6 pm on weekdays. You have to attend a meeting at the local health board from 11 am to 12 pm on Wednesday. You have arranged for another pharmacist to cover the pharmacy from 12 pm to 1 pm.",
    "why": "This is based on Regulation 3 (4) of the Responsible Pharmacist Regulations 2008\u00b9. Option A is incorrect because the RP must be contactable by other pharmacy staff, not just able to return to the pharmacy. Option C is incorrect because the RP cannot supervise the pharmacy remotely. Option D is incorrect because there is no legal requirement for another pharmacist to be on duty during the RP's absence.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "You must display a notice with your name and contact details, make and keep a record of your absence, and ensure that you can return to the pharmacy with reasonable promptness if necessary.",
        "answer_number": 1
      },
      {
        "text": "You must display a notice with your name and contact details, make and keep a record of your absence, and ensure that you can be contacted by other pharmacy staff throughout the period of absence. Ensure that you can return to the pharmacy with reasonable promptness if necessary and ensure that no prescription-only medicines are sold or supplied during the period of absence.",
        "answer_number": 2
      },
      {
        "text": "You must display a notice with your name and contact details, make and keep a record of your absence, and ensure that you can supervise the pharmacy remotely throughout the period of absence.",
        "answer_number": 3
      },
      {
        "text": "You must display a notice with your name and contact details, make and keep a record of your absence, and ensure that there is another pharmacist on duty throughout the period of absence.",
        "answer_number": 4
      },
      {
        "text": "You must display a notice with your name and contact details, make and keep a record of your absence, and ensure that no prescription-only medicines are sold or supplied during the period of absence.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 991,
    "bank": "clinicalOtc",
    "title": "**Which of the following is NOT a red flag referral?**",
    "text": "You are teaching your trainee pharmacist about red flag referrals for fever in paediatric patients",
    "why": "A red flag referral is a symptom or sign that indicates a high risk of serious illness in a child with fever\u2074.\r\n- According to the NICE traffic light system for identifying risk of serious illness in under 5s\u00b2, some of the red flag features are:\r\n\u00a0\u00a0\u00a0\u00a0- Age <3 months, temperature \u226538\u00b0C\r\n\u00a0\u00a0\u00a0\u00a0- Non-blanching rash\r\n\u00a0\u00a0\u00a0\u00a0- Bulging fontanelle\r\n\u00a0\u00a0\u00a0\u00a0- Neck stiffness\r\n\u00a0\u00a0\u00a0\u00a0- Status epilepticus\r\n\u00a0\u00a0\u00a0\u00a0- Focal neurological signs\r\n\u00a0\u00a0\u00a0\u00a0- Focal seizures\r\npost immunisation fever is a common and expected reaction to some vaccinations, especially in children aged under 3 months\u00b2. Post immunisation fever usually resolves within 48 hours and does not indicate a serious infection",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "a 2 month old child with post immunisation fever",
        "answer_number": 1
      },
      {
        "text": "A 3 week old child with  a temperature of 39 degrees",
        "answer_number": 2
      },
      {
        "text": "A 4 month old child who presents with fever and no other symptoms",
        "answer_number": 3
      },
      {
        "text": "A 3 year old child who has had a fever for 6 days",
        "answer_number": 4
      },
      {
        "text": "A 7 year old who has been unwell and has had febrile convulsions",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 978,
    "bank": "clinicalMep",
    "title": "**Which ONE of the following is NOT a legal requirement for the Responsible Pharmacist record?**",
    "text": "You are the responsible pharmacist in a Community Pharmacy",
    "why": "Reason is professional only - not legal - by law you need to enter time of absence",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Date of the Responsible Pharmacist duty",
        "answer_number": 1
      },
      {
        "text": "GPhC registration number",
        "answer_number": 2
      },
      {
        "text": "Pharmacist name",
        "answer_number": 3
      },
      {
        "text": "Reason for absence from the premises.",
        "answer_number": 4
      },
      {
        "text": "Time at which the Pharmacist became the Responsible Pharmacist",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2267,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is not a classic sign of a potentially severe allergic reaction?**",
    "text": "You are working as a Pharmacist Manager in your local community pharmacy. You are refreshing your first-aid knowledge",
    "why": "Correct Answer:\r\n\r\nD) Rhinorrhoea (Runny Nose)\r\n\r\nRationale:\r\n\r\nA severe allergic reaction (anaphylaxis) is a life-threatening hypersensitivity reaction that requires immediate intervention. NICE defines anaphylaxis by rapid-onset, multi-system involvement, particularly affecting the airway, breathing, and circulation.\r\n\r\nWhile rhinorrhoea (runny nose) is a symptom associated with mild allergic reactions (e.g., hay fever), it is not a classic sign of severe allergic reactions or anaphylaxis. Severe symptoms typically involve respiratory distress, circulatory compromise, and significant swelling.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Blotchy Skin \r\n\r\nUrticaria (hives) and flushing are common dermatological symptoms of an allergic reaction.\r\nSevere cases may present with widespread, blotchy, or rapidly spreading rashes.\r\n\r\n(B) Itchy and Puffy Eyes \r\n\r\nAllergic conjunctivitis, swelling of the eyelids, and generalised facial oedema can occur.\r\nSevere swelling may indicate angioedema, which can progress to airway obstruction.\r\n\r\n(C) Tight Chest \r\n\r\nA tight chest suggests bronchospasm or airway constriction, commonly seen in anaphylaxis or allergic asthma.\r\nThis is a red flag symptom, indicating respiratory distress requiring immediate intervention.\r\n\r\n\r\n(E) Swelling of the Face \r\n\r\nFacial swelling can be a warning sign of severe angioedema.\r\nIf the swelling extends to the tongue and throat, it can lead to life-threatening airway obstruction.\r\n\r\nSevere Allergic Reactions\r\n\r\nRecognising Anaphylaxis\r\n\r\nAnaphylaxis is a rapid, systemic allergic reaction affecting the airway (A), breathing (B), and circulation (C). Key symptoms include:\r\n\r\n- Airway symptoms: Swelling of the tongue, throat tightness, difficulty swallowing.\r\n- Breathing symptoms: Shortness of breath, wheezing, chest tightness, stridor.\r\n- Circulatory symptoms: Hypotension, dizziness, collapse, shock.\r\n- Other systemic symptoms: Widespread urticaria, angioedema, gastrointestinal distress (vomiting, diarrhoea).\r\n\r\nFirst-Aid Management:\r\n\r\n1) Administer Adrenaline (1:1000) IM in the mid-thigh (anterolateral aspect) \u2013 dose: 0.15 mg (for children <6 years), 0.3 mg (for 6\u201312 years), 0.5 mg (for adults and children >12 years).\r\n\r\n2) Call 999 immediately and state \"Anaphylaxis.\"\r\n\r\n3) Lay the patient flat (unless breathing difficulty worsens in this position \u2013 in which case, they should be in a sitting position).\r\n\r\n4)Administer oxygen and IV fluids if trained to do so.\r\n\r\n5)Repeat adrenaline every 5 minutes if there is no improvement.\r\n\r\n6)Give antihistamines and corticosteroids as secondary treatment after stabilisation.\r\n\r\nFor more information, please watch BNF lesson Chapter 3 (Respiratory System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Blotchy skin",
        "answer_number": 1
      },
      {
        "text": "Itchy and puffy eyes",
        "answer_number": 2
      },
      {
        "text": "Tight chest",
        "answer_number": 3
      },
      {
        "text": "Rhinorrhoea",
        "answer_number": 4
      },
      {
        "text": "Swelling of the face",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2265,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following drugs is she most likely to have been started on?**",
    "text": "A 33-year-old with rheumatoid arthritis is also started on a drug at the same time as her methotrexate prescription to help limit its side effect profile.",
    "why": "Correct Answer:\r\n\r\n(B) Folic Acid\r\n\r\nRationale:\r\n\r\nMethotrexate is a first-line disease-modifying anti-rheumatic drug (DMARD) used to treat rheumatoid arthritis (RA). While effective, it inhibits dihydrofolate reductase, leading to folate deficiency, which can cause side effects such as mucosal ulcers, gastrointestinal discomfort, hepatotoxicity, and bone marrow suppression.\r\n\r\nTo reduce the risk of methotrexate-induced side effects, NICE recommends that all patients prescribed methotrexate should also receive folic acid supplementation (typically 5 mg once weekly, taken on a different day from methotrexate). This helps replenish folate stores and minimise toxicity.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Artificial Saliva \r\n\r\nUsed for patients with xerostomia (dry mouth), commonly seen in Sjogren\u2019s syndrome, but it does not counteract methotrexate toxicity.\r\n\r\n(C) Folinic Acid \r\n\r\nA more potent form of folate, used as a methotrexate antidote in cases of overdose or severe toxicity but not routinely given for methotrexate side effect prevention.\r\n\r\n(D) Pyridoxine (Vitamin B6) \r\n\r\nUsed to prevent isoniazid-induced neuropathy but does not play a significant role in managing methotrexate toxicity.\r\n\r\n(E) Zinc Lozenges \r\n\r\nUsed for cold symptom relief and immune function support, with no role in preventing methotrexate toxicity.\r\n\r\nMethotrexate and Folic Acid Supplementation \r\n\r\nMethotrexate is a widely used DMARD for treating rheumatoid arthritis, psoriasis, and other autoimmune conditions. Folic acid supplementation is essential to reduce the risk of adverse effects while maintaining the drug\u2019s efficacy.\r\n\r\nThe recommended regimen is 5 mg folic acid once weekly, taken on a different day than methotrexate.\r\nMonitoring includes regular full blood counts (FBC), liver function tests (LFTs), and renal function tests to detect early toxicity.\r\n\r\nPatients must be advised to avoid live vaccines and alcohol due to the risk of hepatotoxicity.\r\n\r\nFor more information, watch BNF lesson Chapter 10 ( Musculoskeletal System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Artificial saliva",
        "answer_number": 1
      },
      {
        "text": "Folic acid",
        "answer_number": 2
      },
      {
        "text": "Folinic acid",
        "answer_number": 3
      },
      {
        "text": "Pyridoxine",
        "answer_number": 4
      },
      {
        "text": "Zinc lozenges",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2327,
    "bank": "clinicalTherapeutics",
    "title": "Which of the following is the most appropriate advice?",
    "text": "A 26-year old woman has been diagnosed with dry eye syndrome and has been prescribed theoloz duo eye drops, one drop in each eye 10 times a day, Ikervis (ciclosporin) one drop in each eye morning and evening and hylonight eye ointment each evening before bed. She asks you whether she can administer thealoz duo and ikervis eye drops at the same time.",
    "why": "She should leave an interval of at least 5 minutes between administering eye drops\r\n\r\nRationale:\r\n\r\nAccording to BNF Chapter 11: Eye, when two different eye drops are prescribed to be used at the same time of day, an interval of at least 5 minutes should be left between administering the drops. This ensures the first eye drop is fully absorbed and not diluted or washed away by the second drop. Additionally, eye ointments should always be applied last, after all eye drops, to avoid interfering with the absorption of the drops.\r\n\r\nIn this case, the patient should administer Thealoz Duo and Ikervis (ciclosporin) at least 5 minutes apart and use Hylonight eye ointment after all the eye drops, just before bedtime.\r\n\r\nExplanation of Other Options:\r\n\r\nA: Ikervis eye drops need to be administered before Thealoz Duo eye drops\r\n\r\nThis is incorrect because there is no requirement to prioritise one drop over the other. What matters is leaving an adequate interval of time to ensure proper absorption.\r\n\r\nB: She should leave an interval of at least 2 minutes between administering eye drops\r\n\r\nThis is incorrect because 2 minutes is insufficient time to ensure the first drop is absorbed properly, especially with a viscous product like Ikervis.\r\n\r\nC: She should leave an interval of at least 3 minutes between administering eye drops\r\n\r\nThis is incorrect as it falls short of the recommended 5-minute interval, which is advised for all eye drop combinations.\r\n\r\nE: She can administer both eye drops at the same time\r\n\r\nThis is incorrect because administering drops simultaneously can lead to the dilution or washing away of one or both medications, reducing their effectiveness.\r\n\r\n\r\nWhen using multiple ophthalmic preparations, it is important to administer them in the correct sequence to optimise their efficacy, patients should:\r\n\r\n- Leave an interval of at least 5 minutes between administering different eye drops to allow the first medication to be absorbed fully.\r\n\r\n- Apply eye ointments last, as their viscous nature can interfere with the absorption of eye drops.\r\n\r\n- Be counselled on proper application techniques to minimise wastage and ensure accurate dosing.\r\n\r\nFor patients with dry eye syndrome, a tailored approach combining lubricants (e.g., Thealoz Duo), anti-inflammatory drops (e.g., Ikervis), and protective ointments (e.g., Hylo-night) is recommended to alleviate symptoms and improve quality of life. Regular follow-up is essential to assess adherence and treatment efficacy.\r\n\r\n\r\nFor more information please watch BNF lesson Chapter 11 (Eye):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Ikervis eye drops needs to be administered before theoloz duo eye drops drops.",
        "answer_number": 1
      },
      {
        "text": "She should leave an interval of at least 2 minutes between administering eye drops",
        "answer_number": 2
      },
      {
        "text": "She should leave an interval of at least 3 minutes between administering eye drops",
        "answer_number": 3
      },
      {
        "text": "She should leave an interval of at least 5 minutes between administering eye drops",
        "answer_number": 4
      },
      {
        "text": "She can administer both eye drops are the same time",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2550,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropiate action?\u00a0**",
    "text": "You receive a prescription for a 35- year-old female who has been prescribed isotretinoin for severe acne. You dispensed 20 capsules to the patient on 1st December 2023. Today is the 30th December 2023 and she wishes to collect the remainder of her prescription.\u00a0\r\n\r\nAn extract of the prescription has been provided for you.\r\nnote: PPP exempt\r\n\r\n![3](https://i.ibb.co/Mk8NsY0/3.png \"400x600\")",
    "why": "(E) The prescription meets all legal requirements therefore dispense the remainder of the prescription.\r\n\r\nRationale:\r\n\r\nSince the prescription includes the note \u201cPPP exempt,\u201d it indicates that the patient is not required to follow the Pregnancy Prevention Programme (PPP), likely because of specific individual circumstances discussed with the prescriber. As a result, the remaining capsules can be dispensed without requiring an additional pregnancy test or new prescription. The prescription meets all necessary legal requirements, and the patient is permitted to collect the remainder of her medication.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Advise the patient to return to their GP for a new prescription:\r\nIncorrect. This is unnecessary, as the current prescription remains valid, and the note \"PPP exempt\" indicates the patient is not subject to PPP requirements.\r\n\r\n(B) Contact the GP surgery to specify which brand of isotretinoin is required:\r\nIncorrect. There is no indication in the scenario that the brand needs clarification or has caused issues. Therefore, contacting the GP about brand specification is irrelevant here.\r\n\r\n(C) Provide an emergency supply and request a new prescription from the GP:\r\nIncorrect. An emergency supply is not required because the prescription remains legally valid, and the PPP exemption allows for continued dispensing as directed.\r\n\r\n(D) Request a negative pregnancy test prior to dispensing:\r\nIncorrect. The \u201cPPP exempt\u201d notation on the prescription confirms that the patient does not require a negative pregnancy test prior to dispensing, as she is exempt from PPP requirements.\r\n\r\nIsotretinoin prescriptions for women of childbearing potential are generally subject to the Pregnancy Prevention Programme, which includes monthly pregnancy tests and strict dispensing intervals. However, a prescriber may determine that a patient is exempt from PPP requirements if clinically justified, which should be clearly noted on the prescription (e.g., \"PPP exempt\"). In such cases, as long as the prescription remains valid, the remainder of the medication can be dispensed without additional PPP-related checks, ensuring adherence to patient-specific directives and legal requirements.\r\n\r\nPlease for more information watch the MEP lesson on Chapter 2 (Professional and Legal Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the patient to return to their GP for a new prescription",
        "answer_number": 1
      },
      {
        "text": "Contact the GP surgery to specify which brand of isotretinoin is required",
        "answer_number": 2
      },
      {
        "text": "Provide an emergency supply and request a new prescription from the GP.",
        "answer_number": 3
      },
      {
        "text": "Request a negative pregnancy test prior to dispensing.",
        "answer_number": 4
      },
      {
        "text": "The prescription meets all legal requirements therefore dispense the remainder of the prescription",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2601,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the frequency of thrombocytopenia as a side effect?**",
    "text": "A 38 year old female patient presents to the pharmacy requesting to purchase Pyrocalm 20mg tablets for the treatment of dyspepsia. She informs you she is concerned regarding some of the side effects as her friend told her it can cause blood disorders.\u00a0\r\n\r\nThe SmPC for pyrocalm 20mg tablets has been provided for you\r\n\r\n\r\n[SmPC for Pyrocalm 20mg](https://www.medicines.org.uk/emc/product/9154/smpc#gref)",
    "why": "(\u22651/10,000 to <1/1,000)\r\n\r\nRationale:\r\n\r\nAccording to the Summary of Product Characteristics (SmPC) for Pyrocalm 20 mg tablets (omeprazole), thrombocytopenia is a rare side effect, occurring with a frequency between 1 in 10,000 and 1 in 1,000. Although this side effect is rare, patients should be aware of the potential risk and be advised to monitor for any signs of abnormal bruising or bleeding, which may indicate thrombocytopenia. Regular monitoring and reporting of unusual side effects are crucial, especially for those on long-term proton pump inhibitor (PPI) therapy.\r\n\r\n\r\nAccording to NICE guidelines, PPIs like omeprazole are generally safe and well-tolerated treatments for dyspepsia. However, rare side effects such as thrombocytopenia can occur. NICE emphasizes the importance of regular treatment reviews, particularly for patients on long-term PPI therapy, to ensure the benefits continue to outweigh the risks. Patients should be informed about the possibility of rare side effects and encouraged to report any unusual symptoms promptly.\r\n\r\nThe initial management of dyspepsia focuses on lifestyle modifications, including changes to diet, reducing alcohol intake, avoiding known irritants like caffeine and spicy foods, quitting smoking, and maintaining a healthy weight. If these measures do not adequately control symptoms, pharmacological interventions are recommended, with proton pump inhibitors (PPIs) such as omeprazole being the first-line treatment to reduce stomach acid and provide symptom relief. Though PPIs are generally well-tolerated, they can occasionally cause rare side effects, such as thrombocytopenia (a blood disorder). Therefore, regular review of treatment effectiveness and close monitoring, especially for those on long-term PPI therapy, are essential to ensure the benefits outweigh the risks. Patients should be informed to report any unusual symptoms, particularly signs related to blood disorders like unexplained bruising or bleeding.\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "(\u22651/10)",
        "answer_number": 1
      },
      {
        "text": "(\u22651/100 to <1/10)",
        "answer_number": 2
      },
      {
        "text": "(\u22651/1,000 to <1/100)",
        "answer_number": 3
      },
      {
        "text": "(\u22651/10,000 to <1/1,000)",
        "answer_number": 4
      },
      {
        "text": "(<1/10,000)",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 967,
    "bank": "clinicalMep",
    "title": "**Which of the following is INCORRECT regarding schedule 2 and 3 controlled drug prescriptions?**",
    "text": "Schedule 2 and 3 controlled drugs have additional prescription requirements under the misuse of drugs regulations 2001 as ammended.",
    "why": "It is good practice not to prescribe anymore than a 30 day supply (this is not a legal requirement). All other options are legal requirements",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "An address of \u201cno fixed abode\u201d is legally acceptable.",
        "answer_number": 1
      },
      {
        "text": "Prescriptions are valid for 28 days after the appropriate date",
        "answer_number": 2
      },
      {
        "text": "The quantity must be written in words and figures",
        "answer_number": 3
      },
      {
        "text": "The dose must be clearly defined",
        "answer_number": 4
      },
      {
        "text": "The quantity prescribed should not exceed 28 days",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 1012,
    "bank": "clinicalTherapeutics",
    "title": "A 35-year-old man who is a vegan has been diagnosed with pernicious anaemia and has been prescribed a course of intramuscular injections to correct his deficiency.",
    "text": "**Theme: Vitamins and Supplements**\u2028\u2028\r\n\r\n**For each of the following clinical scenarios, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "why": "Correct answer: \r\n\r\nF. Vitamin B12\r\n\r\nRationale:\r\n\r\nPernicious anaemia is caused by vitamin B12 deficiency due to lack of intrinsic factor, a protein needed for B12 absorption in the gut. This leads to impaired red blood cell production and neurological symptoms if untreated. In pernicious anaemia, oral B12 supplementation is ineffective because absorption is impaired. The treatment of choice is intramuscular hydroxocobalamin, typically given every 2\u20133 months for maintenance. Vegans are also at higher risk of B12 deficiency due to the absence of animal products in the diet.\r\n\r\nExplanation of other options:\r\n\r\nA. Calcium\r\n\r\nUsed for bone health, not related to anaemia or B12 deficiency.\r\n\r\nB. Iron\r\n\r\nIron-deficiency anaemia is different from pernicious anaemia. Iron would not correct the underlying B12 deficiency.\r\n\r\nC. Folic acid\r\n\r\nCan also cause macrocytic anaemia, but this patient has pernicious anaemia, which is specifically due to vitamin B12 deficiency.\r\n\r\nD. Magnesium\r\n\r\nUsed for muscle cramps and certain electrolyte imbalances, but not indicated in B12 deficiency.\r\n\r\nE. Vitamin B1\r\n\r\nUsed in Wernicke\u2019s encephalopathy and alcohol-related deficiencies. Not relevant here.\r\n\r\nG. Vitamin D\r\n\r\nImportant in bone and immune health, but not related to pernicious anaemia.\r\n\r\nH. Zinc\r\n\r\nPlays a role in immunity and wound healing, but not in red cell production or B12 absorption.\r\n\r\nPernicious anaemia results from vitamin B12 deficiency due to lack of intrinsic factor, leading to poor absorption from the gut. The treatment is intramuscular hydroxocobalamin. Vegans are already at risk of B12 deficiency from dietary restriction, and the presence of intrinsic factor deficiency confirms the need for parenteral treatment. \r\nEarly recognition and lifelong maintenance therapy are essential to prevent irreversible neurological damage.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 6,
    "weighting": 3,
    "answers": [
      {
        "text": "Calcium",
        "answer_number": 1
      },
      {
        "text": "Iron",
        "answer_number": 2
      },
      {
        "text": "Folic acid",
        "answer_number": 3
      },
      {
        "text": "Magnesium",
        "answer_number": 4
      },
      {
        "text": "Vitamin B1",
        "answer_number": 5
      },
      {
        "text": "Vitamin B12",
        "answer_number": 6
      },
      {
        "text": "Vitamin D",
        "answer_number": 7
      },
      {
        "text": "Zinc",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2502,
    "bank": "clinicalMep",
    "title": "**Which of the following is correct regarding the sale and supply of emergency hormonal contraception?**",
    "text": "Ulipristal and levonorgestrel can sold by pharmacists for emergency hormonal contraception",
    "why": "a) Levonorgestrel is licensed for women over the age of 16 for emergency contraception within 72 hours of unprotected sexual intercourse.\r\n\r\nRationale\r\n\r\nLevonorgestrel 1.5mg, when sold over-the-counter (OTC), is licensed for women aged 16 years and above. It is used as an emergency contraceptive within 72 hours (3 days) of unprotected sexual intercourse (UPSI) or contraceptive failure.\r\n\r\nExplanation of the Other Options\r\n\r\nb) Pharmacists cannot provide advanced emergency hormonal contraception in case of contraceptive failure.\r\n\r\nThis is incorrect. Pharmacists can provide advanced supplies of emergency hormonal contraception (EHC) to women under certain circumstances, such as anticipated contraceptive failure. The pharmacist must ensure the patient is competent and will use the medication appropriately.\r\n\r\nc) Ulipristal acetate cannot be sold to those under the age of 16.\r\n\r\nThis is incorrect. Ulipristal acetate (EllaOne) can be supplied to patients under 16 years of age, provided the pharmacist assesses the patient for competence under the Fraser guidelines.\r\n\r\nd) Ulipristal acetate for emergency contraception is available as 5mg tablets.\r\n\r\nThis is incorrect. Ulipristal acetate (EllaOne) is available as a single 30mg tablet for emergency contraception and must be taken within 120 hours (5 days) of UPSI.\r\n\r\ne) Ulipristal acetate is licensed for those over the age of 16 within 4 days of unprotected sexual intercourse.\r\n\r\nThis is incorrect. Ulipristal acetate (EllaOne) is licensed for use in all reproductive-age women, including those under 16, and is effective for up to 5 days (120 hours) after UPSI.\r\n\r\nPharmacists can supply levonorgestrel and ulipristal acetate for emergency contraception, adhering to specific guidelines:\r\n\r\nLevonorgestrel: Licensed for women aged 16+ for use within 72 hours (3 days) of UPSI.\r\nUlipristal acetate (EllaOne): Licensed for use in all reproductive-age women (including under 16) within 120 hours (5 days) of UPSI.\r\nAdvanced supply: Permissible after assessing patient competency and ensuring appropriate use.\r\nPharmacists must counsel patients on proper use, efficacy timelines, and additional contraception measures to ensure optimal outcomes. \r\nNICE and MEP guidelines stress the importance of accessibility, safety, and patient-centred care.\r\n\r\n\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Levonorgestrel is licensed for women over the age of 16 for emergency contraception within 72 hours of unprotected sexual intercourse.",
        "answer_number": 1
      },
      {
        "text": "Pharmacists cannot provide advanced emergency hormonal contraception in case of contraceptive failure",
        "answer_number": 2
      },
      {
        "text": "Uliprisal acetate cannot be sold to those under the age of 16.",
        "answer_number": 3
      },
      {
        "text": "Ulipristal acetate for emergency contraception is available as 5mg tablets",
        "answer_number": 4
      },
      {
        "text": "Uliprisal acetate is licensed for those over the age 16 within 4 days of unprotected sexual intercourse",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2600,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 41 year old patient presents to the pharmacy with constipation for the past 8 weeks. They explain this has been a marked change to their bowel habits and has lost weight. He informs there has been no changes in his diet, is adequately hydrated and does not take regular medication",
    "why": "He needs to see his GP as soon as possible.\r\n\r\nRationale for the Correct Answer:\r\n\r\nHe needs to see his GP as soon as possible: This is the most appropriate advice because the patient presents with significant red flag symptoms, including a marked change in bowel habits and unexplained weight loss over 8 weeks. These symptoms raise the concern for serious underlying conditions, such as colorectal cancer or other gastrointestinal disorders, necessitating a prompt medical evaluation for further investigation and appropriate management.\r\n\r\nExplanation of Other Options:\r\n\r\nAdvise to purchase lactulose for constipation treatment: \r\nWhile lactulose may be helpful, it is not suitable as the first-line response without investigating the cause of the constipation due to the patient's concerning symptoms.\r\n\r\nAdvise to purchase a bulk-forming laxative for constipation treatment: \r\nSimilar to lactulose, bulk-forming laxatives may help, but they are not appropriate without first ruling out serious underlying conditions.\r\n\r\nAdvise he needs to increase dietary fibre intake: \r\nIncreasing dietary fibre is a standard recommendation for managing mild constipation, but given the patient's symptoms, this should not be the sole advice without further investigation.\r\n\r\nThe symptoms are self-limiting: \r\nThis is not an appropriate stance, as the patient's weight loss and the marked change in bowel habits warrant further evaluation.\r\n\r\nConstipation is defined as having fewer than three bowel movements per week, often accompanied by straining, hard stools, or a sensation of incomplete evacuation. \r\nNICE guidelines recommend a thorough assessment of constipation, particularly in adults, to identify any underlying causes. This includes taking a detailed medical history, examining the patient's bowel habits, and checking for red flag symptoms such as weight loss, rectal bleeding, or a recent change in bowel habits. Patients presenting with significant symptoms should be referred for further investigation to rule out serious conditions, such as bowel obstruction or malignancy. Management typically starts with lifestyle modifications, including increased dietary fibre intake and hydration, and may include the use of laxatives if necessary. Regular monitoring and follow-up are essential to ensure effective management and resolution of symptoms.\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise to purchase lactulose for constipation treatment",
        "answer_number": 1
      },
      {
        "text": "Advise to purchase a bulk-forming laxative for constipation treatment",
        "answer_number": 2
      },
      {
        "text": "Advise he needs to increase dietary fibre intake",
        "answer_number": 3
      },
      {
        "text": "He needs to see his GP as soon as possible",
        "answer_number": 4
      },
      {
        "text": "The symptoms are self limiting",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2532,
    "bank": "clinicalMep",
    "title": "**Which of the following medicines is NOT under safe custody regulations?**",
    "text": "The safe custody regulations refer to physical security of some controlled medicines.",
    "why": "B) Midazolam 5mg/ml ampoules\r\n\r\nRationale:\r\n\r\nMidazolam is classified as a Schedule 3 controlled drug, and while it is a controlled substance, Schedule 3 drugs are not subject to the Safe Custody Regulations unless in injectable form. As such, midazolam 5mg/ml ampoules do not need to be stored under the stringent security measures required for Schedule 2 drugs. The Safe Custody Regulations apply only to Schedule 2 controlled drugs and certain Schedule 3 drugs with high misuse potential.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Buprenorphine 2mg sublingual tablets\r\n\r\nCorrect: Buprenorphine is a Schedule 3 controlled drug, but as it has significant misuse potential, it is subject to Safe Custody Regulations. Therefore, it must be stored securely.\r\n\r\nC) Morphine sulfate 10mg/1ml ampoules\r\n\r\nCorrect: Morphine sulfate is a Schedule 2 controlled drug, which is subject to the Safe Custody Regulations. Schedule 2 drugs require storage in a locked cabinet or safe.\r\n\r\nD) Oramorph 20mg/5ml oral solution\r\n\r\nCorrect: Oramorph is a Schedule 2 controlled drug. Like other Schedule 2 substances, it must be stored in secure conditions as per the Safe Custody Regulations.\r\n\r\nE) Temazepam 20mg tablets\r\n\r\nCorrect: Temazepam is classified as a Schedule 3 controlled drug and, due to its misuse potential, is subject to the Safe Custody Regulations. It must be securely stored in the pharmacy.\r\n\r\nThe Safe Custody Regulations require that specific controlled substances be stored securely to prevent misuse and diversion.\r\n\r\nSchedule 2 controlled drugs, such as morphine and Oramorph, must be stored in a locked cupboard or safe.\r\nCertain Schedule 3 drugs, such as buprenorphine and temazepam, also fall under the Safe Custody Regulations due to their misuse potential and must be securely stored.\r\nMidazolam 5mg/ml ampoules, although a Schedule 3 drug, do not require secure storage under the Safe Custody Regulations unless in injectable form.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Buprenorphne 2mg sublingual tablets",
        "answer_number": 1
      },
      {
        "text": "Midazolam 5mg/ml ampoules",
        "answer_number": 2
      },
      {
        "text": "Morphine sulfate 10mg/1ml ampoules",
        "answer_number": 3
      },
      {
        "text": "Oramorph 20mg/5ml oral solution",
        "answer_number": 4
      },
      {
        "text": "Temazepam 20mg tablets",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2389,
    "bank": "clinicalTherapeutics",
    "title": "**\r\nWhat is the most appropriate treatment option for acute sinusitis?**",
    "text": "A 35-year-old man comes to the pharmacy with symptoms of nasal congestion, facial pain, and yellowish nasal discharge. He says he has had a cold for the last 12 days and his symptoms have not improved. He has no fever, allergies, or other medical conditions. He asks for your advice on what he can do to relieve his symptoms.",
    "why": "A) High-dose nasal corticosteroids\r\n\r\nRationale\r\n\r\nAccording to the BNF, the most appropriate treatment for acute sinusitis when symptoms persist for 10 days or more without improvement is high-dose nasal corticosteroids. These can help reduce inflammation and relieve symptoms of nasal congestion, facial pain, and pressure. Corticosteroids are typically used for symptom relief, though they are not likely to shorten the duration of the condition.\r\n\r\nExplanation of Other Options:\r\n\r\nB) Nasal saline irrigation\r\n\r\nThis option can be useful for symptom relief in acute sinusitis, particularly for clearing nasal passages, but it is generally not the first-line treatment if symptoms persist for more than 10 days.\r\n\r\nC) Oral amoxicillin\r\n\r\nThis is typically reserved for cases where the patient is very unwell or at high risk for complications (e.g., older adults, immunocompromised individuals), or if there is evidence of bacterial infection. Most cases of acute sinusitis are viral, and antibiotics are not necessary unless complications are suspected.\r\n\r\nD) Oral decongestants\r\n\r\nWhile these can provide temporary relief of nasal congestion, they are not recommended for prolonged use due to potential side effects (e.g., increased blood pressure) and are not considered the most appropriate treatment for sinusitis in this case.\r\n\r\nE) Watchful waiting\r\n\r\nThis is an appropriate approach for mild cases, particularly those lasting less than 10 days. However, for persistent symptoms (like in this case), more active treatment is recommended.\r\n\r\nIn line with NICE guidelines, acute sinusitis is commonly caused by viral infections and typically resolves within 7\u201310 days. For cases where symptoms persist longer than 10 days without improvement, nasal corticosteroids are recommended to reduce inflammation and alleviate symptoms. Antibiotics are generally not recommended unless the patient presents with severe symptoms, signs of bacterial infection, or other complications.\r\n\r\nFor more information watch BNF lesson Chapter 5 (Infections):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "High-dose nasal corticosteroids",
        "answer_number": 1
      },
      {
        "text": "Nasal saline irrigation",
        "answer_number": 2
      },
      {
        "text": "Oral amoxicillin",
        "answer_number": 3
      },
      {
        "text": "Oral decongestants",
        "answer_number": 4
      },
      {
        "text": "Watchful waiting",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2279,
    "bank": "clinicalTherapeutics",
    "title": "**What advice would be inappropriate for the patient whilst on isotretinoin?**",
    "text": "This question relates to a female patient who wears contact lenses and has been initiated on isotretinoin. Their blood test results are shown below:\r\n\r\nLDL 1.9 mmol/L (<3mmol/L)\r\nALT 42 units/L. (7 \u2013 56 units/L)\r\nTotal bilirubin. 0.7 mg/dL (0.3 - 1.9 mg/dL)",
    "why": "Correct Answer:\r\n\r\nD) Sun protection should be worn only on limbs\r\n\r\nRationale:\r\n\r\nThis statement is incorrect because sun protection should be applied to all exposed skin, not just the limbs. Isotretinoin significantly increases photosensitivity, leading to a higher risk of sunburn, hyperpigmentation, and long-term skin damage. Patients should be advised to:\r\n\r\nUse a broad-spectrum sunscreen (SPF 30 or higher).\r\nWear protective clothing and avoid excessive sun exposure.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Dry eyes may interfere with contact lenses \u2013 Correct but not inappropriate. Isotretinoin reduces tear production, leading to dry eyes, which can make wearing contact lenses uncomfortable. Patients may need lubricating eye drops.\r\n\r\nB) It may cause increased photosensitivity \u2013 Correct but not inappropriate. Photosensitivity is a well-known side effect, and patients should be warned to avoid excessive sun exposure.\r\n\r\nC) It may cause skin dryness and cracking \u2013 Correct but not inappropriate. Mucocutaneous dryness is a common adverse effect. Patients should moisturise regularly to prevent skin damage.\r\n\r\nE) You will need to avoid the use of sunbeds \u2013 Correct but not inappropriate. Sunbeds should be completely avoided due to the high risk of severe burns and long-term skin damage while on isotretinoin.\r\n\r\nIsotretinoin is an oral retinoid used for severe nodulocystic acne that is unresponsive to conventional therapy. It is highly teratogenic, meaning it can cause severe birth defects if taken during pregnancy. Therefore, it is only prescribed under the Pregnancy Prevention Programme (PPP) for females of childbearing potential. This programme requires:\r\n\r\n- A negative pregnancy test before starting treatment.\r\n- Monthly pregnancy tests during treatment.\r\n- Two forms of contraception (e.g., oral contraceptive + barrier method) to be used one month before, during, and one month after stopping isotretinoin.\r\n\r\nPrescription Validity & Dispensing Rules:\r\n\r\n- Prescriptions for isotretinoin are only valid for 7 days for females under the PPP.\r\n- A maximum of 30 days\u2019 supply can be issued at a time.\r\n- Only prescribers registered in the PPP can issue isotretinoin prescriptions for women of childbearing age.\r\n\r\nFor more Information, please watch BNF lesson chapter 13 (Skin):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "dry eyes may interfere with contact lenses",
        "answer_number": 1
      },
      {
        "text": "It may cause increased photosensitivity",
        "answer_number": 2
      },
      {
        "text": "It may cause skin dryness and cracking",
        "answer_number": 3
      },
      {
        "text": "sun protection should be worn only on limbs",
        "answer_number": 4
      },
      {
        "text": "you will need to avoid the use of sunbeds",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2623,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A 23 year old female patient presents to the pharmacy with dysuria and discomfort. She explains her symptoms have been gradual in onset as well as vaginal discharge and pyuria.",
    "why": "### Chlamydia Overview \r\n\r\nChlamydia, caused by the bacterium *Chlamydia trachomatis*, is a common sexually transmitted infection (STI). Many people with chlamydia are asymptomatic, especially in the early stages. When symptoms do occur, they may include:\r\n\r\n- **Painful Urination**: A burning sensation during urination.\r\n- **Abnormal Vaginal or Penile Discharge**: Unusual discharge from the vagina or penis.\r\n- **Pelvic or Lower Abdominal Pain**: Women may experience pelvic pain, while men may have testicular discomfort.\r\n- **Painful Intercourse**: Women may experience discomfort during sex.\r\n- **Bleeding Between Periods**: Women may notice abnormal bleeding between menstrual periods.\r\n- **Rectal Symptoms**: Rectal pain, discharge, or bleeding if the infection affects the rectum.\r\n\r\n### Genital Chlamydia Infection \r\n\r\n- **Prevalence**: Chlamydia is the most common bacterial STI in the UK.\r\n- **Affected Areas**: Typically infects the urethra in men, and the cervix or urethra in women. It can also affect the conjunctiva, rectum, and nasopharynx.\r\n- **Asymptomatic Rates**: 70% of women and 50% of men show no symptoms.\r\n\r\n### Screening & Testing\r\n\r\n- **Screening**: \r\n  - Annual screening is recommended for sexually active people under 25 or those with frequent partner changes.\r\n  \r\n- **Testing**:\r\n  - **Women**: Vulvo-vaginal swab is preferred. Alternatives include an endocervical swab or first-void urine sample.\r\n  - **Men**: First-void urine is the sample of choice, but a urethral swab is an option.\r\n\r\n### Treatment\r\n\r\n- **First-line**: Doxycycline 100 mg twice daily for 7 days.\r\n- **Pregnancy/Breastfeeding**: After consulting a specialist, azithromycin, amoxicillin, or erythromycin may be considered.\r\n\r\n### Management\r\n\r\n- Referral to a Genito-Urinary Medicine (GUM) clinic is recommended for treatment and partner notification. If GUM referral is not possible, primary care can manage the condition.\r\n- Educate on STI transmission and risk reduction. Sexual activity should be avoided until treatment completion.\r\n  \r\n### Follow-up\r\n\r\n- **Test of Cure**: Not usually necessary but recommended during pregnancy or if symptoms persist.\r\n- **Repeat Testing**: Advised 3\u20136 months post-treatment for under-25s or those at high risk of reinfection.\r\n\r\nFor more information watch the OTC lesson on  Chapter 6 Gynaecology:\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the symptoms are self limiting and maintain adequate hygiene",
        "answer_number": 1
      },
      {
        "text": "Advise to purchase sodium citrate sachets",
        "answer_number": 2
      },
      {
        "text": "Advise to purchase clotrimazole 500mg pessary",
        "answer_number": 3
      },
      {
        "text": "Advise to see her GP as soon as possible",
        "answer_number": 4
      },
      {
        "text": "Advise to visit a sexual health centre",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 981,
    "bank": "clinicalMep",
    "title": "A veterinary prescription under the cascade for fluoxetine 20mg capsules",
    "text": "**Theme: Timeframes**\r\n\r\n**For the following descriptions, please select the most suitable validity period of prescriptions from or after the appropriate date, from the list provided.\r\nEach option may be used once, more than once, or not at all.**",
    "why": "Correct Answer: \r\n\r\nD) 6 months\r\n\r\nRationale:\r\n\r\n- Veterinary prescriptions, including those issued under the Cascade for unlicensed use of human medicines like fluoxetine, are legally valid for 6 months from the appropriate date, unless they involve Schedule 2, 3 or 4 controlled drugs, in which case the validity is 28 days.\r\n\r\n- Since fluoxetine is not a controlled drug, the standard validity of 6 months applies.\r\n\r\nExplanation of Other Options:\r\n\r\nA) 7 days \u2013 Used for veterinary Schedule 2 or 3 controlled drugs, not applicable here.\r\n\r\nB) 28 days \u2013 Only applies to CDs Schedule 2\u20134, not to fluoxetine.\r\n\r\nC) 30 days \u2013 Not a recognised timeframe for veterinary prescriptions.\r\n\r\nE\u2013H (2 years to 10 years) \u2013 Refer to record retention timeframes, not prescription validity.\r\n\r\n\r\nAlthough NICE guidelines primarily cover human prescribing, the Veterinary Medicines Regulations (VMR) govern the validity of veterinary prescriptions. According to VMR, a prescription for a POM-V medicine or a human medicine prescribed under the Cascade is valid for 6 months, unless it contains a controlled drug, in which case the validity is reduced to 28 days.\r\n\r\nPharmacists supplying veterinary medicines must check prescription details carefully, especially when dispensing human medicines for animal use, and record them appropriately.\r\n\r\nFor more information, please watch MEP (Chapter 2) Professional and Legal Issues:\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "7 days",
        "answer_number": 1
      },
      {
        "text": "28 days",
        "answer_number": 2
      },
      {
        "text": "30 days",
        "answer_number": 3
      },
      {
        "text": "6 months",
        "answer_number": 4
      },
      {
        "text": "2 years",
        "answer_number": 5
      },
      {
        "text": "5 years",
        "answer_number": 6
      },
      {
        "text": "7 years",
        "answer_number": 7
      },
      {
        "text": "10 years",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 965,
    "bank": "clinicalMep",
    "title": "**Which of the following statements is the LEAST appropriate method of denaturing prior to disposal?**",
    "text": "Schedules 2, 3 and 4 (part 1) controlled drugs should be denatured prior to disposal",
    "why": "Liquid formulations need to be poured into a CD denaturing kit. If you denaturing more than one medicine, liquids are often best to be added last so it doesn\u2019t start setting half way through your destruction.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Aerosol formulations should be expelled into water and the resulting liquid poured into a CD destruction kit",
        "answer_number": 1
      },
      {
        "text": "Contents of ampoules to be broken and poured into a CD denaturing kit.",
        "answer_number": 2
      },
      {
        "text": "crush tablets and/or capsules prior to adding them to a CD denaturing kit",
        "answer_number": 3
      },
      {
        "text": "Liquid formulations to be poured down the sink",
        "answer_number": 4
      },
      {
        "text": "Remove the backing of patches and fold in half.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2375,
    "bank": "clinicalTherapeutics",
    "title": "**How many drops per minute should the infusion pump deliver?**",
    "text": "A 23-year old female patient is prescribed an infusion of 5% dextrose solution at a rate of 150 mL/hour. The infusion set has a drop factor of 20 drops/mL.",
    "why": "C. 50\r\n\r\nTo calculate the infusion rate in drops per minute, follow these steps:\r\n\r\nStep 1: Calculate the total drops per hour\r\n\r\nFlow rate = 150 mL/hour\r\n\r\nDrop factor = 20 drops/mL\r\n\r\nTotal drops/hour = 150 mL/hour \u00d7 20 drops/mL = 3000 drops/hour\r\n\r\nStep 2: Convert to drops per minute\r\n\r\nThere are 60 minutes in an hour.\r\n\r\nDrops/minute = Total drops/hour \u00f7 60 = 3000 \u00f7 60 = 50 drops/min\r\n\r\nFinal Answer: The infusion pump should deliver 50 drops/min.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "25",
        "answer_number": 1
      },
      {
        "text": "42",
        "answer_number": 2
      },
      {
        "text": "50",
        "answer_number": 3
      },
      {
        "text": "83",
        "answer_number": 4
      },
      {
        "text": "100",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2614,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate advice?**",
    "text": "A mother presents to the pharmacy with her 8 year old son. She informs you her son has been diagnosed with ADHD. Her son takes Concerta (methylphenidate) 18mg tablets and has been struggling to sleep.",
    "why": "Her son is experiencing a side effect of methylphenidate, and whilst safe to continue taking it, she may wish to see the specialist for insomnia treatment.\r\n\r\nRationale:\r\n\r\nRecognising Side Effects: Methylphenidate (Concerta) is known to cause side effects, including insomnia and difficulties with sleep, particularly when taken later in the day. It is important to recognise that this can be a common side effect of stimulant medications used to treat ADHD.\r\n\r\nSafety of Continuing Medication: The advice indicates that while insomnia is a recognised side effect, it is generally safe to continue taking methylphenidate. Stopping the medication abruptly is not typically recommended without consulting the prescribing healthcare provider.\r\n\r\nReferral to Specialist: The best course of action is to advise the mother to consult with the specialist or the child\u2019s prescribing physician to discuss the insomnia. The healthcare provider can assess the situation and potentially recommend adjustments to the medication regimen or suggest appropriate treatments for managing insomnia, such as behavioural interventions or sleep hygiene practices.\r\n\r\nOther Options:\r\n\r\nPhenergan (Promethazine) and Diphenhydramine: While these medications can cause sedation, they are not typically recommended for managing insomnia in children with ADHD, as they may not address the underlying issue and could introduce additional side effects. Moreover, the long-term use of antihistamines in children is generally discouraged.\r\nStopping Methylphenidate: Stopping the medication outright without discussing it with a healthcare provider could lead to a return of ADHD symptoms, which is not ideal.\r\nInformation on ADHD in Children:\r\nAccording to the NICE guidelines, Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopment disorder characterised by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with functioning or development. The guidelines outline the following key points regarding the assessment and management of ADHD in children:\r\n\r\nDiagnosis: The diagnosis of ADHD should be based on a comprehensive assessment that includes gathering information from multiple sources, such as parents, teachers, and the child. The symptoms must be present in multiple settings (e.g., at home and school) and significantly impact the child's daily functioning.\r\n\r\nManagement:\r\n\r\nBehavioural Interventions: Non-pharmacological approaches, such as parent training in behaviour management and school-based interventions, should be offered as first-line treatment, especially for preschool-aged children.\r\nPharmacological Treatment: For children aged 5 years and older with moderate to severe ADHD symptoms that do not respond adequately to behavioural interventions, pharmacological treatment may be considered. Stimulants, such as methylphenidate (Concerta), are often the first-line medications, with careful monitoring for side effects, including insomnia.\r\nMonitoring and Follow-Up: Regular follow-up is essential to evaluate the effectiveness of treatment and adjust as needed. The healthcare provider should monitor for side effects, growth, and overall well-being. If insomnia or other side effects arise, a reassessment of the medication regimen may be warranted.\r\n\r\nCoexisting Conditions: Many children with ADHD may have coexisting conditions, such as anxiety or learning disabilities. The guidelines emphasise the need for a holistic approach to care that addresses these additional challenges.\r\n\r\nEducation and Support: Parents and caregivers should be provided with information and support regarding ADHD to help them understand the condition and its management better. Engaging with educational resources and support groups can also be beneficial for families.\r\n\r\nFor more informatio watch BNF lesson chapter 4 (ADHD):\r\n\r\n(https://preregshortcuts.com/courses/bnf-course)",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Her son is experiencing a side effect of methylphenidate, and whilst safe to continue taking it, she may wish to see the specialist for insomnia treatment",
        "answer_number": 1
      },
      {
        "text": "Her son is experiencing a side effect of methylphenidate, and whilst safe to continue taking it, she may wish to purchase phenergan 10mg tablets",
        "answer_number": 2
      },
      {
        "text": "Her son is experiencing a side effect of methylphenidate, and whilst safe to continue taking it, she may wish to purchase diphenhydramine 25mg tablets",
        "answer_number": 3
      },
      {
        "text": "Stop taking methylphenidate straight away and see the specialist as soon as possible",
        "answer_number": 4
      },
      {
        "text": "The symptoms are not known to be caused by methylphenidate",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2147,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Signs a and Symptoms of toxicity** \r\n\r\n\u2028\u2028**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 58 year-old female with dry mouth, seizures, coma and arrhythmias.",
    "why": "Correct answer: \r\n\r\nB) Amitriptyline\r\n\r\n\r\nRationale:\r\n\r\nAmitriptyline, a tricyclic antidepressant (TCA), is strongly associated with toxicity symptoms such as:\r\n\r\n- Dry mouth (anticholinergic effect)\r\n\r\n- Seizures (pro-convulsant effect)\r\n\r\n- Coma (CNS depression)\r\n\r\n- Arrhythmias (due to sodium channel blockade causing QRS widening and ventricular arrhythmias)\r\n\r\n- TCAs are particularly dangerous in overdose and can cause rapid deterioration.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Aspirin \u2013 Toxicity causes tinnitus, hyperventilation, metabolic acidosis, not typically seizures or arrhythmias\r\n\r\nC) Amlodipine \u2013 Causes hypotension and reflex tachycardia, not seizures or coma\r\n\r\nD) Bisoprolol \u2013 Causes bradycardia and hypotension, not dry mouth or seizures\r\n\r\nE) Citalopram \u2013 Can cause QT prolongation and seizures at high doses, but dry mouth and coma are less common\r\n\r\nF) Fentanyl \u2013 Causes respiratory depression, pinpoint pupils, not arrhythmias or dry mouth\r\n\r\nG) Naproxen \u2013 NSAID, not associated with CNS or cardiac toxicity\r\n\r\nH) Paracetamol \u2013 Causes liver failure, not neurological or cardiac toxicity\r\n\r\nAmitriptyline, a tricyclic antidepressant, is the most likely cause of the constellation of dry mouth, seizures, coma, and arrhythmias, especially in overdose scenarios. Its anticholinergic and sodium-channel-blocking effects make it one of the most toxic antidepressants in overdose.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Aspirin",
        "answer_number": 1
      },
      {
        "text": "Amitriptyline",
        "answer_number": 2
      },
      {
        "text": "Amlodipine",
        "answer_number": 3
      },
      {
        "text": "Bisoprolol",
        "answer_number": 4
      },
      {
        "text": "Citalopram",
        "answer_number": 5
      },
      {
        "text": "Fentanyl",
        "answer_number": 6
      },
      {
        "text": "Naproxen",
        "answer_number": 7
      },
      {
        "text": "Paracetamol",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2534,
    "bank": "clinicalMep",
    "title": "**Which ONE of the following statements is CORRECT regarding pseudoephedrine?**",
    "text": "A 43-year-old female patient presenting in your pharmacy with nasal congestion and would like to purchase some decongestants",
    "why": "C. She can purchase a maximum legal quantity of 720mg of pseudoephedrine.\r\n\r\nRationale:\r\n\r\nAccording to UK regulations, pseudoephedrine-containing products can only be sold in limited quantities. The maximum legal quantity that can be sold without a prescription is 720 mg. This limit applies to any combination of products containing pseudoephedrine or ephedrine in a single transaction.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Pseudoephedrine-containing medicines can only be sold either by the Pharmacist or under supervision of the responsible pharmacist:\r\nThis is incorrect. While pseudoephedrine is a regulated substance and must be sold under supervision, it is not specifically restricted to only being sold by the pharmacist or under their direct supervision. As long as the responsible pharmacist is available, others can assist with the sale, but it must be done in accordance with legal requirements, such as limiting the quantity sold.\r\n\r\nB. She can purchase a maximum legal quantity of 180mg of pseudoephedrine:\r\nThis is incorrect. The maximum legal quantity is 720 mg, not 180 mg. The 180 mg limit applies to ephedrine, not pseudoephedrine.\r\n\r\nD. She can purchase one packet of pseudoephedrine for herself and the other packet for her daughter:\r\nThis is incorrect. The legal limit of 720 mg applies to the total amount of pseudoephedrine being sold in a single transaction. A customer cannot buy multiple packets that, together, exceed the 720 mg limit.\r\n\r\nE. She can purchase two separate products which containing pseudoephedrine and the other phenylephrine:\r\nThis is incorrect. While phenylephrine is a common decongestant, it does not count toward the limit on pseudoephedrine. However, the key point here is that the law limits the total amount of pseudoephedrine in a single transaction, not phenylephrine. If the total amount of pseudoephedrine from the products exceeds 720 mg, it would be illegal.\r\n\r\nPseudoephedrine is a regulated substance due to its potential for misuse in the production of illicit drugs. As per UK regulations, the maximum legal quantity of pseudoephedrine that can be sold without a prescription is 720 mg. Any sales exceeding this limit must be prescribed by a doctor. Additionally, sales of pseudoephedrine-containing products must be controlled to ensure the amount sold in any given transaction does not exceed legal thresholds. Pharmacists are responsible for ensuring that sales comply with these regulations to prevent misuse while ensuring that legitimate patients have access to the medication they need for conditions like nasal congestion.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Pseudoephedrine containing medicines can only be sold either by the Pharmacist or under supervision of the responsible pharmacist",
        "answer_number": 1
      },
      {
        "text": "She can purchase a maximum legal quantity of 180mg of pseudoephedrine",
        "answer_number": 2
      },
      {
        "text": "She can purchase a maximum legal quantity of 720mg of pseudoephedrine",
        "answer_number": 3
      },
      {
        "text": "She can purchase one packet of pseudoephedrine for herself and the other packet for her daughter",
        "answer_number": 4
      },
      {
        "text": "She can purchase two separate products which containing pseudoephedrine and the other phenylephrine",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2388,
    "bank": "clinicalTherapeutics",
    "title": "**What is the most appropriate treatment option for moderate to severe allergic rhinitis?**",
    "text": "A 25-year-old woman presents to the pharmacy with symptoms of sneezing, nasal congestion, and itchy eyes. She says she has been suffering from hay fever for the last few weeks and has tried various over-the-counter antihistamines, but they have not helped much. She asks for your advice on what else she can do to relieve her symptoms.",
    "why": "B) Intranasal corticosteroids\r\n\r\nRationale: \r\n\r\nAccording to the BNF, intranasal corticosteroids are considered the first-line treatment for moderate to severe allergic rhinitis. They are effective in reducing inflammation in the nasal passages, thereby alleviating nasal congestion, sneezing, and itchy eyes. Intranasal corticosteroids provide sustained relief and have a good safety profile when used appropriately.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Intranasal antihistamines\r\n\r\nWhile intranasal antihistamines are effective for treating allergic rhinitis, they are generally considered less effective than intranasal corticosteroids for moderate to severe symptoms. They may also cause sedation as a side effect, which can limit their use, especially in people who need to remain alert.\r\n\r\nC) Leukotriene receptor antagonists\r\n\r\nThese are typically used as add-on therapy for conditions like asthma and are less effective in treating allergic rhinitis compared to intranasal corticosteroids. They may be used if other treatments are insufficient, but they are not a first-line option.\r\n\r\nD) Oral corticosteroids\r\n\r\nOral corticosteroids may be used for severe cases of allergic rhinitis, but they are not recommended for long-term use due to their potential systemic adverse effects (e.g., weight gain, increased blood pressure, osteoporosis). They are typically used only for short-term flare-ups or when other treatments have failed.\r\n\r\nE) Oral decongestants\r\n\r\nOral decongestants may provide temporary relief of nasal congestion but should not be used for extended periods due to the risk of rebound congestion, as well as side effects like hypertension and insomnia. They are not suitable as a long-term solution for allergic rhinitis.\r\n\r\nIn line with NICE guidelines, intranasal corticosteroids are the most effective treatment for moderate to severe allergic rhinitis and are recommended as first-line therapy. These corticosteroids help control the inflammatory response in the nasal passages, offering relief from symptoms such as congestion, sneezing, and itching. For patients who do not respond adequately to intranasal corticosteroids, intranasal antihistamines or leukotriene receptor antagonists may be considered as additional treatments. Oral decongestants and oral corticosteroids should be avoided for long-term use due to their side effects.\r\n\r\nFor more information watch BNF lesson chapter 13 (Skin):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Intranasal antihistamines",
        "answer_number": 1
      },
      {
        "text": "Intranasal corticosteroids",
        "answer_number": 2
      },
      {
        "text": "Leukotriene receptor antagonists",
        "answer_number": 3
      },
      {
        "text": "Oral corticosteroids",
        "answer_number": 4
      },
      {
        "text": "Oral decongestants",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2506,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "You are the responsible pharmacist and you receive a Welsh prescription written in Welsh. You do not speak Welsh",
    "why": "d) Use a translation service such as Language Line and write the dispensing label in English as you are a non-Welsh speaker\r\n\r\nRationale\r\n\r\nWhen presented with a Welsh prescription and the pharmacist does not understand the language, patient safety is the priority. Using a recognised translation service ensures accurate interpretation of the prescription. Writing the dispensing label in English minimises the risk of errors, as it allows the pharmacist to confidently verify the information. This approach complies with the Medicines, Ethics, and Practice (MEP) guidelines for patient safety.\r\n\r\nExplanation of the Other Options\r\n\r\na) Google translate the prescription and write the dispensing instructions on the label in Welsh\r\n\r\nThis is incorrect. Using an unverified translation tool such as Google Translate poses a high risk of errors due to potential inaccuracies, which could compromise patient safety.\r\n\r\nb) Inform the patient you do not understand Welsh, therefore decline the prescription\r\n\r\nThis is incorrect. Pharmacists must take reasonable steps to assist patients, such as using professional translation services, rather than outright refusing service.\r\n\r\nc) It is illegal for you to dispense a prescription written in Welsh, therefore you refuse to dispense the medication\r\n\r\nThis is incorrect. Welsh prescriptions are legally valid within Wales. Declining to dispense such prescriptions without taking further action would be inappropriate and could lead to patient harm.\r\n\r\ne) Use a translation service such as Language Line and write the dispensing label in Welsh\r\n\r\nThis is incorrect. As a non-Welsh-speaking pharmacist, you might not fully understand Welsh labels, which increases the risk of errors. Writing labels in English ensures you can review and verify the information.\r\n\r\n\r\nWelsh prescriptions are legally valid and recognised in Wales, and pharmacists must ensure they handle these appropriately to maintain patient safety. Key considerations include:\r\n\r\nTranslation services: Use reliable services such as Language Line to ensure accurate interpretation of prescriptions written in Welsh.\r\nDispensing labels: Non-Welsh-speaking pharmacists should write dispensing instructions in English to minimise errors.\r\nPatient communication: If clarification is required, discuss with the patient or prescriber in a respectful and professional manner.\r\nLegality: It is legal to dispense Welsh prescriptions, provided the pharmacist ensures accurate understanding of the instructions.\r\nBy following these steps, pharmacists can ensure safe and effective dispensing while meeting the needs of all patients.\r\n\r\nFor more information watch MEP lesson chapter 4 (The Responsible Pharmacist)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Google translate the prescription and write the dispensing instructions on the label in Welsh",
        "answer_number": 1
      },
      {
        "text": "Inform the patient you do not understand Welsh therefore decline the prescription",
        "answer_number": 2
      },
      {
        "text": "It is illegal for you to dispense a prescription written in Welsh therefore you refuse to dispense the medication",
        "answer_number": 3
      },
      {
        "text": "Use a translation service such as Language line and write the dispensing label in English as you are a non- Welsh speaker",
        "answer_number": 4
      },
      {
        "text": "Use a translation service such as Language line and write the dispensing label in Welsh",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2235,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Electrolyte imbalances**\r\n\r\n\r\n\r\n**Instruction: For each of the following patients, select the most likely electrolyte imbalances they are experiencing from the list of options. Each option may be used once, more than once, or not at all**",
    "text": "Mr W, a 55-year-old male presents for an annual medication review at his GP practice where you are the practice pharmacist that will conduct a consultation with him. He tells you he has recently been suffering from a mild tremor in his hands since his asthma exacerbation. He was recently started on ramipril in hospital to help control his blood pressure. His PMR shows he is also on aspirin, salbutamol, simvastatin, and metformin.",
    "why": "Correct Answer:\r\n\r\nB) Hypokalaemia\r\n\r\nRationale:\r\n\r\n- Mr W is experiencing a mild hand tremor following an asthma exacerbation. This is strongly suggestive of salbutamol-induced hypokalaemia.\r\n\r\n- Salbutamol, a short-acting beta-2 agonist, is known to drive potassium into cells, lowering serum potassium levels. This effect is dose-dependent, and the risk increases when salbutamol is used frequently during exacerbations.\r\n\r\n- Additionally, the presence of tremor is a classic symptom of hypokalaemia, along with muscle cramps and palpitations. This effect is well-recognised and documented in both the BNF and NICE Clinical Knowledge Summaries (CKS).\r\n\r\nExplanation of Other Options:\r\n\r\nA) Hypercalcaemia \r\n\r\nWould present with thirst, constipation, and abdominal pain; no link to current meds.\r\n\r\nC) Hypernatraemia \r\n\r\nTypically associated with dehydration or water loss, not relevant here.\r\n\r\nD) Hypocalcaemia \r\n\r\nWould present with muscle spasms or paraesthesia, not tremor from salbutamol.\r\n\r\nE) Hyperkalaemia \r\n\r\nRamipril can cause this, but it\u2019s early in therapy, and tremor isn\u2019t a typical feature.\r\n\r\nF) Hypomagnesaemia \r\n\r\nMay cause neuromuscular symptoms, but less likely with this drug profile.\r\n\r\nG) Hyponatraemia \r\n\r\nCan cause confusion or fatigue; not linked with tremor in this context.\r\n\r\nH) Hypophosphataemia \r\n\r\nUnlikely without malnutrition or alcohol abuse; not related to current medications.\r\n\r\nSalbutamol and Hypokalaemia:\r\n\r\n- Beta-2 agonists such as salbutamol are essential in managing asthma exacerbations, but they are also associated with dose-dependent hypokalaemia, particularly when used in high or repeated doses. \r\n\r\n- According to NICE asthma guidance and BNF cautions, patients using salbutamol excessively during exacerbations may experience lowered serum potassium, which can lead to tremor, palpitations, or even cardiac arrhythmias in severe cases. \r\n\r\n- Monitoring for hypokalaemia is recommended in patients with frequent salbutamol use, and clinical signs such as tremor can provide early warning of electrolyte imbalance. Education around proper inhaler technique and frequency of use is key in preventing this complication.\r\n\r\nFor more information please watch BNF lesson Chapter 9 (Blood & Nutrition):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Hypercalcaemia",
        "answer_number": 1
      },
      {
        "text": "Hyperkalaemia",
        "answer_number": 2
      },
      {
        "text": "Hypernatraemia",
        "answer_number": 3
      },
      {
        "text": "Hypocalcaemia",
        "answer_number": 4
      },
      {
        "text": "Hypokalaemia",
        "answer_number": 5
      },
      {
        "text": "Hypomagnesaemia",
        "answer_number": 6
      },
      {
        "text": "Hyponatraemia",
        "answer_number": 7
      },
      {
        "text": "Hypophosphataemia",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2259,
    "bank": "clinicalTherapeutics",
    "title": "**Which ONE of the following administration instructions would be acceptable practice?**",
    "text": "This question  relates to the administration of intravenous potassium which has been responsible for some deaths in hospitals nationally. For this reason, a safety alert was issued which provided advice on the need for careful monitoring and the need to double-check dosing and administration instructions to ensure they are safe and that the infusion is given via the appropriate route.\u00a0\r\n\r\nThe hospital you are working in has a potassium administration policy which specifies the following patient safety points:\u00a0\r\n\r\nPotassium Chloride is available as a 1.5 g ampoule containing 20mmol potassium in 10 mL\u00a0\r\nPotassium chloride concentrate must be diluted with not less than 50 times its volume of diluent\r\nIt must be diluted with only sodium chloride 0.9%\u00a0\r\nThe maximum concentration is 40 mmol/L\u00a0\r\nThe absolute maximum infusion rate is 10 mmol/hour\r\nConcentrations greater than 30 mmol/L must be given only via a central line",
    "why": "Correct Answer:\r\n\r\nA) 750 mg of potassium chloride added, 500 mL of sodium chloride 0.9% as a diluent, infusion duration of 60 minutes via a peripheral line.\r\n\r\nRationale:\r\n\r\nIntravenous potassium chloride (KCl) administration requires strict monitoring due to its risk of fatal cardiac arrhythmias. The NICE guidelines and national patient safety alerts outline specific requirements for dilution, infusion rates, and administration routes.\r\n\r\nKey Safety Considerations for IV Potassium:\r\n\r\n\u2714 Dilution: KCl concentrate must be diluted at least 50-fold in sodium chloride 0.9%.\r\n\u2714 Maximum Concentration: 40 mmol/L.\r\n\u2714 Maximum Infusion Rate: 10 mmol/hour.\r\n\u2714 Peripheral Line vs. Central Line:\r\n\r\nIf KCl concentration >30 mmol/L \u2192 Must be given via a central line.\r\nIf KCl concentration \u226430 mmol/L \u2192 Can be given via a peripheral line.\r\n\r\nA) 750 mg of potassium chloride added to 500 mL sodium chloride 0.9%, infusion duration of 60 minutes via peripheral line. \r\n\r\n\u2714 750 mg KCl = 10 mmol potassium.\r\n\u2714 Final concentration: 10 mmol / 500 mL = 20 mmol/L (acceptable for a peripheral line).\r\n\u2714 Infusion rate: 10 mmol over 1 hour = 10 mmol/hour (maximum allowed rate).\r\n\r\n\r\nSafe Potassium Administration:\r\n\r\n- IV potassium chloride should only be prescribed and administered by trained healthcare professionals.\r\n\r\n- Maximum concentration: 40 mmol/L (higher concentrations require further dilution).\r\n\r\n- Maximum infusion rate: 10 mmol/hour to prevent cardiac toxicity.\r\n\r\n- Central line requirement: If KCl concentration >30 mmol/L, infusion must be given via a central line.\r\n\r\n- Dilution: Only sodium chloride 0.9% should be used (glucose solutions can cause intracellular potassium shifts, reducing serum levels).\r\n\r\nFinal Answer:\r\n\r\nA) 750 mg of potassium chloride added, 500 mL of sodium chloride 0.9%, infusion duration of 60 minutes via peripheral line.\r\n\r\nThis is the only option that meets all NICE  safety guidelines for IV potassium administration in terms of dilution, infusion rate, and peripheral administration.\r\n\r\nFor more information, please watch BNF lesson Chapter 9 (Nutrition and Blood):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "750mg of potassium chloride added, 500mL of sodium chloride 0.9% as a diluent, infusion duration of 60 minutes via peripheral lime",
        "answer_number": 1
      },
      {
        "text": "750mg of potassium chloride added, 1000mL of sodium chloride 0.9% as a diluent, infusion duration of 20 minutes via peripheral line",
        "answer_number": 2
      },
      {
        "text": "1.5g of potassium chloride added, 200mL of sodium chloride 0.9% as a diluent, infusion duration of 180 minutes via central line",
        "answer_number": 3
      },
      {
        "text": "3g of potassium chloride added, 1000mL of sodium chloride 0.9% as a diluent, infusion duration of 3 hours via peripheral line",
        "answer_number": 4
      },
      {
        "text": "3g of potassium chloride added, 800mL of sodium chloride 0.9% as a diluent, infusion duration of 3 hours via central line",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2546,
    "bank": "clinicalMep",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "You receive a prescription for a 54-year-old male who has been prescribed gabapentin for monotherapy of focal seizures. Todays date is the 28th December 2023.\u00a0\r\n\r\nAn extract of the prescription has been provided for you.\r\n\r\n![2](https://i.ibb.co/MVKJ3jT/2.png)",
    "why": "(d) Refuse to dispense the prescription as it is not on a standardised form.\r\n\r\nRationale: \r\n\r\nGabapentin is classified as a Schedule 3 controlled drug, which requires it to be prescribed on a standardised, approved form (such as the pink FP10PCD) to meet legal requirements for dispensing. The prescription provided does not meet this requirement, so dispensing is not permitted.\r\n\r\nRegarding other criteria:\r\n\r\nThe prescription is not out of date. For Schedule 3 controlled drugs, prescriptions remain valid for 28 days from the date on the prescription. \r\nSince today\u2019s date is 28th December, the prescription would remain valid until the following day, 29th December.\r\nThe quantity is correctly written in both words and figures, meaning no amendment is necessary.\r\nEmergency supply is not allowed for Schedule 3 controlled drugs (except for phenobarbital in the treatment of epilepsy), so an emergency supply cannot be provided in this case.\r\n\r\nExplanation of Other Options:\r\n\r\n(a) Advise the patient to return to their consultant for a new prescription as it is out of date \u2013 Incorrect, as the prescription is still within the valid 28-day period.\r\n\r\n(b) Amend the quantity of the prescription to meet all legal requirements and then dispense the prescription \u2013 Incorrect, as the quantity is already written in both words and figures, so no amendment is needed.\r\n\r\n(c) Provide an emergency supply and request a new prescription from the consultant \u2013 Incorrect, as gabapentin cannot be supplied in an emergency.\r\n\r\n(e) The prescription meets all legal requirements therefore dispense the prescription \u2013 Incorrect, as it is not on the required standardised form.\r\n\r\nAs gabapentin is a Schedule 3 controlled drug, it must be prescribed on a standardised form for legal compliance. \r\nThe pharmacist cannot dispense this prescription as it lacks the required form and cannot be supplied in an emergency. \r\nThe patient should be informed and referred back to their prescriber for a valid prescription to ensure safe and lawful dispensing.\r\n\r\nWatch MEP lesson on Chapter 2 (Professional and Legal Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the patient to return to their consultant for a new prescription as it is out of date",
        "answer_number": 1
      },
      {
        "text": "Amend the quantity of the prescription to meet all legal requirements and then dispense the prescription",
        "answer_number": 2
      },
      {
        "text": "Provide an emergency supply and request a new prescription from the consultant",
        "answer_number": 3
      },
      {
        "text": "Refuse to dispense the prescription as it is not on a standardised form.",
        "answer_number": 4
      },
      {
        "text": "The prescription meets all legal requirements therefore dispense the prescription",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2594,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the patient's symptoms?**",
    "text": "A 21 year old female patient presents to the pharmacy with a new onset of abdominal discomfort. She informs you she is also experiencing heartburn which wakes her up at night and her stools have \u201ctar\u201d colour. She has no allergies. Her regular medication is below:\u00a0\r\n\r\nNaproxen 250mg tablets: Take one tablet three times a day\u00a0\r\nCitalopram 10mg tablets: Take one daily\u00a0\r\nFexofenadine 180mg tablets: Take one daily\u00a0\r\nMometasone 50mcg/dose nasal spray: Two sprays in each nostril once a day\u00a0\r\n\r\n\r\n\r\n.",
    "why": "Duodenal or gastric bleed\r\n\r\nRationale:\r\n\r\nThe patient's symptoms, including abdominal discomfort, heartburn, and tar-coloured stools (melena), strongly suggest the presence of a duodenal or gastric bleed. The dark, tarry appearance of the stools indicates the presence of digested blood, which typically originates from the upper gastrointestinal tract. The most common cause of such bleeding is an ulcer, often associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) like naproxen, which the patient is taking regularly. NSAIDs are known to increase the risk of gastrointestinal bleeding by inhibiting the production of protective gastric mucosa.\r\n\r\nExplanation of Other Options:\r\n\r\nDuodenal or gastric ulcer: While ulcers could explain the abdominal discomfort and heartburn, the presence of melena (black, tarry stools) indicates that the ulcer has likely progressed to bleeding.\r\n\r\nFunctional dyspepsia: This could cause abdominal discomfort and heartburn, but it does not typically cause tarry stools, which suggest a gastrointestinal bleed.\r\n\r\nGastro-oesophageal reflux disease (GORD): GORD could explain the heartburn and discomfort, but tarry stools are not a common feature of reflux and suggest a more serious underlying condition like a bleed.\r\n\r\nIrritable bowel syndrome (IBS): IBS does not usually present with tarry stools or gastrointestinal bleeding, and its symptoms typically involve a pattern of bowel habit changes (diarrhoea or constipation) without the presence of melena.\r\n\r\n\r\nNICE guidelines highlight the risk of gastrointestinal bleeding associated with the use of NSAIDs such as naproxen, especially in individuals taking them regularly for pain or inflammation. These drugs can cause irritation and ulceration of the stomach lining, leading to symptoms like abdominal discomfort, heartburn, and serious complications such as bleeding. Patients at risk (e.g., those on long-term NSAIDs) should be monitored, and prophylactic treatment with proton pump inhibitors (PPIs) may be considered to reduce the risk of GI bleeding. Immediate referral is warranted if there are signs of bleeding, such as melena or hematemesis.\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Duodenal or gastric ulcer",
        "answer_number": 1
      },
      {
        "text": "Duodenal or gastric bleed",
        "answer_number": 2
      },
      {
        "text": "Functional dyspepsia",
        "answer_number": 3
      },
      {
        "text": "Gastro-oesophageal reflux disease",
        "answer_number": 4
      },
      {
        "text": "Irritable bowel syndrome",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2630,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the correct dose of ibuprofen for the child?**",
    "text": "A father presents to the pharmacy with his 5 year old son. He requests to purchase Nurofen (ibuprofen) oral suspension.",
    "why": "BNFC: Child 4\u20136 years\r\n150 mg 3 times a day, maximum daily dose to be given in 3\u20134 divided doses; maximum 30 mg/kg per day.\r\n\r\nMemorise following table:\r\n\r\nhttps://ibb.co/TL75B50\r\n\r\nFor more information about Paracetamol and Ibuprofen Doses watch the BNF lesson on Chapter 4 Central Nervous system (Pain management session):\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "50mg three times a day",
        "answer_number": 1
      },
      {
        "text": "50mg three or four times a day",
        "answer_number": 2
      },
      {
        "text": "100mg three times a day",
        "answer_number": 3
      },
      {
        "text": "150mg three times a day",
        "answer_number": 4
      },
      {
        "text": "200mg three times a day",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2598,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate first- step treatment for her symptoms?**",
    "text": "A 28 year old 24 week pregnant female presents to the pharmacy with hard, dry and difficult to pass stools. She explains to you this is the first time she has experienced these symptoms. She has no allergies and takes no regular medication.",
    "why": "Dietary advice\r\n\r\nRationale:\r\n\r\nFor a pregnant woman experiencing hard, dry stools for the first time, dietary advice is the most appropriate first-step treatment. Recommendations may include increasing dietary fibre intake through fruits, vegetables, and whole grains, as well as ensuring adequate hydration. This approach is non-pharmacological and safer for both the mother and the developing fetus.\r\n\r\nExplanation of Other Options:\r\n\r\nBulk forming laxative: While these can help with constipation, dietary changes should be the first-line approach before introducing any medication.\r\n\r\nOsmotic laxative: These are effective for treating constipation, but they are generally considered after dietary changes do not provide relief.\r\n\r\nStimulant laxative: These should be avoided in the initial treatment of constipation, especially during pregnancy, due to potential adverse effects on bowel function.\r\n\r\nStool softener: Although useful, it is usually recommended after dietary modifications if symptoms persist.\r\n\r\n\r\nConstipation is a common issue during pregnancy due to hormonal changes, decreased physical activity, and pressure on the bowel from the growing uterus. NICE guidelines emphasise the importance of dietary modifications as a first-line intervention, encouraging increased fibre intake and hydration to manage constipation effectively. If dietary changes are insufficient, laxatives may be considered, but pregnant women should avoid certain types of laxatives, such as stimulants, to reduce the risk of complications. Regular monitoring and supportive care are essential to ensure maternal comfort and health.\r\n\r\nFor more information please watch OTC lesson chapter 7 (Gastroenterology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Bulk forming laxative",
        "answer_number": 1
      },
      {
        "text": "Dietary advice",
        "answer_number": 2
      },
      {
        "text": "Osmotic laxative",
        "answer_number": 3
      },
      {
        "text": "Stimulant laxative",
        "answer_number": 4
      },
      {
        "text": "Stool softener",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2210,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Drugs used in musculoskeletal and joint diseases**\u2028\r\n\r\n**Instruction: For each of the scenarios below, select the single most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 45-year-old man with acute gout who has a history of peptic ulcer and renal impairment.",
    "why": "(Colchicine is an alternative to NSAIDs for the treatment of acute gout in patients who have contra-indications or intolerance to NSAIDs. It inhibits the inflammatory response to urate crystals. It should be started within 12 hours of the onset of an attack and continued until the attack is resolved\u2075, p. 10-16)",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Allopurinol",
        "answer_number": 1
      },
      {
        "text": "Colchicine",
        "answer_number": 2
      },
      {
        "text": "Febuxostat",
        "answer_number": 3
      },
      {
        "text": "Hydroxychloroquine",
        "answer_number": 4
      },
      {
        "text": "Methotrexate",
        "answer_number": 5
      },
      {
        "text": "Naproxen",
        "answer_number": 6
      },
      {
        "text": "Paracetamol",
        "answer_number": 7
      },
      {
        "text": "Prednisolone",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2384,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is not used for the treatment of allergic conjunctivitis?\u00a0**",
    "text": "A 25-year-old woman presents to the pharmacy with symptoms of itchy, red, and watery eyes. She says she has a history of hay fever and suspects that she has allergic conjunctivitis. She asks for your advice on which eye drops she can use to relieve her symptoms.",
    "why": "Chloramphenicol\r\n\r\nRationale:\r\n\r\nChloramphenicol is an antibiotic used for bacterial eye infections, such as bacterial conjunctivitis, and is not indicated for allergic conjunctivitis. Allergic conjunctivitis requires treatment with antihistamines, mast cell stabilisers, or combination preparations designed to reduce inflammation and itching caused by allergens.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Antazoline with xylometazoline\r\n\r\nThis combination contains an antihistamine (antazoline) and a decongestant (xylometazoline) and is used to relieve redness and itching caused by allergic conjunctivitis.\r\n\r\nC. Ketotifen\r\n\r\nAn antihistamine with mast cell stabilising properties, ketotifen is highly effective in managing allergic conjunctivitis by preventing the release of inflammatory mediators.\r\n\r\nD. Olopatadine\r\n\r\nA dual-action agent that works as an antihistamine and mast cell stabiliser, olopatadine effectively reduces itching, redness, and swelling in allergic conjunctivitis.\r\n\r\nE. Sodium cromoglicate\r\n\r\nA mast cell stabiliser, sodium cromoglicate prevents the release of histamine and other inflammatory mediators, making it a common choice for allergic conjunctivitis.\r\n\r\nAllergic conjunctivitis is an inflammation of the conjunctiva caused by allergens such as pollen, dust, or animal dander. It is characterised by symptoms such as redness, itching, and watery eyes. The primary treatment involves antihistamines, mast cell stabilisers, or combination products that alleviate the allergic response. Antibiotics like chloramphenicol are inappropriate for this condition as they target bacterial infections and provide no relief for allergic symptoms. Proper identification of the underlying cause is essential to guide treatment effectively.\r\n\r\nFor more information watch BNF lesson Chapter 11 (Eyes):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Antazoline with xylometazoline",
        "answer_number": 1
      },
      {
        "text": "Chloramphenicol",
        "answer_number": 2
      },
      {
        "text": "Ketotifen",
        "answer_number": 3
      },
      {
        "text": "Olopatadine",
        "answer_number": 4
      },
      {
        "text": "Sodium cromoglicate",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2376,
    "bank": "clinicalTherapeutics",
    "title": "**How many drops per min should the infusion pump deliver?**",
    "text": "A 87-year-old male is prescribed an infusion of 0.9% sodium chloride solution at a rate of 100 mL/hour. The infusion set has a drop factor of 15 drops/mL.",
    "why": "A. 25\r\n\r\nTo calculate the number of drops per minute, follow these steps:\r\n\r\nStep 1: Calculate the number of drops per hour\r\n\r\nInfusion rate = 100 mL/hour\r\n\r\nDrop factor = 15 drops/mL\r\n\r\nDrops per hour = 100 mL/hour \u00d7 15 drops/mL = 1500 drops/hour\r\n\r\nStep 2: Convert drops per hour to drops per minute\r\n\r\nSince there are 60 minutes in an hour, divide the drops per hour by 60 to find the drops per minute:\r\n\r\nDrops per minute = 1500 drops/hour \u00f7 60 = 25 drops/min\r\n\r\nTherefore, the infusion pump should deliver 25 drops per minute.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "25",
        "answer_number": 1
      },
      {
        "text": "50",
        "answer_number": 2
      },
      {
        "text": "60",
        "answer_number": 3
      },
      {
        "text": "75",
        "answer_number": 4
      },
      {
        "text": "100",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2536,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a suitable prescription?**",
    "text": "Podiatrists independent prescribers have prescribing restrictions on Controlled medicines",
    "why": "(d) Morphine sulfate\r\n\r\nRationale:\r\n\r\nPodiatrists who are independent prescribers have specific restrictions on the controlled medicines they are permitted to prescribe. They are allowed to prescribe certain Schedule 4 and Schedule 5 controlled drugs, but they cannot prescribe Schedule 2 controlled drugs such as morphine sulphate.\r\n\r\nOther Options Explained:\r\n\r\n(a) Diazepam: Podiatrists can prescribe diazepam, a Schedule 4 controlled drug, for appropriate conditions within their prescribing scope.\r\n\r\n(b) Dihydrocodeine: This is a Schedule 5 controlled drug, which podiatrists are authorised to prescribe within their scope of practice.\r\n\r\n(c) Lorazepam: As a Schedule 4 controlled drug, lorazepam can be prescribed by independent prescribers like podiatrists for appropriate cases.\r\n\r\n(e) Temazepam: Temazepam, also a Schedule 3 controlled drug, is within the prescribing authority of podiatrists.\r\n\r\nThe Podiatry Prescribing Regulations allow independent prescribers to prescribe certain controlled medicines, but they cannot prescribe Schedule 2 controlled drugs, which are considered more potent and carry a higher risk of abuse and dependency. Therefore, morphine sulphate is excluded from their prescribing rights due to its classification as a Schedule 2 controlled substance. Podiatrists can prescribe other controlled drugs like dihydrocodeine, diazepam, lorazepam, and temazepam if appropriate for the patient's needs.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Diazepam",
        "answer_number": 1
      },
      {
        "text": "Dihydrocodeine",
        "answer_number": 2
      },
      {
        "text": "Lorazepam",
        "answer_number": 3
      },
      {
        "text": "Morphine sulfate",
        "answer_number": 4
      },
      {
        "text": "Temazepam",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2245,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following would have a definite risk to this patient?**",
    "text": "Patients with a G6PD deficiency who take certain medicines are at a higher risk of developing acute haemolytic anaemia.",
    "why": "Correct Answer:\r\n\r\nB) Co-trimoxazole\r\n\r\nRationale:\r\n\r\nCo-trimoxazole is a sulfonamide antibiotic that can induce oxidative stress in red blood cells. Patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency are at a higher risk of acute haemolytic anaemia because their red blood cells lack the ability to effectively neutralise oxidative damage. Co-trimoxazole is a well-documented trigger for haemolysis in G6PD-deficient individuals and is contraindicated or should be used with extreme caution in these patients.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Aspirin\r\n\r\nAspirin in low doses is generally safe for G6PD-deficient patients, but high doses may contribute to oxidative stress and lead to haemolysis. However, it is not as strong a trigger as co-trimoxazole.\r\n\r\nC) Clonazepam\r\n\r\nClonazepam is a benzodiazepine used for epilepsy and anxiety and has no known risk of causing haemolysis in G6PD-deficient patients.\r\n\r\nD) Gliclazide\r\n\r\nGliclazide is a sulfonylurea used for diabetes management. While some sulfonylureas may have a mild oxidative effect, gliclazide is not classified as a high-risk drug for G6PD deficiency.\r\n\r\nE) Ibuprofen\r\n\r\nIbuprofen, a nonsteroidal anti-inflammatory drug (NSAID), is generally safe for G6PD-deficient patients at normal doses. However, some NSAIDs (e.g., mefenamic acid) pose a higher risk of haemolysis and should be used cautiously.\r\n\r\nG6PD Deficiency and Drug-Induced Haemolysis :\r\n\r\nGlucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked genetic disorder that affects the ability of red blood cells to withstand oxidative stress. Exposure to certain medications, infections, or foods (e.g., fava beans) can trigger acute haemolytic anaemia, leading to symptoms such as jaundice, dark urine, pallor, fatigue, and shortness of breath.\r\n\r\nCertain drugs must be avoided in G6PD deficiency due to their oxidative potential, which can cause red blood cell destruction. High-risk medications include:\r\n\r\n- Sulfonamides (e.g., co-trimoxazole, dapsone)\r\n- Nitrofurantoin\r\n- Primaquine (antimalarial)\r\n- Quinolones (e.g., ciprofloxacin)\r\n- Certain NSAIDs (e.g., mefenamic acid)\r\n\r\nAccording to NICE guidelines, it is essential to review medication history in G6PD-deficient patients before prescribing potential oxidative drugs. Where alternatives are available, lower-risk medications should be considered to prevent haemolysis.\r\n\r\nFor more information, please watch BNF lesson Chapter 5 (Infections):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Aspirin",
        "answer_number": 1
      },
      {
        "text": "Co-trimoxazole",
        "answer_number": 2
      },
      {
        "text": "Clonazepam",
        "answer_number": 3
      },
      {
        "text": "Gliclazide",
        "answer_number": 4
      },
      {
        "text": "Ibuprofren",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2629,
    "bank": "clinicalOtc",
    "title": "**What is the most likely diagnosis and the most appropriate treatment for this patient?**",
    "text": "A 25-year-old woman presents to the pharmacy with a red, itchy and watery right eye. She says she woke up this morning with a sticky discharge on her eyelid and lashes. She has no history of eye problems or contact lens use. She is otherwise healthy and takes no medication. She asks you for advice on how to treat her condition.",
    "why": "This is because the patient has symptoms of acute bacterial conjunctivitis, such as redness, discharge, itching and crusting of the eyelids. Chloramphenicol eye drops are available over the counter for the treatment of bacterial conjunctivitis in adults and children over 2 years old.\r\n\r\n- Infective conjunctivitis is caused by viral, bacterial, or parasitic infections.\r\n- **Viral conjunctivitis** (mainly adenoviruses) is the most common type.\r\n- **Bacterial causes** include **Streptococcus pneumoniae**, **Staphylococcus aureus**, and **Haemophilus influenzae**.\r\n- **Hyperacute conjunctivitis** is a severe form caused by **Neisseria gonorrhoeae**.\r\n- **Ophthalmia neonatorum (ON)** affects newborns within the first four weeks of life and can be infectious or non-infectious.\r\n- Conjunctivitis is usually self-limiting; viral cases resolve in 7 days, bacterial in 5\u201310 days.\r\n- Contact lens wearers and immunocompromised people are at higher risk of complications.\r\n- Untreated ON can lead to severe complications like sight loss.\r\n- Symptoms include conjunctival redness, gritty or burning sensation, watering, and discharge.\r\n- Urgent referral to ophthalmology is needed for serious cases (e.g., ON, gonococcal or chlamydial infection, herpes, or severe disease).\r\n  \r\n**Primary care management:**\r\n- Reassure patients that most cases are self-limiting.\r\n- Advise self-care (cleaning eyelids, cool compresses, lubricating drops, avoid contact lenses).\r\n- Use antibiotics like **chloramphenicol** or **fusidic acid** for suspected bacterial infections.\r\n- Provide follow-up\r\nFor more information watch the OTC lesson on  Chapter 3 Opthalmology and Otology (conjunctivitis) :\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Allergic conjunctivitis; antihistamine eye drops",
        "answer_number": 1
      },
      {
        "text": "Bacterial conjunctivitis; chloramphenicol eye drops",
        "answer_number": 2
      },
      {
        "text": "Blepharitis; lid hygiene and warm compresses",
        "answer_number": 3
      },
      {
        "text": "Dry eye syndrome; lubricating eye drops",
        "answer_number": 4
      },
      {
        "text": "Viral conjunctivitis; artificial tears",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 881,
    "bank": "clinicalMep",
    "title": "**Which of the following dates is the last day you can dispense the prescription?**",
    "text": "You receive a prescription for isotretinoin for a 23 year old female patient of a child bearing potential, and is under the pregnancy prevention programme. The prescription has been dated as 10th June 2023.",
    "why": "Prescriptions for oral retinoids under the pregnancy prevention programme are only valid for 7 days. Any prescription presented after 7 days should be considered expired. Ideally prescriptions should be prescribed and dispensed on the same day.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "16th June 2023",
        "answer_number": 1
      },
      {
        "text": "20th June 2023",
        "answer_number": 2
      },
      {
        "text": "10th July 2023",
        "answer_number": 3
      },
      {
        "text": "10th December 2023",
        "answer_number": 4
      },
      {
        "text": "11th December 2023",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2581,
    "bank": "clinicalOtc",
    "title": "**Which of the following is INCORRECT regarding the sale and supply of hydrocortisone 1% cream?**",
    "text": "A mother presents to the pharmacy with her 10 year old son. She explains her son suffers from atopic eczema. She is away from home visiting family and unable to get a GP appointment. She is wondering if it is possible to purchase a steroid cream over the counter.",
    "why": "b) Hydrocortisone is a low potency steroid therefore safe to use on the face\r\n\r\nRationale:\r\n\r\nThis statement is incorrect because, while hydrocortisone 1% is a low-potency steroid, it is generally not recommended for use on the face without medical supervision. The facial skin is particularly sensitive, and prolonged or unsupervised use of steroids in this area can lead to adverse effects such as skin thinning, perioral dermatitis, or worsening of skin sensitivity.\r\n\r\nExplanation of Options:\r\n\r\na) Hydrocortisone can be sold to those 10 years and older for the treatment of eczema\r\n\r\nOver-the-counter regulations allow hydrocortisone 1% cream to be sold for children aged 10 and above to treat mild cases of eczema.\r\n\r\nc) Hydrocortisone must not be used on broken or infected skin\r\n\r\nIt is important to avoid applying hydrocortisone on broken or infected skin, as this can exacerbate infection risks and increase sensitivity in those areas.\r\n\r\nd) Hydrocortisone can be used once or twice a day\r\n\r\nThe standard recommendation is to apply hydrocortisone 1% cream once or twice daily to manage symptoms such as inflammation and itching for short-term use.\r\n\r\ne) Maximum treatment duration is for one week\r\n\r\nTo reduce the risk of side effects, it is advised that hydrocortisone 1% cream be used for no longer than one week for self-treatment purposes.\r\n\r\n\r\nAtopic eczema is a chronic, inflammatory skin condition characterized by dry, itchy, and inflamed skin. According to NICE guidelines, the mainstays of treatment are regular emollient use to maintain skin hydration and topical corticosteroids for flare-ups to manage inflammation and itching. Emollients should be applied frequently, even when the skin appears clear, to prevent flare-ups. NICE also advises parents and caregivers to avoid known triggers and keep nails short to minimize skin damage from scratching. For severe or persistent cases, referral to a healthcare professional is recommended to consider additional treatments or alternative management options.\r\n\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Hydrocortisone can be sold those 10 years and older for the treatment of eczema",
        "answer_number": 1
      },
      {
        "text": "Hydrocortisone is a low potency steroid therefore safe to use on the face",
        "answer_number": 2
      },
      {
        "text": "Hydrocortisone must not be used on broken or infected skin",
        "answer_number": 3
      },
      {
        "text": "Hydrocortisone can be used once or twice a day",
        "answer_number": 4
      },
      {
        "text": "Maximum treatment duration is for one week.",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2500,
    "bank": "clinicalMep",
    "title": "**Which of the following medications must be prescribed on a standardised form?**",
    "text": "You are the responsible pharmacist in your community pharmacy and you teaching your trainee pharmacists about private controlled drug prescriptions",
    "why": "e) Tramadol\r\n\r\nRationale\r\n\r\nPrivate prescriptions for Schedule 2 and 3 Controlled Drugs must be written on a standardised private prescription form (e.g. FP10PCD in England). Tramadol is classified as a Schedule 3 Controlled Drug, and as such, it must adhere to this legal requirement.\r\n\r\nExplanation of the Other Options\r\n\r\na) Clenbuterol\r\n\r\nClenbuterol is not a controlled drug in the UK. It is a prescription-only medicine (POM), and POMs do not require a standardised form.\r\n\r\nb) Diazepam\r\n\r\nDiazepam is a Schedule 4 (Part I) Controlled Drug. Schedule 4 drugs do not require a standardised private prescription form.\r\n\r\nc) Lorazepam\r\n\r\nLike diazepam, lorazepam is also a Schedule 4 (Part I) Controlled Drug, and therefore a standardised form is not needed.\r\n\r\nd) Sativex\r\n\r\nSativex is a Schedule 4 (Part I) Controlled Drug, which does not require a standardised private prescription form.\r\n\r\ne) Tramadol\r\n\r\nTramadol is a Schedule 3 Controlled Drug and must be prescribed on a standardised private prescription form, such as FP10PCD in England.\r\n\r\nKey Points About Controlled Drug Prescriptions\r\n\r\nSchedule 2 and 3 Controlled Drugs:\r\n\r\nMust be prescribed on a standardised private prescription form (e.g. FP10PCD in England).\r\nExamples include tramadol (Schedule 3) and morphine (Schedule 2).\r\n\r\nSchedule 4 and 5 Controlled Drugs:\r\n\r\nThese do not require a standardised form for private prescriptions.\r\nExamples include diazepam, lorazepam, and Sativex.\r\n\r\nMisuse of Drugs Regulations 2001:\r\n\r\nEstablishes the classification of controlled drugs into Schedules 1\u20135.\r\n\r\nSummary\r\n\r\nIn the UK, private prescriptions for controlled drugs must comply with legal requirements established under the Misuse of Drugs Regulations 2001. A standardised private prescription form (e.g. FP10PCD in England) is mandatory for Schedule 2 and 3 Controlled Drugs, including tramadol, to ensure proper documentation and reduce misuse. In contrast, Schedule 4 and 5 Controlled Drugs\u2014such as diazepam, lorazepam, and Sativex\u2014are exempt from this requirement. Pharmacists must verify that prescriptions for controlled drugs meet all legal requirements to maintain compliance and safeguard patient safety. For detailed guidance, refer to MEP Chapter 4.\r\n\r\n\r\nFor more information watch MEP lesson chapter 4 (The Responsible Pharmacist)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Clenbuterol",
        "answer_number": 1
      },
      {
        "text": "Diazepam",
        "answer_number": 2
      },
      {
        "text": "Lorazepam",
        "answer_number": 3
      },
      {
        "text": "Sativex",
        "answer_number": 4
      },
      {
        "text": "Tramadol",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 882,
    "bank": "clinicalMep",
    "title": "**Which one of the following is NOT a legal requirement for schedule 2 and 3 controlled drugs?**",
    "text": "Prescriptions for Schedule 2 and 3 controlled drugs must meet legal requirements under the Misuse of Drugs Regulations 2001 as amended,",
    "why": "Schedule 2 and 3 controlled drugs are  valid for 28 days after the appropriate date not 30 days",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Age of the patient if under 12",
        "answer_number": 1
      },
      {
        "text": "If the prescription is written by a registered dentist \u201cfor dental treatment only\u201d must be present",
        "answer_number": 2
      },
      {
        "text": "Quantity of the medicine in words and figures",
        "answer_number": 3
      },
      {
        "text": "Signature of the prescriber",
        "answer_number": 4
      },
      {
        "text": "The prescription is valid for 30 days after the appropriate date on the prescription",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 992,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "A 45 year old male presents to the pharmacy requesting to purchase Viagra Connect. He informs you he has tadalafil 10mg tablets prescribed however he has run out. The Pharmacy checklist has been provided for you.",
    "why": "a) Refuse the sale and refer the patient to his GP for a prescription of tadalafil 10mg tablets.\r\n\r\nRationale:\r\n\r\nSince the patient is currently prescribed tadalafil 10mg by his GP, it's important to advise him to consult his GP for a new prescription rather than switching to over-the-counter (OTC) sildenafil (Viagra Connect). This ensures continuity of treatment and confirms that the medication he is taking is appropriate for his current health status.\r\n\r\nExplanation of Other Options:\r\n\r\n(b) Sell Viagra Connect and inform the patient they must see their GP within 6 months:\r\nIncorrect. Since the patient is on a prescribed medication (tadalafil) for erectile dysfunction, selling Viagra Connect would be inappropriate without consulting the GP, as it could interfere with the prescribed treatment plan.\r\n\r\n(c) Sell Viagra Connect and inform the patient they must see their GP for a new prescription:\r\nIncorrect. While this option addresses the need for a follow-up with the GP, switching him to Viagra Connect without consultation may affect his current treatment with tadalafil.\r\n\r\n(d) Sell Viagra Connect as long as nothing has changed with respect to his health status or medicines usage:\r\nIncorrect. Even if there are no changes in his health status, the patient\u2019s current medication (tadalafil) is GP-prescribed, and it is preferable to continue with his current treatment plan under medical supervision.\r\n\r\n(e) Sell Viagra Connect as there is no need to repeat the questioning as treatment was already prescribed by his GP:\r\nIncorrect. Though he has a prescription for erectile dysfunction treatment, the medication prescribed (tadalafil) differs from sildenafil (Viagra Connect). Confirming suitability through his GP is essential to ensure safe and effective treatment.\r\n\r\nTadalafil is available over the counter (OTC) in some formulations and countries, though it often requires consultation with a pharmacist. In the UK, for instance, tadalafil 10mg has been made available OTC under the brand name Cialis Daily, but typically this applies only to lower dosages and requires pharmacist assessment to ensure safety. Higher doses or longer-acting versions of tadalafil (like the 10mg and 20mg) are generally prescription-only due to increased risk of side effects and contraindications, particularly when there are underlying health concerns.\r\n\r\nIn the scenario given:\r\n\r\nSince the patient is already on tadalafil 10mg via prescription, it\u2019s best practice to maintain consistency with his prescribed medication rather than switching to OTC sildenafil (Viagra Connect). This minimizes risk and ensures optimal management, as the GP can reassess the need and dosage.\r\n\r\nIf the patient requires tadalafil urgently and no GP appointment is available, he may discuss OTC tadalafil availability with the pharmacist. However, switching medications without professional guidance, especially in cases of erectile dysfunction, can affect efficacy and safety.\r\n\r\nIn such cases, referring the patient back to the GP or consulting with them regarding OTC tadalafil options would be prudent.\r\n\r\nFor more information please watch OTC lesson Chapter 9 (Reclassified Medicines)\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": "https://bucketeer-e785e884-c4af-45ab-9a36-63a60ccc6444.s3.amazonaws.com/bucketeer-e785e884-c4af-45ab-9a36-63a60ccc6444/media/public/73efd913-85fc-45c4-a7e7-dfc6369fe21b.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIARVGPJVYVHK6QIBWU%2F20250729%2Feu-west-1%2Fs3%2Faws4_request&X-Amz-Date=20250729T222509Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=a489b80b8e58d4d28fa685e1d47bddbfafbc67754b23373847b4ec9c73213d93",
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "refuse the sale and refer the patient to his GP for a prescription of tadalafil 10mg tablets",
        "answer_number": 1
      },
      {
        "text": "sell Viagra connect and inform the patient they must see their GP within 6 months",
        "answer_number": 2
      },
      {
        "text": "sell Viagra Connect and inform the patient they must see their GP for a new prescription",
        "answer_number": 3
      },
      {
        "text": "sell Viagra Connect as long as nothing has changes with respect to his health status or medicines usage",
        "answer_number": 4
      },
      {
        "text": "sell Viagra Connect as there is no need to repeat the questioning as treatment was already prescribed by his GP",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2212,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Drugs used in musculoskeletal and joint diseases**\u2028\r\n\r\n**Instruction: For each of the scenarios below, select the single most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 50-year-old man with osteoarthritis who has mild to moderate pain and stiffness in his knees and hips.",
    "why": "Paracetamol is an analgesic drug that can be used for the treatment of mild to moderate pain and stiffness in osteoarthritis. It has a lower risk of adverse effects than NSAIDs and is the first-line drug for most patients. However, it may not be effective for some patients and higher doses may increase the risk of hepatotoxicity\u2075, p. 10-2",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "Allopurinol",
        "answer_number": 1
      },
      {
        "text": "Colchicine",
        "answer_number": 2
      },
      {
        "text": "Febuxostat",
        "answer_number": 3
      },
      {
        "text": "Hydroxychloroquine",
        "answer_number": 4
      },
      {
        "text": "Methotrexate",
        "answer_number": 5
      },
      {
        "text": "Naproxen",
        "answer_number": 6
      },
      {
        "text": "Paracetamol",
        "answer_number": 7
      },
      {
        "text": "Prednisolone",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2380,
    "bank": "clinicalTherapeutics",
    "title": "**How many tablets should the pharmacist dispense to the patient?**",
    "text": "A 59 year old male patient presents a prescription for metformin 500 mg tablets with the following directions: Take one tablet twice a day for the first week, then increase to two tablets twice a day for the next three weeks.",
    "why": "D. 98\r\n\r\nRationale:\r\n\r\nThe calculation involves determining the total number of tablets needed for the prescribed regimen:\r\n\r\nFirst Week (7 days):\r\n\r\nDose: 1 tablet twice a day = 2 tablets/day\r\nTotal for 7 days: \r\n2 \u00d7 7 = 14\r\n2\u00d77=14 tablets\r\nNext Three Weeks (21 days):\r\n\r\nDose: 2 tablets twice a day = 4 tablets/day\r\nTotal for 21 days: \r\n4 \u00d7 21 = 84\r\n4\u00d721=84 tablets\r\n\r\nTotal Quantity:\r\n\r\n14 + 84 = 98\r\n\r\n14+84=98 tablets\r\n\r\nMetformin is a first-line oral hypoglycaemic agent used in managing type 2 diabetes. Titrating the dose gradually helps to minimise gastrointestinal side effects such as nausea and diarrhoea. Always verify patient understanding of dose adjustments and provide advice on potential side effects.\r\n\r\nPlease watch BNF lesson Chapter 6 (Endocrine System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "28",
        "answer_number": 1
      },
      {
        "text": "56",
        "answer_number": 2
      },
      {
        "text": "84",
        "answer_number": 3
      },
      {
        "text": "98",
        "answer_number": 4
      },
      {
        "text": "140",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2251,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Analgesics**\r\n\r\n**Instruction: For the following scenarios select the most suitable analgesic in each of the following scenarios. Each option may be used once, more than once, or not at all**",
    "text": "A 25-year-old man presents to your chemist for some advice. He twisted his ankle a few says ago whilst playing football and is currently taking co-codamol 30/500 tablets four times a day with limited benefit. He tells you he has \u2018no allergies that he is aware of\u2019 and takes levetiracetam 500 mg twice a day for epilepsy.",
    "why": "Correct Answer:\r\n\r\nE) Ibuprofen tablets\r\n\r\nRationale:\r\n\r\nThe patient is experiencing inadequate pain relief from co-codamol (paracetamol + codeine) for a twisted ankle (musculoskeletal injury).\r\n\r\n- Ibuprofen is an NSAID and is recommended as first-line treatment for musculoskeletal injuries such as sprains, strains, and soft tissue injuries.\r\n\r\n- Ibuprofen has a better safety profile than naproxen in short-term use, with fewer gastrointestinal (GI) side effects at standard doses.\r\n\r\n- Ibuprofen has a lower cardiovascular risk compared to diclofenac and naproxen, making it a safer option.\r\n\r\n- It does not interact with levetiracetam (antiepileptic drug), making it a suitable choice for a patient with epilepsy.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Aspirin tablets \r\n\r\nNot routinely used for musculoskeletal pain.\r\nHigher risk of GI irritation and bleeding compared to ibuprofen.\r\n\r\nB) Codeine liquid \r\n\r\nThe patient is already taking co-codamol (which contains codeine).\r\nIncreasing codeine intake would increase the risk of side effects (drowsiness, constipation, respiratory depression).\r\n\r\nC) Diazepam tablets \r\n\r\nNot an analgesic.\r\nUsed for muscle spasms or anxiety, not for ankle sprains.\r\n\r\nD) Diclofenac tablets \r\n\r\nHigher cardiovascular risk compared to ibuprofen.\r\nNot first-line for musculoskeletal injuries due to its side effect profile.\r\n\r\n\r\nF) Naproxen tablets \r\n\r\nLonger-acting NSAID but higher GI irritation risk compared to ibuprofen.\r\nMore suitable for chronic pain conditions (e.g., osteoarthritis, rheumatoid arthritis) rather than acute injuries.\r\n\r\nG) Paracetamol suspension \r\n\r\nNot needed, as the patient is already taking co-codamol (which contains paracetamol).\r\n\r\nH) Tramadol capsules \r\n\r\nTramadol is an opioid and not first-line for musculoskeletal pain.\r\nCan lower seizure threshold, making it unsuitable for a patient with epilepsy.\r\n\r\nMusculoskeletal Injury Management \r\n\r\nFor soft tissue injuries (sprains, strains, and minor trauma):\r\n\r\n- NSAIDs (e.g., ibuprofen) are the preferred choice for pain relief and inflammation control.\r\n\r\n- Opioids (e.g., codeine, tramadol) should be avoided unless absolutely necessary.\r\n\r\n- Naproxen may be considered for longer-term inflammatory conditions, but ibuprofen is preferred for acute injuries due to its lower GI risk.\r\n\r\n- Patients with epilepsy should avoid tramadol due to its potential to lower seizure threshold.\r\n\r\nFor more information, please watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Aspirin tablets",
        "answer_number": 1
      },
      {
        "text": "Codeine liquid",
        "answer_number": 2
      },
      {
        "text": "Diazepam tablets",
        "answer_number": 3
      },
      {
        "text": "Diclofenac tablets",
        "answer_number": 4
      },
      {
        "text": "Ibuprofen tablets",
        "answer_number": 5
      },
      {
        "text": "Naproxen tablets",
        "answer_number": 6
      },
      {
        "text": "Paracetamol suspension",
        "answer_number": 7
      },
      {
        "text": "Tramadol capsules",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2577,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most appropriate action?**",
    "text": "A 15 year old female presents to the pharmacy and she is feeling a bit embarrassed as she is experiencing a few acne spots on her face. She has had it for three weeks and is desperate to try something over the counter. She does not wear too much make up and is currently using a mild cleanser both morning and evening. She is on no other medication.",
    "why": "b) Offer Benzoyl Peroxide 5% gel over the counter with counselling\r\n\r\nRationale:\r\n\r\nBenzoyl Peroxide 5% gel is an effective and commonly recommended over-the-counter (OTC) treatment for mild acne, especially for teenage patients. Benzoyl peroxide has both antibacterial and comedolytic properties, helping to reduce acne-causing bacteria on the skin and unclog pores. It is generally considered the first-line treatment for mild acne and can be used safely in young patients. The patient should be advised on potential side effects, such as skin dryness and irritation, and should start with a small amount to assess tolerance. She should also be reminded to use sunscreen as benzoyl peroxide may increase photosensitivity.\r\n\r\nExplanation of Options\r\n\r\na) Advise the patient to carry on using a mild cleanser twice a day\r\n\r\nAlthough continuing with a mild cleanser is beneficial, it may not be sufficient to address her acne. Benzoyl peroxide would be more effective for active treatment.\r\n\r\nb) Offer Benzoyl Peroxide 5% gel over the counter with counselling\r\n\r\nThis is the most appropriate action, as benzoyl peroxide is effective for mild acne and can be recommended as an OTC option. Proper counselling on usage, possible irritation, and the need for sun protection makes this a suitable first step in treating her acne.\r\n\r\nc) No treatment is required the condition will improve with age\r\n\r\nWhile acne may lessen over time, starting an OTC treatment like benzoyl peroxide can help manage her symptoms more effectively now and improve her confidence.\r\n\r\nd) Recommend Nicotinamide gel due to its anti-inflammatory effect\r\n\r\nNicotinamide (or niacinamide) gel is sometimes used in acne treatment due to its anti-inflammatory effects, but benzoyl peroxide is more effective as a first-line option. Additionally, nicotinamide gel is not commonly available OTC for acne.\r\n\r\ne) Refer to the GP as it could be something else\r\n\r\nSince this case presents as mild acne, referral to a GP is unnecessary at this stage. OTC treatment is typically the initial approach.\r\n\r\n\r\nAcne vulgaris is a common skin condition, particularly in adolescents, characterised by comedones (blackheads and whiteheads), papules, and pustules. NICE guidelines recommend beginning treatment with topical agents, such as benzoyl peroxide, for mild cases. Benzoyl peroxide is available OTC and is often the first-line treatment due to its dual action in reducing bacteria and helping to clear blocked pores.\r\n\r\nGuidelines also suggest lifestyle support, such as gentle cleansing routines and avoiding products that might clog pores. If OTC treatments are ineffective or acne worsens, a healthcare provider may recommend additional treatments, including topical retinoids or antibiotics.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the patient to carry on using a mild cleanser twice a day",
        "answer_number": 1
      },
      {
        "text": "Offer Benzoyl Peroxide 5% gel over the counter with counselling",
        "answer_number": 2
      },
      {
        "text": "No treatment is required the condition will improve with age",
        "answer_number": 3
      },
      {
        "text": "Recommend Nicotinamide gel due to its anti-inflammatory effect",
        "answer_number": 4
      },
      {
        "text": "Refer to the GP as it could be something else",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2527,
    "bank": "clinicalMep",
    "title": "**Which of the following dates is the last day you could dispense the medication?**",
    "text": "You receive a prescription for oxycodone 5mg capsules dated for 2nd June 2024",
    "why": "C. 30th June\r\n\r\nRationale\r\n\r\nThe correct answer is C. 30th June. For Schedule 2 controlled drugs, such as oxycodone, the prescription is valid for 28 days after the appropriate date (the date written on the prescription). Since the prescription is dated 2nd June 2024, counting 28 days from this date brings us to 30th June 2024 as the final valid day for dispensing.\r\n\r\nExplanation of Other Options\r\n\r\nA. 28th June \u2013 This is within the 28-day period but not the final day for dispensing.\r\nB. 29th June \u2013 Similarly, this is within the 28-day period but not the last day for validity.\r\nD. 29th December \u2013 Incorrect, as it is well beyond the 28-day validity period for Schedule 2 controlled drugs.\r\nE. 30th December \u2013 Also incorrect, as this is far beyond the valid dispensing period.\r\n\r\nThe Medicines, Ethics, and Practice (MEP) guidelines specify that prescriptions for Schedule 2 controlled drugs must be dispensed within 28 days after the date on the prescription. This strict 28-day window helps ensure these medications are dispensed in a controlled, safe manner, aligning with regulations to mitigate risks associated with high-risk drug\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "28th June",
        "answer_number": 1
      },
      {
        "text": "29th June",
        "answer_number": 2
      },
      {
        "text": "30th June",
        "answer_number": 3
      },
      {
        "text": "29th December",
        "answer_number": 4
      },
      {
        "text": "30th December",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 994,
    "bank": "clinicalOtc",
    "title": "**Which of the following symptoms is most likely to be specific to influenza?**",
    "text": "A 23 year old female patient presents to the pharmacy requesting to purchase paracetamol and pseudoephedrine. She is unsure if she has a common cold or influenza.",
    "why": "The symptom that is most likely to be specific to influenza is a fever (>38\u00b0C), muscle aches, pain and being bed bound (option D). Influenza, commonly known as the flu, is a viral infection that affects the respiratory system and can cause symptoms such as fever, cough, sore throat, muscle aches, and fatigue. A fever is a common symptom of the flu and is usually accompanied by other symptoms such as muscle aches and pain. Being bed bound is also a common symptom of the flu, as the illness can cause fatigue and weakness.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Patient who is feeling hot (no raised temperature) with a sore throat and cough",
        "answer_number": 1
      },
      {
        "text": "Patient who is experiencing facial pain, nasal congestion and a slight headache",
        "answer_number": 2
      },
      {
        "text": "Patient with rhinorrhoea, nasal congestion, cough and frequent sneezing",
        "answer_number": 3
      },
      {
        "text": "Patient who has a fever (>38oC), muscle aches, pain and is bed bound",
        "answer_number": 4
      },
      {
        "text": "Patient coughing up white coloured phlegm, with a  headache and sore throat",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2604,
    "bank": "clinicalOtc",
    "title": "**Which of the following is NOT a red flag referral for patients suffering with haemorrhoids?**",
    "text": "You are teaching your trainee pharmacist about haemorrhoids.",
    "why": "The option that is NOT a red flag referral for patients suffering with haemorrhoids is:\r\n\r\nA 39 year old with no persistent change in bowel habits.\r\n\r\nRationale:\r\n\r\nA 39-year-old patient with haemorrhoids and no persistent change in bowel habits does not present any red flag symptoms. This indicates the absence of more serious underlying conditions, such as colorectal cancer or inflammatory bowel disease. Haemorrhoids can occur without changes in bowel habits, and this symptom alone is not concerning if other warning signs are absent.\r\n\r\nA 63-year-old patient with blood mixed in the stool: This is a red flag symptom, as blood mixed in the stool rather than on its surface could suggest a more serious condition such as colorectal cancer. Immediate referral to a GP is necessary.\r\n\r\nA 24-year-old who has severe pain on defecation: Severe pain could indicate complications such as thrombosed haemorrhoids or an anal fissure. Referral may be necessary for further assessment.\r\n\r\nA 55-year-old who has unexplained rectal bleeding: Unexplained rectal bleeding in a patient over 50 is considered a red flag and should be referred for further investigation to rule out serious pathology.\r\n\r\nA 74-year-old patient who needs to reduce their haemorrhoids manually: This suggests prolapsed haemorrhoids that are not resolving on their own. In elderly patients, it is especially important to rule out more severe conditions.\r\n\r\nNICE Guidance on Haemorrhoids and Red Flag Symptoms\r\n\r\nNICE guidelines for the management of haemorrhoids include recognising red flag symptoms that warrant referral:\r\n\r\nRectal Bleeding:\r\n\r\nPatients over 50 years old with new-onset or unexplained rectal bleeding should be referred for further investigation, as it could be a sign of colorectal cancer.\r\n\r\nBlood mixed in the stool is also a red flag, as it may indicate bleeding higher up in the gastrointestinal tract.\r\n\r\nPersistent Change in Bowel Habits:\r\n\r\nAny persistent change in bowel habits, particularly diarrhoea or constipation lasting more than 6 weeks, should prompt further investigation in patients over 40.\r\nSevere Pain or Prolapse:\r\n\r\nSevere pain during defecation, especially if associated with swelling or a prolapsed haemorrhoid, may require medical intervention.\r\n\r\nHaemorrhoids that prolapse and need to be manually reduced should be assessed by a healthcare provider.\r\n\r\nWeight Loss or Anemia:\r\n\r\nUnexplained weight loss, fatigue, or signs of anemia alongside haemorrhoids are also red flags that necessitate referral.\r\n\r\nAdditional Insights\r\n\r\nHaemorrhoids are a common condition that can cause discomfort and bleeding, but they are generally benign. However, it is essential to identify any red flags that could suggest more severe underlying conditions. Patients should be educated on the importance of recognising symptoms such as persistent changes in bowel habits, blood mixed in stool, and severe pain, as these may require further medical evaluation.\r\n\r\nPreventive advice for haemorrhoids includes maintaining a high-fibre diet, adequate hydration, and avoiding straining during bowel movements. For patients without red flags, over-the-counter treatments like topical creams, warm baths, and lifestyle modifications can effectively manage symptoms. If symptoms do not improve, or if any concerning signs develop, patients should be advised to seek medical attention promptly.\r\n\r\nFor more information watch OTC lesson chapter 7 Gastroenterology (haemorrhoids):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "A 63 year old patient who informs you blood is mixed in the stool",
        "answer_number": 1
      },
      {
        "text": "A 39 year old with no persistent change in bowel habits",
        "answer_number": 2
      },
      {
        "text": "A 24 year old who has severe pain on defecation",
        "answer_number": 3
      },
      {
        "text": "A 55 year old who has unexplained rectal bleeding",
        "answer_number": 4
      },
      {
        "text": "A 74 year old patient who needs to reduce their haemorrhoids manually",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2535,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a requirement of oral retinoids pregnancy prevention programme?**",
    "text": "Pregnancy prevention programmes (PPP)\u00a0 for oral retinoids protect females of a childbearing potential by minimising the risk of becoming pregnant.",
    "why": "E. The maximum quantity for supply is 30 days for oral retinoids under the pregnancy prevention programme.\r\n\r\nRationale:\r\n\r\nThe maximum quantity that can be supplied for oral retinoids under the Pregnancy Prevention Programme (PPP) is 30 days, not 28 days. This is to ensure that patients do not receive excessive amounts of medication and to promote ongoing monitoring.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Pharmacists can accept emergency supplies at a request of a PPP specialist prescriber:\r\nThis is correct. Emergency supplies for oral retinoids can be accepted if requested by a PPP specialist prescriber, ensuring the patient has access to the medication in urgent situations while still complying with safety protocols.\r\n\r\nB. Pharmacists should not accept repeat prescriptions for oral retinoids:\r\nThis is correct. Repeat prescriptions are not allowed under the PPP for oral retinoids because each prescription must be reviewed to ensure continued compliance with the programme's strict monitoring requirements.\r\n\r\nC. Prescriptions are valid for 7 days:\r\nThis is correct. Prescriptions for oral retinoids under the PPP are only valid for 7 days from the date the prescription is issued. This short timeframe helps ensure the medication is used in close accordance with safety protocols.\r\n\r\nD. Prescriptions should ideally be dispensed on the date prescription is written:\r\nThis is correct. Ideally, prescriptions for oral retinoids should be dispensed as soon as possible after being written to minimise the time a patient is exposed to the potential risks of pregnancy and to ensure compliance with PPP requirements.\r\n\r\n\r\nThe Pregnancy Prevention Programme for oral retinoids ensures the safe use of these drugs for females of childbearing potential. The programme has strict requirements to minimise the risk of pregnancy while the patient is using the medication. These requirements include restricting repeat prescriptions, limiting the quantity to 30 days, ensuring prescriptions are dispensed promptly (within 7 days), and requiring ongoing monitoring of the patient's condition and compliance. Emergency supplies are allowed under specific circumstances with an appropriate prescriber request. These guidelines are in place to safeguard both the patient and the unborn child.\r\n\r\nFor more information watch MEP lesson chapter 2 (Professional and legal issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Pharmacists can accept emergency supplies at a request of a PPP specialist prescriber",
        "answer_number": 1
      },
      {
        "text": "Pharmacists should not accept repeat prescriptions for oral retinoids",
        "answer_number": 2
      },
      {
        "text": "Prescriptions are valid for 7 days",
        "answer_number": 3
      },
      {
        "text": "Prescriptions should ideally be dispensed on the date prescription is written",
        "answer_number": 4
      },
      {
        "text": "Quantity is only for 28 days supply",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 885,
    "bank": "clinicalOtc",
    "title": "**What is the most likely cause of the infant's condition?**",
    "text": "A 2-month-old infant is brought to the pharmacy by their mother. The infant has a history of eczema and cow's milk allergy. The mother says that the infant has been crying inconsolably for several hours every evening for the past two weeks, and that the crying is accompanied by drawing up the legs, clenching the fists, and passing wind. The infant is otherwise healthy, feeding well, and gaining weight. The mother has tried giving the infant a lactose-free formula, gripe water, and a warm bath, but nothing seems to help.",
    "why": "Infantile colic. The infant has classic symptoms of infantile colic, which is a common and benign condition that affects up to 20% of infants in the first three months of life\u00b9. Infantile colic is defined as recurrent and prolonged episodes of crying, fussing, or irritability in an otherwise healthy and well-fed infant, without an obvious cause\u00b9. The exact cause of infantile colic is unknown, but it may be related to immature gastrointestinal function, altered gut microbiota, excessive gas production, hypersensitivity to stimuli, or psychosocial factors\u00b9. Infantile colic usually resolves spontaneously by 4-6 months of age\u00b9.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Gastro-oesophageal reflux",
        "answer_number": 1
      },
      {
        "text": "Infantile colic",
        "answer_number": 2
      },
      {
        "text": "Intestinal obstruction",
        "answer_number": 3
      },
      {
        "text": "Food intolerance",
        "answer_number": 4
      },
      {
        "text": "Urinary tract infection",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2379,
    "bank": "clinicalTherapeutics",
    "title": "**How many capsules should the pharmacist dispense to the patient?**",
    "text": "A 54 year old male presents a prescription for amoxicillin 500 mg capsules with the following directions: Take one capsule three times a day for seven days, then reduce to one capsule twice a day for another seven days.",
    "why": "C. 35\r\n\r\nTo calculate the total quantity to supply, follow these steps:\r\n\r\nStep 1: Calculate the quantity for the first 7 days\r\n\r\nDose per day = 1 capsule x 3 times per day = 3 capsules/day\r\n\r\nDuration = 7 days\r\n\r\nQuantity = 3 capsules/day x 7 days = 21 capsules\r\n\r\nStep 2: Calculate the quantity for the next 7 days\r\n\r\nDose per day = 1 capsule x 2 times per day = 2 capsules/day\r\n\r\nDuration = 7 days\r\n\r\nQuantity = 2 capsules/day x 7 days = 14 capsules\r\n\r\nStep 3: Add the quantities from both periods\r\n\r\nTotal quantity = 21 capsules (first 7 days) + 14 capsules (next 7 days) = 35 capsules\r\n\r\nWatch BNF lesson Chapter 5 (Infections):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "21",
        "answer_number": 1
      },
      {
        "text": "28",
        "answer_number": 2
      },
      {
        "text": "35",
        "answer_number": 3
      },
      {
        "text": "42",
        "answer_number": 4
      },
      {
        "text": "49",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2258,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is a useful measure for monitoring compliance in a patient utilising smoking cessation treatment?**",
    "text": "You are running a smoking cessation service in your local community pharmacy",
    "why": "Correct Answer:\r\n\r\nB) Carbon monoxide monitoring\r\n\r\nRationale \r\n\r\nIn smoking cessation services, the most effective and objective way to monitor compliance and progress is through carbon monoxide (CO) monitoring.\r\n\r\nCarbon monoxide (CO) is a byproduct of tobacco combustion and is absorbed into the bloodstream when a person smokes.\r\n\r\nExhaled CO levels drop within 24 hours of smoking cessation, making it a reliable biomarker of smoking status.\r\n\r\nNICE recommends CO monitoring as a motivational tool to help patients see measurable progress when quitting smoking.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Carbon dioxide monitoring \r\n\r\nIncorrect, as carbon dioxide (CO\u2082) levels are not directly linked to smoking cessation. CO\u2082 is a natural byproduct of metabolism and does not serve as an indicator of smoking status.\r\n\r\nC) Monitoring of withdrawal symptoms \r\n\r\nWhile tracking withdrawal symptoms (e.g., cravings, irritability, anxiety) is useful in tailoring support, it is a subjective measure and does not confirm compliance.\r\n\r\nD) Nicotine replacement levels \r\n\r\nNot routinely measured, as nicotine pharmacokinetics vary between individuals. The focus of NICE smoking cessation guidelines is on reducing tobacco-related harm, not nicotine levels.\r\n\r\nE) Oxygen saturation levels in air \r\n\r\nOxygen saturation (SpO\u2082) is not a useful measure for smoking cessation. Chronic smokers may have normal oxygen saturation despite high CO levels, making this an unreliable marker of smoking status.\r\n\r\nGuidance on Smoking Cessation Monitoring\r\n\r\nSmoking cessation is a key public health priority due to its significant impact on reducing morbidity and mortality. \r\n\r\nAn effective smoking cessation programme should include:\r\n\r\n- Carbon monoxide (CO) breath testing \u2013 A validated tool to objectively assess smoking status and compliance.\r\n- Behavioural support and follow-ups \u2013 Regular one-to-one or group counselling improves success rates.\r\n- Pharmacological interventions \u2013 Nicotine replacement therapy (NRT), varenicline, or bupropion should be considered based on patient preference and suitability.\r\n- Personalised relapse prevention strategies \u2013 Addressing withdrawal symptoms and triggers helps reduce relapse risk.\r\n\r\nBy integrating objective CO monitoring with tailored behavioural and pharmacological support, community pharmacists can significantly improve smoking cessation success rates and reduce long-term health risks associated with smoking.\r\n\r\nFor more information, please watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Carbon dioxide monitoring",
        "answer_number": 1
      },
      {
        "text": "Carbon monoxide monitoring",
        "answer_number": 2
      },
      {
        "text": "Monitoring of withdrawal symptoms",
        "answer_number": 3
      },
      {
        "text": "Nicotine replacement levels",
        "answer_number": 4
      },
      {
        "text": "Oxygen saturation levels in air",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2632,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the child's symptoms?**",
    "text": "A mother brings her 4 year old daughter into your pharmacy because she is concerned about a rash. The mother explains her daughter has not been well over the past few days and has\u00a0 noticed there were white spots in the mouth before the rash appeared.\u00a0\r\n\r\nA photograph of the rash has been shown below:\u00a0\r\n\r\n\r\n![measles08-Watermarked-Wy-JXYXRlcm1hcmtl-ZCJd-2](https://i.ibb.co/WGy9fJT/measles08-Watermarked-Wy-JXYXRlcm1hcmtl-ZCJd-2.jpg)",
    "why": "Measles is a highly contagious airborne infection caused by a morbillivirus from the paramyxovirus family. It spreads through the respiratory tract and infects nearly all susceptible individuals, providing lifelong immunity once contracted. While measles was once endemic in the UK, it has become rare due to immunisation.\r\n\r\n**Complications** primarily affect the respiratory system and central nervous system, including:\r\n- Otitis media.\r\n- Pneumonia, pneumonitis, and tracheobronchitis.\r\n- Convulsions, encephalitis, and blindness.\r\n- Subacute sclerosing panencephalitis (a rare but serious complication affecting 1 in 25,000).\r\n\r\nMeasles is often more severe in adults, infants, immunocompromised individuals, and during pregnancy. Symptoms usually resolve within a week, but complications may occur. Early signs (prodromal stage) include fever, cough, coryza (cold-like symptoms), and conjunctivitis, followed by a characteristic maculopapular rash and possibly Koplik\u2019s spots in the mouth. \r\n\r\n**Differential diagnoses** for measles include:\r\n- Parvovirus B19 (fifth disease or slapped cheek syndrome).\r\n- Scarlet fever.\r\n- Roseola infantum.\r\n- Rubella.\r\n- Kawasaki disease.\r\n- Early meningococcal disease.\r\n\r\nMeasles is a notifiable disease, and suspected cases must be reported to the local Health Protection Team (HPT). Treatment mainly involves rest, fluid intake, and paracetamol or ibuprofen for symptom relief. Those with measles should stay away from nursery, school, or work for four days after the rash develops and avoid contact with vulnerable individuals, including unvaccinated people, pregnant women, and those who are immunocompromised.\r\n\r\nSpecialist advice is essential for those at higher risk, such as pregnant women, infants, or immunocompromised individuals who have been in contact with someone with measles. Hospital admission may be necessary if complications arise, such as pneumonia or neurological issues like encephalitis or febrile convulsions.\r\n\r\n**Stages of measles:**\r\n- **Prodromal stage:** High fever (38.3\u201340\u00b0C), cough, Koplik's spots in the mouth (though not always present), coryza, and conjunctivitis.\r\n- **Rash stage:** A red, blotchy maculopapular rash begins on the face and spreads downwards to the body. Other symptoms may include conjunctivitis, light sensitivity, and general malaise.\r\n**Image reference: DermnetNZ.org**\r\n\r\nFor more information watch the OTC lesson on Chapter 1 Paediatrics (Measles):\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Coxsackie virus",
        "answer_number": 1
      },
      {
        "text": "Measles",
        "answer_number": 2
      },
      {
        "text": "Mumps",
        "answer_number": 3
      },
      {
        "text": "Parvovirus B19",
        "answer_number": 4
      },
      {
        "text": "Rubella",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2520,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT a record requirement for signed orders?**",
    "text": "Schools can obtain adrenaline auto injections and/or salbutamol on signed order for emergency treatment for pupils previously prescribed these medicines",
    "why": "D) Pharmacist name and address supplying the medicine\r\n\r\nRationale:\r\n\r\nThe name and address of the pharmacist supplying the medicine are not required as part of the record for a signed order. The signed order record focuses on details necessary to trace the supplied medication, confirm its use, and document relevant patient and supply information, rather than the specifics of the pharmacist's identity or business address.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Date of POM supplied \u2013 This is a required record detail, as it documents when the prescription-only medicine (POM) was supplied. Recording the supply date is essential for tracking and verifying the timing of medication provision for school emergencies.\r\n\r\nB) Name and address of business or profession to whom medicine is supplied to \u2013 This is a required detail, ensuring that the medicine is being supplied to a legitimate recipient, such as a school. This information allows traceability and accountability, confirming the medicine\u2019s intended destination.\r\n\r\nC) Name and quantity of medicine supplied \u2013 Recording the name and quantity of the medicine supplied is necessary for clarity and verification of the type and amount of medication provided, which is critical for accurate inventory and regulatory compliance.\r\n\r\nE) Purpose of signed order \u2013 The purpose of the signed order must be documented, confirming that the medication is intended for emergency use for pupils previously prescribed the treatment. This detail helps ensure that the medication is used correctly and supports its intended purpose in an emergency situation.\r\n\r\n\r\nThe Medicines, Ethics and Practice (MEP) guidelines outline specific requirements for signed orders to ensure safe and accountable medication provision in schools. When schools obtain emergency medicines, such as adrenaline auto-injectors or salbutamol inhalers, a record must include the date of supply, the name and address of the receiving institution, the name and quantity of medicine supplied, and the intended purpose of the medication. These requirements allow for clear tracking and traceability, confirming that these medicines are held securely and used appropriately in school emergencies.\r\n\r\nHowever, the name and address of the supplying pharmacist are not part of the legal requirements. The MEP guidelines prioritise details directly related to patient safety and regulatory compliance, focusing on the purpose, recipient, and medication specifics to ensure that schools can access emergency treatments safely and responsibly without unnecessary administrative burdens.\r\n\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Date of POM supplied",
        "answer_number": 1
      },
      {
        "text": "Name and address of business or profession to whom medicine is supplied to",
        "answer_number": 2
      },
      {
        "text": "Name and quantity of medicine supplied",
        "answer_number": 3
      },
      {
        "text": "Pharmacist name and address supplying the medicine",
        "answer_number": 4
      },
      {
        "text": "Purpose of signed order",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2514,
    "bank": "clinicalMep",
    "title": "**Which of the following would be the LEAST suitable emergency supply?**",
    "text": "Regulation 225 of the Human Medicines Regulations 2012 enables patients to request emergency supplies of their medication",
    "why": "E) 28 x Phenobarbital 50mg tablets for epilepsy\r\n\r\nRationale:\r\n\r\nThis answer is least suitable for an emergency supply because Phenobarbital is classified as a Schedule 3 Controlled Drug under the Misuse of Drugs Regulations 2001. While it is commonly used to treat epilepsy, the maximum quantity that can be supplied for emergency treatment is 5 days' supply, not 28 days. This is due to its controlled status, which limits the quantity available for emergency supply to prevent misuse and to ensure careful monitoring of its use.\r\n\r\nExplanation of Other Options:\r\n\r\nA) 4 x Zopiclone 7.5mg \u2013 This is a suitable emergency supply in the context of a short-term need for insomnia treatment. Zopiclone is not a controlled drug and can be given in limited quantities for emergency situations, although care should be taken to assess for misuse risks.\r\n\r\nB) 7 x Medroxyprogesterone 5mg tablets \u2013 This is an appropriate emergency supply. Medroxyprogesterone is a hormone used in various therapeutic contexts, and a 7-day supply is reasonable for ensuring continuity of treatment.\r\n\r\nC) 14 x Metformin 500mg tablets \u2013 This is a suitable supply for patients with diabetes. A 14-day supply of Metformin ensures the patient can continue managing their blood sugar levels without interruption while awaiting a full prescription.\r\n\r\nD) 21 x Amlodipine 10mg tablets \u2013 This is a suitable emergency supply. Amlodipine is used for managing hypertension and angina. A 21-day supply is appropriate to maintain ongoing treatment for patients with chronic conditions.\r\n\r\n\r\nUnder Regulation 225 of the Human Medicines Regulations 2012, patients can request emergency supplies of their prescribed medication when they have run out and are unable to get a new prescription in time. However, controlled drugs, such as Phenobarbital (a Schedule 3 controlled drug), are subject to stricter regulations. The maximum quantity that can be supplied for emergency treatment is 5 days, reflecting the need for careful monitoring and regulation of controlled substances.\r\n\r\nMedications such as Zopiclone, Medroxyprogesterone, Metformin, and Amlodipine, which are not subject to such strict controls, can be supplied in more appropriate quantities for emergency purposes, depending on the clinical need. Pharmacists must balance the patient's immediate needs with regulatory requirements to ensure patient safety and compliance with the law.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "4 x Zopiclone 7.5mg",
        "answer_number": 1
      },
      {
        "text": "7 x Medroxyprogesterone 5mg tablets",
        "answer_number": 2
      },
      {
        "text": "14 x Metformin 500mg tablets",
        "answer_number": 3
      },
      {
        "text": "21 x Amlodipine 10mg tablets",
        "answer_number": 4
      },
      {
        "text": "28 x Phenobarbital 50mg tablets for epilepsy",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2570,
    "bank": "clinicalOtc",
    "title": "A four-year-old child who presents with an itchy, red vesicular rash, which has been present for the last two days, since he came home from nursery. The rash is apparent on his torso and face.",
    "text": "**Theme: Dermatological preparations**\r\n\r\n**For each of the following scenarios select the best option for over-the-counter treatment. Each option may be used once, more than once or not at all.**",
    "why": "b) Aqueous calamine cream\r\n\r\nRationale:\r\n\r\nAqueous calamine cream is the best choice for this four-year-old child, as it provides a soothing effect and helps to relieve itching commonly associated with vesicular rashes. Calamine is especially suitable for children due to its gentle action, and it is generally well-tolerated on sensitive skin areas like the face and torso. This product also helps to cool and mildly dry the vesicles, offering temporary relief without introducing any steroids, which are typically avoided in very young children without a prescription.\r\n\r\nExplanation of Other Options:\r\n\r\na) Aloe vera gel: Although soothing, aloe vera lacks the anti-itching effects needed for a vesicular rash and may be insufficient for symptom relief in this case.\r\nc) Aveeno\u00ae lotion: Aveeno is an emollient that moisturizes the skin but does not specifically alleviate itching or address the discomfort of a vesicular rash.\r\nd) Dermol\u00ae wash: Dermol is antimicrobial and may help prevent infection, but it is not typically used to relieve itching in vesicular rashes.\r\ne) Diprobase\u00ae cream: While Diprobase provides hydration, it lacks the soothing and anti-itch properties necessary for managing this type of rash.\r\nf) Eumovate\u00ae cream: Eumovate is a moderate-potency corticosteroid that would be too strong for a child of this age without medical supervision. Corticosteroids are not generally recommended for young children without a prescription, especially on facial areas.\r\ng) Hydrocortisone 1% cream: Hydrocortisone is a mild steroid but is typically used in children over 10 years old and only for conditions where inflammation is the primary concern. It is not usually recommended as a first-line treatment for vesicular rashes in young children without a doctor\u2019s approval.\r\nh) Oilatum\u00ae Junior Bath Additive: Oilatum is helpful for maintaining skin hydration and reducing dryness but does not specifically address itching or provide immediate relief for vesicular rash symptoms.\r\n\r\n\r\nFor vesicular rashes in young children, NICE guidelines emphasize gentle, soothing treatments that provide itch relief and avoid unnecessary use of corticosteroids or other strong treatments. Calamine is commonly used due to its cooling and drying effects, which are helpful in managing mild skin conditions in children. Parents should monitor for any signs of infection, such as increased redness, swelling, or discharge, as these symptoms may require further medical evaluation. Encouraging children to avoid scratching and maintaining regular skin hygiene can help manage symptoms and promote healing.\r\n\r\n\r\n\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Aloe vera gel",
        "answer_number": 1
      },
      {
        "text": "Aqueous calamine cream",
        "answer_number": 2
      },
      {
        "text": "Aveeno\u00ae lotion",
        "answer_number": 3
      },
      {
        "text": "Dermol\u00ae wash",
        "answer_number": 4
      },
      {
        "text": "Diprobase\u00ae cream",
        "answer_number": 5
      },
      {
        "text": "Eumovate\u00ae cream",
        "answer_number": 6
      },
      {
        "text": "Hydrocortisone 1% cream",
        "answer_number": 7
      },
      {
        "text": "Oilatum\u00ae Junior Bath Additive",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2554,
    "bank": "clinicalMep",
    "title": "**What is the most appropriate action to take?**\r\n\r\nGreenwood Primary School\r\n123 School Road\r\nLondon, AB1 2CD\r\n\r\nOrder for Adrenaline Auto-Injectors\r\n\r\nI, Ms. Jane Smith, Head Teacher of Greenwood Primary School, hereby authorize the pharmacy to dispense adrenaline auto-injectors for emergency use on school premises. This order complies with current government guidelines and the requirements outlined in the Medicines, Ethics and Practice (MEP) guidelines. No doctor\u2019s prescription is required for this transaction.\r\n\r\nProduct: Adrenaline Auto-Injector (EpiPen\u00ae 0.3 mg)\r\nQuantity: 10 units\r\n\r\nPlease ensure that a record of this transaction is made in the prescription register as required.\r\n\r\nAuthorized by:\r\n____________________________\r\nMs. Jane Smith\r\nHead Teacher, Greenwood Primary School\r\n\r\nDate: 15 April 2023",
    "text": "A school nurse comes to your pharmacy with a signed order for adrenaline auto-injectors.\u00a0\r\nAn extract of the signed order has been provided for this question.",
    "why": "(C) Dispense the medication and make a record in the prescription register.\r\n\r\nRationale:\r\n\r\nGovernment guidelines allow schools to purchase adrenaline auto-injectors (AAIs) without a traditional prescription for emergency use on children who may be at risk of anaphylaxis. A signed order from the school\u2019s head teacher or principal suffices, permitting the pharmacist to dispense the medication under these circumstances.\r\n\r\nExplanation of Other Options:\r\n\r\n(A) Advise the nurse to return to the school and get a prescription:\r\nIncorrect. A prescription from a doctor is not necessary; a signed order from the head teacher or principal is adequate.\r\n\r\n(B) Contact the head teacher to discuss the order:\r\nUnnecessary if the signed order complies with legal requirements for supplying AAIs to schools.\r\n\r\n(D) Refuse to dispense the medication as it\u2019s not a prescription from a doctor:\r\nIncorrect. Government regulations permit schools to use a signed order rather than a doctor\u2019s prescription in this case.\r\n\r\n(E) Treat it as a private prescription:\r\nIncorrect. The signed order doesn\u2019t need to be treated as a private prescription. However, an entry should be made in the prescription register for record-keeping.\r\n\r\n\r\nUnder the Medicines, Ethics, and Practice (MEP) guidelines, schools in the UK are permitted to purchase AAIs for emergency anaphylaxis treatment based on a signed order from the head teacher or principal. This provision ensures rapid access to life-saving medication, especially for children who may have undiagnosed allergies. The pharmacist can supply the requested AAIs on receipt of a signed order, which must include the product details, quantity, and be authorised by the head teacher. Following the supply, pharmacists must log the transaction in the prescription register to comply with record-keeping requirements, enhancing accountability and ensuring the availability of emergency anaphylaxis treatment in school settings.\r\n\r\nFor more information watch MEP lesson Chapter 3 (Underpinning knowledge: legislation and professional Issues):\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise the nurse to return to the school and get a prescription",
        "answer_number": 1
      },
      {
        "text": "Contact the head teacher to discuss the order.",
        "answer_number": 2
      },
      {
        "text": "Dispense the medication and make a record in the prescription register",
        "answer_number": 3
      },
      {
        "text": "Refuse to dispense the medication as it\u2019s not a prescription from a doctor.",
        "answer_number": 4
      },
      {
        "text": "Treat it as a private prescription",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2297,
    "bank": "clinicalTherapeutics",
    "title": "**If the initial plasma concentration was 40mg/L, what is the plasma concentration after 7 hours?**",
    "text": "A 35 year old female patient is prescribed paracetamol 500mg tablets, she has been admitted into hospital due to an overdose. Paracetamol has a half-life of 2 hours.",
    "why": "3.75 mg/L\r\n\r\nRationale:\r\n\r\nParacetamol follows first-order elimination kinetics, meaning its plasma concentration reduces by half with each half-life.\r\n\r\nThe half-life of paracetamol is 2 hours\r\nThe initial plasma concentration is 40 mg/L\r\nThe time elapsed is 7 hours\r\n\r\nStep-by-step calculation:\r\n\r\n1. Determine the number of half-lives within 7 hours:\r\n\r\n\r\nNumber of half-lives = Total time / Half-life  \r\nNumber of half-lives = 7 hours / 2 hours  \r\nNumber of half-lives = 3.5\r\n\r\n2. Calculate plasma concentration at each half-life:\r\n\r\n0 hours (Initial) \u2192 40 mg/L  \r\n2 hours (1st half-life) \u2192 20 mg/L  \r\n4 hours (2nd half-life) \u2192 10 mg/L  \r\n6 hours (3rd half-life) \u2192 5 mg/L  \r\n\r\n3. Determine concentration at 7 hours (halfway between 6 and 8 hours):\r\n\r\nAt 8 hours \u2192 2.5 mg/L  \r\nAt 7 hours (average of 6 and 8 hours): (5 mg/L + 2.5 mg/L) / 2  \r\nPlasma concentration = 3.75 mg/L\r\n\r\nThus, after 7 hours, the plasma concentration is 3.75 mg/L.\r\n\r\nExplanation of Other Options:\r\n\r\nA: 20 mg/L\r\nThis would be the plasma concentration after 2 hours, not 7 hours.\r\n\r\nB: 10 mg/L\r\nThis would be the plasma concentration after 4 hours, which is too early.\r\n\r\nD: 2.5 mg/L\r\nThis would be the plasma concentration after 8 hours, which is beyond the given 7-hour timeframe.\r\n\r\nE: 1.25 mg/L\r\nThis would be the plasma concentration after 10 hours, which is later than the required 7 hours.\r\n\r\nParacetamol Overdose \r\n\r\nAccording to NICE guidelines (2025), paracetamol overdose is a medical emergency due to the risk of acute liver failure, primarily from toxic N-acetyl-p-benzoquinone imine (NAPQI) accumulation.\r\n\r\nKey management principles:\r\n\r\nPlasma paracetamol levels should be plotted on the prescription nomogram (using time post-ingestion) to assess toxicity risk.\r\nN-acetylcysteine (NAC) is the antidote and should be administered if levels exceed the treatment threshold or if there is uncertainty about the overdose timing.\r\nLiver function tests (LFTs), prothrombin time (PT), and renal function should be monitored for signs of organ damage.\r\nActivated charcoal can be considered if the patient presents within 1 hour of overdose to reduce absorption.\r\n\r\nFor more Information please watch BNF lesson Chapter 4 (Central Nervous System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 3,
    "weighting": 3,
    "answers": [
      {
        "text": "20mg/L",
        "answer_number": 1
      },
      {
        "text": "10mg/L",
        "answer_number": 2
      },
      {
        "text": "3.75mg/L",
        "answer_number": 3
      },
      {
        "text": "2.5mg/L",
        "answer_number": 4
      },
      {
        "text": "1.25mg/L",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2521,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT suitable for a nurse to prescribe?**",
    "text": "Nurse independent prescribers have prescribing restrictions",
    "why": "B) Diamorphine for the treatment of addiction\r\n\r\nRationale:\r\n\r\nNurse Independent Prescribers (NIPs) are permitted to prescribe certain controlled drugs for medical purposes; however, they are restricted from prescribing these drugs for addiction treatment. Diamorphine, for example, may only be prescribed by NIPs for palliative care but not for the treatment of addiction. Addiction management is a highly specialised area that requires training and expertise typically limited to certain doctors, ensuring that patients receive the most appropriate care under structured regulations.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Diamorphine for palliative care treatment \u2013 NIPs are authorised to prescribe diamorphine for palliative care settings where it is used to manage severe pain, particularly at the end of life. This exception allows NIPs to provide compassionate care by alleviating pain and discomfort in terminally ill patients.\r\n\r\nC) Off-label medicines \u2013 NIPs are allowed to prescribe medicines off-label, meaning the medication is used outside of its licensed indication, provided it is clinically appropriate and aligns with best practice guidelines. This authority helps meet patient needs when standard treatments do not suffice, as long as the prescriber is competent and has a clear clinical rationale.\r\n\r\nD) Schedule 2 Controlled Medicines \u2013 NIPs can prescribe certain Schedule 2 controlled drugs for pain management and other authorised medical uses. However, strict limitations apply, such as the prohibition on prescribing controlled substances like diamorphine for addiction treatment, which ensures patient safety and aligns with prescribing authority boundaries.\r\n\r\nE) Unlicensed medicines \u2013 NIPs may prescribe unlicensed medicines if no licensed alternative meets the patient\u2019s clinical requirements. While unlicensed, these prescriptions must still be justified based on clinical evidence and professional judgement, allowing NIPs to address unique or complex cases where licensed options may not be available.\r\n\r\n\r\nThe Medicines, Ethics and Practice (MEP) guidelines and NICE guidelines provide Nurse Independent Prescribers (NIPs) with an extensive scope of prescribing authority. NIPs can prescribe a range of medications, including certain controlled substances, off-label, and unlicensed medications, where clinically justified and within their area of competence. This scope allows NIPs to play a vital role in managing conditions such as chronic pain, palliative care needs, and other complex health issues, contributing to comprehensive patient care.\r\n\r\nHowever, important restrictions apply, particularly concerning controlled drugs in the context of addiction. Prescribing for addiction treatment remains outside the scope of NIPs, as this field requires highly specialised expertise to ensure safe and effective care for patients dealing with substance dependence. Addiction treatment is legally regulated and requires prescribers with specific training, usually limited to qualified doctors with expertise in this area.\r\n\r\nAdditionally, MEP and NICE guidelines stipulate that NIPs prescribing off-label or unlicensed medications should do so only when a suitable licensed alternative is unavailable and when they possess the requisite clinical knowledge. This flexibility is essential in scenarios where licensed therapies are insufficient, allowing NIPs to fulfil patient needs within safe and ethical boundaries.\r\n\r\nThese guidelines safeguard patient welfare, encourage responsible prescribing, and support regulatory compliance, ensuring that NIPs deliver care effectively while respecting professional limitations. This structured approach helps maintain high standards of care, promotes patient safety, and reinforces the importance of specialised training for managing complex conditions such as addiction.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Diamorphine for palliative care treatment",
        "answer_number": 1
      },
      {
        "text": "Diamorphine for the treatment of addiction",
        "answer_number": 2
      },
      {
        "text": "Off label medicines",
        "answer_number": 3
      },
      {
        "text": "Schedule 2 Controlled medicines",
        "answer_number": 4
      },
      {
        "text": "Unlicensed medicines",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2556,
    "bank": "clinicalMep",
    "title": "A podiatrist independent prescriber is considering prescribing a controlled drug for the treatment of organic disease.",
    "text": "**Theme: Controlled drug prescribing**\r\n**Instruction: For each of the scenarios below, select the most appropriate answer option from the list above. Each option may be used once, more than once, or not at all.**",
    "why": "B. Can only prescribe oral diazepam, lorazepam, temazepam, and di-hydrocodeine\r\n\r\nRationale:\r\n\r\nPodiatrist independent prescribers are limited in their controlled drug prescribing authority. They are restricted to prescribing oral formulations of diazepam, lorazepam, temazepam, and di-hydrocodeine for conditions related to their scope of practice, such as musculoskeletal pain or anxiety associated with podiatric treatment. Other controlled drugs, particularly those beyond Schedule 4, are outside their permitted prescribing range, necessitating a referral to an appropriately qualified prescriber for further treatment.\r\n\r\nExplanation of Other Options:\r\n\r\nA. Cannot prescribe controlled drugs in Schedules 2-5\r\nIncorrect. Podiatrist independent prescribers do have some authority, limited to specific Schedule 4 and 5 controlled drugs, within their scope of practice.\r\n\r\nC. Can only prescribe oral diazepam, lorazepam, temazepam, di-hydrocodeine, oxycodone, IV and oral morphine, and fentanyl patches\r\nIncorrect. This authority applies to advanced practitioners in fields like palliative care; podiatrists are limited to fewer controlled drugs and cannot prescribe stronger opioids like oxycodone or morphine.\r\n\r\nD. Can prescribe Schedule 2-5 controlled drugs and does not need a standardised form for private prescriptions for Schedules 2 and 3\r\nIncorrect. Podiatrist prescribers cannot prescribe Schedule 2 or Schedule 3 drugs and must adhere to a limited selection of Schedule 4 and 5 drugs.\r\n\r\nE. Can prescribe any controlled drug listed in Schedules 2-5 for the treatment of addiction\r\nIncorrect. Only practitioners licensed to treat addiction, such as specific doctors, may prescribe for addiction treatment. Podiatrists are not permitted to prescribe controlled drugs for addiction treatment.\r\n\r\nF. Schedules 2-5 for any medical condition within their competence, except diamorphine, cocaine, and dipipanone for addiction treatment\r\nIncorrect. Podiatrists have a restricted scope, limited to specific Schedule 4 drugs; they cannot prescribe controlled drugs more broadly.\r\n\r\nG. Schedule 2 and 3 controlled drugs only\r\nIncorrect. Podiatrists cannot prescribe Schedule 2 or Schedule 3 drugs, as their authority extends only to specific drugs within Schedules 4 and 5.\r\n\r\nH. Schedule 4 and 5 controlled medicines only\r\nPartially correct but incomplete. While podiatrists can prescribe Schedule 4 and 5 controlled drugs, only a limited range is authorised within their professional scope.\r\n\r\nAccording to the MEP, prescribing authority for controlled drugs depends on the practitioner's qualifications and the specific drug schedule. Podiatrist independent prescribers are restricted to a small selection of controlled drugs, specifically oral diazepam, lorazepam, temazepam, and di-hydrocodeine, for use within their scope of practice. These restrictions are designed to ensure that controlled drug use aligns with the practitioner's expertise while maintaining patient safety.\r\n\r\nFor more information watch OTC lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Cannot prescribe controlled drugs \u00a0Schedule 2-5 controlled drugs",
        "answer_number": 1
      },
      {
        "text": "Can only prescribe oral diazepam, lorazepam, temazepam and dihydrocodeine.",
        "answer_number": 2
      },
      {
        "text": "Can only prescribe oral diazepam, lorazepam, temazepam and dihydrocodeine and oxycodone. As well as IV and oral morphine and fentanyl patches. .",
        "answer_number": 3
      },
      {
        "text": "Can prescribe schedule 2 - 5 controlled drugs and does not need a standardised form for private prescriptions for schedule 2 and 3",
        "answer_number": 4
      },
      {
        "text": "Can prescribe any controlled drug listed in schedules 2-5 for the treatment of addiction",
        "answer_number": 5
      },
      {
        "text": "Schedules 2-5 for any medical condition within their competence, except diamorphine, cocaine and dipipanone for the treatment of addiction1.",
        "answer_number": 6
      },
      {
        "text": "Schedule 2 and 3 controlled drugs only.",
        "answer_number": 7
      },
      {
        "text": "Schedule 4 and 5 controlled medicines only",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2582,
    "bank": "clinicalOtc",
    "title": "**Which of the following medications is the most likely cause of medicine induced psoriasis?**",
    "text": "A 45 year old female presents to the pharmacy complaining of thick scaly plaques on her elbows, trunk and knees. Upon examination, you establish the patient has psoriasis. She informs you she has never had this before and it only started since starting a new medication.",
    "why": "Lithium\r\n\r\nRationale:\r\n\r\nLithium is the most likely cause of medicine-induced psoriasis. It is a well-known trigger that can induce new onset or worsen pre-existing psoriasis. Lithium influences skin cell turnover and immune responses, leading to the formation of thickened, scaly plaques typical of psoriasis. This side effect is associated with the pro-inflammatory effects of lithium, which can disrupt normal skin regeneration processes.\r\n\r\nThe other options are less likely:\r\n\r\nCiclosporin is actually used to treat severe psoriasis due to its immunosuppressive properties.\r\nLosartan, an antihypertensive medication, is not typically linked with inducing psoriasis.\r\nClarithromycin, this antibiotic, is not associated with psoriasis development.\r\nSertraline, an SSRI, is not commonly linked with causing psoriasis, although there are rare reports of dermatological side effects.\r\n\r\n\r\nPsoriasis is a chronic autoimmune condition characterized by accelerated skin cell turnover, resulting in thick, scaly plaques commonly found on the elbows, knees, trunk, and scalp. The condition is often triggered by infections, stress, trauma, and medications, with lithium, beta-blockers, and antimalarial drugs being common medication triggers. According to NICE guidelines, first-line treatments for psoriasis include topical corticosteroids and vitamin D analogues. In more severe cases, systemic therapies such as methotrexate or biologics may be used. It's important to review and discontinue any medications that could be exacerbating or causing psoriasis, where possible.\r\n\r\nFor more information please watch OTC lesson chapter 8 (dermatology):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Ciclosporin",
        "answer_number": 1
      },
      {
        "text": "Lithium",
        "answer_number": 2
      },
      {
        "text": "Losartan",
        "answer_number": 3
      },
      {
        "text": "Clarythromicin",
        "answer_number": 4
      },
      {
        "text": "Sertraline",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 998,
    "bank": "clinicalOtc",
    "title": "**What is the estimated prevalence of the CYP2D6 mutation in the greek population?**",
    "text": "A patient has been recommended to buy migraleve for their migraine pain. On further questioning you find they are worried after they heard in the news that people may get opioid toxicity from the medication. She is Greek and states that she believes that this increases her risk of opioid toxicity. You explain that some people are ultra-metabolisers of one of the components, codeine, due to a mutation in an enzyme.\u00a0The SPmC for Migraleve has been provided for this question.\r\n\r\n[SPmC for Migraleve](https://www.medicines.org.uk/emc/product/1062/smpc#gref)",
    "why": "Information from resource pack: Estimates of prevalence of ultra-rapid metabolisers in different populations are summarized below:\r\n\r\n\r\nPopulation\r\nPrevalence %\r\nAfrican/Ethiopian\r\n29%\r\nAfrican American\r\n3.4% to 6.5%\r\nAsian\r\n1.2% to 2%\r\nCaucasian\r\n3.6% to 6.5%\r\nGreek\r\n6.0%\r\nHungarian\r\n1.9%\r\nNorthern European\r\n1%-2%",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "1.9%",
        "answer_number": 1
      },
      {
        "text": "6.0%",
        "answer_number": 2
      },
      {
        "text": "6.5%",
        "answer_number": 3
      },
      {
        "text": "18.5 %",
        "answer_number": 4
      },
      {
        "text": "29.0%",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2150,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Antidotes** \u2028\u2028\r\n\r\n**For each of the following statements, select the most appropriate drug from the list of options. Each option may be used once, more than once, or not at all.**",
    "text": "A 20-year-old woman who has overdosed on heroin and is found unconscious",
    "why": "Correct answer: \r\n\r\nF) Naloxone hydrochloride\r\n\r\nRationale:\r\n\r\nNaloxone hydrochloride is the first-line antidote for opioid overdose, including heroin. It is an opioid antagonist that rapidly reverses the effects of opioids such as respiratory depression, unconsciousness, and pinpoint pupils, by competitively binding to opioid receptors (primarily Mu receptors).\r\n\r\nIn emergency settings, naloxone is often administered intramuscularly or intranasally by paramedics or even by trained bystanders.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Acetylcysteine\r\n\r\nFor paracetamol overdose\r\n\r\nB) Deferoxamine mesilate \r\n\r\nFor iron overdose\r\n\r\nC) Dicobalt edetate \r\n\r\nFor cyanide poisoning\r\n\r\nD) Flumazenil \r\n\r\nFor benzodiazepine overdose\r\n\r\nE) Glucagon \r\n\r\nFor beta-blocker or calcium channel blocker overdose\r\n\r\nG) Phytomenadione \r\n\r\nFor warfarin overdose\r\n\r\nH) Sodium bicarbonate \r\n\r\nFor tricyclic antidepressant overdose or severe metabolic acidosis\r\n\r\nIn cases of suspected opioid overdose, especially with signs such as unresponsiveness and respiratory depression, Naloxone should be administered without delay. It is safe, effective, and life-saving.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 6,
    "weighting": 3,
    "answers": [
      {
        "text": "Acetylcysteine",
        "answer_number": 1
      },
      {
        "text": "Deferoxamine mesilate",
        "answer_number": 2
      },
      {
        "text": "Dicobalt edetate",
        "answer_number": 3
      },
      {
        "text": "Flumazenil",
        "answer_number": 4
      },
      {
        "text": "Glucagon",
        "answer_number": 5
      },
      {
        "text": "Naloxone hydrochloride",
        "answer_number": 6
      },
      {
        "text": "Phytomenadione",
        "answer_number": 7
      },
      {
        "text": "Sodium bicarbonate",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2264,
    "bank": "clinicalTherapeutics",
    "title": "**Which of the following is most likely to be a suitable oral dose?**",
    "text": "A 33-year-old with rheumatoid arthritis which is unresponsive to initial treatment options and it is decided to start her on methotrexate.",
    "why": "Correct Answer:\r\n\r\nB) 5 mg once weekly\r\n\r\nRationale (Based on NICE Guidelines 2025):\r\n\r\nMethotrexate is a cornerstone in the management of rheumatoid arthritis (RA). The National Institute for Health and Care Excellence (NICE) 2025 guidelines recommend initiating methotrexate at a weekly dose, typically starting at 7.5 mg once weekly, with the possibility of increasing the dose based on patient response and tolerability. \r\nThe dosing schedule is once weekly to balance efficacy and minimise potential adverse effects.\u200b\r\n\r\nExplanation of Other Options:\r\n\r\nA) 5 mg once daily\r\n\r\nDaily dosing of methotrexate is contraindicated due to a significantly increased risk of toxicity, including bone marrow suppression and hepatotoxicity.\u200b\r\n\r\n\r\nC) 7.5 mg on alternate days\r\n\r\nAlternate-day dosing is not recommended and does not align with methotrexate's pharmacokinetics or established treatment protocols.\u200b\r\n\r\nD) 10 mg fortnightly\r\n\r\nDosing every two weeks is inadequate for maintaining therapeutic drug levels and is not supported by clinical guidelines.\u200b\r\n\r\nE) 20 mg once a month\r\n\r\nMonthly dosing is ineffective for RA management and deviates from standard treatment recommendations.\u200b\r\n\r\nMethotrexate Dosing in Rheumatoid Arthritis:\r\n\r\n- Starting Dose: Initiate methotrexate at 7.5 mg once weekly, with the exact dose tailored to the individual patient's needs and tolerability.\u200b\r\n\r\n- Administration: The oral route is commonly used, but subcutaneous administration is an alternative, especially if gastrointestinal side effects occur.\u200b\r\n\r\n- Folic Acid Supplementation: To mitigate side effects, prescribe folic acid 5 mg once weekly, taken on a different day than methotrexate.\u200b\r\n\r\n- Monitoring: Regular monitoring of full blood count (FBC), liver function tests (LFTs), and renal function is essential to detect potential adverse effects.\u200b\r\n\r\nIt's crucial to educate patients on the once-weekly dosing schedule to prevent dosing errors, which can lead to serious toxicity. Clear communication and patient education are vital components of safe and effective methotrexate therapy.\u200b\r\n\r\nFor comprehensive guidance, refer to the NICE guidelines on the management of rheumatoid arthritis.\u200b\r\n\r\nMethotrexate is a cornerstone in the management of rheumatoid arthritis (RA), offering both efficacy in controlling disease activity and a well-established safety profile. Initiating treatment with an appropriate dosing regimen, as outlined by NICE guidelines, is crucial for optimising therapeutic outcomes and minimising potential adverse effects. Regular monitoring and patient education on the importance of adhering to the once-weekly dosing schedule are essential components of effective RA management.\r\n\r\nFor more information, please watch BNF lesson Chapter 10 (Musculoskeletal System):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "5 mg once daily",
        "answer_number": 1
      },
      {
        "text": "5 mg once weekly",
        "answer_number": 2
      },
      {
        "text": "7.5 mg alternate days",
        "answer_number": 3
      },
      {
        "text": "10 mg fortnightly",
        "answer_number": 4
      },
      {
        "text": "20 mg once a month",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 1001,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the most likely cause of the patient's symptoms?**",
    "text": "A 59 year old female patient presents to the pharmacy with a rash. She explains she has had symptoms for the past few weeks and has not seen any improvement. Her rash is on her elbows, knees and scalp.\r\nA picture of the rash has been shown below:\u00a0\r\n![psoriasis](https://i.ibb.co/qJc5tP9/psoriasis.jpg)",
    "why": "The signs and symptoms of psoriasis are the following:\r\nChronic Plaque Psoriasis: Can affect the scalp, trunk, buttocks, and extensor surfaces (e.g. elbows and knees)\r\nPlaques are distributed symmetrically\r\nCan be a single, few or a large number of lesions\r\nPlaques are pink with oval or irregular shape\r\nSilver and white scales present, can be a waxy yellow or orange/brown",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 4,
    "weighting": 3,
    "answers": [
      {
        "text": "Atopic eczema",
        "answer_number": 1
      },
      {
        "text": "Acne vulgaris",
        "answer_number": 2
      },
      {
        "text": "Pityriasis versicolor",
        "answer_number": 3
      },
      {
        "text": "Psoriasis",
        "answer_number": 4
      },
      {
        "text": "Rosacea",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2621,
    "bank": "clinicalOtc",
    "title": "**Which of the following is the LEAST appropriate advice for sleep hygiene?**",
    "text": "A 48 year old female presents to the pharmacy requesting advice because she has been suffering from insomnia. She informs you she prefers not to purchase sleep aid.",
    "why": "Maintaining a cool room temperature is generally recommended for better sleep hygiene. A very warm room can disrupt sleep and may not be conducive to a restful night's sleep.\r\n\r\nAccording to NICE guidelines, sleep hygiene recommendations aim to improve sleep by addressing lifestyle, environmental, and behavioural factors. Key elements include:\r\n\r\nRegular sleep schedule: Go to bed and wake up at the same time every day, even on weekends.\r\nSleep environment: Ensure the bedroom is quiet, dark, comfortable, and at a cool temperature. Use earplugs or blackout curtains if needed.\r\nAvoid stimulants: Limit caffeine, nicotine, and heavy meals, particularly in the evening.\r\nExercise: Engage in regular physical activity but avoid vigorous exercise close to bedtime.\r\nLimit alcohol: Reduce alcohol intake, as it can disrupt sleep later in the night.\r\nWind down: Establish a relaxing pre-sleep routine, such as reading or taking a bath, to signal the body that it's time to sleep.\r\nScreen time: Avoid screens (phones, tablets, TV) before bed, as blue light can interfere with melatonin production.\r\nUse bed for sleep: Avoid using the bed for activities like work, eating, or watching TV, to associate it solely with sleep.\r\nThese strategies can help improve sleep patterns and reduce the likelihood of insomnia.\r\n\r\nFor more information watch the OTC lesson on  Chapter 4 Neurology (Insomnia):\r\n\r\nhttps://preregshortcuts.com/courses/over-the-counter-medicines-course-otc",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 5,
    "weighting": 3,
    "answers": [
      {
        "text": "Avoid sleeping in to catch up on sleep",
        "answer_number": 1
      },
      {
        "text": "Avoid exercise within 4 hours before bed",
        "answer_number": 2
      },
      {
        "text": "Avoid day time naps",
        "answer_number": 3
      },
      {
        "text": "Avoid alcohol within 6 hours before bed",
        "answer_number": 4
      },
      {
        "text": "Sleep in a very warm room",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 996,
    "bank": "clinicalOtc",
    "title": "**Which of the following would be the most suitable treatment?**",
    "text": "A 26 year old male hairdresser presents to the pharmacy. For the last week he has noticed his thumb getting quite dry and itchy. He has tried using hand cream but there has not been much improvement. He informs he suffered from eczema as a child but since then he hasn\u2019t had many flare ups. He thinks it may be related to the substances he uses at work and would like something strong to treat it.",
    "why": "The symptoms described, such as dry and itchy skin on the thumb, suggest that the man may be experiencing a flare-up of his childhood eczema, possibly triggered by exposure to substances at work. A steroid cream can help to reduce inflammation and itching, while an emollient can help to moisturise and protect the skin. The other options, such as continuing to use hand cream, taking a non-sedating antihistamine, taking time off work, or seeing a specialist, may not be as effective at treating the man\u2019s symptoms.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Advise Dally to carry on using his hand cream",
        "answer_number": 1
      },
      {
        "text": "Offer Dally a steroid cream and an emollient",
        "answer_number": 2
      },
      {
        "text": "Recommend a non-sedating antihistamine",
        "answer_number": 3
      },
      {
        "text": "Take a week off work to allow the skin to recover",
        "answer_number": 4
      },
      {
        "text": "Refer Dally to his GP as he will need to see a specialist",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 878,
    "bank": "clinicalMep",
    "title": "**Which ONE of the following is NOT a legal requirement for a veterinary prescription to be valid?**",
    "text": "There are prescription requirements for POM-V, POM-VPS products for veterinary medicine, including those to be prescribed under the cascade.",
    "why": "Under the Veterinary Medicines Regulations 2013 as amended, you need name and address of the owner as a legal requirement, not the date of birth. All other options are legal requirements.",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Any necessary warning and if relevant the withdrawal period",
        "answer_number": 1
      },
      {
        "text": "Date of birth of the owner",
        "answer_number": 2
      },
      {
        "text": "Date of the prescription",
        "answer_number": 3
      },
      {
        "text": "Quantity of the medicine prescribed",
        "answer_number": 4
      },
      {
        "text": "Signature of the prescriber",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2236,
    "bank": "clinicalTherapeutics",
    "title": "**Theme: Electrolyte imbalances**\r\n\r\n\r\n\r\n**Instruction: For each of the following patients, select the most likely electrolyte imbalances they are experiencing from the list of options. Each option may be used once, more than once, or not at all**",
    "text": "Mrs F presents to hospital in a confused and lethargic state and biochemical parameters suggest an electrolyte disturbance. As the ward pharmacist, you conduct a drug history. You note she has been on carbamazepine 200mg twice daily for the past year. Upon speaking to her, she tells you it is for her nerve pain and that she also takes co-codamol 30/500mg tablets and gabapentin 300mg capsules.",
    "why": "Correct Answer:\r\n\r\nG) Hyponatraemia\r\n\r\nRationale:\r\n\r\nHyponatraemia (low serum sodium) is a well-recognised adverse effect of carbamazepine, particularly in elderly patients or those taking the drug long-term. It can cause:\r\n\r\n- Confusion\r\n\r\n- Lethargy\r\n\r\n- Headache\r\n\r\nIn severe cases: seizures or coma\r\n\r\nCarbamazepine can lead to syndrome of inappropriate antidiuretic hormone secretion (SIADH), causing the kidneys to retain free water and dilute sodium levels.\r\n\r\nMrs F\u2019s confusion and lethargy, combined with her long-term use of carbamazepine, strongly suggest drug-induced hyponatraemia.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Hypercalcaemia \r\n\r\nUsually presents with thirst, abdominal pain, and bone pain. No drug link here.\r\n\r\nB) Hyperkalaemia \r\n\r\nWould present with cardiac rhythm changes and muscle weakness. No risk with her current meds.\r\n\r\nC) Hypernatraemia \r\n\r\nPresents with confusion, but caused by dehydration, not SIADH.\r\n\r\nD) Hypocalcaemia \r\n\r\nAssociated with tingling, muscle cramps, not commonly caused by carbamazepine.\r\n\r\nE) Hypokalaemia \r\n\r\nCauses arrhythmias, weakness; not expected with her medicines.\r\n\r\nF) Hypomagnesaemia \r\n\r\nMay cause neuromuscular symptoms but not the most likely here.\r\n\r\nH) Hypophosphataemia \r\n\r\nCauses bone pain, weakness; unrelated to her current medication history.\r\n\r\nDrug-Induced Hyponatraemia and Carbamazepine:\r\n\r\n- Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is often linked to drugs that stimulate inappropriate ADH secretion, such as carbamazepine. \r\n\r\n- NICE advises clinicians to monitor sodium levels in patients on such medications, especially when symptoms such as confusion, drowsiness, or seizures are present. \r\n\r\n- Carbamazepine induces SIADH, leading to water retention and dilutional hyponatraemia, particularly in elderly patients or those with co-morbidities. In such cases, the offending agent should be reviewed, and fluid restriction or sodium correction considered based on severity. Ongoing patient education and routine biochemical monitoring can prevent this complication from becoming life-threatening.\r\n\r\n\r\nFor more information please watch BNFChapter 4 (Central Nervous System) :\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 7,
    "weighting": 3,
    "answers": [
      {
        "text": "Hypercalcaemia",
        "answer_number": 1
      },
      {
        "text": "Hyperkalaemia",
        "answer_number": 2
      },
      {
        "text": "Hypernatraemia",
        "answer_number": 3
      },
      {
        "text": "Hypocalcaemia",
        "answer_number": 4
      },
      {
        "text": "Hypokalaemia",
        "answer_number": 5
      },
      {
        "text": "Hypomagnesaemia",
        "answer_number": 6
      },
      {
        "text": "Hyponatraemia",
        "answer_number": 7
      },
      {
        "text": "Hypophosphataemia",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2512,
    "bank": "clinicalMep",
    "title": "**Which of the following is NOT required to label broken bulk?**",
    "text": "Bulk containers of medicine can be broken down into smaller quantities suitable for dispensing",
    "why": "B) Drug interactions\r\n\r\nRationale:\r\n\r\nThis answer is not required for the labelling of broken bulk medicine. While drug interactions are important information for pharmacists to consider, they are not a legal requirement to be included on the label of broken bulk medicines. The legal labelling requirements for broken bulk medicines focus on information directly related to the medicine's identity, safety, and handling, rather than its interactions with other drugs.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Batch reference number \u2013 This is required for broken bulk labelling. The batch number ensures traceability in case of a recall or quality control issues and is part of the legal requirements for labelling.\r\n\r\nC) Expiry date \u2013 This is required for broken bulk labelling. The expiry date ensures that the medicine is used before it becomes ineffective or potentially unsafe.\r\n\r\nD) Name of medicine \u2013 This is required for broken bulk labelling. The name of the medicine is essential for identifying the product, ensuring that it is dispensed and used correctly.\r\n\r\nE) Quantity of medicines \u2013 This is required for broken bulk labelling. The quantity of medicine being dispensed (e.g., number of tablets or volume) must be clearly stated to ensure proper dosing and to comply with labelling regulations.\r\n\r\nUnder UK law, when breaking down bulk containers of medicines into smaller quantities suitable for dispensing, certain label requirements must be followed to ensure the safe and effective use of the medicine. The label must include the name of the medicine, the quantity, the expiry date, the batch reference number, and any relevant handling and storage requirements. Drug interactions are important for clinical consideration but do not need to be included on the label of the broken bulk container. These labelling regulations help ensure that medicines are correctly identified, stored, and used, and that there is traceability in case of any issues with the product.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Batch reference number",
        "answer_number": 1
      },
      {
        "text": "Drug interactions",
        "answer_number": 2
      },
      {
        "text": "Expiry date",
        "answer_number": 3
      },
      {
        "text": "Name of medicine",
        "answer_number": 4
      },
      {
        "text": "Quantity of medicines",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 887,
    "bank": "clinicalOtc",
    "title": "A 32-year old woman with sores inside her mouth (white centre, red inflamed outer edge)",
    "text": "**Theme: Dermatology Conditions**\u2028\u2028\r\n\r\n**For the patient described, please select the most suitable condition. Each option may be used once, more than once or not at all**",
    "why": "The most suitable condition for the patient described is mouth ulcers. Mouth ulcers are painful sores that appear inside the mouth, often on the inside of the cheeks . They are usually round or oval with a white or yellow center and a red border . Mouth ulcers can be caused by a variety of factors, including stress, injury, hormonal changes, or certain medications",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 6,
    "weighting": 3,
    "answers": [
      {
        "text": "Acne Vulgaris",
        "answer_number": 1
      },
      {
        "text": "Contact Dermatitis",
        "answer_number": 2
      },
      {
        "text": "Cold Sore",
        "answer_number": 3
      },
      {
        "text": "Eczema",
        "answer_number": 4
      },
      {
        "text": "Impetigo",
        "answer_number": 5
      },
      {
        "text": "Mouth ulcers",
        "answer_number": 6
      },
      {
        "text": "Oral Thrush",
        "answer_number": 7
      },
      {
        "text": "Psoriasis",
        "answer_number": 8
      }
    ],
    "is_free": false
  },
  {
    "id": 2558,
    "bank": "clinicalOtc",
    "title": "**Which of the following medications is most likely to cause a sore throat and require referral?**",
    "text": "A 42 year old male is complaining of a sore throat, he has recently started on a new medication and has been taking it for two weeks. He has tried sore throat lozenges which he bought at his local supermarket but there has been no improvement.",
    "why": "a) Carbimazole\r\n\r\nRationale:\r\n\r\nCarbimazole is an antithyroid medication used to treat hyperthyroidism. One of its potential side effects is the development of a sore throat, which can occur due to agranulocytosis (a decrease in white blood cells). This condition increases the risk of infections, including throat infections, making it crucial to refer the patient for further evaluation. Given that the patient has been taking this medication for two weeks and has experienced persistent sore throat symptoms despite using over-the-counter lozenges, it is essential to assess for possible complications associated with carbimazole.\r\n\r\nExplanation of Other Options:\r\n\r\nb) Lithium: While lithium can cause various side effects, sore throat is not a common one. Patients on lithium should be monitored for thyroid function, but a sore throat is not typically indicative of a serious adverse effect.\r\nc) Morphine: Morphine can cause dry mouth and throat irritation, but it is less likely to directly cause a sore throat compared to carbimazole. Morphine's side effects generally do not necessitate immediate referral for a sore throat.\r\nd) Ramipril: This ACE inhibitor can lead to a dry cough, which might contribute to throat irritation, but it is not directly associated with causing a sore throat requiring referral.\r\ne) Warfarin: Warfarin is an anticoagulant that can cause bleeding complications but is not commonly associated with a sore throat.\r\n\r\n\r\nAccording to NICE guidelines, patients presenting with a sore throat that persists despite symptomatic treatment should be evaluated, particularly if they are on medications known to affect blood cell counts, such as carbimazole. Referral to a healthcare professional is necessary to assess for possible agranulocytosis and to perform a full blood count if indicated. Prompt recognition of side effects from medications can prevent serious complications and ensure appropriate management. Additionally, educating patients about potential side effects and the importance of monitoring for symptoms during new medication initiation is crucial for safe pharmaceutical care.\r\n\r\nFor more information please watch BNF lesson chapter 2 (Respiratory):\r\n\r\nhttps://preregshortcuts.com/courses/bnf-course",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 1,
    "weighting": 3,
    "answers": [
      {
        "text": "Carbimazole",
        "answer_number": 1
      },
      {
        "text": "Lithium",
        "answer_number": 2
      },
      {
        "text": "Morphine",
        "answer_number": 3
      },
      {
        "text": "Ramipril",
        "answer_number": 4
      },
      {
        "text": "Warfarin",
        "answer_number": 5
      }
    ],
    "is_free": false
  },
  {
    "id": 2516,
    "bank": "clinicalMep",
    "title": "**Which of the following is INCORRECT relating to emergency supplies at the request of the prescriber?**",
    "text": "Regulation 224 of the human medicines regulations 2012 enables emergencies supplies on the request of a prescriber",
    "why": "B) Maximum of 30 days supply of medication\r\n\r\nRationale:\r\n\r\nThis statement is incorrect. The maximum supply of medication for an emergency supply at the request of a prescriber does not have a set limit of 30 days. Unlike emergency supplies requested by a patient, which are limited to a maximum of 30 days, emergency supplies requested by a prescriber are not subject to such a restriction. The amount of medication supplied is determined based on the clinical need and the prescriber\u2019s directions.\r\n\r\nExplanation of Other Options:\r\n\r\nA) Entry must be made in the POM register \u2013 This is a correct requirement. When an emergency supply is made, an entry must be recorded in the Prescription-Only Medicines (POM) register, which ensures proper tracking and documentation of the supply in compliance with regulatory standards.\r\n\r\nC) Medicine is supplied in accordance to prescriber directions \u2013 This is accurate. The medicine supplied under an emergency supply request from a prescriber must be given in accordance with the directions provided by the prescriber, ensuring the treatment aligns with the intended clinical management.\r\n\r\nD) Prescription must be provided within 72 hours \u2013 This is a correct condition. For an emergency supply at the request of a prescriber, the patient must obtain a full prescription within 72 hours. This ensures that the emergency supply is only a temporary solution until the proper prescription is issued.\r\n\r\nE) Schedule 2 Controlled drugs cannot be supplied \u2013 This is accurate. Schedule 2 controlled drugs cannot be supplied as an emergency supply under Regulation 224. These medications are subject to strict controls, and their supply must be managed according to additional regulations that prevent emergency provision.\r\n\r\nRegulation 224 of the Human Medicines Regulations 2012 outlines the provisions for emergency supplies made at the request of a prescriber. This regulation allows pharmacists to provide an emergency supply of medication to patients when a prescriber requests it, provided that specific conditions are met.\r\n\r\nThe key requirements include that the supply must be recorded in the POM register, and the medicine must be dispensed according to the prescriber\u2019s instructions. For Schedule 2 controlled drugs, emergency supplies cannot be made, ensuring strict control over these substances. Additionally, the patient must obtain a prescription within 72 hours of receiving the emergency supply.\r\n\r\nImportantly, unlike patient-requested emergency supplies, which are limited to a 30-day supply, there is no maximum supply period for emergency supplies requested by a prescriber. This distinction helps ensure that patients receive the necessary amount of medication based on their individual needs, as determined by the prescriber, while also maintaining compliance with legal and regulatory frameworks designed to ensure patient safety.\r\n\r\nFor more information watch MEP lesson chapter 3 (Underpinning knowledge: legislation and professional issues)\r\n\r\nhttps://preregshortcuts.com/courses/medicines-ethics-practice-course-mep",
    "resource_image": null,
    "visible": true,
    "is_calculation": false,
    "correct_answer": null,
    "answer_unit": null,
    "correct_answer_number": 2,
    "weighting": 3,
    "answers": [
      {
        "text": "Entry must be made in the POM register",
        "answer_number": 1
      },
      {
        "text": "Maximum of 30 days supply of medication",
        "answer_number": 2
      },
      {
        "text": "Medicine is supplied in accordance to prescriber directions",
        "answer_number": 3
      },
      {
        "text": "Prescription must be provided within 72 hours",
        "answer_number": 4
      },
      {
        "text": "Schedule 2 Controlled drugs cannot be supplied",
        "answer_number": 5
      }
    ],
    "is_free": false
  }
];
